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Abstract 
Organ morphogenesis relies on dynamic cell behaviors, which are highly coordinated to 
ensure a functional cellular organ architecture. During vascular morphogenesis, the 
process of angiogenesis is driven by cell migration, cell shape changes and cell 
rearrangements. Here, a dynamic balance between inter-endothelial cell adhesion and 
plasticity allows angiogenic sprouting while maintaining the endothelial seal.  
Previous analyses on blood vessel formation and anastomosis in zebrafish have shown that 
junctional remodeling is central to many aspects of morphogenetic endothelial cell-cell 
interactions. In particular, the adhesion molecule VE-cadherin (Cdh5) is essential for 
coordinated cell shape changes during multicellular tube formation, as loss of VE-cadherin 
was shown to inhibit cell rearrangements (Sauteur et al., 2014). This study also proposed 
an active, force generating function for VE-cadherin in this process. This hypothesis is 
supported by our study showing that cell elongation is mediated by junction-based 
lamellipodia (JBL), which are thought to provide a tractile force for junction elongation 
(Paatero et al., 2018).  
 
In my thesis, my goal was to further analyze the molecular mechanisms which underly JBL 
function. In particular I focused on molecular players that influence F-actin dynamics or 
contractility (Arp2/3, Rac1 and ROCK) in order to identify critical players in the process of 
the cell elongation movement. Furthermore, I elucidated, how JBL might generate motile 
forces and how these forces are transmitted onto endothelial cell junctions (e.g. VE-
cadherin) 
 
In the course of my experiments I identified the actomyosin contractility as an important 
basis for junctional ring elongation. Inhibition of ROCK did interfere with the correct 
localization of junctional protein ZO1 as it is abrogated formation of double junctions- a 
hallmark during JBL oscillations and an indispensable step to since it leads to the formation 
of a new attachment site. Furthermore, I found that the establishment of differential VE-
cadherin tension is also ROCK-dependent, which might provide the basis for junctional 
remodeling. Junctional rearrangements were not only impaired after inhibition of ROCK. 
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Also, interference with the F-actin dynamics significantly altered junctional ring elongation. 
Arp2/3 (and concomitant formation of branched F-actin networks) is necessary for 
maintaining junctional stability and responsible for the correct localization of F-actin during 
the process, whereas Rac1 mostly seem to play a role in the induction phase of the JBL. 
Last but not least I generated two new transgenic fish lines (fli:iRFP-UCHD and 
kdrl:mCherry-PA-Rac1), which will open up a whole lot of new possibilities for future 
experiments. Making use of the photoactivatable Rac1 will give manifold new insights into 
processes during vascular morphogenesis, which underly Rac1 activity (sprouting, 
anastomosis, etc.).  
 
In summary JBL function and subsequent endothelial cell rearrangements rely on a tight 
interplay between generation and maintenance of a dynamic F-actin cytoskeleton and 
regulation of junctional proteins. The F-actin cytoskeleton furthermore provide a basis for 
local force generation, which is reflected in differential VE-cadherin tension and thus exert 
mechanical forces, which in turn are a major driver of the process of junctional ring 
elongation. Last but not least my experiments suggest, that JBL formation and local 
protrusion formation might be a general mechanism of endothelial cells to induce cell 
movements and cell shape changes (e.g. in the dorsa aorta). 
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1. Introduction 
 
1.1. Biological tubes in multicellular organisms  
Tubular systems exist in all multicellular organisms throughout the animal kingdom and 
represent the fundamental structural architecture of several organs including the intestine, 
the kidney, the lung and the cardiovascular system. Tubes serve different functions in an 
organism such as transport and absorption of gases, nutrients, waste and hormones within 
or between organs. Furthermore, they are crucial for providing a barrier and necessary for 
the compartmentalization of organ functions. Tube architecture is very much determined 
by organ function and tailored to serve organ-specific processes. The architectural features 
are multi-variant and come along with the organization of cells and processes that lead to 
the formation of tubes. Despite the great variety, there are basic structures that are 
commonly shared or processes of tube formation that can be used for classification of 
tubes. They have been already extensively reviewed for epithelial tubes (Andrew and 
Ewald, 2010; Baer et al., 2009; Lubarsky and Krasnow, 2003)  and for blood and lymphatic 
vessels, which are made up by endothelial cells (Carmeliet, 2000; Ellertsdóttir et al., 2010). 
Here, briefly two aspects will be described in more detail for epithelial tubes: cellular 
architecture of biological tubes (see 1.1.1.) and lumen formation in tubular systems (1.1.2).  
 
1.1.1. Cellular architecture of biological tubes  
Tubes are always made up of polarized cells that surround a central luminal space. Cells are 
either endothelial (for the vasculature) or epithelial cells (for all other organs), with the 
apical site pointing towards the lumen and the basal side facing other tissues or the 
basement membrane. Depending on their cellular architecture, tubes can be classified into 
different types (reviewed among others in Baer et al., 2009; Lubarsky and Krasnow, 2003): 
multicellular, auto-cellular and intracellular (or seamless) tubes, whereas the latter two 
both are representative of a unicellular tube architecture (Figure 1). In multicellular tubes, 
several cells form the tube as observed in a cross section. This type of tube is most 
commonly found in mature tubular organs of vertebrates.  
Introduction 
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In unicellular tubes only one cell is wrapped around the lumen (one cell in a cross section 
visible) and forms an auto cellular junction (also referred to as a self-contact). Such simple 
tubes have been among others described in the Caenorhabditis elegans (C. elegans) 
intestine, the drosophila tracheal system and have also been reported to be present in the 
vertebrate vasculature. Sealing of tubes without the formation of adherens junctions can 
be observed in seamless tubes (also referred to as transcellular tube). Here, the lumen is 
confined within a single cell, which was described among others for tubes in the digestive 
tract of C. elegans or fusion and terminal tracheal cells in drosophila.  
 
Figure 1: Architecture of epithelial tubes. Based on their cellular architecture, three distinct types 
of tubes can be distinguished: In a multicellular tube (A), several cells make up the cross section of 
a tube (here four are depicted with respective cell junctions), whereas in a unicellular tube, the 
luminal surface is formed by a single cell (B).  A unicellular tube, that has an established lumen 
within a single cell is called seamless tube (C).  
The architectural diversity of biological tubes implicates different physical and cellular 
constraints for each type and indicates that the morphogenetic processes that underlying 
their formation might be manifold. Indeed, five different principles of tube formation can 
be discerned and each process gives rise to a specific type of tube.  
 
1.1.2. Lumen formation in tubes 
Generally, tubes can form from an already polarized epithelium (wrapping or budding) or 
from an unpolarized epithelium (cord hollowing, cell hollowing or cavitation).  During the 
process of wrapping a flat sheet of epithelial cells as a portion of the whole tissue rolls up 
until the edges meet and seal, forming a tubular structure. The final tube runs parallel to 
the plane of the epithelium. This process has been reported during neural tube formation 
in vertebrates (Colas and Schoenwolf, 2001).  
A B C 
autocellular junctioncell junction
nucleus
basal surface
apical surface
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During budding, branches are formed from already existing tubes, thereby enlarging an 
existing tubular network. Here, a group of cells migrate out and the epithelial sheet 
consecutively invaginates and forms a new branch. The new branch extends away from the 
epithelial plane and the lumen is a direct extension of the parental branch lumen. This 
process has been studied extensively in different systems (e.g. lung or kidney development, 
drosophila salivary gland or tracheal development), as it provides the most common used 
strategy to increase the complexity of tubular organs. The mechanism of cavitation has 
been reported in the context of the development of the mammalian salivary gland or the 
formation of the pro-amniotic cavity (Coucouvanis and Martin, 1995; Melnick and Jaskoll, 
2000). Here, the cells in the center of a thick cylindrical mass of cells are eliminated, thereby 
generating a hollow tube.  
 
 
 
Figure 2: Morphological processes of tube formation. Distinct modes of tube formation give rise 
to different types of tubes. During wrapping, a part of the epithelial sheet invaginates. The edges 
roll up until they meet and seal the tube. In budding, a group of cells migrate out from an already 
existing tube, extending a new branch. Cavitation describes the process, in which cells in the center 
of a solid cylindrical cell mass are eliminated. In cord hollowing, a de novo lumen is formed by 
formation of an open space. Remodeling of the apical cells lead to a lumenized tube. In cell 
hollowing, the lumen is formed within the cytoplasm of a single cell, spanning its entire length. 
Image taken from Lubarsky and Krasnow, 2003 (with permission). 
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Another process of lumen formation whereby a space is created within a solid cylindrical 
cord of cells is chord hollowing.  In this case, the lumen is subsequently formed by an open 
space, which is created between the remodeling cells that point towards the future lumen. 
In contrast, cell hollowing is very different from the processes describes so far. Instead of 
a group of cells, only a single cell is involved and the lumen is formed within single cells, 
thereby resulting in a seamless tube. For instance, this mechanism of tube formation has 
been described in terminal tracheal cells and has been hypothesized to occur in vascular 
capillaries (Wolff and Bär, 1972). 
On overview of the described processes is provided in Figure 2. The descriptions were 
based on information published in excellent reviews (Andrew and Ewald, 2010; Baer et al., 
2009; Lubarsky and Krasnow, 2003).  
Although a lot of general knowledge of common principles has already been collected, 
major questions have to be answered individually in the context of the particular organ/ 
process one is interested in. What molecules mediate certain cell behaviors? Can we 
describe cellular and molecular mechanisms or principles that are crucial for all the 
different processes of tube formation? In order to answer these questions different model 
systems each having their strengths and limitations are available and have to be chosen 
carefully. For my thesis, I have employed embryonic zebrafish and chose to study 
endothelial tube morphogenesis during development. In the following, I will specifically 
(and somewhat complementary to section 1.1.2) describe the processes of lumen 
formation in the zebrafish vasculature in detail. Following up, I will highlight advantages of 
the zebrafish as a model organism (1.2.) as well as highlight and explain cellular behaviors 
that are important for vascular morphogenesis and tube formation.   
1.1.2.1. Mechanisms of vascular lumen formation in the zebrafish  
Proper function of the cardiovascular system relies on the lumenization of blood vessels. 
Several mechanisms have been suggested, including cord hollowing, budding, lumen 
ensheathment and cell hollowing, each of them being specific or predominant during 
certain processes such as sprout formation or anastomosis. Some of these processes have 
been already described in 1.1.2, but will be further elaborated on in the context of the 
zebrafish vascular network.  
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Cord hollowing 
The best analyzed model for cord hollowing in zebrafish and mice is represented by the 
dorsal aorta, the first axial vessel to form (Jin et al., 2005). The endothelial cells are 
assembled in a vascular chord, which subsequently polarize and forme an apical membrane 
(by the deposition of sialomucins). This is followed by cell shape changes (from round to 
elongated) and cell rearrangements, which allow for the formation of a potent lumen 
within elongated endothelial cells (Strilić et al., 2010, 2009). Besides the dorsal aorta, a cord 
hollowing process has also been described in the dorsal longitudinal anastomotic vessel 
(DLAV) (Herwig et al., 2011) (compare Figure 3).  
 
Figure 3: Cord hollowing mechanism forming a multicellular tube. Two junctional rings (encircling 
a local lumen between two apical membrane compartments) are brought together by cell 
rearrangements. A new junction is formed (orange) and the middle cell (purple) detaches at the 
new contact site. Eventually, the two luminal compartments merge into one. Figure taken from 
Herwig et al., 2011 (with permission). 
During the process of anastomosis, lumen formation commences with the establishment 
of several luminal pockets (local lumens), which are contained within junctional rings. Here, 
at least three adjacent cells contribute to this process, generating two junctional rigs at 
their respective contact sites. These junctional rings (driven by cell rearrangements) 
converge towards each other, until a novel contact can be established between the two 
outer cells. This new junctional contact is subsequently enlarged, followed by the 
detachment of the medial cell.  
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Thereby, the local lumens coalesce, resulting in a fully lumenized vessel of multicellular 
architecture. It is important to mention, that this process happens independent of blood 
pressure. Another mechanism that was described in the context of the DLAV and was 
determined to be the more frequent (in around 63 % of investigated cases) is described in 
the section of cell hollowing.  
Budding 
Budding can be observed during angiogenic sprouting, when a sprout grows out from a 
vessel with continuous lumen. Simultaneously, the blood pressure drives the expansion of 
the lumen into the sprout or even into the tip cell (Baer et al., 2009; Lenard et al., 2013). 
This process occurs predominantly in larger caliber vessels and was suggested to occur in 
the zebrafish cranial vasculature, as determined by time lapse in vivo recording (Huisken 
and Stainier, 2009) 
Lumen ensheathment 
Lumen ensheathment is a rather newly discovered process and was described to be the 
underlying principle of lumen formation in the zebrafish common cardinal vein (CCV) 
(Helker et al., 2013). The CCV is initially an open-ended tube, collecting all the blood in 
order to transport it back towards the heart. With the initiation of heart beat and blood 
flow, endothelial cells start to migrate, subsequently engulfing the lumen as they fold 
around the blood stream.   
Cell hollowing (vacuole fusion and membrane invagination) 
As mentioned in 1.1.2, cell hollowing describes the process, in which a lumen is formed 
within one single cell, ultimately leading to a unicellular architecture. This mechanism was 
shown to be prevalent in the intersegmental vessels (ISVs) and the DLAV of zebrafish 
embryos. Different mechanisms were proposed to occur in terms of ontogenesis of the 
intracellular lumen. In what way they have a joint or independent appearance remains 
elusive. One of the processes is vacuole fusion, which was investigated in Kamei et al., 2006. 
The results they obtained from high-resolution time-lapse two-photon imaging supported 
a model, in which inter and intracellular fusion of endothelial vacuoles are the driving 
mechanism of vascular lumen formation; intracellular vacuoles first fuse within stalk cells 
and then with the plasma membrane to generate an interconnected lumen.  
Introduction 
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This view was challenged more recently in a study conducted by Gebala et al., 2016. They 
report a process they term inverse blebbing, in which spherical deformations of the apical 
membrane appear during lumen expansion. These inverse blebs appear in response to high 
hemodynamic forces (blood pressure), inducing deformations in endothelial cells that 
ultimately lead to a unidirectional expansion of the lumen. A rather similar mechanism of 
forming a consecutive intracellular lumen that is based on membrane deformations 
(membrane invaginations, respectively) and is highly dependent on blood pressure was 
observed in the DLAV during the anastomosis process (Herwig et al., 2011) (Figure 4). Here, 
apical membrane invaginating into tip cells of already lumenized angiogenic sprouts (which 
are thus connected to the circulation) fuse with their second apical membrane that was 
previously established at the contact site with the neighboring cell. Under the effect of 
blood pressure, the cell membrane will push through and into the next, non-lumenized 
endothelial cell. This directional membrane invagination process is therefore based on the 
invagination and extension of a transcellular lumen and ultimately gives rise to a unicellular 
(or seamless) tube. In comparison to the lumen formation process during anastomosis in 
the DLAV described earlier (compare Figure 3), the cells exhibit less migratory behavior and 
the formation of lumen does not depend of cell rearrangements, neither on blood flow.  
 
Figure 4: Formation of a unicellular, seamless tube by membrane invagination. The apical 
membrane of the green cell invaginates and fuses with its own apical membrane at the cell interface 
site. Driven by blood pressure, the lumen expands through the neighboring cell as the invagination 
continues (in the purple cell). Figure taken from Herwig et al., 2011 (with permission). 
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1.2. The zebrafish as model to study vascular morphogenesis 
The zebrafish (Danio rerio) is a small tropical freshwater species, native to the region of 
India and Southeast Asia. The life span of an adult zebrafish is between two to three years, 
and they reach maturity at an approximate age of 3 months. One pair of zebrafish is capable 
to produce a large amount of offspring (around 200 eggs/week) (Hill et al., 2005). Embryos 
develop ex-uterine and show a rapid development. The first cell division is completed 
within 45 minutes after fertilization, and the following cell divisions occur within shorter 
periods of time. Zebrafish development is already well characterized (Kimmel et al., 1995). 
In recent years, the zebrafish has become a very powerful model organism in laboratory 
research due to several attributes. Besides the ex utero development, zebrafish embryos 
are transparent, which facilitates not only staging but also enables easy monitoring of 
different processes during development (Dooley and Zon, 2000; Lessman, 2011). One of 
these processes that can be easily investigated is the formation of complex vascular 
networks. Vascular development starts very early in the embryo and by 24 hours post 
fertilization (hpf), the first heart beats can be observed and blood circulation starts shortly 
thereafter (Kimmel et al., 1995). In terms of cardiovascular research, many different 
transgenic marker lines are available. This allows for live imaging of different processes of 
vascular development due to the exceptional optical clarity of the embryo. Furthermore, a 
considerable variety of genetic tools have been developed, which make functional analysis 
possible (e.g. CRISPR/Cas9, (Cong et al., 2013; Hwang et al., 2013)). Additionally, 
pharmacological studies (e.g. inhibitor treatments) can be performed easily and also enable 
large-scale drug screenings (Parng et al., 2002). Last but not least, zebrafish embryos are 
able to survive without a fully developed blood circulation until larval stages. Hence, 
cardiovascular defects that would lead to premature death in other model organism such 
as in mice, can be studied and characterized (Glickman and Yelon, 2002). In summary, all 
the mentioned aspects make the zebrafish an outstanding model to study vascular 
development. Even though there is a huge difference in the overall vascular anatomy 
between species, most molecular and cellular processes were described to be very similar 
between the zebrafish and other vertebrates (also mammals) (Howe et al., 2013).  
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Additionally, the branching program in the zebrafish vasculature is rather simple and is 
driven by only a few cells in comparison to other branched systems. As sprouting and 
anastomosis do not rely on a collective behavior of a larger group of cells, it makes it fairly 
easier to investigate and understand single-cell behaviors better (Kotini et al., 2019). 
 
1.3. Blood vessel formation in the zebrafish: angiogenesis and 
vasculogenesis 
During vascular tube formation, two distinct morphogenetic processes can be described: 
vasculogenesis and angiogenesis. Vasculogenesis describes the de novo formation of blood 
vessels via the assembly of angioblasts in a guided manner (Poole and Coffin, 1989). 
Angioblasts are mesoderm-derived precursors of endothelial cells (Kimmel et al., 1995). 
The first vessel with arterial cell fate that is built via vasculogenesis in the zebrafish is the 
dorsal aorta (DA) at around 13 hpf, followed by the posterior cardinal vein (PCV) via ventral 
sprouting at around 20 hpf (Isogai et al., 2001). Together, they establish a primitive vascular 
network in early steps of network formation. In order to meet the changing needs of the 
growing embryo and to adapt to environmental cues, the network grows in size and 
complexity. Further ramification of the vascular network, however, mostly results from a 
process called angiogenesis.  
During sprouting angiogenesis, secondary (new) blood vessels are formed from preexisting 
vessels. Sprouting is very dynamic and needed for constant adaptation during physiological 
(e.g. growth, wound healing) but also pathological (tumor vascularization) conditions. The 
intersegmental vessels in the zebrafish embryo are the first ones to be formed by 
angiogenesis and emerge from the dorsal aorta at around 22 hpf onwards (Isogai et al., 
2003). In the meantime, there are two different mechanisms described, termed sprouting 
angiogenesis and intussusception (Makanya et al., 2009). As initially described and 
extensively studied in Patan, 2000, three different major events happen sequentially: 
selection of a tip cell and initial sprout formation, followed by the extension and final 
interconnection of sprouts to form a fully functional network upon lumen formation. An 
overview of the fully established zebrafish vasculature is depicted in Figure 5. 
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Figure 5: The vascular system in the zebrafish embryos. The zebrafish vasculature of a 72 hpf old 
embryo expressing Tg(kdrl:EGFP) in green and using microangiography (red quantum dots). PHS: 
primary head sinus, AA: aortic arches, CCV: common cardinal vein, PCV: posterior cardinal vein, DA: 
dorsal aorta, DLAV: dorsal longitudinal anastomotic vessel, SV: segmental vein, SA: segmental 
artery, CV: caudal vein. Adapted from Ellertsdóttir et al., 2010 (with permission).  
Angiogenesis is accompanied by a lot of different cellular behaviors, that will be briefly 
described in the next paragraph. Hereby, I will exclusively focus on the cellular processes 
rather than on molecular pathways, that were considered to occur in the zebrafish 
vasculature.  
1.3.1. Morphogenetic processes during angiogenesis  
Vascular networks are formed by a variety of morphogenetic processes such as cell 
migration, anastomosis, membrane invagination, cell rearrangements or cell division. 
Some of the mentioned behaviours (like membrane invagination) were already mentioned 
or discussed in a previous paragraph, therefore I will elucidate only on some of them in 
greater detail.   
 
1.3.1.1. Cell migration  
Cell migration mainly occurs during vascular sprout formation, when ISVs arise from the 
dorsal aorta and grow dorsally. The sprout is guided by an endothelial tip cell at the front, 
which is connected to trailing stalk cells (Siekmann et al., 2008).  
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Tip cells are highly migratory leader cells, that scan the environment for information with 
long filopodial extensions. High migratory capacity is reflected in the activity of different 
pathways; tip cells have higher activity of VEGFR2/3 but comparably lower activity of Notch 
and TGF-ß (Habeck et al., 2002; Siekmann and Lawson, 2007; Wild et al., 2017). Pathfinding 
is determined by attractive (Vegf-a) and repulsive signals (e.g. Semaphorin 3a) from the 
environment (Zygmunt et al., 2011). Stalk cells are the more proliferative element of this 
cell group and therefore represent the building blocks of the growing sprout. Extension of 
the sprout is highly dependent on coordination of tip cell and stalk cell behavior, and relies 
not only on proper cell proliferation but most importantly on cell migration and on 
elongation of single stalk cells (Sauteur et al., 2014).  
1.3.1.2. Cell elongation  
Proliferation of tip and stalk cells (in addition to migration) supports the growth of the 
sprout (Costa et al., 2016; Siekmann and Lawson, 2007). However, it is not the only 
mechanism important for sprout extension.  Sauteur et al., 2014 added a new facet to this 
morphogenetic process by showing that the elongation of stalk cells is associated with 
prominent cell shape changes and rearrangements of junctional contacts (Figure 6).  
 
Figure 6: Stalk elongation during angiogenic sprouting. An angiogenic sprout is shown, consisting 
of three different cells at the beginning (blue, orange and green). Cell junctions are indicated as 
rings. In the sprouting phase, the junctional ring undergoes a round to elliptic shape transformation. 
Cell migration as well as cell elongation lead to an extension of the vascular sprout and a 
multicellular tube architecture (left image). 
Stalk elongation driven by cell elongation and rearrangements
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Junctional contacts undergo a transition from a round towards a more elliptic shape, which 
drives the process of cell elongation. In mutants lacking VE-cadherin function, the capacity 
of ring elongation is diminished. Cell elongation is strongly dependent not only on the 
presence of VE-cadherin, but also on its interaction with the actin cytoskeleton. It was 
hypothesized that contact extension between two cells and concomitant junctional ring 
elongation requires an active deforming force. This force is specifically transmitted by VE-
cadherin and promotes the transformation of the junctional ring from a round to elliptic 
shape (Sauteur et al., 2014).   
 
1.3.1.3. Cell behaviours during anastomosis and membrane invagination 
When sprouts of the ISVs reach their dorsal-most point (around the position of the neural 
roof), tip cells extent both anterior and posterior (“T-shape”) in a process called bifurcation 
(Carmeliet and Tessier-Lavigne, 2005). Neighboring sprouts of two ISVs eventually will get 
interconnected via a process called anastomosis (Adams and Alitalo, 2007; Blum et al., 
2008; Herwig et al., 2011). This happens in a quite stereotypical manner, including a 
sequence of different steps which finally will lead to the formation of a new circulatory loop 
(more detailed description in Lenard et al., 2013). Two tips cells that move towards each 
other establish their first contact by filopodial extension. Once this contact is established, 
junctional proteins such as VE-cadherin and ZO1 are deposited at the contact site for 
further manifestation. The contact area increases and leads to the formation of a ring-
shaped junction. During this step, an apical compartment is created at the contact site, 
marked by the localization of Podocalyxin within the ring-shaped junctions. From this point 
onwards, two different mechanisms are used to complete the anastomosis process in the 
DLAV, either leading to unicellular or multicellular tube architecture (independent or 
dependent on blood pressure, respectively). These processes were described earlier in the 
sections describing cord hollowing or transcellular lumen formation.  
In the PLA of the zebrafish cranial vasculature, the processes following the establishment 
of an initial contact site and an apical membrane are very stereotypical and always proceed 
like described in the following:  
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Once the apical-basal polarity is established, the protrusive activity of filopodia decreases 
and cells continue to move along each other, thereby enlarging their mutual surface. While 
the apical compartment continues to grow, it subsequently fuses with a transcellular lumen 
initially formed in the tip cell, which invaginates rapidly due to blood pressure. This results 
in the formation of a unicellular tube with a transcellular lumen. Cell rearrangement 
processes (including cell splitting) finally lead to the conversion of the unicellular 
architecture into a more potent multicellular tube (Lenard et al., 2013). A simplified version 
of anastomosis is summarized in Figure 7. Steps of lumenization are excluded; but can be 
found in section 1.1.2.1.  
 
Figure 7: Steps of blood vessel fusion during anastomosis. Two tips cells (blue and orange) extent 
filopodia in the direction of migration. Upon filopodial contact between the two opposing sprouts, 
a new contact site is established and junctional material is deposited (marked by ZO1 and VE-
cadherin). Subsequently, the cell junction elongates (ring shaped), thereby increasing the mutual 
cell surface contact. Eventually, cell rearrangements will convert the initial unicellular tube into a 
multicellular tube architecture (not shown). Intracellular lumens are not depicted for simplicity 
reasons of simplicity.  
For the establishment of a continuous vessel during the process of anastomosis, proper 
junctional connections are inevitable. In VE-cadherin mutants, tip cells maintain a dynamic 
sprouting behavior, even after they have already encountered the opposing cell.  
Filopodial extension
Interfilopodial contact extension and
establishmet of a junction
Circular junction
Junction elongation
filopodia
VE-cadherin
ZO-1
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Since they fail in establishing a stable adherens point after the initial (single) contact, they 
compensate by formation multiple rather short contact points. Filopodia of VE-cadherin 
mutant embryos indeed do adhere and polarize, albeit less efficiently (Lenard et al., 2013). 
The formation of super numerous contacts was also reported to be true for the DLAV, 
implying a defect in endothelial cell recognition (Sauteur et al., 2014). However, mutants 
lacking both VE-cadherin and Esama (endothelial cell-selective adhesion molecule) show 
completely interrupted filopodia interaction, showing that these two molecules are 
important in endothelial cell recognition, in particular during the establishment of de novo 
junction formation in anastomosis (Sauteur et al., 2017). 
1.3.1.4. Cell rearrangements 
Cell rearrangements processes occur throughout development and are a major aspect of 
all steps of angiogenesis. Continuous rearrangements and remodeling behaviors are 
inevitable to respond to different contextual cues or needs of the developing organisms. 
For instance, during sprouting, rearrangement processes drive the elongation of the stalk 
cell, whereas during anastomosis they drive the architectural conversion from a unicellular 
tube to a multicellular tube. Generally, unicellular tube architecture is considered to be 
rather transient, whereas a multicellular structure is the favored and considered to be the 
more stable architecture of vessels.  Even in a potent, mature vessels, cells remain dynamic 
and change their position within a sprout (Jakobsson et al., 2010). Cell rearrangement 
processes rely on cell-cell interactions and among others require the protein VE-cadherin.  
In 2014, Sauteur et al. hypothesized for the first time, that VE-cadherin is required to 
transmit a deforming force on endothelial junctions and thereby promote cell elongation. 
Furthermore, they identified F-actin polymerization to be necessary in this process and 
stated that this might be one of the mechanisms underlying the process of force 
generation. A couple of years later, in 2018, the role of VE-cadherin was further described. 
A study conducted by Paatero et al., 2018 provided substantial support for the previous 
hypothesis; the authors identified and characterized so called junction-based lamellipodia 
(JBL). JBL function relies on both actin dynamics and polymerization as well as proper VE-
cadherin interaction, and were described to be the driving process of cell elongation and 
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consecutive cell rearrangements. These finding confirmed to a great extent the hypothesis 
of Sauteur et al., 2014 and will be described in more detail below.  
Junction based lamellipodia during cell rearrangements  
JBL can be observed at cell-cell junctions during endothelial cell movements and might 
provide a means for the cells to move along each other and to rearrange.  They were 
identified as VE-cadherin and ZO1-rich polarized thicknesses of the junctions during 
junctional ring elongation. Moreover, JBL are oscillating F-actin based lamellipodia-like 
protrusions that appear in the direction of endothelial cell movements or elongation. It was 
shown that JBL exhibit specific spatio-temporal localization of VE-cadherin, ZO1 and F-actin 
during a protrusion and retraction cycle (one JBL oscillation cycle is depicted in Figure 8).  
A protrusive leading front is established by polymerization of actin, which mainly 
colocalizes with a diffuse accumulation of VE-cadherin. Homophilic interaction of VE-
cadherin molecules then might lead to the recruitment of ZO1, which localizes in a more 
distinct pattern. This is represented by two “lines” - a distal and a proximal junction 
(“double junctions”), a phenomenon that is temporally restricted. In a last step, they 
hypothesize, that he two junctions are eventually pulled towards each other, by a so far 
unknown mechanism.  
The formation of JBL strongly relies on F-actin polymerization and dynamics, as well as 
mechanistic coupling of the actin cytoskeleton to the junctions. JBL formation is abolished 
in mutants lacking the F-actin binding domain of VE-cadherin. Furthermore, inhibiting F-
actin polymerization or interfering with remodeling, both lead to an impaired cell 
rearrangement process or JBL formation. JBL formation was described as means employed 
by endothelial cells to move along each other. Dependence on a functional F-actin 
cytoskeleton and dynamics as well as coupling to the junctions led to the hypothesis that 
migratory movements are initiated by local force generation. This hypothesis, however, 
needs to be further investigated.    
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Figure 8: JBL drive junctional remodeling and cell rearrangements. Stepwise elongation of two 
endothelial cells as they move over each other (top view in a). A schematic scheme of events 
happening in a sequential manner is shown in b. Three different proteins are shown in different 
colors. During one oscillation cycle, an actin protrusion (blue) emanates from a stable junction. In 
these protrusions, VE-cadherin is diffusely localized. At later stages, a new junction is formed at the 
distal end, marked by the presence of ZO1. In a final step, dynamic F-actin remodeling results in 
pulling the two junctions towards each other. Image taken from (Paatero et al., 2018).                            
As described in this section for VE-cadherin and in previous chapters for other proteins, it 
became obvious that junctional proteins and cell adhesion play a major role during several 
processed of angiogenesis. Therefore, endothelial cell junctions will be described in more 
detail the following sections, with particular focus on VE-cadherin, as this was repeatedly 
reported to play a major role in different processes.  
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1.4. Endothelial cell junctions 
Cell junctions are sites of contacts between two cells (cell-cell) or between cells and the 
extracellular matrix in a tissue of a multicellular organism (Alberts et al., 2002). All 
junctional proteins are anchored by a transmembrane domain and interact intracellularly 
with specific partners (e.g. with actin for stabilization purposes). Generally, cell junction 
proteins in the endothelium can be classified into two distinct groups, that intermingle 
along the cell- cell interface: Adherens Junctions (AJs) and Tight Junctions (TJs), both of 
which mediate adhesion. Major functions for TJs include providing a barrier within the 
membrane, they regulate the passage of solubles and ions and are important for 
maintenance of cell polarity (reviewed in Bazzoni and Dejana, 2004). Tight junctions are 
protein complexes containing Claudins, Occludins and JAMs (e.g. Esam), of which Claudin5b 
and Esama show endothelial specific expression. Another example is Zona Occludens 1 
(ZO1), which is most commonly considered to be a component of TJs. However, it is 
associated with AJs in earlier steps of their assembly and organization, where it binds 
temporally to a-catenin (Itoh et al., 1997). At AJs, adhesion is mediated by cadherins, which 
interact in homophilic manner in trans and form lateral junctions in cis conformation (for a 
review e.g. Bazzoni and Dejana, 2004; Vestweber et al., 2009). Besides their adhesive 
properties, AJs are responsible for the correct organization of new vessels and regulate 
paracellular permeability. Additionally, they are required for actin cytoskeleton remodeling 
and for local signaling. Although the most prominent example is VE-cadherin, other AJs are 
found in the vasculature such as N-cadherin (Navarro et al., 1998) or PECAM-1 (platelet/ 
endothelial adhesion molecule 1). The latter, however, is concentrated at the intracellular 
cleft but its localization is not specifically confined to AJs or TJs (DeLisser et al., 1994).  AJs 
are multiprotein complexes composed of cadherins (transmembrane) and catenins, that 
are attached to cytoplasmic actin filaments. The structure of AJs is further explained by 
taking VE-cadherin as an example.  
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1.4.1. VE-cadherin  
1.4.1.1. Structure of VE-cadherin  
 
Figure 9: Schematic representation of VE-cadherin and its intracellular binding partners. A 
homophilic trans-interaction between two molecules is shown on the left. Intracellular binding 
partners are depicted on the right. VE-cadherin has five extracellular cadherin repeats and is 
anchored in the cell membrane via a transmembrane domain. Its minimal functional unit is a dimer. 
Proteins that are known to interact with VE-cadherin are p120, b-catenin and Plakoglobin. P120 
interacts with the juxtamembrane domain and stabilizes the junctional complex, whereas the latter 
two associate with the distal binding site. Plakoglobin and b-catenin bind a-catenin and thereby 
provide a link to F-actin.  
VE-cadherin is a single-pass transmembrane protein, composed of 5 extracellular cadherin 
repeats, and a highly conserved cytoplasmic tail (see Figure 9). Expression of VE-cadherin 
is restricted to the endothelium, where it mediates adhesion in a homophilic, calcium- 
dependent manner (Bazzoni and Dejana, 2004). It connects opposing cells by forming a 
zipper-like structure of extracellular domains, and cadherins are among the first proteins, 
that accumulate at new cell-cell interfaces (reviewed by Ebnet, 2008). Through its 
cytoplasmic tail, VE-cadherin is connected to AJ proteins p120, ß-catenin and plakoglobin. 
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b-catenin serves as a scaffold and is important for the recruitment and regulation of 
proteins associated with the cytoskeleton and a-catenin. The latter is important for 
interaction with several actin binding proteins like ZO1 or a-actinin (see Weis and Nelson, 
2006). Plakoglobin exerts similar functions as described for the homologue ß-catenin. 
Hydrophobic and electrostatic properties of p120 are important for stabilization of VE-
cadherin at the junction (Vincent et al., 2004). Furthermore, mutants lacking the ß-catenin 
binding site fail to establish links to the actin cytoskeleton and are unable to form proper 
cell adhesion contacts (Nagafuchi and Takeichi, 1988).  
The biological impact of cell-cell contacts arises from their ability to functionally link 
adhesion to the actin cytoskeleton and to coordinate it with cell signaling (in addition to 
inhibiting cells from disconnecting from neighbors), which will be therefore integral part of 
the following paragraph. The following findings, however, were mainly obtained from cell 
culture experiments. In vivo observations were mostly based on mutant analysis in mouse 
or zebrafish embryos, which will be summarized upfront. 
1.4.1.2. Role of VE-cadherin in vivo  
Generally, VE-cadherin function is most studied with respect to leucocyte transmigration 
and vascular permeability and less is known about its precise role in the vascular system 
(reviewed in Dejana and Vestweber, 2013). 
In the vasculature, loss of VE-cadherin in mice leads to premature death of the embryos at 
E10.5. However, mutant embryos remain undistinguishable from their littermates until E8, 
indicating that VE-cadherin is dispensable for angioblast differentiation. Shortly after, 
severe vascular phenotypes are observed, including detachment of cells or a failure in the 
lumenization or expansion of vessel diameter (Carmeliet et al., 1999; Gory-Fauré et al., 
1999). Partially knocking down VE-cadherin in the zebrafish by a morpholino-antisense 
knockdown approach leads to a hypersprouting phenotype with several small but 
collapsing vessels present. Additionally, the tendency to develop brain hemorrhages is 
increased, mainly pointing towards a role in maintenance of vessel integrity (Montero-
Balaguer et al., 2009). In zebrafish, homozygous mutants develop a severe cardiac 
phenotype (edema) and do not survive beyond 5 dpf as they are not able to establish a 
proper vascular network.  
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Cell elongation as well as cell rearrangements are impaired in endothelial cells (Paatero et 
al., 2018; Sauteur et al., 2014). Furthermore, initial contact formation during anastomosis 
is affected, implicating a potential role of VE-cadherin in contact-mediated adhesion 
(Lenard et al., 2013). 
Most studies indeed point towards a rather passive role of VE-cadherin in line with 
maintenance of endothelial barrier formation (Dejana et al., 2009; Harris and Tepass, 2010; 
Lagendijk and Hogan, 2015). However, recently evidence supports a rather active role of 
VE-cadherin in morphogenetic processes that underlie blood vessel formation (Paatero et 
al., 2018; Perryn et al., 2008). Perryn et al., 2008 show that motion of endothelial cells in 
vascular sprouts is strongly dependent on VE-cadherin and necessary for sustaining 
vasculogenic sprouting during expansion of the whole tissue.  
  
1.4.2. Cadherins and the junctional F-actin cytoskeleton 
Cadherin-actin interaction is not only about how adhesion influences the cell cytoskeleton 
per se, but also how the contractile elements of neighboring cells (the actomyosin-
cytoskeleton) are coupled. Furthermore, it is important to understand, how this 
cooperation finally translates into biological outcomes, both at cell and at tissue level. 
Interfering with F-actin (dis)assembly, actin regulatory proteins but also with myosin II 
negatively influence junctional integrity and stability. Based on these findings, the 
cooperation can be reflected by three processes (compare Liang et al., 2015): cadherins 
interaction with F-actin (see  VE cadherin chapter), regulation of cytoskeletal dynamics and 
actin assembly and ability to recruit and activate myosin II. 
1.4.3. Mechanism of F-actin assembly  
Generally, F-actin filaments are formed by the polymerization of monomeric G-actin 
(“building blocks”). Actin filaments are very dynamic structures with constant turnover 
(assembly and disassembly) of G-actin at the pointed ends. Actin assembly and elongation 
preferentially takes place at the barbed ends of the filaments. Elongation at the barbed 
ends of actin filaments usually drive membrane protrusions (Tilney et al., 1981). Even when 
associated with junctions, dynamic properties are maintained and F-actin turns over with 
half-times of tens of seconds (Kovacs et al., 2011; Smutny et al., 2010).  
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F-actin filaments can assembly in form of actin bundles or as branched networks and are 
often associated with non-muscular myosin for generation of contractile forces.  
Actin assembly can be classified into two different processes: The first is actin nucleation, 
which refers to the process of actin trimer formation out of monomers, and is considered 
to be the rate limiting step. Actin filament nucleation first occurs after cadherin contacts 
are established and is mainly regulated by the Arp2/3 complex (Chesarone and Goode, 
2009; Pollard et al., 2000). The second process involved in actin assembly is the growth of 
trimeric actin into filaments by self-assembly accelerated by proteins like post-nucleation 
actin regulators Ena/VASP (Chesarone and Goode, 2009; Krause et al., 2003; Pasic et al., 
2008; Winkelman et al., 2014). These proteins prevent premature capping of barbed ends 
(Bear and Gertler, 2009) and act as actin polymerases (Hansen and Mullins, 2010), thereby 
supporting the growth of the actin filaments.  
 
1.4.3.1. Actin in the endothelium  
In the endothelium, actin filaments are components of several structures, including cortical 
actin, stress fibers, forming networks at the cell edge and are integral part of the 
cytoskeleton (Schnittler et al., 2014). Actin protrusions forming at the cell edge of migrating 
cells include lamellipodia and filopodia (Rottner et al., 2017). Lamellipodia are protrusions 
forming at the leading edge of a migrating cell, and consist of densely branched actin 
networks and are often referred to as “membrane ruffles”. Lamellipodia formation is 
dependent on Arp2/3 activity, which gets activated downstream of Rac. Filopodia 
(reviewed in Mattila and Lappalainen, 2008) are finger-like cell surface protrusions 
(“microspikes”), that extent beyond the leading edge of lamellipodia. Generally, they play 
a role in several processes including cell migration and guidance towards 
chemoattractants. However they were reported to be dispensable for tip cell guidance in 
the endothelium (Phng et al., 2013). Filopodia formation is mainly regulated by Cdc42. 
Stress fibers have a smaller actin turnover compared to protrusions and can terminate in 
focal contacts or at inter-endothelial adherens junctions (compare Schnittler et al., 2014). 
Stress fibers are important for cellular contractility as they are not only composed of actin, 
but also contain non muscle myosin II (NMII) (e.g. in Rottner et al., 2017).  
Concepts that were mentioned in this paragraph will be described in more detail in the 
following sections.  
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1.4.3.2. Regulation of actin assembly at junctions 
Nucleation of actin itself happens at cadherin-based junctions and is mainly mediated by 
the Arp2/3 complex, favoring formation of branched actin networks (Pollard et al., 2000). 
Arp2/3 concentrates at junctions (Tang and Brieher, 2012; Verma et al., 2012) and was 
shown to coimmunoprecipitate with E-cadherin (Tang and Brieher, 2012; Verma et al., 
2012). Arp2/3 itself has a poor intrinsic activity (Goley et al., 2006), and therefore needs 
other accessory proteins for stimulation, called nucleation promoting factors (NFPs). They 
include WASP and WAVE, which transduce signals from Cdc42 and Rac1 (Insall and 
Machesky, 2009). It was shown that Rac1 acts at E-cadherin adhesions and promotes actin 
assembly. Therefore, it is likely that Arp2/3 functions as mediator of Rac1 dependent actin 
assembly at junctions (Liang et al., 2015). Another NFP is cortactin, which was reported to 
contribute to actin assembly at the junction, promoted by its ability to recruit Arp2/3 and 
WAVE2 to the junction (Han et al., 2014) (see Figure 10).  
 
Figure 10: Regulation of actin assembly at the junction. Formin binds at the barbed ends of actin 
filaments, triggering the incorperation of single actin monomers. Ena/Vasp proteins promote the 
subsequent elongation of actin filaments. The Arp2/3 complex promotes the formation of branched 
actin networks. Arp2/3 transduces signals from Rac and Cdc42, through activation of WAVE and 
WASP, respectively (both NFPs). Cortactin stabilizes nucleation sites for actin branching. 
Intracellular binding partners of VE-cadherin are left out for simplicity. NFP=nucleation-promoting 
factors.  
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Another Arp2/3 dependent mechanism, that alters actin dynamics at VE-cadherin based 
junctions, is the formation of junction-associate intermittent lamellipodia (JAIL) (Abu Taha 
et al., 2014). In subconfluent cell culture experiments, where VE-cadherin shows a 
disrupted pattern and intracellular gaps, the formation of lamellipodia-like structures 
called JAIL can be observed. JAILs are spatio-temporally restricted actin-driven structures, 
dependent on Arp2/3 and WAVE2 (needed for actin polymerization). Locally appearing 
actin protrusions lead to an overlap of opposing endothelial membranes. This induces new 
VE-cadherin-meditated adhesion sites to form. The subsequently formed VE-cadherin 
clusters will eventually be incorporated into the cell-cell junctions upon JAIL retraction. 
Besides the importance of Arp2/3 as mediator for JAIL formation, Rac1 was identified to be 
of major importance. Inhibition of Rac1 blocked local formation lamellipodia (Breslin et al., 
2015). This might be explained by the observation, that activated Rac1 binds to the WAVE 
complex, which in turn activates Arp2/3 (Eden et al., 2002).  This mechanism was suggested 
to be important during dynamic junctional remodeling and maturation and crucial for the 
maintenance of the junctional barrier (Abu Taha et al., 2014).  
 
In contrast to Arp2/3, which promotes the formation of branched filaments, members of 
the formin family typically act at the barbed ends of filaments and promote nucleation to 
create parallel actin filaments. Formins identified at the cell-cell junctions are mDia1 and 
Formin-1 (Chesarone and Goode, 2009). Formin-1 was identified as binding partner of a -
catenin and can be found at radial F-actin bundles at nascent cell-cell contacts (Kobielak et 
al., 2004).  
Depletion of Arp2/3 or cortactin in cell culture experiments decreased steady-state F actin 
content and influences dynamic cell behavior, reflected in a reduction of actin assembly at 
junctions (Han et al., 2014; Verma et al., 2012). Additionally, inhibition of Arp2/3 disrupts 
cadherin organization (Ivanov et al., 2005). Furthermore, in Verma et al., 2012 it was 
shown, that contractile tension as well as myosin II accumulation was reduced in Arp2/3 
depleted cells (and therefore in cells, where local generation of branched F-actin networks 
was inhibited). Moreover, inhibition of myosin II decreased actin assembly at junctions, 
stressing tension-sensitivity of actin assembly (Leerberg et al., 2014).  
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1.4.4. Non-muscle myosin  
Non-muscle myosins play a role in many fundamental processes including cell migration, 
cell adhesion or cell shape changes during tissue morphogenesis and development 
(extensively reviewed in Coluccio, 2008; Vicente-Manzanares et al., 2009). These processes 
are mainly influenced and regulated by its effects on actin bundling and contractility. Non-
muscle myosin II (NMII) itself is tightly regulated among others through folding, filament 
assembly or actin binding. At the same time, it represents an important downstream 
endpoint where a lot of signaling pathways converge, which makes it central in the control 
of the already mentioned processes. In the following paragraphs, I will firstly introduce the 
structural properties of non-muscular myosin II and then focus on its effects on actin 
remodeling and cell adhesion.  
 
1.4.4.1. Structure of non-muscle myosin  
NMII is an actin-binding protein with contractile properties and represents the principle 
force generator in eukaryotic cells (referred to as actomyosin). NMII consists of two heavy 
chains, two light chains and two regulatory light chains (RLC), whereas the latter regulates 
myosin activity. NMII isoforms are determined by the heavy chain isoform (NMIIA, B and C 
in mammalian cells) (Vicente-Manzanares et al., 2009).  
F-actin and ATP are bound in the head domain of the heavy chain, which is crucial for the 
motor activity. Contractility requires the assembly of several single filaments in bipolar 
manner, which in turn is regulated by phosphorylation of the RLC. Phosphorylation of RLC 
changes the conformation of NMII from a very compact molecule into an assembly-
competent form. Minifilaments align in antiparallel manner (Heissler and Manstein, 2013), 
which allows F-actin to slide inward upon myosin activation (and thereby generating 
contractility). Phosphorylation happens on Ser19 (primarily) and effects can be further 
enhanced by T18 phosphorylation (Heissler and Manstein, 2013). Phosphorylation events 
are mainly promoted by myosin-light chain kinase (MLCK) or Rho- kinase (ROCK). The latter 
contributes to the generation of contractility mostly indirectly by inhibiting enzymatic 
activity of the myosin phosphatase, and thereby preventing RLC phosphorylation (Khasnis 
et al., 2014; Riddick et al., 2008).  
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Upon phosphorylation, contractility is not only achieved by assembly of NMII into 
minifilaments, furthermore it increases binding to F-actin and enhances myosin ATPase 
activity (Liang et al., 2015). The mechanisms of assembly at junctions and its molecular 
regulators are schematically shown in Figure 11. 
 
Figure 11: Non-muscular myosin at the junctions. NMII (non-muscular myosin-II) is present in an 
assembly incompetent head to tail conformation. Upon phosphorylation of the regulatory light 
chain (RLC) by MLCK (myosin light chain kinase) in calcium- dependent manner, NMII unfolds, which 
enables the assembly of antiparallel filaments which in turn can bind to actin. RLC phosphorylation 
is also favored by Rho associated Kinase (ROCK), which inhibits MLCP (myosin light chain 
phosphatase). Actin filaments upon NMII assembly can slide along each other, thereby generating 
contractility. ROCK is activated upstream by RhoA.  Intracellular binding partners of VE-cadherin 
are left out for simplicity. 
 
1.4.4.2. Non-muscle myosin at junctions  
Homophilic interaction of E-cadherin at adherens junctions leads to recruitment of myosin 
II to the junctions and therefore might function as an instructive cue (Shewan et al., 2005). 
Furthermore, it induces activation of RLC, as activated NMII was found to be present at the 
junctions (Shewan et al., 2005; Watanabe et al., 2007).  
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contraction
P
P P
P
MLCP RhoAMLCK ROCKCa2+
NMII
RLC
actin
Introduction 
 29 
 
In addition, both kinases (ROCK and MLCK) trigger the recruitment of NMIIA to the 
junctions, indicating that this recruitment might be linked to generation of contractility. 
Inhibition of ROCK disrupts recruitment of myosin II to cadherin junctions, implying that 
ROCK-dependent activation of myosin II functions in a cadherin-dependent way (Shewan 
et al., 2005). 
Interestingly, NMIIA/B both fail to accumulate at the junctions, when the Arp2/3/WAVE2 
mechanism was inhibited, pointing towards a fundamental role of F-actin assembly and 
dynamics in recruiting NMII to cell junctions (Verma et al., 2012).  
Conversely, actin assembly itself is also tuned by contractility. In case of inhibited 
contractility, actin assembly is decreased, whereas increased when stimulated (Leerberg et 
al., 2014). This effect was explained to be dependent on the tension-sensitive recruitment 
of Vinculin (Ishiyama et al., 2013; Leerberg et al., 2014). Vinculin belongs to the family of 
Ena/Vasp proteins, and directly interacts with a-catenin that can promote actin assembly 
at adherens junctions. Recruitment of Vinculin decreases if myosin II is inhibited and, vice 
versa, inhibition of Vinculin (which diminished tension-sensitive actin assembly) decreases 
tension (Leerberg et al., 2014; Yonemura et al., 2010). It is therefore thought that 
interaction of cadherin and actin might be tuned in response to junctional forces (Priya and 
Yap, 2015). 
 
1.4.4.3. VE-cadherin and mechanotransduction  
In the vasculature, VE-cadherin is not only important for cell adhesion, but itself is under 
tension  and plays a crucial role in mechanosensation (Conway et al., 2013). Many of the 
studies reporting such a role were based on cell-culture experiments; to what extent these 
findings can be extrapolated to angiogenesis in vivo needs to be carefully elucidated. 
However, the role of VE-cadherin and its mechanotransduction role became apparent by 
several studies investigating fluid shear stress sensing (Tzima et al., 2005) and the vascular 
response to it. VE-cadherin itself is under tension and together with PECAM-1 and VEGFR2 
and 3 forms a mechanosensory complex (compare Figure 12). Direct binding of VE-cadherin 
to VEGFR2/3 via their transmembrane domains was demonstrated in Coon et al., 2015.  
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Figure 12: Mechanosensory unit in endothelial cells. Fluid shear stress (blood flow) activates the 
mechanosensory complex which consists of PECAM-1, VE-cadherin and VEGFR2/3. The latter two 
interact via their transmembrane domains. Changes are transmitted via PECAM-1 onto VEGFR2/3 
probably through VE-cadherin, affecting endothelial function (not shown).  
Conway et al., 2013 showed for the first time using FRET-based biosensors, that endothelial 
cells rapidly respond to shear stress by changing tension across junctional proteins. 
Furthermore, the authors suggested that cells actively respond to extracellular forces by 
modulation of tension across the junctional proteins, instead of passively transferring 
forces across the cytoskeleton. Increase in shear stress after onset of flow led to a decrease 
of VE-cadherin tension, whereas tension in PECAM-1 simultaneously increased (Conway et 
al., 2013; Conway and Schwartz, 2015). Endothelial signaling pathways that are flow-
dependently activated include activation of Rho, PI3K and Src family kinase (Barry et al., 
2015; Collins et al., 2012; Osawa et al., 2002; Tzima et al., 2005).  
Another important experiment in cell culture investigating junctional remodeling, revealed 
that upon increase of cytoskeletal tension, VE-cadherin based junctions grew larger , but 
at the same time, no loss of tension was observed (Liu et al., 2010), potentially due to 
enhanced adhesive forces. Besides the mechanistic point of view, some molecular events 
that play a role in mechanotransduction responses at VE-cadherin based remodeling 
junctions have been unraveled. The transition from stable, mature junctions with linear 
and continuous VE-cadherin (parallel actin bundles), into a discontinuous VE-cadherin type 
of junction (perpendicular actin bundles =focal adherens junctions = FAJ) is mediated by 
actomyosin (Huveneers et al., 2012). Actomyosin contraction exerts a pulling force on FAJs 
and is required for their formation and for junctional remodeling in general.  
blood flow
PECAM-1
VE-cadherin
VEGFRs
TMDs 
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The switch from stable to remodeling junction relies on the tightly controlled activity of 
GTPases such as Rac or Rho (Yamada and Nelson, 2007). In mature VE-cadherin based AJs, 
Rac has a fundamental role in strengthening these. Local activation of Rac1 leads to a 
release of VE-cadherin tension by supporting and stabilizing linear junctions (Daneshjou et 
al., 2015; Timmerman et al., 2015), whereas Rho activation rather promotes the formation 
of discontinuous AJs (Liu et al., 2010). This is due to their differential role in modulation of 
cytoskeletal dynamics, with Rho increasing actomyosin-mediated tugging forces on the 
junctions. Cytoskeletal dynamics and their differential regulation by Rho-GTPases will be 
described further in the following chapter.  
 
1.4.5. Regulation of actin/adhesion dynamics by Rho-GTPases  
Members of the Rho family of small GTPases profoundly influence cytoskeletal dynamics 
and reorganize actin that is associated with junctions, thereby influencing adhesion. Active 
Rho-GTPases are bound to GFP and bind effector proteins to trigger downstream events. 
Activation of Rho-GTPases is initiated by GEFs (guanine nucleotide exchange factors) acting 
as catalysators for GDP to GTP exchange (Rossman et al., 2005).  
Indeed, Rho, Rac and Cdc42 were all found at cadherin junctions and they belong to the 
best characterized GTPases. Furthermore, it was demonstrated, that homophilic 
interaction of cadherins (assembly of adherens junctions) leads to the recruitment of 
several RhoGTPases such as Rac1, Cdc42, Arp2/3 to the junction (Bershadsky, 2004; Kovacs 
et al., 2002; Nakagawa et al., 2001; Noren et al., 2001).  
RhoA mainly plays a role in contractility-induced changes of the actin cytoskeleton. Its 
effector ROCK can phosphorylate myosin light chain, and thereby stimulate contractility 
(e.g. van Hinsbergh and van Nieuw Amerongen, 2002).Since tugging on the junctions 
increases forces acting on cadherins, Rho primarily has destabilizing effects on endothelial 
barriers.  
 
The proposed roles for Rac1 in the regulation of F-actin dynamics appear to be quite 
contradictory. However, these conflicting observations could be due to a context-
dependent specificity of Rac1 function or to fine-tuned spatial and temporal activation.  
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One the one hand Rac1 was reported to play a role in loss of VE-cadherin cell-cell contacts 
(e.g. Knezevic et al., 2009; Monaghan-Benson and Burridge, 2009; van Wetering et al., 
2003). One the other hand, it seems to play a role in junctional stabilization and 
maintenance of the endothelial barrier. In junctions that were disrupted by thrombin 
treatment, Rac1 was active in the recovery phase and contributed to the reassembly of the 
junctions (Beckers et al., 2010; Timmerman et al., 2015). Nascent adherens junctions were 
stabilized by formation of cortical actin bundles (Timmerman et al., 2015). More detailed, 
in the reassembly phase Rac1 activation lead to the formation of lamellipodia-like 
protrusions.  Upon homophilic interaction of two VE-cadherin molecules, a GEF called Trio 
was recruited to the junctions. This GEF in turn recruited additional Rac1, finally 
transforming nascent into mature junctions based on rearrangement of the actin 
cytoskeleton (Timmerman et al., 2015). In mature junctions, Rac1 reduces the rate of 
dissociation of VE-cadherin (Daneshjou et al., 2015).  
Apart from activation of Rac1, cadherin binding also activates Cdc42, which seems to be 
crucial for junctional stabilization. Cdc42 was activated in a VE-cadherin mutant, which was 
not able to establish homophilic interactions (Broman et al., 2006). Based on this finding, 
it was hypothesized, that discontinuous junctions might induce Cdc42 activation (Spindler 
et al., 2010). In line with this, Cdc42 inhibition lead to junctional fragmentation (Georgiou 
et al., 2008; Shen and Turner, 2008). Overexpression of constitutively active Rac1 or Cdc42 
in epithelial cells lead to accumulation of actin at cell-cell junctions and additionally 
enhanced levels of E-cadherin (Noren et al., 2001). In summary, these findings indicate that 
activities of Rac1 and Cdc42 are needed for the assembly of adherens junctions.  
 
1.5. Tools to investigate intramolecular tension and actin dynamics  
Although junctional remodeling has been topic of many studies, they mainly rely on in vitro 
data. Newly developed tools will make it possible to further investigate junctional 
rearrangement in vivo. With the help of FRET-based biosensors such as the VE-cadherin 
tension sensor it is possible to visualize and quantify force-dependent processes.  
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Furthermore, engineered photoactivatable proteins enable specific (temporal and local) 
activation of certain proteins and thereby allow to decipher their contribution to a distinct 
biological process. Both mentioned tools will be briefly described in the next paragraph, as 
they will be integral part of this thesis.  
 
1.5.1. VE-cadherin Tension sensor 
The VE-cadherin tension sensor line was generated for optical visualization of intra-
molecular tension across VE-cadherin in zebrafish and thoroughly validated (Lagendijk et 
al., 2017). The tension sensor (TS) module consists of two fluorescent proteins, Teal and 
Venus, which are linked by an elastic linker peptide (Grashoff et al., 2010). Förster 
Resonance Energy Transfer (FRET) can be used to quantify changes in energy transfer 
between the fluorescent proteins upon stretching or contraction of the linker. The TS 
module has been placed in the cytoplasmic tail of zebrafish VE-cadherin, between the p120 
binding domain and the β-catenin binding domain, as described previously for mouse VE-
cadherin (Conway et al., 2013). The zebrafish cDNA construct (ve-cadherin-TS) was 
recombined into a ve-cadherin BAC clone in order to express TS protein at endogenous 
protein levels. The tension sensor module as well as the final BAC-clone are shown in Figure 
13. The stable transgenic line TgBAC(ve-cad:vecadTS)uq11bh showed expression restricted to 
the vasculature and to endothelial cell-cell junctions, which allows investigations of cell 
junctional morphology and VE-cadherin dynamics at high resolution. Furthermore, Tg(ve-
cad:ve-cadTS) was crossed into a ve-cadherin mutant background (cdh5ubs8) (Sauteur et al., 
2014), to test the functionality of the VE-cadherin TS fusion protein. Analysis did not reveal 
any phenotypic abnormalities in genotypic mutant embryos, which shows that VE-
cadherin-TS can rescue the null mutant phenotypes. Tension changes across VE-cadherin 
(reflected by changes in energy transfer measured by FRET) were observed during arterial 
maturation as well as upon perturbation of actomyosin contractility. Maturation of the 
dorsal aorta, inhibition of ROCK (and thereby perturbing actomyosin contractility) and a 
decrease of calcium signaling all lead to reduced VE-cadherin tension. Interestingly, acute 
reduction of blood flow did not alter tension within the VE-cadherin molecule (Lagendijk et 
al., 2017).  
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Figure 13: Schematic representation of the VE-cadherin tension sensor (TS) module. A stretchable 
linker peptide separates the donor fluorescent protein (Teal) from the acceptor (Venus) (in a). The 
tension sensor module was inserted between the p120 and the β -catenin binding domain of VE-
cadherin and recombined into the VE-cadherin BAC clone (b). Image taken from Lagendijk et al., 
2017. 
 
1.5.2. Photoactivatable Rac1 
Precise spatial and temporal activation of specific protein activity can be of major 
importance to study cellular behavior. In order to investigate Rac1-dependent actin 
dynamics Wu et al., 2009 developed a genetically encoded photoactivatable Rac1. 
Constitutive active Rac1 was fused to the photoreactive LOV (light-oxygen-
voltage) domain, with a C-terminal helical extension (Jα). The LOV domain is naturally 
occurring in Phototropin in Avena sativa and the mechanism of protein light switch was 
described in Harper et al., 2004, 2003. In a closed conformation (darkstate), the LOV 
domain occludes the effector binding by sterical inhibition. Irradiation with 458 nm light 
induces a conformational change, leading to the unwinding of the Ja helix and revealing of 
effector binding sites, thereby leading to activation of Rac1. 
Activation of Rac1 in mouse fibroblasts lead to actin polymerization and increased 
membrane ruffling, as well as to the recruitment of downstream effectors to the site of 
irradiation. Additionally, local activation of Rac1 resulted in the possibility to control and 
direct cell movement (Wu et al., 2009). 
The latter was also shown in vivo in zebrafish neutrophils, where localized activation of 
Rac1 proved to be sufficient to induced directed migration (Yoo et al., 2010). 
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1.6. Aim of the thesis  
The aim of this thesis is to further analyze the cell rearrangement process, in which two 
cells use junction-based lamellipodia to move along each other and elongate the mutual 
contact surface. Of particular interest are mechanisms, that endothelial cells might use to 
generate contractile forces that drive this process. Additionally, another major aspect of 
this thesis will be to analyze the regulation of F-actin dynamics. Questions that I will try to 
answer and focus on include: How is a tensile force generated during the process of 
junctional ring elongation? How is this force transmitted onto VE-cadherin based 
junctions? Which processes and molecules linked to actin dynamics contribute to JBL 
formation and ring elongation? Are JBLs a specific mechanism of anastomosis in the DLAV 
or might this be a general mechanism employed by other cell types? 
  
 36 
 
 
 
 
 
 
II. 
Materials & Methods 
  
  
Materials and Methods 
 37 
 
2. Materials and Methods 
 
2.1. Materials 
2.1.1. Chemicals 
Unless otherwise stated, chemicals were obtained from AppliChem GmbH, Invitrogen 
GmbH, Merck KGaA, BD Biosciences, Fluka, Machinery Nagel, and Sigma Aldrich Chemie 
GmbH.  
 
2.1.2. Buffers, media and solutions 
Solutions Composition 
DNA loading buffer (10 x) 
30 % (v/v) glycerol 
20 % (w/v) Orange G 
in ddH2O 
Methylene blue solution 
1 % methylene blue (Sigma Aldrich) 
ddH2O 
E3 (50 x) 
250 mM NaCl 
8.5 mM CaCl2 
16.5 mM MgSO4 
adjusted to pH 7.0-7.4 (with Na2CO3) 
egg water (methylene blue + E3) 
1:2000 methylene blue solution (0.0005%) 
1x E3 
LB 
1 % (w/v) tryptone 
0.5 % (w/v) yeast extract 
1 % (w/v) NaCl 
ddH2O 
(autoclaved) 
LB w/o salt 
1% (w/v) tryptone 
0.5% (w/v) yeast extract 
ddH2O (autoclaved) 
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Mounting agarose 
0.7 % low melting agarose in E3 
1x PTU 
1x tricaine 
Blocking buffer 
5 % normal goat serum 
1 % BSA 
0.1 % Triton X-100 
0.01 % sodium azide 
in PBST 
2 % PFA 
12 % PFA (Electron Microscopy Sciences) 
diluted  
in PBST 
PBS (10x) 
1.37 M NaCl 
27 mM KCl 
100 mM Na2HPO4 
18 mM KH2PO4 
ddH2O 
(autoclaved) 
PBST 
1x PBS 
0.1 % Tween-20 
PTU (50x, 2 mM) 
0.15 % (w/v) 1-Phenyl-2-thiourea (PTU) 
(Sigma-Aldrich) 
in E3  
TAE (50x) 
2 M tris base 
5.71 % (v/v) glacial acetic acid 
50 mM EDTA 
in ddH2O 
(autoclaved) 
Tricaine (25x) 
0.4 % (w/v) Tricaine (Sigma-Aldrich) 
ddH2O 
adjust to pH 7 with 1M Tris HCl 
stored at -20 °C  
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TE  
10 mM Tris HCl 
1 mM EDTA 
in ddH2O 
adjust to pH 8.0  
 
2.1.3. Antibodies 
2.1.3.1. Primary antibodies 
 Anti-Species Dilution Provider 
Anti- ZO1 mouse 1:500 Thermo Fisher Scientific 
Anti-Cdh5 guinea pig 1:500 Blum et al., 2008 
Anti-GFP chicken 1:200 Abcam 
 
2.1.3.2. Secondary antibodies 
 Anti-Species Dilution Provider 
Alexa Flour 488 mouse 
 
 
1:2000 
 
 
Thermo Fisher Scientific 
Alexa Flour 488 guinea pig 
Alexa Flour 568 guinea pig 
Alexa Flour 568 mouse 
Alexa Flour 633 guinea pig 
Alexa Flour 633 mouse 
Alexa Fluor 647 chicken  
 
2.1.4. Primer 
Generally, primer stock solutions (100 µM) as well as working solutions (10 µM) were kept 
at -20°C and ordered from Microsynth. 
Primer Name Sequence 5`-3` 
attB primers 
PA-Rac1-FWD attB1 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACAGCCAACATGGCACA
CCATCACCACCA 
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RA-Rac1-REV attB2 GGGGACCACTTTGTACAAGAAAGCTGGGTCGCCAGAAGTCAGATGCTC
AAGG 
UCHD-FWD-attB2R GGGGACAGCTTTCTTGTACAAAGTGGATTCCGGAACCATGGCCAAGTA 
UCHD-REV-attB3 GGGGACAACTTTGTATAATAAAGTTGGAAAAAACCTCCCACACCTCCC 
Sequencing primer 
PA-Rac1-REVmChe TCTGGCAATCTTGGGTCAGT 
mCherry_2_FWD AGTTCATGTACGGCTCCAAG 
attB1_for ACAAGTTTGTACAAAAAAGCAGGC 
attB2_rev CCACTTTGTACAAGAAAGCTGGG 
UCHD-FWD GGACCTGCAGCAGACGAAC 
UCHD-REV CACTGTTCGTCTGCTGCAGG 
 
2.1.5. Antibiotics 
Antibiotic Stock concentration Working concentration 
Ampicillin  100 mg/ml 100 µg/ml 
Kanamycin 50 mg/ml 50 µg/ml 
 
2.1.6. Bacterial strains 
Strain Provider 
E.coli TOP10 electrocompetent cells  Invitrogen 
 
2.1.7. Inhibitors 
Name Working 
concentration 
Provider  Inhibition  
CK-666 200 µM Sigma Aldrich Arp2/3 
Y-27632 45-75 µM Sigma Aldrich ROCK 
NSC23766 900 µM Sigma Aldrich Rac1  
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2.1.8. Plasmids 
Name Purpose Reference 
 
pTriEx-mCherry-PA-Rac1 Template plasmid for attb 
PCR 
Klaus Hahn, Addgene 
plasmid # 22027 
pCS2+eGFP-utrophin William Bement, Burkel et 
al. 2007 
Donor vectors 
pDONRÔ 221 attP1-P2 sites Invitrogen 
pDONRÔ 221 P2r-P3 attP2r-P3 sites Invitrogen 
5`entry clones, attL4-R1 sites 
p5E-fli1ep Promoter Nathan Lawson 
p5E-kdrl Promoter  Massimo Santoro 
Middle entry clones, attL1-L2 
pME-IRFP670 fluorophore Etienne Schmelzer 
pME-mCherry-PA-Rac1 fluorophore-protein fusion This study 
3`entry clones, attR2-L3 sites 
p3E-polyA SV40 late polyA signal Kristen Kwan, Chien lab 
P3E- UCHD-polyA Protein-fluorophore fusion This study  
Destination vectors 
cb24 395 bb eye betacrys 
TagBFP 
transgenesis reporter, 
betacrystalline TagBFP 
Charles Betz 
cb58 395 ck heart cmlc2 
mKate 
transgenesis reporter, 
cmcl2: mKate2 
Charles Betz 
 
2.1.9. Fish lines 
Genotype Allele Designation Reference 
Wildtype lines 
AB  ZIRC, Eugene, Oregon, USA 
TU  ZIRC, Eugene, Oregon, USA  
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Transgenic lines  
Tg(kdrl:EGFP) s843 Jin et al., 2005 
UAS:EGFPhZO1, cmlc2:EGFP Ubs5 Herwig et al., 2011 
4xUAS:EGFP-UCHD Ubs18 Sauteur et al., 2014 
Kdrl:Myl9a-EGFP; 
cmlc2:EGFP 
 Lancino et al., 2018 
Ve-cad:ve-cadTS; ubs8  Uq11bh Lagendijk et al., 2017 
ve-cad:ve-cadTS 
(tension sensor) 
Uq11bh Lagendijk et al., 2017 
10x UAS:Teal 
 Uq13bh Lagendijk et al., 2017 
10x UAS:Venus  Uq8bh Lagendijk et al., 2017 
Fli:iRFP-UCHD, cmlc2:mKate  This study 
Kdrl:mCherry-PA-Rac1, beta-
crystalline: BFP 
 This study 
 
2.1.10. Microscopes and binoculars 
2.1.10.1. Binoculars 
Microscope Manufacturer Information 
Binocular Stemi SV 11 Zeiss binocular 
M205 FA stereo binocular Leica fluorescence binocular 
 
2.1.10.2. Point scanning confocal microscopes 
Microscope Manufacturer Objectives Magnification NA 
SP5-II-Matrix Leica HCX IRAPO L 25x (water) 0.95 
HCX PLAN APO CS 40x (water) 1.1 
SP8 (BSL2) Leica HC PL APO CS2 20x (IMM) 0.75 
HC PL APO CS 40x (water) 1.1 
Zeiss 710 FCS  Zeiss  40x (oil) 1.3 
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2.2. Methods 
 
2.2.1. Zebrafish protocols 
2.2.1.1. Zebrafish maintenance  
Zebrafish were maintained and bred under standardized conditions with constantly 
adapted and controlled pH-levels, conductivity and water temperature. Conditions are 
further described in “The Zebrafish book”(Westerfield, 2000). Embryos were kept at 28.5 
°C and staged by hours post fertilization (hpf) according to Kimmel et al., 1995. 
 
2.2.1.2. Embryo dechorionation 
Embryos (> 24 hpf) were exclusively manually dechorionated using forceps (Dumont #5F). 
 
2.2.1.3. Pigmentation inhibition 
In order to facilitate and improve image acquisition of zebrafish embryos, pigmentation 
was inhibited by incubation in 1-phenyl 2-thiourea (1x PTU) in E3 starting around 24 hpf. 
 
2.2.1.4. Microinjection/ transient expression  
Prior to injection, injection plates (1 % agarose in E3 water) were prepared. Capillaries 
(outer diameter 1.0 mm, inner diameter 0.5 mm, 10 cm length, Sutter Instruments) were 
used to produce borosilicate glass needles with a needle puller (Sutter Instruments). 
Needles were loaded with the respective injection mixture (see Table 1) using Microlader 
tips (Eppendorf) and the tip was opened by breaking it with forceps. The needle was 
connected to the injector (Pneumatic PicoPump, World Precision Instruments) and 
pressure was adjusted to obtain a volume of approximately 5 nl. The embryos were aligned 
in the indentations of the injection ramps.  All embryos were injected at one cell stage. 
After injection, the embryos were transferred into petri dishes containing E3 with 
methylene blue.  
Plasmids were injected at concentrations ranging from 70-200 ng/ul. 
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Table 1: Type of injection mixes and respective concentrations. 
Name Type  
Kdrl:mCherry-PA-Rac1 Plasmid DNA 70-150 ng/µl 
Fli:iRFP-UCHD Plasmid DNA 150-200 ng/µl 
Double injection  Plasmid DNA Total of 150 ng/µl  
 
2.2.1.5. Generation of transgenic fish lines 
In order to generate transgenic fish lines, wild-type embryos were injected at one cell stage. 
To facilitate integration, plasmids (30 ng/µl) were injected together with tol2 RNA (35 
ng/µl).  
From 30 hpf onwards embryos were screened for the respective transgenesis marker and 
positive embryos were raised to adulthood. Eventually, fish were individually outcrossed 
to wild-type zebrafish. Repeatedly, embryos were screened for positive expression of the 
transgene and finally raised in order to generate a stable transgenic fish line.   
 
2.2.1.6. Inhibitor treatment of zebrafish embryos 
Zebrafish embryos were selected for the desired transgene and dechorionated. Inhibitor 
treatment was done in 24 well plates, incubating max. 12 embryos per well in 2 ml solution. 
Inhibitors were diluted in 1x E3 containing 1x PTU to obtain the required concentration (see  
2.1.7). As a control 1 % DMSO was used. Embryos were incubated 2 h prior to imaging 
starting at 30 hpf for imaging of the DLAV and around 48 hpf for imaging of the DA. The 
inhibitor was present during the whole imaging period in the agarose as well as provided 
medium in the glass bottom dish.  
For FRET imaging, incubation time for the DLAV as well as DA ranged between 4-5 hours.   
 
2.2.2. Immunostaining 
Zebrafish embryos of the desired developmental stage were fixed after dechorionation 
using 2 % PFA or Glyofixx (Thermo Fisher Scientific) and incubated at 4°C overnight (ON) in 
1.5 ml Eppendorf tubes (max. 20 embryos per tube). The next day, embryos were washed 
four times for 5 minutes in 1x PBST at room temperature (RT) on a rocking platform. 
Following the washing step, the embryos were permeabilized using 0.5-1 % Triton-X100 in 
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PBST for 30 min at RT. After that, blocking solution (see 2.1.2) was added for a 2 h 
incubation at RT or overnight incubation at 4 °C. After blocking, the primary antibody 
solution was added. A list of used primary antibodies and respective concentration can be 
found in 2.1.3.1. The primary antibodies were either diluted in blocking solution or Pierce 
Immunostain Enhancer Solution (Thermo Fisher Scientific). Primary antibody incubation 
was done at 4 °C and ranged between 1-3 days. After that, the solution was removed and 
the embryos were washes at least 4 times for 30 min with PBST at 4 °C or overnight. This 
step was followed by the incubation of the secondary antibodies (see 2.1.3.2), which were 
diluted 1:2000 in blocking solution and incubated at 4 °C ON. Finally, embryos were washed 
at least 4 times for 30 min in PBST at 4 °C or ON. 
 
2.2.3. Image acquisition  
2.2.3.1. Mounting of zebrafish embryos 
For live imaging, zebrafish embryos were positively selected for the desired transgene using 
a fluorescence binocular (2.1.10.1). Selected embryos were dechorionated and 
anesthetized in 1x E3 containing 1x tricaine. Embryos were mounted using 0.7 % low 
melting agarose (LMA) (Sigma Aldrich) supplemented with tricaine and PTU on a glass 
bottom dish (MatTek). During the mounting procedure, the agarose was kept at 55 °C. 
Embryos were aligned in lateral orientation (anterior to the left). After solidification of the 
agarose, E3 medium (+ PTU and tricaine) was added to the dish.  
For imaging of fixed embryos, the process was performed as described above with minor 
differences. Addition of PTU or tricaine was not required. Furthermore, the head and yolk 
of the embryo was removed during the mounting process in order to guarantee flat 
alignment of the embryos.  
 
2.2.3.2. Confocal imaging 
Prior to live imaging the incubation chamber was set to 28.5 °C. Generally, laser intensities 
were set according to the strength of the fluorescent signal to obtain single saturated 
pixels. The z-step size was set automatically and roughly ranged from 0.1 to 1 µM. The point 
scanning speed ranged between 400-700 Hz with various zooms and bidirectional scanning. 
Frame size was adjusted according to the needs of the imaging session. For imaging of fixed 
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embryos, sequential scanning was used. Imaging settings for each experiment are 
summarized in below in Table 2. 
Table 2: Confocal imaging settings according to performed experiment. 
Experiment Objective Zoom Scanning 
speed 
Frame size Time 
interval 
Result figure   
Ring elongation 40 x 3 x 400 Hz 512x512 10 min Figure 21 
Actin dynamics in 
the junctional ring 
40 x 5.5 400 Hz 512x512 1 min Figure 22 
ZO1 localization 40 x 4 400 Hz 512x512 
or 
1024x512 
1 min Figure 25 /26 
ZO1 localization in 
the DA 
40 x  400 Hz 512 x 512  Figure 33 
Actin dynamics in 
the DA 
40 x 3 700 Hz 1024x512 1 min Figure 34 / 35 
 
2.2.3.3. FRET imaging  
Sample preparation was done as described in 2.2.3.1. For each imaging session, three 
different transgenic fish lines (Tg(10xUAS:Teal), Tg(10xUAS-Venus), Tg(ve-cad:vecadTS)) 
were mounted. Teal and Venus lines were used as control to correct the FRET signal for 
donor bleed through (DBT) and acceptor bleed through (ABT). Controls were imaged at 48-
72 hpf in the dorsal aorta. Imaging of the tension tensor line was performed at 32 hpf for 
the DLAV and 48-50 hpf for the DA. All FRET imaging was performed on Zeiss 710 FCS 
confocal microscopes, line-sequential scanning and GaAsP high sensitivity detectors. 
Imaging settings were optimized for the expression of Tg(ve-cad:ve-cadTS) and remained 
unchanged during one session. Generally, imaging was performed using the 40x oil 
objective and 4x Zoom. Furthermore, laser intensities below 60 % a maximum gain of 800 
were used. Frame size was set to 1024*1024 pixels, Z-stack size 0.99 and laser speed to 5.  
Control embryos were imaged with the same settings.  
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2.2.3.4. FLIM imaging 
FLIM imaging was mainly performed by Dr. Anne Lagendijk with the help of Dr. Sean 
Warren using an HC PL APO CS2 40 Å~ 1.1 NA water objective on an inverted DMI 6000 SP8 
confocal microscope (Leica Microsystems).  Protocol was done according to the description 
in Lagendijk et al., 2017.  
 
2.2.3.5. Imaging of kdrl:PA-Rac1 
Generally, for imaging of Kdrl:mCherry-PA-Rac1 the 561 nm laser was used. For activation, 
458 nm laser was set to an intensity of 20 %. Imaging was performed in the absence of UV-
light to avoid unwanted activation.  
 
Determination of filopodia number and cell size  
For imaging, single cells in the DLAV > 48 hpf were chosen (see Figure 
14, orange cell). The first 12 frames were acquired using only the 561 
nm laser. Time intervals were minimized in order to avoid any dark 
states. Following, the 458 nm laser was turned on additionally in order 
to activate Rac1 and imaging continued with unchanged settings. After 
that, another 12 frames were taken without the activation laser (see 
Figure 15). Time frames ranged from 46.7 s to approximately 2 minutes. 
 
Figure 15: Scheme of time-lapse imaging performed. 12 time points were imaged pre and post 
activation. Imaging during activation with the 458 nm laser was done for 15 time points.  
Transient coexpression of fli:iRFP-UCHD and Kdrl:mCherry-PA-Rac1 
First, live still images of double positive cells in the DLAV were acquired, followed by time 
lapse imaging of fli:iRFP-UCHD only. Similar to the procedure above, UCHD was imaged 
before activation and during 458 nm activation (the whole frame was irradiated) of PA-
Rac1.  
 
Figure 14: Cell 
imaged in the 
DLAV 
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2.2.4. Image Processing and Analysis 
2.2.4.1. General image processing  
Image analysis was done using Fiji (open source, ImageJ). Routinely, maximum projections 
were used. Where necessary, background was subtracted, brightness and contrast 
adjusted.  
 
2.2.4.2. Quantification of junctional ring elongation speed 
Junctional elongation was determined by analysing isolated junctional rings during 
anastomosis in the DLAV in embryos transgenically expressing EGFP-UCHD. Isolated 
junctional rings were imaged every 10 min. The diameter of the junctional ring in µm (along 
the vessel axis) was measured using Fiji at t (0) = 0 min and 40 to 70 minutes later (t (1) = 
40 – 70 min) depending on the imaging quality. Elongation speed in µm/hour was 
calculated using following equation:  𝑒𝑙𝑜𝑛𝑔𝑎𝑡𝑖𝑜𝑛	𝑠𝑝𝑒𝑒𝑑	𝑖𝑛	 µ𝑚ℎ = 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟	𝑡(1)𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟	𝑡(0) ∗ 	 60𝑡(1) − 𝑡(0) 
 
2.2.4.3. Processing of FRET data 
All processing was done in ImageJ (National Institutes of Health, USA). A custom-written 
Matlab (Mathworks) script 54 was used to measure nonlinear DBT and ABT from the images 
obtained from Tg(10xUAS:Teal) and Tg(10xUAS:Venus). Based on these values, images 
were thresholded and a MASK was generated (TEAL_MASK) and VENUS_MASK). Applying 
the MASK ensured, that embryos that fell outside the confidence boundaries were 
excluded from the analysis. By that only those RAW-FRET expressing pixels were processed, 
for which donor and acceptor intensities allowed precise calculation of DBT and ABT 
constants. The MASK was applied on median filtered Raw images. Venus and Teal channels 
were multiplied with the Venus_MASK and Teal_MASK generating Real intensity values 
(RIV) for Teal (Teal_RIV) and Venus (Venus_RIV). The RIVs were again multiplied with the 
values for ABT und DBT (Teal_RIV*DBT and Venus_RIV*ABT). Described values and masks 
were used to process the raw images. The process is schematically summarized in Figure 
16. 
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Figure 16: Scheme of processing of raw data to obtain FRET-Index images.  
Therefore, the final FRET index represents a FRET, that is corrected for the bleed-through 
(BT) and divided by Acceptor (Venus) intensity in each pixel (Figure 17). 
 
 
Figure 17. Explanation of RAW FRET processing. From the original RAW FRET image, values for DBT 
and ABT are subtracted per pixel, resulting in a corrected FRET image. This bleed-though corrected 
image is divided by the Venus intensity to normalise for protein amount. Final image represents 
ratio-metric FRET values.  Scale bar 5 µM. Image taken from Lagendijk et al., 2017. 
Images displaying the FRET index were used to measure FRET- Index in several regions of 
interest. Therefore, ROIs were manually drawn and mean intensity measurements were 
performed on single Z-Slices. Per structure (e.g. JBL, junction in the dorsal aorta etc.) FRET 
indexes from several slices were averaged.  
 
2.2.4.4. Processing of FLIM data  
Processing of RAW FLIM data was done uning FLIMfit software 5.0.1. (provided by Dr. Sean 
Warren) as described in Lagendijk et al., 2017. 
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2.2.4.5. Post- image analysis after activation of Rac1 
Quantification of filopodia number and cell size  
Quantification of filopodia number was done manually on each image acquired during 
time-lapse imaging. In order to compare filopodia number among different cells, individual 
values from each time point before, during and after activation were averaged. Number of 
filopodia are displayed in absolute values. For quantification of the cell area, the images 
were thresholded. The outline of the cell was marked by using the tracing tool and the cell 
area was measured for each time point. Similar to above, an average was determined for 
the time points before, during and after activation of Rac1. The cell size change is 
represented in % of the starting value (t=0).  
 
2.2.4.6. Analysis of actin dynamics in the dorsal aorta using a kymograph-based method 
Kymographs were generated in Fiji using sum Z-projections from time-lapse series (images 
acquired every minute for one hour, t=60 min). Sum Z-projections were corrected for drift 
using the StackReg (Rigid body option) plugin. Additionally, background was subtracted 
(rolling ball radius 50). A straight line was drawn perpendicular to the junction and the 
kymograph was generated using the reslice tool. For further analysis, a custom-written 
MatLab script was used, which identifies local signal maxima for each time point. The 
coordinates were used to generate a curve representing the junctional movement over 
time (1h). The workflow is summarized in Figure 18. 
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Figure 18: Post imaging quantification of actin dynamics in the dorsal aorta. The dorsal aorta was 
imaged each minute for 60 min. A line was drawn perpendicular to a junction and a kymograph was 
generated. With the help of a custom written Matlab script, a graphical representation of 
kymograph could be plotted. The Matlab algorithm identifies the intensity maximum per column (= 
per time point).  
2.2.4.7. Statistical analyses 
Statistical analyses were performed using GraphPad Prism version 8.3.0. Data was checked 
for normal distribution using the D'Agostino & Pearson test. For normal distributed data 
the two- sided paired t-test (to compare two means) or the One-way ANOVA multiple 
comparison- test, to compare more than two means) was used. If the data did not follow a 
normal distribution the non-parametric Kruskal-Wallis H-test (for comparison of multiple 
means) or the Mann-Whitney-U-test (two compare two means) were used. Furthermore, 
the Kolmogorov-Smirnov test was applied. 
 
2.2.5. Molecular biology protocols 
2.2.5.1. Transformation of electrocompetent cells 
For bacterial transformation, the cells were takes out of the -80 °C freezer and thawed on 
ice for 20 minutes. In the meantime, 2 μl of plasmid was dialysed on a membrane (PVDF 
Membrane Filter, MilliporeSigma). After that, the dialysed sample was transferred to 50 μl 
of the electrocompetent cells and gently mixed by stirring with the pipet tip. The mixture 
was left for 15-30 min on ice and then transferred into a Gene Pulser 1mm Cuvette (Biorad). 
The cells were electroporated with 1.8 kV using a MicroPulser (BioRad). Transformed 
bacteria were immediately resuspended in 500 μl LB and incubated for 1-2 hours at 37 °C 
with 200 rpm. Bacteria were plated on LB plates with the appropriate antibiotics overnight 
at 37 °C.  
 
2.2.5.2. Purification of PCR products 
Routinely, PCR products were loaded onto a 1-2 % agarose gel. For that, the agarose was 
dissolved in 1x TAE buffer and heated up in the microwave until everything was dissolved. 
After cooling down, 0.3 % ethidium bromide was added. After polymerization, the gel was 
transferred to a chamber filled with 1x TAE buffer.  
Materials and Methods 
 52 
 
The samples were mixed with loading dye and loaded onto the gel. For later size 
determination a DNA ladder (100 bp or 1 kb ladder, Solis BioDyne), was loaded as well. The 
nucleic acids were visualized using UV-light and the desired PCR fragments were cut using 
a scalpel and transferred into an Eppendorf tube. PCR products were purified by gel 
extraction using NucleoSpinTissue (Machinery Nagel) according to the manufactures 
protocol. For elution of the product, water was used.  
 
2.2.5.3. Plasmid purification 
Single colonies were picked, inoculated in LB (5 ml for Mini Prep, 100 ml for a Midi Prep) 
containing the appropriate antibiotics and left ON at 37 °C with 200 rpm on a shaker. The 
next day, the plasmids were purified either using the NucleoSpin Plasmid purification kit 
(Mini Preps, Machinery Nagel) or the Xtra Midi Plus Plasmid Purification kit (Midi Prep, 
Machinery Nagel). The plasmids were eluted in water and stored in aliquots at -20 °C. 
 
2.2.5.4. Sequencing 
PCR products and plasmids were sequenced using the Economy Bar Service of Microsynth, 
Switzerland. The reactions were assembled according Table 3. The total volume per 
reaction was 15 μl. In case of a premixed sample (DNA template and primers), 2 μl of 10 
μM primer solution was used.  
Table 3: Sequencing reactions. Description of effective amounts of DNA per sequencing reaction. 
DNA template Concentration Effective amount  
Plasmid 40-100 ng/μl 480-1200 μg 
PCR product 18 ng per 100 bases in 12 μl 
 
 
2.2.5.5. Molecular cloning 
All constructs were cloned using the Multisite GatewayÒ Three Fragment Vector 
Construction Kit (Invitrogen). It is based on the GatewayÒ Technology and uses site-specific 
cloning, which allows simultaneous assembly of multiple DNA fragments in specific 
orientation and order. The generated expression clone typically contains the promoter, 
gene of interest and termination or polyadenylation sequence.  
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The three mentioned components are provided in an entry clone generated by BP-cloning 
out of an PCR product containing specific sites for recombination. The expression clone is 
generated by recombination of the entry clones in a LR reaction. Experimental procedures 
for each step are described in the following paragraph, a schematic overview is provided in 
Figure 19. 
 
 
Figure 19: Scheme of Multisite Gateway Cloning Procedure. Attb flanked-PCR products will be 
generated by PCR, followed by a BP reaction to generate entry clones. Three entry clones will be 
combined in an LR reaction to finally give rise to the expression clone.  
AttB primer design 
The primer design was done according to the MultiSiteÒ Gateway Three-Fragment Vector 
construction Kit Manual from Invitrogen. For amplification of the mCherry-PA-Rac1 attB1 
and attB2 sites were added to the primers, to generate a fragment suitable for a middle 
entry clone. Furthermore, a Kozak sequence (CAGCCAAC) was added prior to the start 
codon (ATG).  
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For amplification of the UCHD-polyA, attB2R and attB3 sites were added in order to 
generate a 3`entry clone. Respective attB sequences are listed in Figure 20. Primer 
sequences are summarized 2.1.4.  
Figure 20: attB Primer sequences.  
attB1 5`-GGGG ACA AGT TTG TAC AAA AAA GCA GGC TNN—(template specific sequence)-3` 
                                         attB1 
 
attB2r 5`-GGGG ACA GCT TTC TTG TAC AAA GTG GNN—(template specific sequence)-3` 
                                        attB2r 
 
attB2 5`-GGGG AC CAC TTT GTA CAA GAA AGC TGG GTN—(template specific sequence)-3` 
                                         attB2 
 
attB3 5`-GGGG AC AAC TTT GTA TAA TAA AGT TGN—(template specific sequence)-3` 
                                        attB3 
 
Generation of attB- PCR products 
The PCR was performed using following components (Table 4) and thermocycling 
conditions listed in table 5. The reaction was set up with a volume of 50 µl. Plasmids 
containing the gene of interest were used as template DNA for amplification (see 2.1.8).  
Table 4: PCR components listed including final concentrations.  
Component  Final concentration  Provider 
5x Phusion HF buffer 1X New England Biolabs 
10 mM dNTPs 200 µM Promega 
10 µM forward primer 0.5 µM  
10 µM reverse primer  0.5 µM  
Template DNA < 250 ng  
Phusion DNA polymerase  1.0 unit/ 50 µl PCR New England Biolabs 
Nuclease-free water  To 50 µl Ambion 
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Table 5: Thermocycling conditions chosen for amplification of attB PCR products.  
Step Temperature Time 
Initial denaturation 98 °C 3 min 
40 cycles  
98°C  
72°C 
72°C  
10 seconds 
30 seconds 
3 min 
Final extension 72°C 10 minutes 
Hold 4-10 °C ¥ 
 
The PCR was loaded onto an 1 % agarose gel and the product was purified as described in 
2.2.5.2.    
 
BP recombination reaction- generation of entry clones 
Following the PCR, the BP recombination reaction was assembled as in described in Table 
6. Two different donor vectors were used (pDONRÔ 221, pDONRÔ 221 P2rP3) according 
to the flanked PCR product. The amounts for the PCR product needed were calculated using 
following equation:  
Equation 1 
𝑛𝑔 = (𝑥	𝑓𝑚𝑜𝑙𝑒𝑠)(𝑁)(660	𝑓𝑔𝑓𝑚𝑜𝑙𝑒𝑠)( 1	𝑛𝑔10!	𝑓𝑔) 
N is the length of the DNA in base pairs and x the desired amount of fmoles. 
Table 6: Components of a single BP reaction. 
Component Amount  
attB PCR product (20-50 fmoles) 1-7 µl 
pDONRÔ vector 221(150 ng/µl) 1 µl 
1x TE buffer, pH 8.0 to 8 µl 
BP ClonaseÒ II enzyme mix 2 µl 
 
The reaction was assembled on ice and incubated for 2 h at 25 °C. The reaction was 
terminated by adding 1 µl of 2 µg/µl Proteinase K and incubation at 37 °C for 10 min. Upon 
dialyses, bacteria were transformed and plated on Kanamycin resistant plates.  
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Kanamycin resistant clones were screened with Mini Preps and sequenced with the M13 
primers. Correct clones were reinoculated and purified with a Midi Prep, followed again by 
sequencing. 
 
LR recombination reaction- generation of expression clones 
In the LR recombination reaction multiply entry clones are mixed with the destination 
vector, in order to generate an expression clone. The 5`entry clone (p5E) contains the 
promoter, the middle entry clone (pMe) provides the fluorophore (e.g. iRFP670) or a 
protein-fluorophore fusion (e.g. mCherry- PARac1). The 3`entry clones (p3E) generally 
contain the protein of interest (e.g. UCHD) or a SV40 late polyA signal. The destination 
vector (pDest) contain transgenesis marker, that facilitate the screening for founder fish in 
the F1 generation, as well as tol2 sites for Tol2 transposase mediated integration into the 
genome.  
For the reaction following components were assembled on ice in calculated amounts (see 
Table 7): 
 
Table 7: LR reaction components. Concentrations were calculated using Equation 1.  
Component Concentration sample 
attL4 and attR1 entry clone  
10 fmoles 1-7 µl attL4 and attR1 entry clone 
attL4 and attR1 entry clone 
pDEST 20 fmoles 0.4 µl 
TE Buffer, pH 8.0  to 8 µl 
 
The LR ClonaseÒ  Plus enzyme mix was briefly mixed and 2 µl were added to the reaction. 
Incubation was done ON at 25 °C. The next day, the reaction was stopped by adding 1 µl 
Proteinase K to the solution. Transformation was done as previously described and bacteria 
were plated on ampicillin resistant plates. Sequencing was performed using primers listed 
in 2.1.4. 
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3. Results 
 
F-actin polymerization as well as actomyosin-based contractility is required for junction 
elongation  
JBL function strongly relies on F-actin dynamics and polymerization, as was shown in 
Paatero et al., 2018. Inhibition of the small GTPase Rac1 by NSC23766 did not affect JBL 
formation per se, but instead led to a prolonged duration and a decreased periodicity 
(slower oscillations). Altered JBL behavior did affect cell rearrangements and led to a 
decrease in junctional elongation speed.  
At the cellular level, active Rac1 is indispensable for lamellipodia formation during cell 
migration, and this activity has been shown to be mediated through Arp2/3 (Insall and 
Machesky, 2009; Liang et al., 2015). Arp2/3 is an F-actin nucleation factor, that leads to the 
formation of a branched F-actin network and is important for protrusion formation. In 
order to examine the effects on cell rearrangements upon Arp2/3 inhibition, embryos 
expressing EGFP-UCHD were treated with CK666 (Arp2/3 inhibitor) and cell elongation 
speed was measured starting two hours after treatment (compare to Material and 
Methods 2.2.4.2) (Figure 21 B).  
Elongation speed was significantly decreased (mean 3.4 µm/h) compared to 8.0 µm per 
hour in DMSO treated controls (Figure 21 A). Interestingly, Rac1 inhibition led to a similar 
elongation speed (approximately 3 µm/h) (Paatero et al., 2018). However, control 
endothelial cells showed a different pattern of F-actin distribution compared to Arp2/3 
inhibited embryos; in the latter embryos endothelial cells often showed very long and 
prominent F-actin cables reminiscent of stress fibers (Figure 21 H), which points towards 
the inability of cells to generate branched F-actin networks. Instead it might well be, that 
Arp2/3 inhibition shifts F-actin assembly mechanisms towards long, unbranched linear F-
actin filaments.  
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Figure 21: Junction elongation speed is reduced upon inhibition of Arp2/3 or ROCK.  
Representative still images from movies of embryos expressing EGFP-UCHD 
(Tg(fli:Gal4ffubs3,UAS:EGFP-UCHDubs18) around 32 hpf in inversed contrast. A-C. Still overview images 
of 1 % DMSO treated control embryos (A) or treated with 200 µM CK666 (B) or 45 µM Y-27632 (C) 
2 h prior to imaging. D-F. Magnification of junctional rings (region of the inset from A-C) at imaging 
start (0 min) as well as 40-60 min later. G. Quantification of junctional ring elongation speed. 
Junctional elongation speed is significantly reduced in embryos treated with a ROCK or Arp2/3 
inhibitor.  DMSO n=11 junctional rings, Y-27632 n=9 and n=13 in CK666 treated embryos (n>5 fish 
for all conditions). One data point represents the junctional elongation speed of one ring calculated 
in µm per hour. Mean ± SD displayed. Non-parametric Kruskal-Wallis test was used. **p=0.0057, 
*p=0.0389. H. Magnification of embryo treated with CK666. Arrow points towards filamentous 
EGFP-UCHD. Arp2/3 inhibited embryos often show actin arranged in cables.  I. Magnification of Y-
27632 treated embryo. Arrows point towards EGFP-UCHD accumulation, that can frequently be 
observed. Scale bars 10 µm.  
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Analyzing the F-actin dynamics with higher temporal resolution showed, that Arp2/3 
inhibition caused junctional instability in approximately 50 % of the time-lapse series 
acquired (supplemental figure 1 A).  
EGFP-UCHD intensity was very strong and prominent, with specific F-actin localization 
along the junctional ring in treated embryos. Within shortest time, F-actin accumulation 
(EGFP-UCHD intensity signal) decreased. Although the cells maintained contact with their 
neighbors, the mutual contact surface lost F-actin support. This phenomenon is in line with 
results obtained from in vitro studies, where blocking of Arp2/3 lead to a reduced F-actin 
assembly at cadherin-based junctions (Han et al., 2014; Verma et al., 2004). 
Additionally, I observed, that F-actin localization in the JBL region was altered in junctional 
rings that remained intact (Figure 22). In DMSO treated controls, F-actin localization is 
often presented in two distinct populations at the site of JBL (Figure 22). In a total of 8 
movies this particular F-actin pattern was observed in 6 movies (75 %), usually at 1 or 2 
time points (during an imaging period of 15 min). CK666- treated embryos displayed a 
drastically reduced appearance of F-actin in two distinct populations (I only observed this 
in 2 out of 10 videos (20 %)). Furthermore, in 30 % of the analyzed junctional rings, F-actin 
did form diffuse accumulations at the lateral sites of the ring (instead of two populations). 
An example of a prominent, diffuse F-actin accumulation is shown in Figure 22 C'. In 
Paatero et al., 2018 the establishment of two distinct lines of F-actin coincided with a 
distinct and transient localization of ZO1 in these double junctions. It been shown that ZO1 
is recruited to the emerging endothelial junctions as they stabilize (reviewed in Bazzoni and 
Dejana, 2004; Itoh et al., 1997). I therefore wanted to study whether and how mis-
regulation of F-actin polymerization and dynamics impact on the formation of de novo 
junctions during JBL cycles, which will be discussed at later stages of this thesis.   
Besides the importance of F-actin filament assembly and network formation, I was 
wondering whether and how actomyosin contractility may contribute to junction 
elongation. Especially from the point of view that junctions, due to their underlying 
actomyosin ring, are considered contractile structures and thus normally resist elongation, 
it was postulated that its elongation relies on an active process which is driven by a 
deforming force residing outside the EC junction (Sauteur et al., 2014). Furthermore, it is 
known that F-actin dynamics play a fundamental role in recruitment of NMII (and therefore 
generation of contractility) (Verma et al., 2012). Based on that, the contractile properties 
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of the actomyosin cytoskeleton were altered in a follow-up experiment by specifically 
inhibiting ROCK (Y-27632).  
ROCK triggers the phosphorylation of the myosin regulatory light chain, and therefore 
enables the assembly of myosin and F-actin filaments, thereby allowing for contractility. 
Similar to the previously described experiment, inhibition of ROCK reduced elongation 
speed even more drastically (mean elongation speed at 1.33 µm/h, Figure 21 C, F and I). In 
addition, I observed specific phenotypic changes that were associated with ROCK inhibition 
(Figure 21 I). Endothelial cells often showed prominent accumulation of F-actin (visualized 
as dots) throughout the cell. It seems that inhibition of ROCK not only abolished contractile 
properties but also ultimately influenced the assembly or distribution of F-actin.  This is 
consistent with the finding that inhibition of myosin II decreases F-actin assembly (Leerberg 
et al., 2014). While imaging F-actin behavior during junctional ring elongation with higher 
time resolution (every minute), I observed in approximately 60 % of the movies that the 
ring was not maintained (supplemental Figure 1 B). It seems that rather than extending the 
mutual surface of the two opposing cells, cells lose contact, thereby minimizing overlapping 
structures; instead of continuing moving over each other, they tend to move in opposite 
directions.  
This finding cannot in simple terms be explained by the mis-localization of F-actin during 
the process. As described previously, F-actin localizes in two distinct populations during a 
JBL oscillation phase (Figure 22 A). I made similar observations in embryos, in which ROCK 
was inhibited with almost with the same frequency (in 7 out of 10 movies, 70 %). Figure 22 
B and B' show an overview image of the junctional ring at two different time points. 
Magnifications of the two distinct F-actin pools are shown in A' and B' and a schematic 
drawing of the latter is shown in A" and B". One pool is associate more with the junctional 
ring, whereas the more distal F-actin population precedes in an arc-like fashion in the 
direction of the movement.  
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Figure 22: Distinct localization of actin during ring elongation and JBL formation in control and 
embryos treated with a ROCK or Arp2/3 inhibitor. Still images from movies of embryos expressing 
EGFP-UCHD (Tg(fli:Gal4ffubs3,UAS:EGFP-UCHDubs18) in A – C in inversed contrast of the DMSO control 
(1 %) (A), Y-27632 treated (45 µM) embryos (B) or CK666 treated embryos (C). Images show the 
junctional ring in the DLAV around 32 hpf. Two different time points shown in A – C. A' – C' show 
magnification of insert in A - C. A" – C" are schematic representations of images in A', B' and C'. 
Control embryos as well as Y-27632 treated embryos show two distinct actin populations at the 
lateral sites of a junctional ring, whereas treatment with CK666 often leads to a diffuse 
accumulation of actin rather than localization in two lines. Scale bar 10 µm. 
To see, whether this somewhat abnormal F-actin behavior is reflected at the junctional 
level by visible defects, or leads to overall vascular defects, an antibody staining was 
performed. Embryos treated with inhibitors for Rac1, Arp2/3 and ROCK were analyzed with 
regard to expression of ZO1 (supplemental Figures 2 and 3). Short term treatments did not 
appear to affect junctional integrity. ZO1 localization was continuous and not interrupted, 
and junctional rings did form. Although changes in F-actin dynamics strongly affected the 
cell rearrangement behavior, junctional integrity seemed to be largely unaffected.  
In summary, these experiments showed that JBL function and the resulting junctional 
rearrangements do not only rely on F-actin dynamics (e.g. nucleation, branching or 
remodeling) but are also strongly dependent on contractile forces generated within the 
established F-actin network.  
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The F-actin network might provide a scaffold for NMII for its recruitment and the 
generation of local forces at JBL, which in turn drive ring elongation. Therefore, I wanted 
to find out, whether anisotropy in F-actin localization and junctional behavior is reflected 
by differential localization of myosin regulator light chain (MLC) in the JBL vs the junctional 
ring as a whole.  
 
Myosin light chain colocalized with junctional proteins and F-actin and is enriched at JBL 
As described in the previous paragraph, inhibition of ROCK led to a reduced elongation 
speed of the junctional ring during the cell rearrangement process. However, inhibition 
with Y-27632 abolishes ROCK all over the junctional ring, including the medial and the JBL 
part. Therefore, we cannot distinguish whether the defect in junction elongation is due to 
an overall diminished contractile force (all over the junction) or, in particular, to a lack of a 
deforming force (thus, lack of contractility in the JBL). Since we postulate, that JBL provide 
a deforming force, there should be a “disbalance” between the contractile force (entire 
junctional ring) and the deforming force (JBL). If this was true, this could be reflected in an 
anisotropy of the distribution or activity of components of the actomyosin cytoskeleton.  
In order to test this hypothesis, I examined embryos expressing MLC (Myl9-EGFP) in the 
endothelium from a transgene and compared its localization with that of VE-cadherin and 
ZO1 during anastomosis (Figure 23 A-F). Generally, I observed, that MLC was enriched at 
areas of cell-cell adhesion, consistent with the notion that MLC is recruited to junctions 
upon cell adhesion, where it promotes junctional contractility (23 A). It has indeed been 
reported, that homophilic interaction of E-cadherin leads to the recruitment of Myosin II 
(Shewan et al., 2005). In endothelial cells, I observed that MLC prominently and specifically 
accumulates in the JBL region of the junctional ring (23 B-F). Here, two distinct patterns 
were observed. Mostly, MLC clearly colocalized with ZO1 and VE-cadherin in the JBL (23 
E/F). However, occasionally, MLC intensity was highest in areas more distal to VE-
cadherin/ZO1 and manifested as a “preceding” front (23 B-C).  
Heat map images of both VE-cadherin and ZO1 (23 D) showed a diffuse and broad (but 
rather weak) accumulation of junctional proteins at the site of high MLC intensity.  
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Figure 23: Colocalization of Myl9, junctional proteins and actin in junctional rings. A-E. Maximum 
projections of the DLAV of Tg(Kdrl:Mly9a) (green) embryos fixed in Gylofixx or 2 % PFA at 32 hpf 
and co-stained with VE-cadherin (red) and ZO1 (blue). A. Colocalization of Myl9 and VE-cadherin at 
the cell- cell junctions. Arrow points towards area with prominent colocalization. B. Myl9 precedes 
the distal portion of VE-cadherin and ZO1 in the JBL region of junctional rings and colocalizes in VE-
cadherin /ZO1- low regions, a hallmark of JBL. C shows magnifications of inserts in B. Lines define 
border of Cdh5/ZO1 vs. Myl9 expression. D. Heat map- color coded staining of ZO1 and VE-cadherin. 
Note the very prominent distal portion of junctional proteins but additionally a spread weak 
accumulation in the JBL region E. Myl9 expression is strongly enriched in the JBL region.  F. shows 
magnifications of inserts in E. G. Live still image of Tg(Kdrl:Myl9a) (green) and Tg(fli:Galff4ubs3, 
UAS:mRuby2-UCHDubs20) (red). Arrows highlight colocalization of actin an Myl9 at cell-ell junctions 
in general as well as in JBL of a junctional ring. Scale bars 10 µm. 
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This behavior of junctional proteins is a characteristic during a particular time in the JBL 
cycle and is observed during and shortly after initial F-actin protrusions. Life still images of 
embryos expressing UCHD and Myl9 confirmed that MLC is indeed enriched in F-actin rich 
(JBL) regions (Figure 23 G).  
The observed localization/enrichment patterns of MLC clearly show that specific 
localization changes dependent on the JBL cycle. Since JBL are highly dynamic and transient 
structures, it is not surprising that MLC expression patterns vary.  
However, most importantly, anisotropy of MLC localization (specific accumulation at the 
sites of JBL) could be an indication that the deforming force indeed might be stronger than 
the contractile force within the ring.  
 
It remains to be elucidated, how MLC, F-actin and junctional proteins are dynamically 
interlinked. To this point it seems like F-actin accumulations (protrusions) and recruitment 
of junctional proteins (diffuse ZO1 and VE-cadherin) could act jointly as the instructive cue 
to recruit MLC to the JBL. MLC therefore could be responsible for generating a contractile 
force within the F-actin cytoskeleton.  
The F-actin cytoskeleton itself is directly linked to adhesion molecules like VE-cadherin. 
Therefore, I was wondering in a next step, whether potential actomyosin-induced tugging 
forces might be reflected in intramolecular tension changes in VE-cadherin.  
 
VE-cadherin tension in JBL during junctional ring elongation 
We hypothesized that the local adhesion patches generated by VE-cadherin in JBL during 
junctional elongation exhibit different local and temporal VE-cadherin tension and that this 
process is a major contributor to the elongating force. Therefore, the VE-cadherin tension 
sensor line was used to visualize and measure intra-molecular tension across VE-cadherin. 
In general, the goal was to use this tool to correlate JBL activity with the distribution of VE-
cadherin tension during cell rearrangements along the junctional ring as well as during 
formation of the novel junction at the front of the JBL itself.  
The first measurements using the FRET imaging technology in vivo were performed 
according to Lagendijk et al., 2017 to confirm that the imaging technique (plus post 
acquisition analysis) also work in my hands and gives reliable results.  
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Therefore, I determined ratio-metric FRET values in the dorsal aorta (where the tension 
sensor was validated in Lagendijk et al., 2017) in embryos around 50 hpf (Figure 24 A and 
B). Inhibition of ROCK led to a significant increase of ratio-metric FRET and therefore 
decrease in tension (Figure 24 B). That finding was in line with published results and 
confirmed that differences in energy transfer reflect tension changes through VE-cadherin 
(Lagendijk et al., 2017). 
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Figure 24: VE-cadherin tension in junctional rings and in JBL. A. Scheme of quantification done in 
B. Ratio metric FRET values were determined in linear junctions in the dorsal aorta > 50 hpf in 1 % 
DMSO vs. Y-27632-treated embryos. Ratio-metric FRET values in DMSO (n=10 junctions) and in Y-
27632 treated embryos (n=20) in more than 5 embryos each. Treatment of embryos with Y-27632 
led to a decrease in tension in the dorsal aorta at 50 hpf. ****p<0.0001 from unpaired two-sided 
t-test. C. Maximum projection of a junctional ring in the DLAV at around 32 hpf showing the 
expression of venus. Scale bar 10 µm. C'. Example of a heatmap image of ratio-metric FRET values 
in the junctional ring displayed in C. Blue indicates low FRET index (high tension) whereas red 
indicates high FRET (low tension). D. Scheme of quantifications done in E and F. Isolated junctional 
ring is shown. Basis of comparison are JBL vs. medial part of a junctional ring.  E. Quantification of 
the ratio-metric FRET values of JBL vs. the medial junctional part in wild-type (E, n=23 JBL and n=15 
medial part in 10 embryos) and Ve-cadherinubs8-/- background (F, n=20 JBL and n=14 medial part in 
13 embryos). Embryos show no significant mean difference in energy transfer (and therefore VE-
cadherin tension) between the JBL region and the medial part of a junctional ring. Data of two 
independent experiments are shown together. Each datapoint represent one ROI. Unpaired two-
sided t-test used in E and unpaired two-sided Mann-Whitney test in F. G. Schematic representation 
of the measurements quantified in H. Here, the VE-cadherin tension in JBL was determined of 1 % 
DMSO treated embryos vs. Y-27632 treated embryos by measuring ratio-metric FRET (n=20 for 
DMSO (13 embryos) and n=20 for Y-27632 (11 embryos). There was no significant mean difference 
between the two groups. Kolmogorov -Smirnhov test was used. I. Quantification of the absolute 
deviation (from the mean value) was calculated and is displayed in H. There is a significant decrease 
between the DMSO control and ROCK-inhibited JBL, pointing towards a loss of dynamic tension 
changes in VE-cadherin molecules. Unpaired t-test was used *p= 0.0444.  B, E, F, H, I mean ± SD is 
displayed.  
Based on the dynamic nature of JBL, the first experiment after the establishment of the 
method was to investigate temporal changes of VE-cadherin tension during the JBL 
oscillation cycle. Ratio-metric FRET values were determined every minute for several 
consecutive time points. Unfortunately, temporal changes of VE-cadherin tension could 
not be measured due to technical limitations and rapid bleaching of the fluorophores (see 
supplemental Figure 4 A/B). As time resolution of VE-cadherin tension could not be reliably 
performed, we decided to use still images of JBL. The goal of these experiments was to 
analyze the scattering/dispersion of FRET-values both in wild-type conditions (JBL and 
medial part) and upon inhibition of ROCK.  
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Figure 24 C and C' show examples of a junctional ring (maximum projection of the venus 
channel in C) and a representative heat map of the FRET-Index in C'. Colors range from blue 
(high tension, low FRET) to red (low tension, high FRET). Measurements were performed 
both on embryos expressing Tg(ve-cad:ve-cad-TS) in a WT background (24 E) as well as in a 
VE-cadherin mutant background (cdh5ubs8-/-) (24 F). In both cases, there was no difference 
in mean values of JBL and the medial part of a junctional ring. Although this was an 
unexpected result, we observed a slight difference in the distribution of data points 
between JBL and the medial junction part, possibly reflecting the dynamic and non- 
uniform behavior of JBL. To further investigate this, I decided to focus on JBL and compare 
VE-cadherin tension between control embryos and embryos treated with a ROCK inhibitor. 
Based on the observed localization of MLC (see Figure 23) in the JBL, I hypothesized that 
upon inhibition of ROCK JBL dynamics might be abolished and scattering of data points 
might also decrease. Determination of ratio-metric FRET values again showed no difference 
between mean values in JBL from DMSO vs. Y-27632 treated embryos (Figure 24 H). 
However, I could observe a smaller scattering of individual datapoint around the mean 
value. Indeed, quantification of the absolute deviation from the mean proved to be 
statistically significant (24 I). The results for no mean difference between JBL and medial 
part as well as in DMSO vs. ROCK inhibited conditions were also confirmed using donor 
fluorescence lifetime imaging FLIM (Supplemental Figure 4 C & D).  
In summary, these experiments proved and confirmed the dynamic nature of JBLs which is 
also reflected in differential VE-cadherin tension. Of special importance is the finding that 
interference with the actomyosin contractility reduces dispersal of VE-cadherin tension 
values. This shows that ROCK inhibition reduces the possibility of VE-cadherin molecules to 
exhibit differential tension throughout JBL formation.  
The sum of these experiments hints towards a model proposing that JBL generate a 
contractile force via mechanical coupling to the actomyosin network. Furthermore, they 
could do so by transmitting differential tension onto VE-cadherin molecules themselves.  
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Distinct localization of ZO1 as a hallmark during JBL formation and ring elongation 
Since the junctional protein VE-cadherin was demonstrated to play a major role in JBL 
formation (and link proteins to the F-actin cytoskeleton, see Paatero et al., 2018) and for 
force transmission processes (this study), I was wondering how other junctional proteins 
might be affected. During a certain phase during the JBL oscillation cycle (late phase), ZO1 
in particular shows a distinct distribution pattern. It is often localized in two lines 
representing a distal and proximal junction, hereinafter referred to as “double junctions”.  
Double junction formation represents a distinct step during a JBL cycle, in which a new 
distal junction is formed while the “old” one is still maintained. The formation of a new 
junction is initiated by deposition of VE-cadherin and subsequent and transient recruitment 
of ZO1. ZO1 is recruited to new adhesion sites and can be considered as a good indicator 
for formation of new junctions (Itoh et al., 1997). The new junction provides a new anchor 
point more distally and is proposed to be important in driving the movement of endothelial 
cells. I was interested how interference with the F-actin dynamics impacts on the formation 
of a new distal junction, and whether a new attachment site can be formed.  
Junctional adaptor proteins (like ZO1) provide the link between junctional molecules and 
the F-actin cytoskeleton. Therefore, it is very likely, that localization /recruitment of ZO1 is 
dependent on the F-actin cytoskeleton and that the double junction formation is impaired 
at different levels (e.g. formation/maintenance).  
 
Figure 25: Distinct localization of ZO1 during ring elongation and JBL formation in control and 
embryos treated with a ROCK or Arp2/3 inhibitor. 
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Figure 26: Distinct localization of ZO1 during ring elongation and JBL formation in control and 
embryos treated with a Rac1 inhibitor. 
Figure 25/26 : Representative still images from movies of embryos expressing ZO1 
Tg(fli:Gal4ffubs3;UAS:EGFP-hZO1ubs5) in inversed contrast of the DMSO control (1 %) (A), and 
embryos treated with Y-27632 inhibitor (Figure 25 B-B") , CK666 (Figure 25 C-C") and NSC23766 
(Figure 26 B-B"). Images show the junctional ring in the DLAV around 32 hpf. A' – C' show 
magnification of insert in A - C. Three different time points shown. A" – C" are schematic 
representations of images in A '- C '. In control embryos ZO1 is often localized in two lines, a distal 
and proximal junction (“double junction” in A). Interfering with actomyosin tension (Y-27632 in 
Figure 25 B) often leads to diffuse proximal accumulation of ZO1 instead of a defined linear 
junction. Inhibition of Rac1 or Arp2/3 does not abrogate double junction formation (Figure 26 B 
and 25 C respectively) Additionally, treatment with CK666 often leads to dissolution of the 
junctional ring (Figure 25 C' at 6 min). Scale bars 10 µm. 
 
To this end, embryos transgenically expressing EGFP-ZO1 were treated with a Rac1, Arp2/3 
or ROCK inhibitor and imaged ever minute, focusing on the appearance on double junction 
formation (Figure 25 and Figure 26). As mentioned earlier, ZO1 in DMSO controls often 
shows a very distinct localization in two lines, a more distal junction and a proximal one. 
The latter was shown to be the “old” junction, whereas the distal one is considered to be 
the newly formed junction at the site of the JBL. Double junctions in the DMSO treated 
embryos almost appear with a prevalence of almost 100 % (observed in 12 out of 13 
movies) (compare Figure 25A and 26A).  
Inhibiting Rac1 did not alter localization of junctional proteins, and double junctions were 
observed at similar frequency as in DMSO controls (9 double junctions observed in 12 
movies). A representative example is shown in Figure 26 B.  
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When using the Arp2/3 inhibitor CK666, distal and proximal junctions still formed (Figure 
25 C, 0 min), although only half as often as compared to DMSO controls (in 55 % of the 
movies). Interestingly, the junctions appeared to be less stable. In 7 (out of 11) movies the 
junctional ring showed signs of instability or diffuse ZO1 accumulation, up to dissolution of 
the junctions (C' at 6 min). At this stage, it is noteworthy to remember, that Arp2/3 
inhibition led to an altered F-actin localization (compare Figure 22 C). The localization of F-
actin in two distinct outlines might provide a scaffold for junctional proteins to adhere to 
(or vice versa). Sine correct F-actin localization is diminished, this might be reflected in the 
localization of junctional proteins and their disability to maintain integrity.  
In embryos treated with Y-27632, double junctions appear less frequently (in 6 out of 12 
movies). Additionally, I observed that ZO1 manifests as a diffuse but yet prominent 
accumulation which precedes the proximal junction (Figure 25 B). This diffuse 
accumulation of ZO1 was observed in 50 % of the movies. In these cases, elongating cells 
were unable to form double junctions and were impaired in “correctly” localizing ZO1 at 
the JBL.  Interestingly, that F-actin localization remained unaffected (as described in Figure 
22). Therefore, the recruitment of ZO1 and the coherent formation of double junctions, is 
therefore not exclusively dependent on F-actin localization, but rather influenced by ROCK 
functioning as a mediator between ZO1 and the F-actin cytoskeleton.  
Additionally, Arp2/3 inhibition influenced junctional stability, showing that junctional 
integrity and maintenance rely on proper nucleation of the F-actin network, specifically 
downstream of Rac1 (since Rac1 inhibition did neither alter double junction formation nor 
junctional integrity). However, the most obvious phenotype did arise upon ROCK inhibition. 
Loss of double junction formation (resulting in loose accumulation of ZO1) points to the 
possibility that the actomyosin cytoskeleton signals back to the junctions and influences 
their localization.  
In summary, I found that the formation and stabilization of a new distal junctions, which is 
reflected in the intermediate state of double junction formation is altered after interfering 
with F-actin dynamics at different levels. Whereas Rac1 inhibition does not impact the 
formation nor stabilization a new junction, ROCK interfered with recruitment of ZO1 to a 
newly formed adheres-based junction. Arp2/3, on the other hand, led to normal 
unimpaired formation of the new junction; however, Arp2/3 seemed to be required for its 
maintenance and stabilization.  
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It is very interesting that in all of these studied cases the cell rearrangement process was 
impaired (compare Figure 21). Thus, the elongation does not only dependent on the 
formation of a new distal junction but relies on several other components that interplay 
along the junctional ring.  
Junctional ring elongation mediated by JBL seems to be a very complex process and 
requires a proper and tightly regulated interplay of F-actin dynamics and contractility but 
also proper localization and recruitment of junctional proteins. I hypothesize that double 
junction formation is indispensable for junction elongation, and these junctions need to be 
embedded in a functional and dynamic F-actin network.  
 
Generation and transgenic expression of Kdrl:mCherry-PA-Rac1  
Based on previous findings from Paatero et al., 2018 and on my own studies, Rac1 function 
does not seem to be strictly required for JBL function. Formation of JBL is largely 
unimpaired upon Rac1 inhibition, although the oscillatory behavior is slightly affected 
(increased oscillation time). Additionally, also the formation of a new distal junction 
seemed to be largely unaffected upon inhibition.  
Although the requirement for Rac1 was relatively relaxed, we wanted to investigate 
whether Rac1 activation could drive JBL formation during cell rearrangements in the 
process of anastomosis.  
Therefore, I decided to generate a plasmid containing a photoactivatable version of Rac1 
(PA-Rac1) under an endothelial specific promoter. This construct has previously been 
already successfully expressed in vivo in zebrafish neutrophils, and it was subsequently 
shown that localized activation of Rac1 can indeed induce protrusion formation and 
induced directed cell migration (Yoo et al., 2010). 
 
For transient expression in the zebrafish vasculature, I designed a plasmid construct 
containing the endothelial specific promotor kdrl as well as sequences encoding PA-Rac1 
fused to mCherry. Using the gateway multisite cloning approach, also a Kozak sequence 
and a poly-A tail were included. Furthermore, a transgenesis marker was added for future 
screening purposes. A scheme of the final plasmid is presented in simplified version in 
Figure 27 A.  
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Injection of plasmid DNA into zebrafish embryos showed specific expression in the 
vasculature (Figure 27 C) and expression of the transgenesis marker in the eye (27 B).  
 
Figure 27: Design and generation of a Kdrl:mCherry-PA-Rac1 construct and its transient 
expression. A. Scheme of the designed expression vector, containing the endothelial specific kdrl 
promotor, the protein of interest (PA-Pac1) fused to a fluorophore (mCherry) in a beta crystalline 
backbone (transgenesis marker), resulting in the expression of BFP in the eyes. B. Expression of ß-
crystalline-BFP in the eye of a 48 hpf old embryo expressing (Tg(fli:Gal4ffubs3,UAS:EGFP-UCHDubs18). 
B' magnification of the insert in B. C. Transient endothelial expression of kdrl:mCherry-PA-Rac1 (C' 
in red) in an embryo expressing Tg(fli:Gal4ffubs3,UAS:EGFP-UCHDubs18 embryo at 48 hpf. Merge 
shown in C". Live still images. Scale bar 30 µm.  
To date, there is no in vivo data available regarding endothelial- specific expression of Rac1 
or its activation via PA-Rac1. Therefore, the functionality was tested at first, combined with 
the establishment of an appropriate experimental setup and imaging method. 
Activation of Rac1 leads to a decrease in filapodial number as well as in cell size 
mCherry-PA-Rac1 was transiently expressed and initial experiments were performed at 
around 50 hpf in the DLAV. Time lapse imaging was done for 12 timepoints in an inactivated 
state, then Rac1 was activated with 20 % intensity of the 458 nm laser for 15 time points 
(while imaging continued), followed again by post- activation image acquisition. Activation 
of Rac1 was not locally restricted but performed on the whole frame/image.  
Temporal activation of Rac1 led to the observation of two different phenomena, which 
were all confirmed in at least three independent experiments.  
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Firstly, during the time of Rac1 activation, the number of dynamic filipodia was reduced 
(even to zero), but recovered after the 458 nm laser was turned off again. In Figure 28 A, 
three exemplary images are shown for each imaging period. Quantifications are presented 
in C and D. Furthermore, it looked like cell membrane ruffles did increase (Figure 28 B). 
Secondly, the cell size temporarily decreased during the time of Rac1 activation (28 E-G).  
 
 
 
458 nm ac)va)onbefore ac)va)on a0er ac)va)on
0 10 20 30
0
2
4
6
8
time in min
N
um
be
r o
f F
ilo
po
di
a
DLAV- 48 hpf No of Filopodia
t (1) =46.7 s
19.06.2019- Fish 1 Pos 1
activation
Be
for
e a
cti
va
tio
n
Ac
tiv
ati
on
Af
ter
 ac
tiv
ati
on
0
2
4
6
8
No of Filopodia activation vs no activation
N
um
be
r o
f F
ilo
po
di
a Before activation
Activation
After activation
PA-Rac1-mcherry in WT 48-50 hpf
activation
458 nm ac)va)onbefore ac)va)on merge
Be
for
e A
cti
va
tio
n
Ac
tiv
ati
on
Af
ter
 ac
tiv
ati
on
 
70
80
90
100
110
Data 6
C
el
l S
iz
e 
in
 %
 
0 10 20 30
85
90
95
100
105
110
time in min
C
el
l S
iz
e 
in
 %
1 Cell example in %
activation
A
B C D
E
F G
A   ̍
E   ̍ E  ̎
A  ̎
Results  
 75 
 
Figure 28: Change of cell size and filopodia number in endothelial cells after temporal 
photoactivation of PA-Rac1. A-A" Endothelial cell at 48 hpf in the DLAV transiently expressing 
mCherry-PA-Rac1. Images were taken out of a movie and shown in inversed contrast. 
Representative images were chosen before activation (A) of Rac1, during activation with 20 % 458 
nm (A') and after activation (A"). Arrows point toward filopodia. Scale bars 20 µm. Magnification of 
insert in A" shown in B. Membrane ruffling seems to increase after Rac1 activation at the cell-cell 
border C. shows a quantification of the absolute number of filopodia of the cell displayed in A, 
during the imaging period (12 time points before activation, 15 with activation of PA-Rac1 and 12 
post activation). Time of activation is highlighted in orange. Activation of Rac1 led to a reduction of 
filopodia number, which again increased in the post-activation period. D. Quantification of number 
of filopodia in four different cells in the DLAV (n=4 fish). Numbers before, during and after activation 
are displayed as average during the respective time period. D-D' Show the same cell as in A-A" but 
with emphasize on the cell shape and area. In D the cell area is colored in black (before activation), 
D' during activation (orange) and the merge is displayed in D". E. Quantification of the cell size 
during the imaging period. For each time point the cell area is displayed. Cell size at t=0 is 
considered to be 100 %. Cell size decreased upon Rac1 activation, but went back to the original cell 
size (or bigger) post-activation. F. Quantification of the cell area of three independent cells in the 
DLAV (n=3 fish). For each time period (before, during and after activation) the average cell size is 
displayed in % of the cell size determined at t=0.  
 
Filopodia reduction and cell size decrease represented an unexpected finding. However, 
since this cell behavior only occurred during the time of Rac1 activation and returned to 
the baseline state (before activation) afterwards, it appeared to be a specific response to 
Rac activation. Nevertheless, how this might be induced by the activation of Rac1 remains 
to be elucidated. Rac1 is mainly known to be an important factor for lamellipodia formation 
and accumulation of F-actin in larger protrusions at the cell edge, but not for the formation 
of filopodia.  
How Rac1 directly regulates cell size, is to the best of my knowledge, not known. However, 
two possible scenarios might account for the change in cell size. Firstly, Rac1 overactivation 
could alter the cortical actomyosin network and leading to increased tension. Secondly, it 
could act on the cell junctions. Overactivation of Rac1 could lead to increased tension at 
cell-cell interfaces, leading to the shrinkage of the cell.  
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To further explain this phenomenon, it would be really interesting to analyze ubiquitous 
activation of Rac1 in an isolated cell (without affecting cell junctions).  
Another explanation would be, that ubiquitous activation of Rac1 alters or abolishes 
polarity of the cell. This aspect proves the importance of locally restricted activation of 
Rac1, in order to not change the entire polarization of the cell.  
Based on these findings, I decided that activation of Rac1 needs to be not only temporarily 
but also locally restricted. Furthermore, I considered it as a necessity to concomitantly 
visualize F-actin in these experiments.  
 
Generation of a new iRFP- UCHD fishline 
In all available transgenic fish lines, F-actin is either fused to the fluorophore EGFP or to 
mRuby, neither of which is compatible with the coexpression with PA-Rac1. Imaging EGFP 
with the 488 nm laser already leads to unwanted activation of PA-Rac1 (data not shown), 
whereas mRuby is imaged using the same wavelength as mCherry (561 nm).  
 
 
Figure 29: Design of the fli:iRFP-UCHD; cmlc2-mKate2 vector and its transient expression. A. 
Scheme of the designed expression vector, containing a vascular endothelial specific promoter fli, 
the fluorophore (iRFP) as well as the protein (UCHD) labelling actin in a cmlc2:mKate2 backbone 
vector, resulting in mKate2 expression in the heart. B. Expression of the transgenesis marker 
(cmlc2:kate2) in the heart (red) of a 2 dpf embryo. C-C". Transient and vascular expression of 
fli:iRFP-UCHD (C') in a Tg(Kdrl:EGFPs843) expressing embryo (C). Merge is shown in C". Live still 
images. Scale bars 30 µm.  
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To overcome this problem, I generated another transgenic fish line with an iRFP-UCHD- 
reporter, which can be visualized using the 633 nm laser and thus does not interfere with 
activation of the PA-Rac1 transgene. The design of the plasmid is displayed in Figure 29 A. 
A transient expression pattern in the zebrafish vasculature after injection is shown in C.  
Both constructs (kdrl:mCherry-PA-Rac1 and fli:iRFP-UCHD) were injected and successfully 
co-expressed, which is shown in Figure 30 A.  
 
Activation of PA-Rac1 leads to recruitment of F-actin to cell-cell junctions 
In order to examine the effects of Rac1 activation on F-actin linked behaviors, activation of 
PA-Rac1 was performed ubiquitously in an endothelial cell of the DLAV in embryos around 
50 hpf. In these experiments, time lapse imaging was only performed in the UCHD channel 
pre-activation (Figure 30 B) and during activation of PA-Rac1 (Figure 30 B'). 
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Figure 30: UCHD localization upon temporal activation of PA-Rac1 in embryos expressing 
kdrl:mCherry-PA-Rac1 and fli:iRFP-UCHD transiently at around 50 hpf. A-A" Still images from a 
movie of a cell in the DLAV showing transient expression of iRFP-UCHD (A) and kdrl:mCherry-PA-
Rac1 (A') after co-injection of the two constructs. Colocalization is shown in A". B and B' show still 
images of the same cell as shown in A.  Only iRFP-UCHD was imaged. Three different time points 
are shown for the un-activated state (B, before activation) as well as for the activated state (B'; PA-
Rac1 activation with 20 % 458 nm in the whole image). Images shown in inversed contrast. 
Activation of Rac1 leads to actin accumulation at the cell borders. In B' also magnifications of the 
inserts at 6 min as well as 15 mins are shown. Arrows point towards actin accumulation at the cell 
junction. Scale bars 20 µm.  
After activation of PA-Rac1 an immediate increase of UCHD-signal at the region of the cell-
cell junction was observed (see Figure 30 B' at 6 min and 15 min). This F-actin accumulation 
was not present before activation and furthermore, did remain at this specific localization 
during the activation period.  
Having zebrafish transgenically expressing both proteins (iRFP-UCHD and mCherry-PA-
Rac1) at hand, I decided to repeat the previous experiments. Using a stable line, instead of 
relying on transient expression, offers several advantages. First of all, the yield of double 
positive cells is much higher, and secondly, it enables analyses, that go beyond single cells. 
The latter allows to include the surrounding cells in the analysis, rather than focusing on a 
single cell without looking at effects of or in direct neighbors. Last but not least, working 
with stable lines provides a certain flexibility concerning duration or timepoint of the 
analyses.  
The expression pattern of G0 founder fish is presented in Figure 31. In A and A', iRFP-UCHD 
is shown during two timepoints of embryonic development (2 dpf in A and 5 dpf in A'). An 
embryo coexpressing both constructs (incross of the two G0 founder fish) is shown in Figure 
3 in the trunk (B) and head (C) region. Generally, I observed, that expression of PA-Rac1 is 
mosaic in the trunk and much stronger (and not mosaic) in the brain vasculature. iRFP-
UCHD expression, on the other hand, is rather uniform throughout the vasculature.  
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Figure 31: Endothelial specific expression of fli:iRFP-UCHD and Kdrl:mCherry-PA-Rac1 in 
transgenic fish lines.  A and A'. Live still images of the vasculature of an embryo expressing 
Tg(fli:iRFP-UCHD) at 2 dpf (A) and 5 dpf (A"). Images shown in inversed contrast. Scale bar 50 µm. 
B-C. Still live images of a Tg(fli:iRFP-UCHD; kdrl:mCherry-PA-Rac1) expressing embryo at 48 hpf in 
the tail (B-B") and head (C- C") region. Individual channels are shown in red Tg(Kdrl:mCherry-PA-
Rac1) (B and C) and green (fli:iRFP-UCHD) (B' and C'). Merges are shown in (B" and C"). Scale bars 
30 µm.    
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Imaging was performed as previously described. A still image of the vasculature at 50 hpf 
is shown in Figure 32 A-A''. Still images from embryos expressing iRFP-UCHD from movies 
are shown in inversed contrast in B and B''.  
Activation of Rac1 led to a prominent accumulation of UCHD at cell-cell junctions (arrow 
and magnification in B'), which confirmed the observation of my initial experiments. 
Specific, Rac1-induced F-actin accumulation at the junctions point towards an increase of 
junctional F-actin. This finding supports the previous hypothesis, that changes in cell shape 
might be linked to enhanced junctional contractility, as overactivation of Rac1 led to 
enhanced junctional F-actin. 
 
 
Figure 32: Temporal activation of PA-Rac1 led to the recruitment of actin to the junctions. For this 
experiment two individual founder fish were crossed. A-A" live still images of the vasculature 
expressing both iRFP-UCHD (A) and mCherry-PA-Rac1 (A") at around 50 hpf. Merge is shown in A". 
B and B' show still images from movies of the region as shown in A.  Time-lapse imaging was only 
performed in the iRFP-UCHD channel. Three different time points are shown for the un-activated 
state (B, before activation) as well as for the activated state (B'); PA-Rac1 activation with 20 % 458 
nm in the whole image). Inversed contrast. Temporal activation of Rac1 led to accumulation of actin 
at the cell-cell junction, confirming previous results (Figure 30).  Arrow in B' (at T=13) points towards 
actin accumulation at the cell junction. Magnifications are shown as well. Scale bars 20 µm. One 
time point is equal 59.81 s. 
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It should be kept in mind that these experiments were performed at rather late stages 
during vascular development (50 hpf), when compared to the majority of the other 
experiments presented in this thesis (32 hpf).  At 50 hpf, the DLAV is already fully 
established and carries blood flow, whereas at 32 hpf, during anastomosis, prominent cell 
rearrangements take place. Whether Rac1 activation has a different effect on cell behavior 
at earlier time points will be very interesting to test. In general, analyzing the effects of 
Rac1 at earlier stages during vascular development will give important insights into 
differential effects of Rac1 activation during cell rearrangement processes. Whereas at 50 
hpf recruitment of F-actin might serve to stabilize the mature junctions, activation of Rac1 
might lead to a different phenotype at earlier stages. Presumably, Rac1 might rather act at 
the leading edge in migratory cells and its activation might result in enhanced protrusive 
activity (and F-actin assembly).  
 
Analysis of JBL dynamics in the dorsal aorta  
JBL were identified and characterized in the DLAV during cell rearrangement processes. 
Whether this behavior is restricted to the process of anastomosis or might possibly be a 
general mechanism that cells use for cell shape changes/rearrangements or migration, has 
not been analyzed in much detail. However, analyzing F-actin intensity fluctuations at 50 
hpf in the DA showed that local forward movements correlated with higher intensity of 
UCHD. This indicates that F-actin protrusions also are present in the DA and mechanistically 
contribute to behaviors linked to cell migration (Paatero et al., 2018). Analysis in this study 
identified double junction formation as an important hallmark of JBL formation. Specific 
protein localization in conjunction with a functional and contractile F-actin network provide 
the basis for cell rearrangements. Therefore, I wanted to analyze whether the observed cell 
protrusions during later development of the vasculature are similar or equivalent to the 
JBL observed during anastomosis. Therefore, I first checked for the presence of double 
junctions, since they appear to be a salient feature of JBL.  
 
Double junction formation in the dorsal aorta  
I imaged embryos transgenically expressing EGFP-ZO1 starting around 50 hpf in the DA and 
mainly focused on the formation of double junctions along cell-cell interfaces. 
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Indeed, I did observe this specific transient structure (compare Figure 33). They seemed to 
last much longer and were observed consecutively during 10-13 min (A ') (3 independent 
examples observed). The overall frequency was not quantified. This observation supports 
the hypothesis, that JBL are of more general nature, and employed in different tissue 
context throughout the vasculature.   
 
Figure 33: ZO1 double junctions in the dorsal aorta at 52 hpf. A. Still images from a movie of a cell 
in the dorsal aorta expressing Tg(fli:Gal4ffubs3;UAS:EGFP-hZO1ubs5) at around 52 hpf shown in 
inversed contrast. Dashed lines mark the outline of the DA. Magnifications of the inset in A are 
shown in A' at 6 different time points. Double junctions can be also observed at cell-cell junctions 
in the dorsal aorta. ZO1 accumulates in two distinct outlines. Scale bar 10 µm. 
Since cells in the dorsal aorta are embedded in a very different cellular context, I was 
wondering what cell behaviors might be influenced by JBL in the DA. For this purpose, I 
imaged the dorsal aorta (EGFP-UCHD) during three different time points (26 hpf, 50 hpf, 
and 74 hpf) in embryonic development and vascular maturation. Hereby I focused on 
changes in the cell architecture and on F-actin dynamics at the cell junctions (Figure 34).  
 
Cell shape changes and F-actin dynamics during maturation of the dorsal aorta 
At 26 hpf (Figure 34 A) the cells in the DA show very dynamic behavior. Even during a 60 
min imaging period, dynamic junctional behavior accompanied by very prominent cell 
shaped changes can be observed. Along the junctions themselves, F-actin intensity is 
fluctuating massively, indicative for a very high F-actin turnover and local protrusion 
formation.  
 
Dorsal Aorta ZO1 52 hpf 
1 min 3 min 5 min
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A A ̍
Results  
 83 
 
 
Figure 34: Cell shape changes and actin dynamics in the dorsal aorta during vascular maturation. 
A-A". Still images from movies of embryos expressing Tg(fli:Gal4ffubs3,UAS:EGFP-UCHDubs18) in the 
dorsal aorta at 26 hpf (A), 50 hpf (A') and 74 hpf (A") shown in grey scale. Scale bar 20 µm. B-B". 
Schematic representation of cell shaped based on the image displayed in A-A". Note the change of 
cell shape during time of development. C-C". Shell shape changes during an imaging period of 60 
minutes. Schemes are drawn based on movies at imaging start 0 minutes and 60 minutes later. At 
26 hpf, cell shape changes can be observed within shortest time, whereas among more mature cells 
the architecture is mostly maintained. D-D" Kymographs across the junction during an imaging 
period of 60 minutes (X-axis). Representative examples picked. E-E" Plots of the kymographs in D-
D" based on a custom written Matlab algorithm.  
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Cell shape changes occur in very short time and can be observed remarkably already 60 
min after imaging start (Figure 34 C). 24 hours later, at 50 hpf (34 A'), endothelial cell shape 
in the DA became much more stable, as reflected by less junctional movement. Although 
F-actin was still recruited to the junctions (local intensity changes) and protrusions were 
still formed, these activities did not translate into prominent cell architectural changes. The 
cell contacts remained almost stable and F-actin dynamics was only be observed very 
locally.  During 60 minutes, cell shape changes are minimal (34 C'). At 74 hpf (34 A"), the 
cells seemed to become almost entirely quiescent. The junctional F-actin turnover was 
almost abolished (no intensity peaks). Furthermore, there was no protrusive activity. This 
is reflected in the very stable and rigid architecture/network. Changes in junctional 
dynamics over time, were also well reflected in kymographs. Kymographs draw a graphical 
representation of a certain point of the junction over time (here 60 min, C"). The actual 
kymograph is presented in D-D", whereas a graphical representation is plotted in E-E". The 
kymograph at 26 hpf shows a clear movement of junction (E), which gets reduced over 
time. By 74 hpf (D"), the kymograph is almost a flat line, meaning that the followed point 
at the junction did not change its position.  
In summary, these observations pointed towards a potential role of JBL/local F-actin 
protrusions during the maturation process and concomitant morphological changes. They 
might be of importance for corrects alignment of endothelial cells, potentially in response 
to shear stress. Further studies will be needed to support this hypothesis.  
 
Junctional integrity and dynamics are altered upon interfering with F-actin branching, 
protrusion formation and actomyosin contractility.  
Because I was able to confirm the presence of JBL in the DA and furthermore observed F-
actin based JBL dynamics in the young DLAV (32 hpf), I was wondering whether 
interference with regulators of F-actin also impact on junctional F-actin dynamics in the 
dorsal aorta (a fully lumenized vessel). Similar to the experiments performed in the DLAV, 
ROCK, Arp2/3 and Rac1 were inhibited and F-actin dynamics was analyzed (Figure 35).  
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F-actin based junctions in ROCK inhibited embryos (Figure 35 A) appeared as linear and 
continuous structures. F-actin dynamics (reflected in intensity changes) seemed to be 
reduced compared to the wildtype vasculature, indicating a reduced F-actin dynamic. 
However, this was not quantified and observations were purely made visually by video 
analysis of the time-lapse series. Interestingly, I did observe locally formation of F-actin 
accumulations and protrusions (see 35 A'). Although inhibition of ROCK did not seem to 
affect junction stability per se, F-actin turnover seemed to be decreased, pointing towards 
a defect in recruitment of new F-actin, which in turn initiates JBL formation at the junctions.  
Inhibition of Arp2/3 led to a more pronounced phenotype (B and B'). The junctions were 
interrupted and F-actin localization at the junctions was less defined (“fuzzy” appearance 
and gap formation). This suggests that inhibition of Arp2/3 reduces F-actin assembly at 
junctions and is in line with findings obtained during anastomosis. Furthermore, it points 
toward the necessity of branched F-actin networks to stabilize junctions and to maintain 
endothelial barrier integrity. Moreover, the cells appear to be stacked one behind the 
other, potentially pointing towards impaired cell rearrangements. Disruption of junctions 
was also observed when inhibiting Rac1 (Figure 25 C and C'), an upstream activator of 
Arp2/3; however, the effect was not as dramatic as when Arp2/3 was inhibited. 
Additionally, junctions also appeared less “defined”. Interestingly, I observed the formation 
of very prominent F-actin protrusions that resemble filopodia (C'). Generally, it seemed 
that junctions are more dynamic leading to subtle but yet visible cell shape changes. The 
latter observation is rather unexpected, and enhanced dynamics might be explained by 
increased filopodia formation. That in turn might be translated into increased junctional 
movement which lead to cell shape changes. Junctional movement and cell shape changes 
over 60 minutes are schematically represented in A"-C". In general, the cellular architecture 
upon ROCK and Arp2/3 inhibition appeared to be quite constant and unchanged over time, 
whereas in Rac1 inhibited embryos a small change of cell shape was detectable.  
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Figure 35: Actin dynamics in the dorsal aorta upon interfering with the F-actin network. A-C. Still 
images from movies of embryos expressing Tg(fli:Gal4ffubs3,UAS:EGFP-UCHDubs18) in the dorsal aorta 
treated with Y-27632 (A), CK666 (B) or NSC23766 (C) shown in grey scale. Scale bar 20 µm. A'-C' 
Magnifications of inserts in A-C. Prominent UCHD accumulation and long actin protrusions can be 
observed (A' and C'), resembling filopodia. Furthermore, junctions appear to be discontinuous (B' 
and C') and disrupted after Arp2/3 or Rac1 inhibition. Junctional integrity was maintained in 
embryos where ROCK was inhibited (A). Endothelial cell shape after Inhibition of ROCK (A") and 
Arp2/3 (B") did not change in a 60 min imaging interval, whereas Rac1 inhibition (C") lead to 
increased morphogenetic changes. Observations were made based on movies.  
 
In summary, the experiments provide evidence to support the hypothesize that JBL are 
required for morphogenetic cell shape changes during vascular development. JBL function 
and junctional integrity rely on and can only be maintained when the F-actin network is 
fully functional. Further experiments need to done in order to get a full picture e.g. 
analyzing the dynamics of F-actin and junctional components in parallel.  
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4. Discussion 
 
Organ morphogenesis relies on dynamic cell behaviors, which are tightly coordinated to 
ensure a functional cellular organ architecture. The vasculature represents one of the most 
ramified organs in vertebrates and captivates due to its enormous plasticity, which is crucial 
for the organism to respond to different contextual cues e.g. responses to inflammation or 
would healing. Organ plasticity on cellular level requires a repertoire of dynamic cell 
behaviors, which include cell migration, proliferation, cell shape changes and cell 
rearrangements during formation of new blood vessels. Here, a dynamic balance between 
inter-endothelial cell adhesion and plasticity allows angiogenic sprouting while maintaining 
the endothelial seal. In order to get an insight into the physical and molecular dynamics 
underlying cell rearrangements and dynamic cell shape changes, I have analyzed so-called 
junction based lamellipodia (JBL), that were recently identified (Paatero et al., 2018). JBL 
were found to be employed by endothelial cells for movement and rearrangement 
behavior and appear to function via a VE-cadherin/F-actin driven ratchet mechanism. 
During the work of my thesis, I focused in particular on the cytoskeletal F-actin dynamics, 
its regulation and consequences of changes in F-actin dynamics on JBL formation and 
function.  
As discussed below, my work has led me to a better understanding of F-actin dynamics, 
which can be used to refine the existing working model of JBL oscillations.  
 
Proposed oscillatory mechanism of JBL  
One cycle of JBL during the elongation of endothelial cell junctions can be schematically 
subdivided into four steps. In a first step, an F-actin protrusion emanates distally from a 
stable junction, representing sites of F-actin polymerization. Inhibition of F-actin 
polymerization by latrunculin (but not Rac1) drastically reduced the appearance of JBL, 
supporting a key role for actin polymerization. However, inhibition of Rac1 did interfere 
with the oscillation time (longer oscillation cycle). Furthermore, protrusion formation and 
correct localization of F-actin at the sites of JBL relies on Arp2/3 and its activity as F-actin 
nucleation factor and generator of branched F-actin networks.  
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F-actin based membrane protrusions lead to the recruitment of the junctional protein VE-
cadherin in diffuse manner (step 2). Next (step 3), the adaptor protein ZO1 is recruited to 
the sites of newly established VE-cadherin junctions, thereby stabilizing them. At this point, 
a very distinct localization of ZO1 in two lines can be observed. We call this transient 
structure “double junctions”. Double junction formation was impaired upon ROCK 
inhibition, indicative for the necessity of actomyosin contractility for correct localization of 
junctional proteins. Additionally, maintaining the double junctions, but not the initial 
formation required the presence Arp2/3. In a last step (step 4), it is hypothesized that the 
two junctions are eventually pulled towards each other, generating the motile force which 
is necessary for junction elongation. This force that is needed for the junction conversion 
seemed to be mediated by actomyosin contractility and this could be supported by the 
finding, that the myosin regulatory light chain specifically localizes at the sites of the JBL. 
Changes in actomyosin contractility were also reflected in differential VE-cadherin tension. 
The latter was shown to be dependent on ROCK as well.   
 
Actin driven membrane protrusions: JBL vs. JAIL  
Recently, oscillatory protrusions have been described also in vitro in HUVECs. Abu Taha et 
al., 2014 identified highly dynamic and spatiotemporally confined actin-driven structures, 
that they call junction-associated intermittent lamellipodia (JAIL). JAIL also lead to the 
formation of new VE-cadherin sites and during their oscillation cycle distinct steps can be 
identified. JAIL (in vitro) and JBL (in vivo) both were postulated to contribute to cell 
migration; however, besides their structural and behavioral similarities, it is necessary to 
look at them closely to compare them.  
A prerequisite for JAIL to form is a local decrease of VE-cadherin density/concentration, 
whereas the actin-driven membrane protrusions in JBL emanate from a stable junction at 
the pole oriented in the direction of cell movement. In both scenarios, the establishment 
of protrusion is Arp2/3-dependent and VE-cadherin protein is diffusely localized in this 
area. However, during JAIL formation, VE -cadherin forms cluster at the respective end of 
the protrusion, which leads to the formation of a new junction. The basis of the 
lamellipodia is not supported by a junction. During the JBL oscillatory cycle, a new junction 
is established as well (marked by the presence of VE-cadherin and ZO1).  
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However, the new junction is formed, while the “old” one is still maintained- leading to the 
characteristic intermediate state of double junction formation. These two junctions are 
hypothesized to be pulled towards each other, whereas during JAIL formation, the junction 
rather “dissolves”. Conceptually, maintenance of junctional integrity during JBL formation 
might be an important factor to ensure proper vascular sealing and to prevent 
hemorrhages. Therefore, although the appearance of actin-driven membrane protrusions 
as described in vitro and in vivo might share similar properties, they potentially play 
different biological roles, which is reflected in their different structural appearance. The 
two mentioned concepts are contrasted in Figure 36.  
 
 
Figure 36: Formation of JAIL vs JBL. During one JBL oscillation cycle (top row), an F-actin-based 
protrusion emanates from a stable junction. Subsequently a new distal junction is formed, leading 
to double junction formation as an intermediate step. In a last step, the two junctions are eventually 
pulled towards each other. Bottom row: JAIL (junction-associated intermittent lamellipodia) have 
originally been described in HUVECs, where they form under subconfluent conditions (Abu Taha et 
al., 2014). JAIL formation is preceded by the local decrease of VE-cadherin density at the junctions 
and following the protrusions are formed. New VE-cadherin clusters form at the front of 
lamellipodia, giving rise to a stable junction. VE-cadherin is indicated in orange. Protrusions contain 
F-actin (blue) and VE-cadherin.  
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Last but not least, JAIL formation was discovered in subconfluent HUVECs cultures, where 
they are required to maintain the integrity of a monolayer. The model system in which I 
investigated JBL formation and regulation is very different. Anastomosis in the zebrafish 
DLAV is a two-cell mechanism, and therefore allows analyses at single (or two) cell level, 
rather than statements based on a multicellular system. Findings obtained in multicellular 
systems regarding junctional remodeling and cell shape changes conceptually might 
underlie very different morphogenetic and physical principles, which will be discussed in 
the following section.  
 
Junctional ring elongation and cell rearrangements require a deforming force  
Previous work has identified JBL as a central means of endothelial cells to drive cell 
movements as well as cell rearrangements during the process of anastomosis. Cell 
rearrangements and movements are reflected in extensive junctional remodeling, 
ultimately changing the vessel architecture from a unicellular to a multicellular tube 
(Lenard et al., 2013; Paatero et al., 2018).  
Generally, how local cell shape changes and regulation of cell-cell contacts are drivers for 
tissue-level deformations such as elongation has been addressed in several studies 
throughout the last decades (reviewed among others in Heisenberg and Bellaïche, 2013; 
Lecuit et al., 2011). It is known that intercellular adhesion enables extensive remodeling 
and that these rely on the generation of traction forces by the actomyosin cytoskeleton 
transmitted onto the cell cortex. Morphogenetic processes such as convergence extension 
movements in drosophila tissue elongation or tissue invaginations due to apical 
constriction illustrate how the polarized regulation of force generation and transmission 
leads to changes in tissue shape. In this specific cellular context, cells are mechanically 
coupled and e.g. local contractility generated in a single cell coordinates and influences 
behavior of the neighboring cell, up to tissue level effects (Martin et al., 2010). This 
ultimately raised the questions of what drives cell elongation and rearrangements during 
anastomosis in the DLAV (as investigated in this study). It is important to mention that this 
process relies on the interaction of two single neighboring cells.  
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The analyzed junction is of isolated nature and not influenced by several surrounding cells, 
as this is the case for multicellular systems (compare Figure 37). In consequence, no outside 
forces from surrounding cells are expected.  
 
 
Figure 37: JBL as driving force for junctional elongation of an isolated ring-shaped junction. A. In 
a multicellular system, a single cell is surrounded by several neighbors, with which they establish 
junctions. A potential force tugging on the cell junctions has effects on the whole tissue, as they are 
all coupled to each other (indicated as arrows). B. During anastomosis in the DLAV, only two cells 
contribute to the process of ring elongation. The junction is isolated. Since no outside force can be 
generated, it is postulated that JBL provide the force needed for the round to elliptic shape 
conversion. Green= adherens junctions. Red= actomyosin ring. 
If no force can be generated within a complex multicellular environment by secondary 
junctions in the surrounding, what exactly drives this junctional elongation? Based on these 
reflections we therefore postulated that in such a two-cell configuration with an isolated 
junction, a deforming force is required driving the round to elliptic shape conversion of the 
junction. This force in our case originates from the JBL and these are considered to be the 
active motor.  
 
JBL as local motile force generator during junctional ring elongation  
Postulating a local force originating from JBL has led me to investigate the role of 
actomyosin contractility in this cell rearrangement process. At that time, there was no data 
on non-muscular myosin II in the context of JBL. Therefore, I analyzed the localization of 
myosin regulatory light chain (MLC) in the junctional ring. Indeed, analysis of MLC in 
conjunction with the junctional markers ZO1 and VE-cadherin showed that MLC is 
specifically associated with EC junctions.  
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Not only did MLC localize to cell-cell junctions, I also found that it specifically localized to 
the JBL themselves. The exact localization of MLC seemed to be dependent on the 
timepoint during an oscillation cycle. I could distinguish several patterns, ranging from an 
enrichment in VE-cadherin/ZO1 low areas (where one expects F-actin protrusions) to a 
perfect colocalization with the distal junction (high ZO1 and VE-cadherin staining). 
Mosaicism in the expression of the transgenic line (kdrl:Myl9-EGFP) allowed me to further 
distinguish between the protein localization in the “donor” (migrating) and “receiving cell”. 
In a Myl9 positive cell, MLC specifically accumulated at the migration front in the donor 
cell, whereas no enhance signal could be observed at the respective “back”. This is 
illustrated in Figure 38. These findings supported the hypothesis that 1) actomyosin 
contractility could be involved in local force generation and 2) that this local contractility 
could be specifically restricted to the leading edge of the migratory cell. The latter might 
serve to drive the process of junction conversion, where the proximal and the distal 
junction are pulled towards each other.  
 
 
Figure 38: Mosaic expression of Myl9-EGFP on two tip cells during anastomosis (DLAV formation). 
Localization of myosin regulatory light chain (MLC) in the JBL. The cell in green is Myl9-EGFP 
positive, whereas the cell in yellow is negative. The two cells form a ring-shaped junction, in which 
Myl9 is accumulated at the site of the right JBL, but not at the left respectively. This indicates, that 
Myl9 accumulates or is recruited specifically in the “donor cell” at the site of the lamellipodia. It is 
postulated that Myl9 serves to pull the double junctions together, resulting in a forward movement 
of the cells.  
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The importance of the actomyosin network was further supported by evidence coming 
from experiments done with a ROCK inhibitor (Y-27632). Inhibiting ROCK in the experiment 
conducted during my study has shown that junctional rearrangements are impaired upon 
actomyosin contractility, manifesting in reduced junctional elongation speed. Since several 
evidences pointed to an importance of a of local force generation in order for JBL to 
function properly, I was wondering how or whether these forces are transmitted onto 
endothelial junctions. It was shown that polarization of forces require the presence of 
cadherin-based junctions (Mertz et al., 2013; Tambe et al., 2011), and that VE-cadherin 
tension is dependent on actomyosin contractility (observed among others in Borghi et al., 
2012; Conway et al., 2013). This led me to investigate tension across VE-cadherin molecules 
during the process of anastomosis using the VE-cadherin tension-sensor line.  
 
VE-cadherin tension in JBL 
Using the VE-cadherin tension sensor line, I aimed for answering several questions that 
should have helped to understand the mechanical changes occurring during EC 
rearrangements: How is VE-cadherin tension in the junctional ring distributed? Does 
tension change over time during junction elongation? Do changes in VE-cadherin tension 
correlate with JBL oscillations?  
I postulated that tension within the junctional ring is not evenly distributed, and that there 
is a difference in tension between the JBL and the medial cell part (1). Secondly, I 
hypothesized that VE-cadherin tension changes over time coherent with the JBL oscillatory 
behavior (2) and that thirdly there might be spatial differences of VE-cadherin tension 
within a single JBL (3).  
 
I was assuming that VE-cadherin tension in the medial part of the junctions is evenly 
distributed and very homogenous. Instead, there might be local and temporal tension 
changes in the JBL, specifically where a local force is generated. However, analyzing tension 
within VE-cadherin molecules via determination of FRET-values did not show significant 
mean differences in JBL versus other junctional parts. Nevertheless, I noticed that values 
for JBL showed a greater spread, possibly representing the dynamic nature of JBL, and that 
the obtained values possibly strongly depend on the state of oscillation.  
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Based on this, and to prove or disprove my second and third hypothesis, I aimed for 
determining FRET values at consecutive time points to observe temporal changes of VE-
cadherin tension. Furthermore, and ideally, FRET measurements would have provided the 
basis to obtain a topographical map of VE-cadherin tension in a JBL. Unfortunately, both of 
the mentioned approaches were not feasible due to technical limitations that will be 
discussed in the course of this discussion. Nevertheless, I will discuss expectations or 
potential outcomes in relation to a single JBL cycle (Figure 40).  
 
Differential spatial and temporal VE-cadherin tension during a JBL cycle 
The fact that VE-cadherin tension could reflect different intra and intercellular processes 
makes it intrinsically difficult to predict temporal and spatial changes and fluctuations in 
VE-cadherin molecules. Differences in ratio-metric FRET values could result from 1) 
differences in the adhesive strength between two VE-cadherin molecules upon homophilic 
interaction, where the actomyosin cytoskeleton can pull from two sites, or 2) reflect 
differences in actomyosin contractility from one cell (rather than from both cells). This 
would mean that e.g. tension could build up as result of an increase in 1) adhesive strength 
or a 2) high actomyosin contractility, pulling on the junctions (see Figure 39). These two 
scenarios cannot be distinguished by determining intermolecular FRET values.  
 
 
Figure 39: Determination of intramolecular FRET values as proxy for VE-cadherin tension.  
Tension in the VE-cadherin molecular can arise from the actomyosin cytoskeleton pulling from 
one site of the cell (green arrow), or due to homophilic interaction and formation of adhesive 
bond (indicated in yellow).  
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How VE-cadherin tension in the JBL changes temporally and spatially remains very 
speculative. There are of course several possible scenarios how VE-cadherin tension might 
change, and I will propose only one possibility (Figure 40). I base my hypothetical model on 
the findings that VE-cadherin tension decreases during the maturation process of junctions 
in endothelial cells (Lagendijk et al., 2017) and that tension is released at mature adherens 
junctions in confluent endothelial cells (Daneshjou et al., 2015).  Therefore, I indicated VE-
cadherin tension as “medium” in the junction, where the JBL emanates from. Tension 
changes in the model have to be considered relative to this.  
 
 
Figure 40: Hypothetical spatial and temporal distribution of VE-cadherin tension during one JBL 
cycle. From a stable junction (medium tension in green), a F-actin based membrane protrusion 
arises, also containing VE-cadherin (low tension). The forming protrusion pulls on the junction it 
emanates from, thereby temporally increasing its tension (blue). Subsequently, a new junction 
(high tension) is formed at the front of the protrusion and matures over time (shift from blue to 
green). At the same time, the old junction starts to decrease tension, indicative for a reduction of 
adhesive strength while the two junctions are pulled towards each other. The latter is achieved by 
actomyosin-generated contractility in the JBL, which is represented as tension change from rather 
low (red-yellow) to high (blue) in the protrusion itself.  
 
Initially, a new protrusion is formed at the site of a stable VE-cadherin based junction 
(medium tension). The protrusion also contains diffuse VE-cadherin deposits, thought to 
be of rather low tension, as no homophilic interactions might be established yet. However, 
the emerging protrusion might pull on the junction, leading to a temporally limited increase 
in tension (blue). Subsequently, a new distal junction is formed. Since the VE-cadherin 
contact sites are still nascent adhesions, VE-cadherin tension might be relatively high.  
JBL oscillation cycle
Protrusion
formation
Establishment of
a new junction
„old“ junction „new“ junctionProtrusion
„old“ junction
high tension
low tension
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As the cycle progresses, the distal junction matures, which is reflected in a decrease of 
tension over time (blue to green), whereas the old junction decreases tension as it 
“disappears”. Dependent on the actomyosin cytoskeleton, the two junctions are eventually 
pulled towards each other, which would be reflected in very high VE-cadherin tension in 
the protrusion zone (blue area), as the actomyosin possible pulls on the junctions while 
generating contractility. Finally, once the two junctions are being merged, tension reaches 
again a high level similar to the first step, before the new cycle of protrusion formation 
starts.  
 
That a certain force is generated during the formation of membrane protrusions was shown 
in Cai et al., 2014. The authors investigated collective cell migration behavior of so-called 
border cells in drosophila ovaries. Firstly, they propose that the formation of a F-actin 
based protrusion pushing the membrane outward gives rise to a membrane tension that 
ultimately generates tension within VE-cadherin molecules.  
Similarly, Ji et al., 2008 spatially and temporally link filament assembly to forces across 
adhesions in epithelial cells. In context of specific localization of high vs low VE-cadherin 
tension areas, Cai et al., 2014 observed differences in tension in the front versus the back 
of the border cell clusters, independently from the number of E-cadherin molecules 
(homogenous distribution). Tension was higher at the front suggesting that cells actively 
disassemble (from each other, or disassemble forces) at the back. They argue that 
differences in FRET values possibly reflect differences in the strength of adhesive bonds or 
actomyosin contractility between front and back. Interestingly, high tension in the front 
correlated with high Rac activitiy.  
 
Influence of actomyosin contractility on VE-cadherin tension 
In order to investigate whether VE-cadherin tension might be dependent on actomyosin 
contractility (as proposed in Cai et al., 2014), I used an inhibitor for ROCK and analyzed VE-
cadherin tension in the JBL. FRET values in the JBL showed a high spread around the mean 
value, which significantly decreased upon inhibition of ROCK. This finding points towards 
an important role of the cellular force-generating machinery in the establishment of 
differential tension among VE-cadherin.  
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ROCK inhibition blocks actomyosin contractility, thereby abolishing a potential tugging 
force in VE-cadherin molecules, leading to VE-cadherin tension returning to a baseline level 
(as indicated by FRET values, represented by the mean).  
These findings and evidence of spatial differences in VE-cadherin tension highlight the 
importance to investigate spatial patters in JBL in the future. It will be of great importance 
to map VE-cadherin tension on a JBL during different timepoints of the oscillation cycle, to 
fully elucidate the mechanism by which they generate and transmit forces. However, to 
the present days, experimental approaches are limited by technical restrictions, that need 
to be carefully considered.  
 
Technical limitations using FRET imaging  
From a technical point of view, several aspects have to be considered when using FRET-
based biosensors and the ratio-metric method for FRET determination. This method is 
intensity-based, since for FRET index calculation, the ratio of the donor and acceptor is 
determined. Intensity related issued were the main limitations in my experimental setup. 
Intensity of the fluorophores can vary due to several aspects such as laser fluctuations, 
microscopy settings, penetration depth of the tissue and, most importantly for in vivo 
experiments, the biological heterogeneity of expression levels among zebrafish embryos 
(Eder et al., 2017). Microscope settings (e.g. laser intensities) are adjusted in each imaging 
setting based on control embryos expressing only the acceptor or donor, respectively. 
These settings remained constant throughout the entire imaging session and were identical 
for each sample. Variation in expression levels of the transgene often resulted in over-
/underexposure, leading to a dropout of several images after post acquisition in silico 
processing.  As a result, comparably low sample size decreased the significance of the 
obtained results; higher sample size would have been required to get a broader picture of 
JBL (especially since they are of such highly dynamic nature). Too low intensity levels of the 
fluorophores were never encountered in the dorsal aorta, increasing both quantity and 
quality of the obtained data from this vessel. For acquisition of still images, this problem 
could be overcome manifold. As JBL are proposed to be a general mechanism at work in 
endothelial cells, switching to another vascular bed as model system might indeed be very 
useful.  
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On that account, similar analyses could be performed in the dorsal aorta or in the cranial 
vasculature (PLA), where the process of anastomosis has been extensively described 
(Lenard et al., 2013).  
Another way would be facing the technical site. FLIM (Fluorescence life time 
measurements) is a quantitative imaging technique that is reported to be less sensitive to 
artifacts compared to FRET (Cost et al., 2015; Wallrabe and Periasamy, 2005). It is based on 
the determination of the life time of individual fluorophores rather than relying on their 
emission spectra. Additionally, it is more robust compared to intensity-based methods as 
it does not depend on factors such as bleaching or excitation intensity, sample thickness 
etc. (picoquant.com). 
In summary, during JBL formation and cellular rearrangements, I observed that VE-cadherin 
molecules indeed exhibit actomyosin-dependent tension. In order to fully explore and 
describe the mechanism that underlie force transmission, time-lapse analysis and temporal 
distribution of VE-cadherin tension will be inevitable. These experiments in fact will be 
dependent on the improvement of technical equipment (faster imaging technique) or 
biological improvements of FRET-sensors in vivo. 
 
Besides the importance of VE-cadherin for JBL function and junctional ring elongation, I 
investigated the junctional behavior based on other proteins functioning in cell adhesion, 
namely ZO1.  
 
Transient appearance of ZO1- based double junctions during the JBL oscillatory cycle 
One very prominent hallmark during the JBL oscillation cycle is the appearance of so-called 
double junctions. They were discovered as an intermediate step, in which both a proximal 
(“old”) and distal (“new”) junction are visible at the same time, just before they eventually 
merge with each other. I postulate that this very specific junctional localization reflects a 
very important step, in which the cell can reach out in the direction of movement, establish 
a de novo junction while maintaining the old one in order to guarantee junctional integrity 
and maintenance of the vascular seal. The formation of a new distal junctions is an 
important step, as it provides a new attachment site, which we hypothesize is 
indispensable for junctional ring elongation.  
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To study how these double junctions form and how they are regulated, was part of my 
thesis, which I will now further discuss in the context of three proteins ROCK, Arp2/3 and 
Rac1. 
 
ROCK is important for the formation of the distal junction  
Upon inhibition of ROCK, I observed significant reduction in junctional ring elongation 
speed, which shows that ROCK is needed for the rearrangement process. Furthermore, 
ROCK not only influences VE-cadherin tension (as explained before), it also alters 
localization of the protein ZO1 and therefore has an impact on double junction formation. 
Correct localization of ZO1 in two distinct lines was impaired and resulted in a rather loose 
accumulation of junctional material (a schematic drawing is shown in Figure 41). In most 
cases, it was not possible to establish correct double junctions and therefore a new distal 
junction, which provides the basis for successful ring elongation. 
 
 
Figure 41: ROCK is indispensable for the formation of a distal junction. During a JBL cycle VE-
cadherin gets deposited at the sites, where a new junction is formed at the front of the protrusion 
(left). Subsequently ZO1 is recruited to the VE-cadherin junction, stabilizing it. This leads to the 
characteristic intermediate step of double junction formation. Inhibition of ROCK interferes with 
recruitment of ZO1 to the new VE-cadherin attachment sites. This is represented as rather diffuse 
ZO1 localization distally from the “old” junction. Whether ROCK inhibition interferes with VE-
cadherin localization is not clear.  VE-cadherin in green, ZO1 in red. F-actin is represented in blue. 
Two cells (top in blue and lower one in orange) are shown.  
with ROCK without ROCK
?
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This finding is in accordance with the literature, where a link between ZO1 localization and 
ROCK is provided. In Walsh et al., 2001 polarized intestinal epithelia were investigated and  
it was shown that ROCK colocalizes with ZO1 at the junctions and that inhibition is 
associated with the failure of tight junction molecule assembly. Furthermore, the authors 
concluded that targeting of TJ molecules to the membrane is altered due to the 
disorganization of apical F-actin, which ultimately results from ROCK inhibition. 
Similarly, Tornavaca et al., 2015 showed that loss of ZO1 induces reorganization of the 
actomyosin cytoskeleton towards stress fiber formation and that junctional myosin II is 
reduced. Providing this connection, it is very likely that inhibiting ROCK also vice versa 
influences ZO1 localization (as reported in my case). Interestingly they provide a direct link 
between ZO1 and VE-cadherin tension. Depletion of ZO1 leads to increased FRET 
(decreased tension) using the VE-cadherin tension sensor, thereby identifying ZO1 as an 
essential regulator for maintenance of tensile forces on adherens junctions. 
During the course of experiments, I could show that double junction formation is not only 
dependent on ROCK, and therefore on actomyosin contractility, but additionally requires a 
functional F-actin network. This will be elaborated in the following section.  
 
Role of Arp2/3 in protrusion formation and maintenance of junctional integrity  
Arp2/3 is a well know F-actin nucleation factor leading to the formation of branched F-actin  
networks, and is indispensable for protrusion/lamellipodia formation (Pollard, 2016;  
Pollard et al., 2000). 
Consistent with this, JAIL formation in HUVECs was blocked upon inhibition of Arp2/3 and 
also Rac, where the GTP bound form binds to and activates Arp2/3 (Abu Taha et al., 2014). 
Furthermore, Arp2/3 is characteristically also recruited to sites of newly formed cadherin 
contacts, where contact zones were being extended (Verma et al., 2004).  
When blocking Arp2/3 during the process of JBL formation and junctional ring elongation, 
I did not only observe defects in the F-actin dynamics but also on junctional protein level. I 
observed that JBL formation focusing on F-actin localization is impaired, stressing the 
importance for the formation of a branched F-actin network. Furthermore, I would like to 
mention that I observed the appearance of quite prominent, long, linear F-actin cables in 
the endothelial cell resembling stress fibers.  
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Inhibition of Arp2/3 and therefore reducing branched F-actin fibers might thus favor the 
formation of stress fibers, which possibly manifests throughout the cell. Besides, I could 
show that Arp2/3 interferes with junctional integrity using a transgenic EGFP-ZO1 line. As 
already mentioned, double junction formation during the JBL oscillation cycle is a very 
important intermediate step. Here, although a distal and proximal junction does form 
(albeit less frequent), the “new” junction often cannot be maintained and seems to 
“dissolve” over time (a scheme is presented in Figure 42).  
 
 
Figure 42: Arp2/3 is required for protrusion formation as well as stabilization of new junction 
(shown here). Arp2/3 is indispensable for formation of branched F-actin networks, which are 
crucial for lamellipodia formation. At later stages, a new VE-cadherin adhesion site is formed and 
ZO1 recruited. At this point, Arp2/3 is not necessary for the formation of the new junction itself, 
rather than maintenance. Inhibition of Arp2/3 led to destabilization of the distal junction (third 
image), which might be due to lack of F-actin support. Roles of Arp2/3 are only indicated in the 
upper cell. VE-cadherin in green, ZO1 in red. F-actin is represented in blue. Two cells (top in blue 
and lower one in orange) are shown.  
 
These findings point towards a role of Arp2/3 in the stabilization of the newly formed 
junction; not being able to maintain and stabilize the newly formed junction at the distal 
end of the JBL ultimately has an impact on the forward movement of the cell. 
Effects on adherens junction assembly upon Arp2/3 inhibition was also reported in Ivanov 
et al., 2005 and Verma et al., 2004. Arp2/3-mediated F-actin assembly is important for 
efficient cadherin contact formation, and blocking Arp2/3 reduced the ability of cells to 
extent cadherin adhesive contacts (Verma et al., 2004). Similarly, Ivanov et al., 2005 
showed that assembly of cadherin junctions was prevented by blocking N-WASP (which 
activates Arp2/3). Based on these findings, it would be very interesting in the future to 
investigate the effects of Arp2/3 inhibition also on the level of VE-cadherin, and not only 
on ZO1.  
Arp2/3
Arp2/3
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In general, the formation of a branched F-actin network is not only indispensable for the 
initial protrusion formation, but also crucial in transmitting a stabilization effect at the 
junctional level. Additionally, it was proposed that F-actin assembly at the junctions is 
required for NMII recruitment (Verma et al., 2012). Therefore, I hypothesize that Arp2/3 
inhibition indirectly also influences contractile properties and recruitment of NM to the 
junctions in the context of JBL.  
The formation of a branched F- actin network might be needed for myosin II to adhere to 
and thereby provide the structural basis for generation of local contractility. In order to test 
this, the localization of MLC could be investigated using antibody staining, similarly to the 
experiment presented in Figure 23. In such a scenario, MLC would not be localized at site 
of JBL upon Arp2/3 inhibition. This is of particular interest as it would confirm the necessity 
of F-actin as basis for local force generation and highlight the importance of the actomyosin 
cytoskeleton in the process of junction elongation. Furthermore, it is indispensable to 
investigate the dynamics between F-actin and Myl9 accumulation using live imaging 
approaches. Following the localization of these two proteins and their differential 
expression in correlation to each other will provide more details about the underlying 
molecular mechanism. 
As already mentioned, Rac1 as an upstream activator of Arp2/3 also inhibited JAIL 
formation, which made it interesting to investigate the role of Rac1 further in the context 
of JBL. 
 
The role of Rac1 in JBL function  
Classically, Rac1 is known to induce lamellipodia (Hall, 1998; Ridley, 2001) and it is well 
known to have a polarized activity highest at the leading edge in migrating cells, where it 
leads to enhanced protrusive activity and the formation of membrane ruffles (lamellipodia 
formation) (Ridley et al., 1992). This made Rac1 a good candidate to study during JBL 
formation.  
Previous experiments done in Paatero et al., 2018 have shown that inhibition of Rac1 does 
not influence the formation of JBL per se, but increased the oscillation time. This indicates 
that Rac1 plays a role in maintaining the dynamic properties rather than the initial step of 
formation.  
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And since junctional rearrangement was yet significantly reduced, these findings at the 
same time point out that dynamic F-actin behavior is a crucial step for proper JBL function 
(compare to Figure 43).   
 
 
Figure 43: Rac1 during JBL formation. Rac1 is known to be a crucial player for the induction of 
lamellipodia. In JBL they mostly play a role in maintaining the F-actin dynamics within the JBL. 
Inhibition of Rac1 does not influence the formation of the JBL but interferes with the oscillation. 
Roles of Rac1 are only indicated in the upper cell. VE-cadherin in green, ZO1 in red. F-actin is 
represented in blue. Two cells (top in blue and lower one in orange) are shown. 
Additionally, I could show in this study (also published) that inhibition of Rac1 does not 
influence structural properties; formation of ZO1-based double junctions is mostly 
unimpaired.  
Generally, the observed defects upon Rac1 inhibition were rather mild, especially 
compared to Arp2/3 inhibition. It is possible that I didn’t achieve full inhibition in vivo, even 
at high doses. Alternatively, the role of Rac1 might have a different role in JBL as compared 
to JAIL (where Rac1 did inhibit JAIL formation).  
Alternative modes of actions for Rac1 could well be at the junctional level, although the 
role of Rac1 in mature cell-cell adhesions in ECs is not well understood and the collected 
evidences seem to be conflicting. One the one hand, Rac1 is reported to be required for 
stabilization and maintenance of the endothelial barrier in response to shear stress of 
barrier-enhancing mediators (e.g. sphingosine-1-posphate) (Liu et al., 2013; Mehta et al., 
2005). On the other hand, Rac1 activation also leads to a loss of cell-cell contacts upon 
stimulation of endothelial cells with VEGF, for example (Gavard and Gutkind, 2006). These 
findings underline the importance of understanding the local and temporal activation of 
Rac1 as distinct spatio-temporal activation can have different effects.  
Rac1
Rac1
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In addition, Timmerman et al., 2015 show that Rac1 activation (downstream of thrombin) 
promotes the reassembly of cell-cell junctions during the phase of recovery, which is 
induced by the formation of lamellipodia protrusions. The stabilizing effect on VE-cadherin 
junctions occurs via Rac1-induced actin rearrangements at nascent junctions by promoting 
the formation of cortical F-actin bundles (Timmerman et al., 2015).  
Generally, it is well documented that an increase in Rac1 activity is linked to junction 
assembly and maturation (Lampugnani et al., 2002; Noren et al., 2001). Additionally, 
activation of Rac1 leads to accumulation of F-actin and enhanced VE-cadherin levels, 
possible by reducing the dissociation in mature junctions.  
Liu et al., 2010 propose a mechanism, in which Rac is responsible for the ability of adheres 
junctions to assemble in response to Rho-mediated tugging forces of actomyosin 
contractility. 
In line with this, Daneshjou et al., 2015 show in their studies done in confluent endothelial 
monolayers that Rac1 induces stabilization of adheres junctions by decreasing the rate of 
VE-cadherin dissociation, but independently from protrusion formation. Interestingly, this 
response was coupled to a decrease in tension across VE-cadherin molecules. Stabilization 
of trans-dimers is achieved by counteracting RhoA- mediated tugging force, thereby 
modulating actomyosin force at the adherens junctions. 
Based on this evidence, it might be very interesting to further investigate the role of Rac1 
in the context of VE-cadherin in JBL formation and junction maturation.   
Potentially, the role of Rac1 in stabilization of junctions can be linked to the observation 
that Rac1 inhibition leads to an increased oscillation cycle of JBL and increased lag phase 
(Paatero et al., 2018). Maturation of nascent adhesions coincides with periodic pauses of 
the forward moving leading edge (Parsons et al., 2010), and prolongation of the cycle might 
be therefore interpreted as impaired ability for adheres junction to mature. 
One way to further elucidate the role of Rac1 in protrusion formation would be to 
specifically activate Rac1 rather than to inhibit it ubiquitously. This can be achieved by an 
engineered photoconvertible Rac1.  
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Altering F-actin dynamic using endothelial specific Photoactivatable Rac1 in vivo  
As mentioned before, Rac1 is responsible for lamellipodia formation and its activity is 
highest at the leading edge of migratory cells (Ridley et al., 1992).  
Specific (light-induced) activation of Rac1 at the leading edge is sufficient to direct 
migration with precise control (spatial and temporal) in vivo (Yoo et al., 2010). Based on 
evidence obtained from the literature, combined with the hypothesis that JBL have similar 
properties to classical lamellipodia and rely on actin-based protrusion formation, I 
generated a photoactivatable Rac1 reporter, which can be specifically expressed in 
endothelial cells of zebrafish embryos.  
Temporally, albeit not spatially, restricted activation led to a reduction in the number of 
filopodia and a decrease of the cell area. Since these phenotypes were reversible (darkstate 
of the activation laser), they might indeed be specifically linked to enhanced Rac1 activity. 
However, these observations were very surprising, as Rac1 is (to the best of my knowledge) 
not directly linked to filopodia formation neither to cell shape determination. However, 
both lamellipodia and filopodia formation are dependent on Arp2/3 activation and on actin 
polymerization. Additionally, Arp2/3 transduces signals from Rac1 (lamellipodia) or Cdc42 
(filopodia) either through WAVE or WASP proteins in order to polymerize actin (e.g. in Insall 
and Machesky et al., 2009). Assuming that these pathways are in equilibrium, over-
activation of Rac1 might shift this potential balance favoring lamellipodia formation at the 
cost of filopodia. Another possible explanation would be that ubiquitous (not locally 
restricted) activation of Rac1 alters/abolished the polarity of cells, losing their ability to 
send out filopodia in a particular direction. 
Explanations for changes in cell size are very speculative. In Yoo et al., 2010, Rac1 activity 
is linked (over a positive feedback loop in the PI3K pathway) to the generation of stable F-
actin filaments at the rear of a migrating cell bearing a contractile actomyosin cytoskeleton. 
Potentially, over-activation of Rac1 could somewhat influence contractility in the cell 
cortex, leading to this “cell contraction”. 
Generally, both of the observations show that future experiments need to be adapted in 
several ways, to guarantee reliability and meaningful biological results. Firstly, activation 
of Rac1 needs to be locally restricted (e.g. leading edge of a migrating cell) in order to not 
change the polarity of the entire cell.  
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Secondly, endothelial cells expressing a control construct will be crucial in order to confirm 
the specificity of the obtained results. A control construct harboring Rac1 with a mutation 
on the LOV domain (and thereby preventing unfolding and releasing the effector binding 
domain) will be of importance (compare Wu et al., 2009). Last but not least, effects of Rac1 
activation need to be investigated in the context of the F-actin cytoskeleton.  
My preliminary results have already proven an effect on the F-actin cytoskeleton, making 
this approach quite promising. Here, activation of Rac1 led to an enhanced EGFP-UCHD 
signal at cell-cell interfaces, indicating that F-actin is recruited to the junctions upon 
activation. This indeed is consistent with the literature, where overexpression of Rac1 lead 
to the accumulation of F-actin at cell-cell junctions (Noren et al., 2001). Furthermore, 
recruitment of F-actin to the junctions might be indicative for their stabilization. Enhanced 
stabilization and potentially decreased remodeling capacity (and flexibility?) might also be 
the mechanism underlying cell shrinkage in my experiments. This could be further 
investigated by abundant activation of Rac1 in a single cell context, where no cell-cell 
junctions are present and the observed behaviors are fully autonomous.  
 
Based on these findings, and combined with my preliminary data, I suggest the following 
experiment to be done in the future: I hypothesize that JBL formation or initial protrusion 
formation respectively, are highly dependent on Rac1 activity and that JBL dynamics and 
formation can be altered by specific (local and temporal) activation of Rac1.  
Questions that I would like to answer include: Does local activation of Rac1 at the lateral 
sites of the junctional ring influence formation or oscillation of JBL? Does activation of Rac1 
lead to an increase in junctional elongation speed? And moreover, could specific spatial 
activation of Rac1 at the medial part of the junctional ring induce ectopic F-actin based 
membrane protrusions? 
Therefore, Rac1 could be specifically activated during junctional ring elongation at the sites 
of the junctional ring, where JBL usually form (compare to Figure 44). Activation is 
supposed to be spatially and temporally restricted and the effects should be observed on 
the level of F-actin (in embryos expressing iRFP-UCHD). It will be interesting to see whether 
Rac1 is sufficient to alter F-actin dynamics, which could be reflected in a change of 
oscillatory behavior (shorter cycle, faster oscillation) or induction of JBL.  
Discussion  
 108 
 
Potentially, activation of Rac1 in the medial parts of the junctional ring could induce 
artificial JBL at ectopic sites.  
 
 
 
Figure 44: Overactivation of Rac1 during JBL formation. Spatially restricted specific overactivation 
of Rac1 will help to understand, whether Rac1 is sufficient enough to induce lamellipodia/JBL 
formation. To this end, Rac1 could be specifically activated at sites where JBL normally form (red) 
to see whether initial formation or dynamic behavior could be influenced (based on F-actin). 
Additionally, activation of Rac1 at the medial parts of the junctional ring will answer the question, 
whether Rac1 activation is able to induce ectopic JBL (blue)  
Additionally, it is very fortunate that the stable transgenic kdrl:mCherry-PA-Rac1 fish line 
seems to be mosaic in its expression pattern. This will allow for experiments, where only 
one of two cells during anastomosis harbor PA-Rac1 expression.   
 
Besides its effect on lamellipodia formation, Rac1 has also been linked to maturation of 
junctions as described in a previous paragraph. Active Rac1 is localized at sites of nascent 
adhesions and is implicated to induce stabilization (by actively remodeling the F-actin 
cytoskeleton (Timmerman et al., 2015) and regulating the strength of adherens junctions 
(Liu et al., 2010). Furthermore, in Seebach et al., 2007 it was reported that Rac1 is 
responsible for VE-cadherin clustering (in response to flow though) and that Rac1 activation 
reduces dissociation rate of VE cadherin from the junctions (Daneshjou et al., 2015). 
Keeping that into consideration, potential effects on JBL function might not exclusively 
originate from F-actin dynamics, but also be induced by changes in junctional properties. 
That this might be the case is supported by the evidence in my study that activation of Rac1 
led to enhanced accumulation of recruitment of F-actin of the junctions.  
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Therefore, it might be very interesting to specifically analyze effects of Rac1 activation on 
VE-cadherin localization or clustering, as well as VE-cadherin tension. In case the 
contribution of Rac1 in JBL is rather observed at the junctional level, activation of Rac1 
could lead to increased VE-cadherin stability due to altered VE-cadherin dissociation rate 
(as described in the literature). This, in turn, might, instead of inducing JBL, lead to an 
adverse situation, in which the dynamic behavior of JBL is abolished and reaches a more 
“stiff” and steady state, due to loss of adherens junction remodeling. However, this remains 
very speculative and needs to be investigated in the future.   
 
JBL as general mechanism of endothelial cells underlying migration and cell shape changes 
Junction based lamellipodia were also identified in larger caliber vessels such as the dorsal 
aorta (Paatero et al., 2018). Here, F-actin based membrane (or cell) protrusions could be 
observed in regular intervals, coinciding with oscillation in F-actin intensity. I could further 
support this observation by successfully proving the formation of double junctions in DA, a 
hallmark of JBL that was identified during anastomosis. Double junctions appeared to be 
present for a longer period of time (around 13 min) compared to the DLAV, where they are 
often just observed for 1-2 minutes. This might be indicative of a lower dynamic of cell 
junctions in the DA, or a lower need for rapid cell shape changes or movements. Double 
junctions were observed in 2 dpf embryos, where junctions appear still irregular and 
immature. Over time, they develop a more linear phenotype and align progressively in the 
direction of blood flow (Lagendijk et al., 2017). It would be interesting to examine, to what 
extent appearance of double junctions is linked to the state of junctional maturation and 
to blood flow. Cell shape changes in the DA are suggested to be induced by blood flow 
(Sugden et al., 2017) and potentially might also influence local protrusion formation. 
Further experiments could focus on the appearance of JBL and length of double formation 
in the DA during maturation and onset of blood flow. This will help to elucidate to what 
extent JBL are employed by endothelial cells to induce cell shape changes (dependent or 
independent of blood flow).  
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Summary and Outlook  
For my thesis work, I have mainly focused on the characterization of JBL during the process 
of anastomosis, which relies on the coordinated interaction between two tip cells. 
However, I could also demonstrate that membrane protrusions in larger caliber vessels 
such as the dorsal aorta, representing a more complex cellular environment, show 
morphological and dynamic characteristics of JBL. Given their occurrence in different 
contexts, JBL may represent a general mechanism of cell rearrangements during vascular 
development and possibly also in other tissues. During anastomosis, JBL are thought to 
provide the motile force, which promotes EC intercalation and concomitant cell elongation, 
ultimately leading to a change in vascular architecture from a unicellular to a multicellular 
configuration. Cells in the early dorsal aorta also undergo extensive rearrangements and 
cell shape changes during blood vessel maturation. Therefore, endothelial cells could 
employ JBL as a general mechanism to induce or drive these morphogenetic processes 
throughout vascular development, for example in response to shear stress or injury. Here, 
JBL could underly dynamic endothelial cell behaviors, while maintaining the vascular seal. 
It remains to be elucidated, whether JBL are unique to blood endothelial cells or whether 
they might occur, for example, in lymphatic ECs during lymphatic vessel 
formation. Interestingly, VE-cadherin levels in the zebrafish lymphatic vasculature appear 
to be very low (H.G. Belting, personal communication), raising the possibility that 
lymphatics may not use a VE-cadherin based mechanism for cell rearrangements.  
Finally, it will be important to better understand the physical mechanism underlying JBL-
driven cell rearrangements. Several questions remain to be answered. For example: Do the 
newly formed distal junctions provide sufficient anchor for cell elongation? Does the 
extracellular matrix play a role? A detailed analysis at the molecular level will require a 
bona fide in vitro model for JBL function. The previously described junction-associated 
intermittent lamellipodia (JAIL), which occur under certain conditions in HUVECs, share 
similarities with JBL, but also display critical differences. Nevertheless, they may provide a 
useful entry point to study the role of cell protrusions in some aspects of blood vessel 
morphogenesis. 
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A Appendix 
A.1. Supplemental Figures 
Supplemental Figure 1 
 
Supplemental Figure 1: Destabilization of actin at the junctional ring or ring dissolution upon 
treatment with a ROCK or Arp2/3 inhibitor. Live still images from movies of embryos expressing 
EGFP-UCHD (Tg(fli:Gal4ffubs3,UAS:EGFP-UCHDubs18) in A – B in inversed contrast of CK666-treated 
embryos (A) or Y-27632-treated embryos (B). A' and B' are schematic drawings of A and B 
respectively. Images show the junctional ring in the DLAV around 32 hpf. Different time points 
shown. A-A' Inhibition of Arp2/3 led to destabilization of actin at the junctional ring. As a decrease 
of EGFP-UCHD signal over time could be observed. B-B' Instead of elongation of the junctional ring, 
the cells decrease their mutual contact face (indicated as purple in B'), rather moving away from 
each other.  Scale bars 10 µm. 
 
 
 
3 min 5 min 8 min 14 min 
A
UCHD 32 hpf
Y-
27
63
2
3 min 1 min 6 min 
CK
66
6
B
3 min 5 min 8 min 14 min 
3 min 1 min 6 min 
B ̍
A ̍
Appendix 
 115 
 
Supplemental Figure 2 & 3  
 
 
Supplemental Figure 2: Inhibition of neither ROCK nor Arp2/3 does not change localization of 
junctional proteins or integrity. 
 
 
Supplemental Figure 3: Inhibition of Rac1 does not change localization of junctional proteins or 
integrity. 
Supplemental Figures 2 and 3: Maximum projections of the DLAV of Tg(fli1a:EGFP)y1 (green) in 
control embryos (Supplemental Figure 2 and 3 A), Y-27632 (2B), CK666 (2C) and NSC23766 (3A and 
B) treated embryos. Embryos were stained for ZO1 (A'-C' and A-B in magenta) at around 32 hpf. 
A"-D" and A"- B" display merges. Junctions from inhibitor treated embryos do not show obvious 
defects, instead are continuous and comparable to control embryos. Scale bars 10 µm. 
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Supplemental Figure 4 
 
Supplemental Figure 4: Temporal and spatial differences in VE-cadherin tension in the JBL. A and 
B. Temporal changes of VE-cadherin tension during a JBL oscillation cycle. A and A'. Maximum 
projections of JBL at 32 hpf in the DLAV of Tg(ve-cad:ve-cad-Venus). B and B'. Heat map images of 
ratio-metric FRET values of JBL displayed in A and A'. B and B'. One JBL imaged twice within a 
timespan of 2 minutes. ROI marks the JBL. Temporal resolution of change in VE-cadherin tension 
was technically not possible due to bleaching of the fluorophores. Scale bars 5 µM. C. Teal life time 
values (obtained from FLIM) for JBL compared to other junctions in the DLAV. Here, as comparison 
to the JBLs, measurements were not exclusively done on the medial part but on every other 
junction in the DLAV (n=24 JBL and n=23 other junctions in > 5 embryos). There was no significant 
difference in mean lifetime values between the two groups. Unpaired two-sided t-test was used. 
D. Teal life time values (nano-sec) of JBLs in DMSO vs. Y-27632 treated embryos (n=24 for DMSO 
and n=20 for Y-27632 (> 5 embryos). No significant changes of mean values VE-cadherin tension 
could be measured upon inhibition of ROCK in the JBLs. Kolmogorov -Smirnhov test was used. 
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A.2. Contribution to publications 
A.2.1. Hübner et al., 2018, Nature communications 
Wnt/β-catenin signaling regulates VE-cadherin-mediated anastomosis of 
brain capillaries by counteracting S1pr1 signaling 
 
Summary 
Hübner et al., investigate the contribution of Wnt signaling to brain angiogenesis and blood 
barrier (BBB) formation and identify Wnt signaling as a coordinator of timing and as 
important factor for anastomosis regulation. They show, that Wnt is dispensable during 
sprout elongation however plays a crucial role in anastomosis events and lumen formation. 
Furthermore, they provide a link between processes of capillary angiogenesis and BBB 
formation. 
 
Aim of the collaboration and my contribution: 
Aim of the collaboration was to analyze events during anastomosis in the zebrafish 
hindbrain vasculature after Wnt-inhibition in vivo in zebrafish embryos. Therefore, I either 
supervised and guided in vivo experiments but mostly performed the experiments 
independently. I was included in experiments for the initial manuscript as well as during 
the revision procedure. Experiments that I have done included the analysis of the hindbrain 
vasculature in: 
- in IWR-1 vs. DMSO treated embryos in embryos carrying Tg(ve-cad:ve-cadTS), cdh5 
ubs8−/− 
- in cdh5ubs8-/- or cdh5ubs8+/- embryos plus subsequent genotyping 
- in cdh5ubs8-/- embryos (DMSO vs. NSC23766) 
- in Esama mutants (DMSO vs. VPC treated) 
Post-acquisition analysis was done by the authors themselves. Obtained results were 
included in the supplemental figures of the manuscript. Furthermore, we provided them 
antibodies against Esama and VE-cadherin and assisted in performing whole-mount 
antibody stainings. last but not least, I reviewed the manuscript and suggested corrections.
ARTICLE
Wnt/β-catenin signaling regulates VE-cadherin-
mediated anastomosis of brain capillaries by
counteracting S1pr1 signaling
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Canonical Wnt signaling is crucial for vascularization of the central nervous system and
blood-brain barrier (BBB) formation. BBB formation and modulation are not only important for
development, but also relevant for vascular and neurodegenerative diseases. However, there
is little understanding of how Wnt signaling contributes to brain angiogenesis and BBB
formation. Here we show, using high resolution in vivo imaging and temporal and spatial
manipulation of Wnt signaling, different requirements for Wnt signaling during brain
angiogenesis and BBB formation. In the absence of Wnt signaling, premature Sphingosine-1-
phosphate receptor (S1pr) signaling reduces VE-cadherin and Esama at cell-cell junctions.
We suggest that Wnt signaling suppresses S1pr signaling during angiogenesis to enable the
dynamic junction formation during anastomosis, whereas later S1pr signaling regulates BBB
maturation and VE-cadherin stabilization. Our data provides a link between brain angio-
genesis and BBB formation and identifies Wnt signaling as coordinator of the timing and as
regulator of anastomosis.
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The central nervous system (CNS) depends on nutrient andoxygen delivery from blood vessels during the developmentand homeostasis, but also requires protection from blood-
born toxins and pathogens. Endothelial cells (ECs) of CNS blood
vessels acquire characteristic properties in order to fulfill the tasks
of this blood-brain barrier (BBB), such as expression of a specific
subset of junction molecules and nutrient transporters, down-
regulation of vesicular transport and establishment of cell–cell
interactions within the neurovascular unit1. During a defined
time window of embryonic development, molecular cues from
neuronal and perineuronal tissues orchestrate CNS angiogenesis
and barriergenesis2–4. The process of brain angiogenesis is well
conserved in vertebrates: After acquiring a pre-sprouting sig-
nature (hereafter called pre-tip cell), these specified cells migrate
out from the resident vessel, with tip cells guiding sprout for-
mation, and invade into the neuronal tissue, where they form
cell–cell contacts and anastomose with other sprouts or extra-
cerebral vessels in order to establish circulatory loops1,3,5. In
zebrafish (Danio rerio), hindbrain capillaries (intra-cerebral
central arteries, CtAs) invade the brain parenchyma at around 32
h post fertilization (hpf) from the primordial hindbrain channel
(PHBC), extend dorsally and connect ventrally to the basilar
artery (BA) or laterally to other CtAs (Fig. 1a)4–7. At 48 hpf, most
CtAs carry blood flow and by 72 hpf most of the respective BBB
properties are established8,9.
Studies in mice and zebrafish demonstrate β-catenin-
dependent Wnt signaling through Wnt7a–Wnt7b to be essen-
tial for brain vascularization10–12. Additionally, Wnt signaling has
been shown to be involved in the establishment of BBB char-
acteristics, such as upregulation of tight junction components
(e.g., Claudin 1 and 3) or nutrient transporters (e.g., Glut1) and
decrease of transcellular transport processes (e.g., Plvap)10,13–15.
Recently, the Gpr124-Reck complex has been identified as an EC
autonomous regulator of Wnt signaling essential for brain vas-
cularization and BBB formation12,15–20. Single-cell analysis of
brain vascular development through live imaging approaches in
zebrafish further revealed that the control of pre-tip cell function
by the Gpr124-Reck complex operates within the parental vessels
(PHBCs) at pre-invasive stages. This early function of Wnt sig-
naling has so far largely precluded the analysis of Wnt signaling
functions at later stages of CNS vascular development, including
the invasion process itself and subsequent patterning events.
Vascular endothelial (VE)-cadherin is the major endothelial-
specific member of the cadherin protein family and is involved in
EC migration, cell–cell contact formation, anastomosis, and
barrier formation5,21,22. Together with the EC-selective adhesion
molecule a (Esama), VE-cadherin is essential for EC–EC recog-
nition and contact formation during intersegmental vessel ana-
stomosis23,24. Experiments using mice and tissue culture revealed
that VE-cadherin is subject to extensive post-transcriptional
regulation, including intracellular complex formation and traf-
ficking, membrane localization as well as association in cell–cell
junctions. This dynamic regulation of VE-cadherin in adherens
junctions is not only crucial for vascular patterning, but also for
the function of mature blood vessels, e.g., for maintenance of EC
integrity or during leukocyte extravasation25,26, and can be
regulated by Sphingosine-1-phosphate (S1p) signaling27,28.
ECs express S1p receptor (S1pr) 1, 2, and 329 and in zebrafish,
two paralogues exist for S1pr3 (S1pr3a and S1pr3b).
S1pr1 signaling promotes BBB integrity in mice30. Additionally,
postnatal EC-specific knockout of S1pr1 induces loss of VE-
cadherin and vascular endothelial growth factor receptor 2
(VEGFR2) from the cell junctions31. To date, the contribution of
neither S1pr nor VE-cadherin signaling has been addressed
during brain capillary angiogenesis, leaving a missing link
between brain EC angiogenesis and BBB formation.
In this study, we clarify the distinct requirements for Wnt
signaling during brain angiogenesis. Whereas Wnt signaling is
essential before sprouting to regulate yet to be defined early
function of the future tip cells (pre-tip cells) within the parental
vessel12, it is surprisingly dispensable during sprout elongation
and migration, although it remains continuously active in the
invading sprout. We show that Wnt signaling is regulating brain
capillary anastomosis and lumen formation. Interestingly, Wnt
signaling is crucial for VE-cadherin and Esama localization at
cell–cell junctions in a transcription-independent manner. Dur-
ing active brain capillary angiogenesis, Wnt signaling counteracts
S1pr signaling, which enables VE-cadherin-dependent anasto-
mosis and lumen formation. In contrast, when angiogenesis is
completed at later stages, S1pr signaling regulates BBB formation.
Our data therefore reveal an important functional link between
the intertwined processes of brain capillary angiogenesis and BBB
formation.
Results
Wnt signaling is required for hindbrain capillary patterning.
Studies in mice have shown that Wnt signaling is essential for
hindbrain capillary angiogenesis10,11,14. Studies using zebrafish
revealed that this control by Wnt signaling reflects an essential
function in defining the pre-tip cell during early, pre-invasive
angiogenic events within the parental vessels (Fig. 1a12). As a
result, no hindbrain capillaries (central arteries, CtA) are formed
in the absence of Wnt signaling. In order to bypass this early
requirement, we blocked Wnt signaling pharmacologically using
IWR-132 and generated transgenic lines, which allow for tem-
porally and spatially controlled expression of a dominant-
negative Tcf transcription factor.
Treatment with Wnt signaling inhibitor IWR-1 after the pre-
tip cell specification phase (29–72 hpf) resulted in severe vascular
defects and hemorrhages in the brain, but not in the trunk
vasculature (Supplementary Fig. 1a), indicating that there are
further requirements for Wnt signaling during brain angiogen-
esis. We therefore analyzed during which stages of brain capillary
angiogenesis active Wnt signaling can be observed using confocal
live imaging and two different transgenic Wnt signaling reporter
lines, which express short-lived fluorophores controlled by Wnt-
responsive promoters: Tg(axin2BAC:Venus-Pest)mu288 and Tg
(14TCF:loxP-STOP-loxP-dGFP)mu20233. Both reporter lines
showed robust fluorophore expression within the migrating
CtA sprouts at 34 hpf (Supplementary Fig. 1b,c), which we
confirmed to be EC specific (Supplementary Fig. 1d). We next
performed time-lapse analysis using cre mRNA-injected Tg
(14TCF:loxP-STOP-loxP-dGFP)mu202 embryos starting from 29
hpf (Fig. 1b, Supplementary movies 1, 2). We detected high Wnt
reporter activity in the determined CtA pre-tip cells, which are
forming within the PHBC. Despite a putative half-life of about 2
h, the destabilized GFP (dGFP) expression remained high in the
emerging CtA sprouts during the following 5.5 h of development,
indicating continuous Wnt signaling activity during CtA sprout
migration and cell–cell contact formation (open arrow, Fig. 1b).
With the onset of lumen formation about 2 h after cell–cell-
contact formation, the dGFP signal decreased to a baseline level,
which was maintained in the perfused CtAs, pointing to a post-
determination role of Wnt signaling.
After pre-tip cell formation, CtA angiogenesis proceeds by
sprouting and sprout invasion into the brain parenchyma. We
asked whether endothelial Wnt signaling regulates these
processes.
We therefore generated a transgenic zebrafish line expressing a
dominant-negative Tcf transcription factor fused to mCherry
(mCherry-dnTcf) under the control of a heat shock inducible
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promoter (hsp70l). To restrict Wnt inhibition to ECs, we
placed a loxP-flanked (floxed) STOP-cassette upstream of the
mCherry-dnTcf coding sequence (Supplementary Fig. 2a, c).
This STOP cassette was removed only in ECs by mating to
fish with endothelial-specific Cre recombinase expression (Tg(kdrl:
cre)s898). Validation of Wnt inhibition by heat shock controlled
mCherry-dnTcf expression is documented in Supplementary
Fig. 2.
To address whether Wnt signaling regulates sprout elongation
or EC migration, we blocked Wnt signaling by EC-specific
mCherry-dnTcf expression or IWR-1 treatment starting from 26
hpf and analyzed CtA sprouts at 32 hpf (Fig. 1c, d). Surprisingly,
we did not observe differences in CtA sprout number or sprout
length after Wnt signaling inhibition (Fig. 1c, d). Furthermore,
sprout formation, behavior, and filopodia appearance were not
affected by IWR-1 treatment (Fig. 1e, f, Supplementary movies 3,
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4). Only the formation of long filopodia (>10 µm) was marginally
decreased after IWR-1 treatment (Fig. 1f). Similarly, heat shock-
induced EC-specific overexpression of mCherry-dnTcf
(mCherry-dnTcfiEC) did not result in differences in filopodia
morphology, but instead in high filopodia motility, which resulted
in slightly blurry images due to fast filopodia movement (Fig. 1g).
We conclude that after being required early within the parental
vessel, Wnt signaling is continuously active during CtA
angiogenesis, but dispensable for efficient sprout elongation and
invasion of CtA tip cells into the brain parenchyma.
Wnt regulates brain capillary anastomosis and lumenization.
To address the role of the active Wnt signaling in the developing
CtAs, we inhibited Wnt signaling by inducing mCherry-dnTcf
expression in ECs at 26 hpf or by applying IWR at 29 hpf and
analyzed CtA pattern and lumen formation at 48 hpf (Fig. 2a, b).
We observed a reduced CtA number, reduced connections to the
BA and ectopic connections between CtAs. CtA patterning
appeared more disorganized, and CtAs had non-lumenized pro-
trusions. To address whether the reduced number of CtAs
(Fig. 2a, b) correlated to a reduced number of EC within CtAs, we
blocked Wnt signaling as before, and quantified the number of
cell nuclei in Tg(fli1a:nGFP)y7 embryos. Both, treatment with
IWR-1 or heat shock-induced EC-specific mCherry-dnTcf
expression, reduced the EC number within CtAs (Supplemen-
tary Fig. 3a, b). However, blocking cell proliferation via the
administration of aphidicolin and hydroxyurea (AHU) did not
result in any patterning defects in CtAs, and the combined
inhibition of Wnt signaling and proliferation did not aggravate
the phenotype of Wnt deficiency (Supplementary Fig. 3c). We
therefore conclude that Wnt signaling is required for CtA pat-
terning, but does not act via cell proliferation.
To understand the processes underlying the CtA patterning
defects observed after Wnt signaling inhibition (Fig. 2a, b), we
performed angiography following IWR-1 treatment (Fig. 2c). In
control embryos, more than 80% of the CtAs were perfused at 48
hpf, whereas after IWR-1 treatment only about 25% of the CtAs
carried the fluorescent tracer. We next performed time-lapse
analysis following IWR-1 treatment or EC-specific mCherry-
dnTcf expression using Tg(fli1a:lifeact-GFP)mu240 embryos to
illustrate the actin cytoskeleton of ECs (Fig. 2d–f). We focused on
laterally connecting CtAs for better visualization and quantified
the time from cell–cell contact until completion of lumen
formation until 48 hpf (Fig. 2d). In control embryos, the average
time from cell–cell contact to lumen formation is less than 2 h
(Fig. 2d, e). After inhibition of Wnt signaling by IWR-1, we noted
a drastic delay in lumen formation or even completely impaired
lumenization within the observation window (Fig. 2e; Supple-
mentary movie 5-8). Additionally, tip cells in CtA sprouts of
IWR-1-treated embryos failed to establish stable cell–cell
contacts, but instead continuously produced filopodia, leading
to the formation of multiple cell–cell contact sites (asterisk in
Fig. 2e, f). This phenotype was fully reproduced by EC-specific
mCherry-dnTcf expression (Fig. 2f; Supplementary movies 9, 10).
However, the time difference was not as prolonged in the latter as
in IWR-1-treated embryos, presumably due to the turnover time
of mCherry-dnTcf, as mCherry is no longer detectable at the
endpoint of analysis.
In summary, our analysis reveals that Wnt signaling is required
for anastomosis of brain capillaries.
Block of Wnt signaling reduces VE-cadherin at cell junctions.
To elucidate how Wnt signaling regulates CtA anastomosis, we
investigated the abundance of the EC-specific adhesion molecules
VE-cadherin and Esama at cell–cell junctions of the CtAs23,24.
VE-cadherin, a member of the cadherin protein family expressed
in ECs, has been shown to be crucial for EC contact formation
during blood vessel anastomosis5,22. Esam belongs to the protein
family of Junction adhesion molecules (Jam) and two paralogues
exist in zebrafish, esama and esamb, of which esama is mainly
expressed in the vasculature24. To address, whether Wnt signaling
inhibition affects protein localization of VE-cadherin or Esama,
we performed immunostaining for VE-cadherin, Esama and ZO-
1 in 42 hpf-old embryos (Fig. 3a–d). In control embryos (DMSO),
VE-cadherin and Esama were expressed continuously along
cell–cell junctions of ECs within CtAs and in anastomosis rings,
which form at positions where two CtAs fuse (arrows in Fig. 3b).
After IWR-1 treatment (Fig. 3b) or EC-specific mCherry-dnTcf
expression (Fig. 3c, d), we found that the protein abundance of
VE-cadherin, Esama, and ZO-1 at cell–cell junctions was dra-
matically reduced. Furthermore, we frequently observed clustered
protein aggregates (stars in Fig. 3b) and the formation of many
small adhesion spots (arrows in Fig. 3b) in Wnt-inhibited
embryos, which is in line with our previous observations of
multiple filopodia contacts (Fig. 2e, f). Hence, reduction and
aberrant localization of VE-cadherin and Esama at the cell
junctions could cause the anastomosis defects. To validate these
findings in another model, we isolated primary brain endothelial
cells (BECs) from microvascular fragments34 of either P3 or adult
mice. We were able to block Wnt signaling using 10 µM IWR-1
for P3 and 20 µM for adult brain ECs (Fig. 3e, Supplementary
Fig. 2e). To analyze the effect on VE-cadherin distribution we
measured the length of the potential cell–cell contact area in form
of opposing or touching membrane length and the actual
Fig. 1 Wnt signaling is not required for migration of brain capillary sprout ECs. a Illustration of hindbrain angiogenesis in zebrafish embryos. Black box
indicates localization of the hindbrain. Brain capillary (central artery, CtA) pre-tip cells can be detected within two bilateral primordial hindbrain channels
(PHBCs, light gray) and sprout dorsally from PHBCs around 32 hpf. Between 32 and 36 hpf, CtA sprouts extend long filopodia and migrate in an arch
toward the basilar artery (BA, dark gray). At 48 hpf CtAs have fused with either the BA or neighboring CtAs and carry blood flow. b Time-lapse analysis of
a cre mRNA-injected Tg(14TCF:loxP-STOP-loxP-dGFP)mu202 embryo starting from around 29 hpf showed continuously active Wnt signaling in CtAs
(arrowheads) before and during sprouting, during invasion, cell–cell contact (open arrowhead) and lumen formation. The bottom panel represents single
channel images in inverted color for better visualization. c, d Inhibition of Wnt signaling by EC-specific dnTcf expression after heat shock at 26 hpf
(mCherry-dnTcfiEC, c) or pharmacologically by IWR-1 treatment (d) resulted in normal CtA sprouting at 32 hpf. CtA sprout number or length of the sprouts
was not affected by mCherry-dnTcfiEC expression in Tg(kdrl:GFP)s843 embryos (c: mCherry-dnTcfiEC: n= 11; mCherryiEC: n= 12) or IWR-1 treatment
(d: DMSO: number n= 22, length n= 17; IWR-1: number n= 24, length n= 18). e Still images from time-lapse movies starting at around 28 hpf displayed
normal CtA sprout formation in Tg(kdrl:ras-mCherry)s896; (fli1a:nGFP)y7 double transgenic embryos treated with IWR-1. f, g CtA sprout morphology was not
affected by IWR-1 treatment (f) or dnTcf expression (g) in Tg(fli1a:lifeact-GFP)mu240 embryos. IWR-1 treatment slightly reduced the formation of long
filopodia (>10 µm) compared to DMSO control (f: IWR-1: n= 15; DMSO: n= 15). Images are displayed in inverted color for better visualization. Confocal
images show dorsal (b) or lateral views (c–g), anterior to the left. Values represent mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, Student’s t-test; n,
number of analyzed embryos; BA, basilar artery; CtAs, central arteries; ECs, endothelial cells; hpf, hours post fertilization; PHBC, primordial hindbrain
channel; Scale bars: 30 µm (b), 50 µm (c–f), 6 µm (g)
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coverage of that area by VE-cadherin. We observed a marked
reduction in the length of VE-cadherin junctions and the cov-
erage of cell–cell contact sides by VE-cadherin in ECs isolated
from P3 mice. Interestingly, Wnt signaling inhibition did not
affect junctional VE-cadherin in adult brain ECs. We conclude
that brain capillary ECs from P3 mice are capable of responding
to Wnt signaling, presumably because these brain ECs are in a
more angiogenic state, whereas ECs from adult mice gain mature
BBB properties and are no longer sensitive to Wnt signaling
inhibition.
We next analyzed how a complete loss of VE-cadherin affects
CtA lumen formation using homozygous ve-cadherinubs835
mutant embryos. In ve-cadherinubs8-deficient mutants, CtAs
form and invade similarly to wild-type siblings (Supplementary
movies 11, 12), but fail to establish stable cell–cell contacts,
continuously produce filopodia toward the ECs in neighboring
CtAs or BA and fail to form continuous lumens (Supplementary
Fig. 4a, b, Supplementary movies 11, 12), a behavior, which
mimics our observations after Wnt signaling inhibition (Fig. 2e,
f). Interestingly, intracellular signaling via VE-cadherin and its
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association with intracellular adaptor proteins seems to be
required, as overexpression of VE-cadherin lacking the intracel-
lular domain could not rescue the lumen formation defects
(Supplementary Fig. 4d). Additionally, rescuing the ve-
cadherinubs8 mutant by expression of endogenous levels of the
VE-cadherin tension sensor (VE-cad-TS)36,37 did not completely
restore wild-type VE-cadherin function, (Supplementary Fig. 4a),
indicating that the presence of the fluorophores within the
intracellular domain of VE-cadherin reduces its signaling some-
what. We also analyzed lumen formation of CtAs in esamaubs1924
mutant embryos. Homozygous esamaubs19 mutants displayed
fewer lumenized CtAs compared to heterozygous controls
(Supplementary Fig. 4c). We conclude that VE-cadherin is
required for CtA anastomosis and that Esama contributes to
efficient CtA lumen formation, which is in agreement with
previous reports23,24. Therefore, we reason that the lumen
formation defects caused by Wnt signaling inhibition were the
result from decreased VE-cadherin and Esama protein levels at
the cell–cell contact sites in CtAs.
Wnt does not regulate transcription of ve-cadherin and esama.
We hypothesized that the reduced protein levels of VE-
cadherin and Esama could result from reduced transcription
in embryos lacking Wnt signaling. In order to analyze ve-
cadherin and esama mRNA expression levels, we performed
whole mount fluorescent in situ hybridization (FISH) after Wnt
signaling inhibition by IWR-1 or EC-specific mCherry-dnTcf
expression (Fig. 4a, b, Supplementary Fig. 4e). We quantified
the fluorescence intensity within CtAs at 32 or 42 hpf and
normalized the fluorescence intensity to the respective CtA
volume (generated from Tg(kdrl:GFP)s843 signal). Surprisingly,
we did not find severe changes of the overall ve-cadherin or
esama mRNA abundance in CtA ECs at 32 or 42 hpf (Fig. 4a, b,
Supplementary Fig. 4e).
At 32 hpf, ve-cadherin mRNA was slightly decreased following
IWR-1 treatment and slightly increased following mCherry-
dnTcfiEC expression. At 42 hpf, at which we detected reduced VE-
cadherin protein levels at the cell–cell junctions (Fig. 4b), ve-
cadherin mRNA was increased using either of the Wnt signaling
inhibition approaches. This indicates, that ve-cadherin mRNA
levels in CtAs were not decreased (as expected from a putative
Wnt target gene), but rather slightly increased over time,
presumably due to a compensatory mechanism. The mRNA
level of esama in CtA ECs was slightly decreased after Wnt
signaling inhibition by IWR-1 or mCherry-dnTcf expression both
at 32 and 42 hpf (Fig. S4e).
Additionally, to gain insights into transcriptional changes in
CtAs mediated by Wnt signaling inhibition, we isolated Kaede-
photoconverted CtA ECs from 1.5 days-old Tg(fli1a:Gal4)ubs3;
(UAS:Kaede)rk8 embryos, which were treated with IWR-1 or
DMSO (Fig. 4c, d) and performed gene expression profiling by
RNA sequencing. We confirmed that ve-cadherin and esama
expression levels were not regulated by Wnt signaling in sharp
contrast to classical Wnt target genes (e.g., axin2 and lef1,
Fig. 4d). We also analyzed the effect of Wnt inhibition on VE-
cadherin mRNA levels by qPCR in BECs isolated from P3 and
adult animals. In line with our zebrafish data, we observed no
transcriptional regulation of mouse VE-cadherin by Wnt signal-
ing (Fig. 4e).
We therefore conclude that post-transcriptional mechanisms
account for the changes in protein abundance at brain capillary
cell–cell junctions following Wnt signaling inhibition.
Wnt signaling counteracts S1pr1 signaling in angiogenesis. To
address how VE-cadherin localization at cell–cell junctions can be
regulated during brain angiogenesis, we focused on Sphingosine-
1-phosphate (S1p) signaling, as it is known to regulate EC
integrity and behavior by modulating junction protein localiza-
tion and cell contractility27,28. In particular, S1p-induced signal-
ing mainly via S1p receptor 1 (S1pr1) has been shown in vivo and
in vitro to increase recruitment of Cadherin protein family
members, including VE-cadherin and N-cadherin, to the plasma
membrane31,38,39. Additionally, S1p receptor 3 (S1pr3) was found
to function cooperatively with S1pr1 in promoting adherens
junction formation in ECs38, whereas S1p receptor 2 (S1pr2)
signaling disrupted EC junctions, thereby increasing vascular
permeability40. We confirmed that similar to what is seen in
mice30, blocking of S1prs using the pharmacological antagonist
VPC23019 (VPC) during barriergenesis (48–72 hpf) resulted in
extravasation of red blood cells into the surrounding brain tissue,
indicating breakdown of the BBB (Supplementary Fig. 5a).
Our RNA sequencing data showed expression of s1pr1 and
s1pr5a as well as very low level expression of s1pr2 and s1pr3b in
zebrafish brain capillary ECs (Supplementary Fig. 5b). In order to
functionally dissect the contribution of these different S1pr’s we
validated various pharmacological antagonists by their potency to
rescue phenotypes of S1pr overexpression (Supplementary
Fig. 5c–g). In the zebrafish, VPC seems to antagonize the tested
S1pr’s (S1pr1, S1pr2, S1pr3a, and S1pr5a), whereas TY52156
(TY) acts specifically on S1pr1. In our hands the S1pr2 antagonist
JTE013 (JTE) did not rescue S1pr2 overexpression (Supplemen-
tary Fig. 5c–g).
Fig. 2 Wnt signaling is crucial for brain capillary patterning and anastomosis. a, b Inhibition of Wnt signaling by IWR-1 treatment (a) or dnTcf expression
(b) impaired CtA patterning. a IWR-1 treatment from 29 to 48 hpf reduced CtA number (n= 39) and the proportion of CtAs connecting to the BA (n=
39), but increased the proportion of interconnecting CtAs (n= 33), compared to DMSO treated embryos (CtA number: n= 35; BA connection: n= 35;
interconnected: n= 29). b Expression of mCherry-dnTcfiEC through heat shock at 26 hpf reduced the number of CtAs (n= 40) and decreased the
proportion of CtAs connecting to the BA (n= 32) or interconnecting (n= 32), compared to mCherryiEC control at 48 hpf (CtA number: n= 39; BA
connection: n= 33; interconnected: n= 33). c Analysis of lumen formation by fluorescent tracer injection into the blood stream at 48 hpf. Treatment with
IWR-1 decreased the proportion of lumenized CtAs (n= 16) compared to DMSO control (n= 18). d Schematic representation of CtA anastomosis (dorsal
view, ~36 hpf). CtA sprouts (gray) migrate, extend filopodia and form cell–cell contacts to neighboring CtA sprouts (asterisk) or the BA. Cell–cell contact
formation triggers anastomosis, cell rearrangements and lumen formation through the connected sprouts in a distinct time window (Δt). e, f Inhibition of
Wnt signaling drastically extended the time window from cell–cell contact formation until lumen formation. Still images from time-lapse movies embryos
treated with DMSO (e: n= 58, N= 9) or IWR-1 (e: n= 33, N= 9) or expressing mCherryiEC (f: n= 36, N= 6) or mCherry-dnTcfiEC (f: n= 39, N= 8) after
heat shock treatment at 26 hpf. Note that for events, where lumen formation was not completed until the end of the time-lapse recording (~48 hpf), the
last measured time point was used for quantification. Confocal images show dorsal views (anterior to the left) of Tg(fli1a:lifeact-GFP)mu240 (a, b, e, f) or Tg
(kdrl:ras-mCherry)s896 (c) embryos. Values represent mean ± SD (a–c) or ± SEM (e, f). *p < 0.05, **p < 0.01, ***p < 0.001, Student’s t-test; n number of
analyzed embryos (a–c) or n number of CtA fusion events analyzed; N, number of embryos analyzed (e, f). BA, basilar artery; CtAs, central arteries; ECs,
endothelial cells; Scale bars: 50 µm
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To test the effects of S1pr inhibition on lumen formation and
VE-cadherin localization, we next applied the antagonists of S1pr
signaling during CtA angiogenesis at 29 hpf and assessed
patterning and lumen formation at 48 hpf. In contrast to
barriergenesis, treatment during brain angiogenesis with either
VPC or TY did not affect CtA development and lumen formation
in zebrafish (Fig. 5a). It is therefore likely that in wild-type
embryos S1pr signaling is required only after the onset of blood
circulation in CtAs, presumably through delivery of high amounts
of its ligand S1p by the blood41. To our surprise, co-treatment of
embryos with the Wnt signaling inhibitor IWR-1 and either VPC
or TY increased the proportion of lumenized CtAs compared to
single IWR-1 treatment and rescued CtA patterning and lumen
formation (Fig. 5a). S1pr inhibition by VPC was also able to
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rescue EC-specific loss of Wnt signaling in embryos over-
expressing mCherry-dnTcfiEC (Fig. 5b).
We further analyzed, whether not only lumen formation, but
also VE-cadherin and Esama levels at cell–cell junctions were
rescued by inhibiting S1pr signaling in Wnt-depleted embryos.
We observed that the reduced VE-cadherin and Esama localiza-
tion at cell–cell contact sides and in anastomosis rings after IWR-
1 treatment was restored by co-treatment with the S1pr1
antagonist TY and similar to control embryos when analyzed
either by immunostaining for VE-cadherin and Esama or by live
imaging of the Venus-fluorophore distribution of the VE-
cadherin-TS (Supplementary Fig. 6). Hence, blocking of S1pr1
in parallel to IWR-1 treatment was sufficient to rescue VE-
cadherin and Esama protein levels at cell–cell junctions. In line
with these results, inhibition of S1pr signaling by VPC restored
VE-cadherin-positive junctions in IWR-1 treated P3 BECs
(Fig. 5c).
As an alternative approach to pharmacological S1pr1 inhibi-
tion in zebrafish, we used transient CRISPR-Cas9-mediated s1pr1
knockdown in combination with IWR-1 treatment. This
manipulation restored lumen formation of CtAs (Fig. 5d) similar
to VPC or TY treatment (Fig. 5a). Furthermore, Wnt signaling
inhibition was unable to affect VE-cadherin localization in
S1pr1iEC knockout BECs isolated from P3 mice (Fig. 5e).
Therefore, loss of S1pr1 signaling rescued Wnt depletion
phenotypes, such as impaired lumen formation and VE-cadherin
localization. Taken together, the studies reveal that Wnt signaling
regulates brain capillary angiogenesis by counteracting
S1pr1 signaling in zebrafish and mouse ECs, presumably to
prevent premature barrier formation, which would impair brain
angiogenesis (Fig. 5f).
Wnt signaling prevents S1pr1-mediated Rac1 activation. So far
we have shown that Wnt signaling regulates brain capillary
angiogenesis in an EC-specific manner by post-transcriptionally
influencing VE-cadherin localization. Furthermore, the mis-
localization of VE-cadherin caused by Wnt signaling inhibition
was dependent on S1pr1 signaling (Fig. 5, Supplementary
Fig. 6). In order to understand the regulatory interaction of
these two signaling pathways, we addressed at which level Wnt
signaling interferes with S1pr1 signaling activation. We there-
fore stimulated S1pr1 signaling using a combination of two
agonists (CYM5541 and CYM5542; validation for agonist
activity, see Supplementary Fig. 5h). Overstimulation of
S1pr1 signaling activity did not induce lumen formation defects
(Fig. 6a) and therefore did not overcome the intrinsic coun-
teraction by Wnt signaling. However, block of S1pr signaling in
ve-cadherin or esama-deficient embryos did not result in a
rescue of lumen formation defects (Supplementary Fig. 7a).
Therefore, Wnt signaling antagonizes S1pr1 signaling down-
stream of receptor activation, but upstream of VE-cadherin and
Esama function.
One potential mechanism that could account for the
downregulation of VE-cadherin could be the regulation of
VE-cadherin degradation or internalization. We therefore
inhibited proteasomal degradation by MG132, dynamin-
dependent internalization by Dynasore and lysosomal degrada-
tion by Chloroquine; however, none of these treatments rescued
Wnt-deficiency (Supplementary Fig. 7b, c). Interestingly, we
also observed a mislocalization of VE-cadherin to seemingly
intracellular vesicular structures in Wnt signaling-deficient
BECs (Fig. 6b), indicating changes in cellular architecture
rather than VE-cadherin degradation following Wnt signaling
inhibition.
S1p-induced signaling in cultured ECs has been linked to
activation of the Rho/Rac-pathway for stabilization of the
cytoskeleton and recruitment of junction proteins to the cell
membrane38,42,43. Similar to S1pr signaling, Rac1 activation as
well as Rho inactivation is known to promote EC barrier function
in mature blood vessels44; however, their contribution to brain
capillary angiogenesis has not been addressed yet. We therefore
applied the pharmacological Rac1 inhibitor (NSC23766, NSC) or
Rho inhibitor (CT03) alone or together with IWR-1 as described.
Single treatment with either Rac1 or Rho inhibitors, did not affect
CtA development or lumen formation. Indeed, co-treatment of
IWR-1 and Rac1 inhibitor, but not of IWR-1 and Rho inhibitor,
robustly restored the lumen formation defects caused by IWR-1
(Fig. 6c, Supplementary Fig. 8a).
We hypothesized that if Rac1 was mediating premature
S1pr1 signaling activation, overexpression of constitutive-active
Rac1 (CA-Rac1) should phenocopy Wnt signaling inhibition.
Therefore, we mated Tg(fli1a:Gal4)ubs3 fish with Tg(UAS:CA-
Rac1)mu211 and analyzed brain capillary lumen formation in 48
hpf-old embryos (Fig. 6d). Vascular-specific overexpression of
CA-Rac1 caused strong lumen formation defects and was
accompanied by multiple filopodia contact sides comparable to
IWR-1-treated (Fig. 2a) or ve-cadherin-deficient (Supplementary
Fig. 4a) embryos. Additionally, vascular-specific Gal4-UAS-
mediated overexpression of dominant negative Rac1 (DN-Rac1,
from Tg(UAS:DN-Rac1)mu212) could partially rescued lumen
formation in IWR-1-treated embryos (Fig. 6e).
Hence, Rac1 activation downstream of S1pr1 signaling is
required and sufficient to mediate lumen formation defects
caused by Wnt signaling inhibition.
In summary, we identified a temporal-specific function of Wnt
signaling for brain capillary angiogenesis by post-transcriptionally
and EC-specifically regulating junction protein localization
upstream or at the level of Rac1 activity, but downstream of
S1pr1 signaling. We suggest that EC-specific Wnt signaling
Fig. 3 Junctional localization of VE-cadherin and Esama is affected by Wnt signaling inhibition. a Schematic of the zebrafish hindbrain vasculature at 42 hpf.
Red box indicates region of analysis. In the following images (b–d) half of the boxed region is displayed. b–d Inhibition of Wnt signaling by IWR-1 from 29
hpf (b) or by dnTcf expression (c, d) strongly reduced expression of VE-cadherin or Esama and ZO-1 at the cell–cell junctions. Immunostaining for VE-
cadherin (b, c; red) or Esama (b, d; red) and ZO-1 (b, c; green). Single channel images were displayed in inverted colors for better visualization. b In control
embryos (DMSO), VE-cadherin and Esama were detected in cell–cell junctions along the CtAs and in anastomosis rings (arrow). Inhibition of Wnt signaling
resulted in reduced staining of VE-cadherin and Esama at the cell junctions, formation of multiple small anastomosis rings (arrows) and ectopic VE-
cadherin-positive cell protrusions (asterisks). c, d In control embryos (mCherryiEC), VE-cadherin and Esama are strongly expressed in cell–cell junctions.
Expression of mCherry-dnTcfiEC dramatically reduced VE-cadherin and ZO-1 (c) or Esama (d) at the cell–cell junctions. e Primary mouse BECs enriched
from microvascular fragments from P3 mice exhibited impaired VE-cadherin junction formation following Wnt signaling inhibition by IWR-1 (DMSO: n=
86; IWR: n= 80; N= 4). In contrast, BECs isolated from adult mice had coverage of cell–cell contact sides by VE-cadherin similar to control (DMSO: n=
143; IWR-1: n= 130; N= 4). Immunostaining for VE-cadherin (red), ZO-1 (green), CD31 (white), and DAPI (blue) of cultured primary mouse BECs after
treatment with IWR-1 (P3: 10 µM; adult: 20 µM) or DMSO, respectively. Values represent mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, Student’s t-test; n,
number of analyzed junctions; N, number of biological replicates. BECs, brain ECs, CtAs, central arteries; ECs, endothelial cells; Scale bars: 20 µm (b–d);
100 µm (e)
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Fig. 4Wnt signaling does not regulate ve-cadherinmRNA expression. aWhole mount fluorescent in situ hybridization (FISH, red) in combination with anti-
GFP immunostaining (green) of Tg(kdrl:GFP)s843 embryos. For quantification the FISH signal within CtA sprouts was normalized to the respective GFP
volume (blue) of each sprout. b Inhibition of Wnt signaling either by incubation with IWR-1 or expression of mCherry-dnTcfiEC did not severely affect ve-
cadherin mRNA expression at 32 or 42 hpf. Treatment with IWR-1 resulted in slightly decreased ve-cadherin mRNA levels in CtA sprouts at 32 hpf, but in
increased ve-cadherinmRNA levels at 42 hpf (32 hpf: DMSO: n= 16, N= 6, and IWR-1: n= 15, N= 6; 42 hpf: DMSO: n= 28, N= 7, and IWR-1: n= 19, N=
7). After mCherry-dnTcfiEC expression in ECs ve-cadherin mRNA expression was slightly increased (32 hpf: mCherryiEC: n= 20, N= 6; mCherry-dnTcfiEC:
n= 18, N= 7; 42 hpf: mCherryiEC: n= 40, N= 7; mCherry-dnTcfiEC: n= 16, N= 7). Quantifications were represented by Box-and-Whisker plots with
median (center line), 25th and 75th percentiles (bounds of box) and Min-to-Max (whiskers), *p < 0.05, **p < 0.01, ***p < 0.001, Student’s t-test; n, number
of CtA volumes analyzed; N, number of embryos analyzed. Scale bars: 50 µm. c, d Expression levels of ve-cadherin or esama were not altered by inhibition of
Wnt signaling, whereas classical Wnt-target genes (e.g., axin2, lef1) were downregulated. For RNA sequencing, CtA ECs of Tg(fli1a:Gal4);(UAS:Kaede)
embryos, which were treated with IWR-1 or DMSO, were photoconverted using the confocal microscope laser and isolated by FACS (photoconverted
Kaede ECs= Kaede+ cells= P4) (n= 3). e Expression levels of VE-cadherin are not affected by IWR-1 treatment. RT-qPCR analysis of Values in
d, e represent mean ± SD, *p < 0.05, **p < 0.01, ***p < 0.001, n, number of biological replicates. BECs, brain ECs, CtAs, central arteries; ECs, endothelial
cells; FISH, fluorescent in situ hybridization
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counteracts S1pr1 signaling during CtA angiogenesis, presumably
to prevent premature barrier formation processes, which would
impair brain angiogenesis (Fig. 6f,g).
Interestingly this mechanism seems to be specific to the role of
Wnt signaling in regulating anastomosis and lumen formation,
but not to the essential function of Wnt signaling during the
earlier pre-tip cell phase12,15. Treatment of embryos lacking Wnt
signaling following IWR-1 treatment or of gpr124 mutants with
S1pr antagonists did not restore CtA sprout formation (Supple-
mentary Fig. 8b, c).
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In conclusion, we describe a temporal control of different steps
of brain angiogenesis and BBB formation, which are differentially
regulated by Wnt signaling. We also discover an interplay
between Wnt and S1pr signaling during brain angiogenesis.
Discussion
We addressed the role of β-catenin-dependent Wnt signaling
during early brain capillary angiogenesis in vivo. We found that
(1) Wnt signaling is highly active in brain capillary sprouts, but
after pre-tip cell formation it is dispensable for brain capillary
invasion into the brain parenchyma. Instead, (2) Wnt signaling is
required for brain capillary anastomosis. During this process, (3)
Wnt signaling influences the post-transcriptional regulation and
cell–cell junction localization of the EC-specific adhesion mole-
cules, VE-cadherin, and Esama, by counteracting S1pr1 signaling
(Fig. 6f, g).
We and others have shown that Wnt signaling is active in brain
capillaries during brain angiogenesis (Fig. 1,11,12,14). Recent
reports demonstrate that Gpr124-Reck-mediated Wnt signaling is
essential for brain vascularization, as homozygous grp124 or reck
mutants are completely devoid of brain capillaries12,15–17. We
hypothesized that Wnt signaling might be involved in the for-
mation of pre-tip cells within the parental vessel, which most
likely occurs at earlier developmental stages12. In line with this, a
role of Wnt signaling for EC specification has already been sug-
gested to drive cell fate from the Fli1a-positive precursor cell
population into ECs at the expense of primitive erythrocytes33. At
later developmental stages, Wnt signaling is required for sub-
specification of EC populations within the vasculature, which has
been shown for hemogenic EC formation45,46 and lymphatic cell
fate specification47.
Here we demonstrate that Wnt signaling is continuously
activated in CtAs during all stages of angiogenesis. Surprisingly,
Wnt signaling is not involved in the process of CtA sprout
invasion and filopodia formation (Fig. 1).
However, our data demonstrate that Wnt signaling is essential
for brain capillary anastomosis (Fig. 2). During the anastomosis
process in intersegmental vessels, VE-cadherin is required for
cell–cell contact formation and together with Esama has been
shown to be essential for efficient blood vessel fusion23,24. We
detected reduced protein levels of VE-cadherin, Esama, and ZO-1
at the cell–cell junctions following Wnt signaling inhibition
(Fig. 3), which presumably impair anastomosis and lumen for-
mation. In line with these findings, knockouts of VE-cadherin (by
ve-cadherinubs8/ubs8) or Esama (by esamaubs19/ubs19) phenocopied
CtA lumen formation defects (Supplementary Fig. 4). Surpris-
ingly, neither ve-cadherin nor esama are transcriptional targets of
Wnt signaling (Fig. 4). Similar to Hupe and colleagues, we
detected mildly increased amounts ve-cadherin mRNA when Wnt
signaling inhibition persists for longer time intervals (>12 h),
indicating a compensatory response to the reduced protein levels
of VE-cadherin at cell–cell junctions48. We therefore conclude
that VE-cadherin and Esama downregulation occurs via a post-
transcriptional mechanism, which interferes with their membrane
localization. Using a series of inhibitors, we excluded inter-
nalization as well as proteasomal and lysosomal degradation as
potential mechanisms (Supplementary Fig. 7). Previously, Wnt
signaling has been shown to be required for the junction locali-
zation of Claudin 1 and 3 in murine brain ECs during BBB
formation, but no direct transcriptional regulation has been
detected13,14. As there have been no mechanisms proposed of
how Wnt signaling could regulate these junctional molecules, we
speculate that they might also be downregulated post-
transcriptionally as a consequence of imbalanced S1pr signaling.
The concept that S1pr signaling regulates EC integrity by
modulating translocation of junction proteins and actomyosin
contractility is widely accepted27,28. So far, S1pr signaling has not
been linked to brain capillary angiogenesis and our data also
indicate that the endogenous S1pr signaling is neither required
for CtA tip cell specification (Supplementary Fig. 5) nor for other
aspects of CtA angiogenesis (Fig. 5). However, as recently shown
in mice30, we demonstrate that S1pr signaling indeed regulates
BBB formation and integrity in zebrafish (Supplementary Fig. 5).
Moreover, our data points to a novel regulatory mechanism of
Wnt signaling during brain capillary angiogenesis, which is to
counteract S1pr-induced BBB formation in order to ensure effi-
cient anastomosis (Fig. 5). We propose that Wnt signaling sup-
presses S1pr1-mediated signaling in CtAs during early stages of
brain vascularization. After lumen formation, Wnt signaling
activity within brain capillaries decreases to a low baseline level
(Fig. 114). In lumenized vessels, activation of S1pr signaling would
occur and be most likely enhanced by increased supply of the
ligand S1p through the blood circulation41, which would enable
functional S1pr signaling for BBB formation and maintenance
(Supplementary Fig. 5).
It seems likely that the S1pr1-mediated pathway signals via Gαi
and activates Rac1 (Fig. 627,49). We hypothesize that over-
activation of Rac1 after Wnt signaling inhibition interferes with
efficient cellular junction formation during brain capillary
angiogenesis. To date, Rac1 activation is well described to pro-
mote EC barrier formation in mature blood vessel44, indicating
Fig. 5 Wnt signaling counteracts S1pr1 signaling during brain capillary angiogenesis. a Treatment with Sphingosine-1-phoshate receptor (S1pr) antagonists
from 29 to 48 hpf did not affect CtA angiogenesis. Combining inhibition of Wnt signaling with antagonizing S1pr signaling led to a rescue of CtA
angiogenesis and lumen formation. Embryos were single or co-treated with IWR-1 and S1pr antagonists VPC23019 (VPC), and TY52156 (TY) (DMSO: n=
23; VPC: n= 8; TY: n= 10; IWR-1: n= 33; IWR-1+VPC: n= 10; IWR-1+ TY: n= 15). b Antagonizing S1pr signaling following EC-specific dnTcf expression
rescues CtA lumen formation defects. Embryos expressing mCherryiEC or mCherry-dnTcfiEC were treated with VPC following heat shock at 26 hpf.
(mCherryiEC: DMSO: n= 4, VPC: n= 4; mCherry-dnTcfiEC: DMSO: n= 6, VPC: n= 5). c Co-treatment with VPC restored the VE-cadherin junction
formation defects of IWR-1-treated primary mouse BECs (from P3 animals; DMSO: n= 84; IWR-1: n= 100; IWR-1+VPC: n= 134; N= 3). d Transient
CRISPR-Cas9-mediated knockout of s1pr1 resulted partial rescue of the lumen formation defects in Wnt-depleted embryos. Embryos were injected with
gRNA targeting s1pr1 and cas9 mRNA (s1pr1 CRISPR) or cas9mRNA (control) and treated with IWR-1 from 29 to 48 hpf (control: DMSO: n= 11, IWR-1: n=
12; s1pr1 CRISPR: DMSO: n= 8, IWR-1: n= 12). e EC-specific knockout of S1pr1 (S1pr1iEC-KO) caused insensitivity to IWR-1 in mouse primary BECs. BECs
isolated from S1pr1iEC-KO animals at P3 showed no difference in VE-cadherin junction formation after DMSO or IWR-1 treatment in contrast to control
siblings (siblings: DMSO: n= 152; IWR: n= 92; N= 4; S1pr1iEC-KO: DMSO: n= 240; IWR: n= 156; N= 5). f Illustration of Wnt and S1pr1 signaling during
brain vascularization in wild type and Wnt-depleted embryos. Confocal images of zebrafish embryos (a, b, d) show dorsal views (anterior to the left) and
GFP expression by Tg(fli1a:lifeact-GFP)mu240. Images of mouse BECs (c, e) display immunostaining for VE-cadherin (red), ZO-1 (green), and DAPI (blue).
Values represent mean ± SEM (a, b) or mean ± SD (c–e). *p < 0.05, **p < 0.01, ***p < 0.001, One-way ANOVA; n, number of analyzed embryos (a, b, d); n,
number of analyzed junctions, N, number of biological replicates (c, e); BECs, brain ECs, CtAs, central arteries; ECs, endothelial cells; ns, not significant;
S1pr, sphingosine-1-phosphate receptor; Scale bars: a, b, d= 50 µm; c, e= 100 µm
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that Rac1 can act downstream of S1pr signaling in barriergen-
esis27. However, we demonstrate a different regulation in Wnt-
responsive brain capillary ECs during capillary angiogenesis,
which is similar to our observation of S1pr signaling regulation
(Fig. 5). Our data in zebrafish and mouse BECs clearly show
altered responsiveness of the ECs to Wnt inhibition depending on
their developmental state. This indicates that S1pr-Rac1-mediated
regulation of VE-cadherin is differently affecting the modulation
of established junctions in mature blood vessels compared to
junctions newly forming during brain angiogenesis.
Additionally, over-activation of Rac1 could destabilize junction
molecule complexes, as has been shown for initial stages of
pharyngeal pouch formation in zebrafish50. In this study, the
authors suggested that Wnt signaling mediates activation of Rac1
by an unknown mechanism50; however, a possible role of S1pr
signaling has not been addressed. The authors also observed a
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reduced membrane localization of the adherens junction mole-
cules E-Cadherin and Alcama after Wnt signaling inhibition by
morpholino-mediated knockdown of Disheveled, which is in line
with our findings during brain angiogenesis. We therefore spec-
ulate that similarly to brain capillary ECs, Wnt signaling regulates
Rac1-mediated S1pr signaling and thereby modulate junction
localization of adhesion molecules also during pharyngeal pouch
formation.
During brain neo-vascularization, we and others report divers
functions of Wnt signaling, which regulate many steps of brain
capillary angiogenesis and BBB formation and cross-
communicate with other signaling cues51. First, Wnt signaling
is required for the formation of the brain capillary pre-tip cells
within the parental vessel, which is dependent on a functional
Gpr124-Reck co-receptor complex12,15–18. Second, Wnt signaling
limits S1pr signaling during brain capillary sprouting and pro-
motes brain capillary anastomosis through efficient VE-cadherin
and Esama localization to the membrane (as shown in this work).
And third, Wnt signaling leads to the induction of BBB compo-
nents, such as glucose transporter Glut1 and Claudin family
members, already during brain angiogenesis in order to subse-
quently establish a functional BBB after brain angiogenesis has
been completed10,26,48,52 and sealing of the BBB is likely to be
promoted by S1pr signaling after the onset of blood circulation
(Supplementary Fig. 530,41). The complexity of the signaling
network regulating EC behavior during brain angiogenesis and
BBB formation is far from being understood. Our study provides
a regulatory function of Wnt signaling during brain angiogenesis,
which was only unraveled by interfering with Wnt signaling in a
temporally and spatially restricted manner in combination
with in vivo time-lapse imaging. We were able to identify a post-
transcriptional level of regulation, which is essential for cell–cell
junction formation and the modulation of EC barrier establish-
ment or tightness. Therefore, interfering with Wnt or S1p sig-
naling during treatment of infectious and neurodegenerative
diseases as well as anti-cancer therapy remains a major clinical
obstacle as adverse effects and cross-reactions are not well pre-
dictable30,53–55. The FDA approved sphingosine analog and
agonist of S1pr1 and S1pr3–5 called Fingolimod (FTY720/Gile-
nya) has been reported to cause side effects of increased of vas-
cular permeability in the lung and cardio-vascular complications.
Moreover, cases with neuroencephalitis were noted when the
drug was applied at higher doses. Therefore, the evaluation of the
potential clinical impact for CNS development and pathology of
these and future substances requires a greater understanding of
signaling cues regulating EC properties and behavior.
Methods
Zebrafish husbandry and strains. Zebrafish (Danio rerio) husbandry and embryo
maintenance were carried out under standard conditions at 28.5 °C56. Embryonic
developmental stages were determined according to ref. 57.
Transgenic lines used in this study were Tg(14TCF:loxP-STOP-loxP-dGFP)
mu20233, Tg(axin2BAC:Venus-Pest)mu28833, Tg(fli1a:dsRed)um1358, Tg(fli1a:lifeact-
GFP)mu24059, Tg(fli1a:nGFP)y760, Tg(fli1ep:Gal4ff)ubs361, Tg(gata1:dsRed)sd262, Tg
(kdrl:cre)s89863, Tg(kdrl:GFP)s84364, Tg(kdrl:mKate2-CAAX)ubs1623, Tg(kdrl:Hras-
mCherry)s89665, Tg(kdrl:tagBFP)mu29366, Tg(UAS:Kaede)rk867, Tg(UAS:VE-
cadherinΔC-EGFP)ubs1223 and Tg(ve-cadBAC:ve-cadTS)uq11bh (referred as VE-
cadTS)36. Mutants used in this study were esamaubs1924, gpr124s98412 and ve-
cadherinubs835.
The Tg(UAS:CA-Rac1)mu211 and Tg(UAS:DN-Rac1)mu212 lines were generated
by injection of plasmids, which were a gift from Gage Crump50, and according to
standard transgenesis protocol68. Both constructs harbor α-crystallin:cerulean,
inducing blue fluorescence in the lenses at 48 hpf. To overexpress CA-Rac1 and
DN-Rac1 in the vasculature the respective fish were mated to Tg(fli1ep:Gal4ff)ubs3;
(kdrl:Hras-mCherry)s896. Please note, that in the case of DN-Rac1 overexpression,
all embryos were presorted for established circulation in PHBC and BA prior to
analysis by confocal microscopy as we most likely obtained multiple integrations of
the construct and thereby varying phenotypes in the offspring embryos.
Generation of transgenic Wnt-manipulating lines. The Tg(hsp70l:loxP-STOP-
loxP-mCherry-dntcf)mu201 line was generated by fusing the coding sequences of
mCherry69 in frame with dntcf70 downstream of a heat shock inducible promoter
(hsp70l69). A floxed STOP cassette (loxP-STOP-loxP, Hesselson 2009) was inserted
upstream of mCherry by AflII-SpeI digest. Using the gateway system, hsp70l:loxP-
STOP-loxP-mCherry-dntcf was cloned into the destination vector pTol2Dest71.
The Tg(hsp70l:loxP-STOP-loxP-mCherry)mu279 line was generated by removing
the dntcf sequence from Tol2-hsp70l:loxP-STOP-loxP-mCherry-dntcf-Tol2 using
AfeI-SnaBI digest followed by Klenow blunting and religation.
For both lines, standard transgenesis was performed68.
Microinjections. For ubiquitous removal of the floxed STOP cassette by Cre
recombinase, 2 nL of cre mRNA (200 pg/nL) were injected at single cell stage.
Therefore the cre coding sequence69 was cloned into pCS2+ and transcribed into
mRNA by using the Sp6 mMessage mMachine kit (Ambion) following NotI-digest
as previously described33.
For overexpression of S1pr’s, the coding sequences of s1pr1, s1pr2, s1pr3a, and
s1pr5a were amplified from 24 hpf-cDNA and cloned into pCS2+ using the
following primers (see also Supplementary Table 1): s1pr1 fwd 5′-
ATGGATGACCTAATCGCC-3′, s1pr1 rev 5′-CGAGACGAAAAAGTTCACG-3′,
s1pr2 fwd 5′-ATGACTACTTGCCGTCTG-3′, s1pr2 rev 5′-GGGATCTGCAAAC
ACTTGG-3′, s1pr3a fwd 5′-ATGGATGACGAGCTTGAACC-3′, s1pr3a rev 5′-
TCAGAACTTCCCCAAAGCG-3′, s1pr5a fwd 5′-GGTCAGCAGAAGTGAAA
TGG-3′, s1pr5a rev 5′-CAGACTTGTTTACTTGGCAG-3′. Transcription into
mRNA following NotI-digest was carried out using the Sp6 mMessage mMachine
kit (Ambion) as described33. Thereafter, 2 nL of 75 ng/µL or 150 ng/µL s1pr1
mRNA, 10 ng/µL s1pr2 mRNA, 150 ng/µL s1pr3a or 150 ng/µL s1pr5a mRNA were
injected at single cell stage as indicated for each experiment. For agonist
experiments, 75 ng/µL s1pr1 mRNA was additionally supplemented with 200 µM
Sphingosine-1-phospate (S1p, Tocris Bioscience, 1370).
For transient CRISPR-Cas9-mediated knockout of s1pr1, annealed template
oligonucleotides were transcribed into gRNAs using MEGAshortscript T7 Kit
(Ambion): s1pr1 5′- AAAGCACCGACTCGGTGCCACTTTTTCAAGTTGAT
Fig. 6Wnt signaling regulates S1pr1 signaling downstream of receptor activation. a Treatment of zebrafish embryos with S1pr agonists did not result in CtA
formation or anastomosis defects. Wild-type embryos were treated from 29 to 48 hpf with S1pr agonists (CYM5541 and CYM5542) or DMSO (DMSO: n
= 10; agonists: n= 10). b High resolution imaging of IWR-1-treated mouse primary BECs revealed intracellular accumulation of VE-cadherin. BECs isolated
from P3 animals were treated with IWR-1 or DMSO (DMSO: n= 12; IWR-1: n= 12; N= 4). c Inhibition of Rac1 rescued lumen formation defects of CtAs in
Wnt-depleted embryos. Embryos were single or co-treated with IWR-1 and NSC23766 (NSC, Rac1 inhibitor) from 29 to 48 hpf. (DMSO: n= 8; NSC: n=
10; IWR-1: n= 14; IWR-1+NSC: n= 12). d EC-specific overexpression of CA-Rac1 results in lumen formation defects. Analysis of Tg(fli1a:Gal4)ubs3;(UAS:
CA-Rac1)mu211 embryos and control siblings at 48 hpf (siblings: n= 15, CA-Rac1: n= 17). e EC-specific overexpression of DN-Rac1 partially rescues IWR-1-
induced lumen formation defects. Treatment of Tg(fli1a:Gal4)ubs3;(UAS:DN-Rac1)mu212 embryos and control siblings with IWR-1 from 29 to 48 hpf (siblings:
n= 17, DN-Rac1: n= 5). f, g Molecular events of brain capillary anastomosis in wild type (f) and Wnt-depleted (g) embryos. Wnt signaling is highly active
in wild-type brain capillary sprouts (f, dark blue), which allows for efficient localization of VE-cadherin (red) and Esama (yellow) to cell–cell junctions, thus
resulting in rapid anastomosis and lumen formation. Following Wnt signaling inhibition (g), brain capillary anastomosis is compromised due to VE-cadherin
and Esama mislocalization caused by premature S1pr1 signaling, which involves activation of Rac1. Confocal images of zebrafish embryos (a, c, d, e) show
dorsal views (anterior to the left) and EC-labeling GFP or mCherry as indicated. Images of mouse BECs (b) display immunostaining for VE-cadherin (red),
CD31 (white), ZO-1 (green), and DAPI (blue). All values represent mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, One-way ANOVA; n number of analyzed
embryos (a, c, d, e); n, number of analyzed embryos, N, number of biological replicates (b); BBB, blood-brain barrier, BECs, brain ECs, CtAs, central arteries;
ECs, endothelial cells; ns, not significant; S1pr, sphingosine-1-phosphate receptor; Scale bars: a, c, d, e= 50 µm; b= 100 µm
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-07302-x ARTICLE
NATURE COMMUNICATIONS |          (2018) 9:4860 | DOI: 10.1038/s41467-018-07302-x | www.nature.com/naturecommunications 13
AACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAACTCTCT-
GAAGAACCATTGCGTTATAGTGAGTCGTATTACGC-3′ (s1pr1 target
sequence: 5′-TCTCTGAAGAACCATTGCGT-3′). A total of 2 nL of 500 ng/µL
gRNA and 300 ng/µL nls-zCas9-nls mRNA72 or only nls-zCas9-nls mRNA as
control were injected at single cell stage. Efficacy of the CRISPR-targeting was
accessed by PCR using s1pr1 fwd 5′-TCTATACTGCCAACATCCTG-3′ and rev
5′-CTGATGAGCATGAAGACCC-3′ (see also Supplementary Table 1) and
subsequent restriction enzyme digest using Hpy188I. This leads to 136 bp and 69
bp fragments in control samples and additionally ~205 bp fragments in samples
obtained from s1pr1 CRISPR injected embryos.
Vascular-specific Cre-mediated recombination. For vascular-specific removal of
floxed STOP-cassettes, transgenic fish (e.g. Tg(hsp70l:loxP-STOP-loxP-mCherry-
dntcf)mu201) were mated with Tg(kdrl:cre)s898. The resulting embryos carrying both
transgenes were used for analysis and in the case of heat shock inducible transgenes
were labeled by iEC (e.g., mCherryiEC, mCherry-dnTcfiEC).
Heat shock and pharmacological treatments. In order to induce gene expression
by heat shock, 26 hpf-old dechorionated embryos were incubated 40 min at 39 °C
in pre-warmed E3 medium and analyzed at indicated developmental stages. For
validation of the Tg(hsp70l:loxP-STOP-loxP-mCherry-dntcf)mu201 and Tg(hsp70l:
loxP-STOP-loxP-mCherry)mu279 lines, embryos were incubated at 10 hpf and 15 hpf
for 1 h at 39 °C and analyzed at 24 hpf.
For pharmacological treatments, dechorionated embryos were incubated from
5.5 to 24 hpf (for validation of S1pr antagonists), from 29 to 48 hpf or from 26 to
32 hpf in E3 medium supplemented with 150 µM Aphidicolin (A, Sigma-Aldrich)
33, 100 µM Chloroquine (Sigma-Aldrich)73,74, 10 µM CYM5541 (Sigma-Aldrich),
10 µM CYM5542 (Tocris Bioscience), 80 µM Dynasore (Sigma-Aldrich)74,75, 20
mM Hydroxyurea (HU, Sigma-Aldrich)33, 20 µM IWR-1 (Sigma-Aldrich)33, 50 µM
JTE013 (JTE, Cayman Chemical), 10 µM MG132 (Sigma-Aldrich)74,76, 100 µM
NSC23766 (NSC, Sigma-Aldrich), 5 µg/mL Rho Activator II (Cytoskeleton)59, 2 µg/
mL Rho inhibitor CT03 (Cytoskeleton)59, 100 µM TY52156 (TY, Tocris
Bioscience) and 50 µM VPC23019 (VPC, Cayman Chemical). Tg(hsp70l:loxP-
STOP-loxP-mCherry-dntcf)mu201 and Tg(hsp70l:loxP-STOP-loxP-mCherry)mu279
embryos were incubated directly after heat shock from 27 to 30 hpf with 12.5 µM
and from 30 to 48 hpf with 25 µM VPC.
Microinjections of fluorescent dye (angiography). To analyze blood vessel
perfusion, 2 nL 40 kDa FITC-Dextran 40 (1 mg/mL; TdB consultancy) were
injected into the blood stream of anesthetized embryos at 48 hpf.
Immunohistochemistry of zebrafish embryos. Immunohistochemistry was car-
ried out as previously described77. Additionally, primary and secondary antibody
dilutions were supplemented 1:1 with Pierce™ Immunostain Enhancer (Thermo
Fisher Scientific). Antibodies used in this study: 1:400 rabbit anti-zf-VE-cadherin77,
1:1000 mouse anti–hZO-1 (Invitrogen, 33910059), 1:400 rabbit anti-Esama23, 1:200
rabbit anti-dnTcf (anti-TCF7L1; Proteintech Group, 14519-1-AP), 1:2000 goat
anti-rabbit IgG Alexa Fluor 594 (Invitrogen, A-21207), 1:2000 goat anti-mouse IgG
Alexa Fluor 647 (Invitrogen, A-21235), 1:2000 goat anti-mouse IgG Alexa Fluor
488 (Invitrogen, A-11001).
Fluorescent in situ hybrisization (FISH). Fluorescent in situ hybrisization (FISH)
was adapted from refs. 78,79. Briefly: MeOH-fixed embryos were rehydrated,
digested with Proteinase K (Roth, 7528.4, 10 µg/mL) for 12 min and refixed in 4%
PFA. After washing with PBS containing 0.3% (v/v) Tween and pre-hybridization
at 65 °C, embryos were incubated hybridization buffer containing digoxigenin
(DIG)-labeled antisense probes at 65 °C for >12 h. Probe removal, blocking, and
primary antibody incubation was performed according to the published protocol.
Primary antibodies were POD-coupled anti-DIG (Roche, 1:400) and anti-GFP
(Abcam, ab6556, 1:400), which was used for counter-staining GFP in transgenic
embryos. After removal of the antibody solution, embryos were incubated for 60
min with TSA Plus Cy3 solution (Perkin Elmer, NEL744001KT), washed three
times with PBS-Tween to remove excess staining solution and subjected to 1:500
goat anti-rabbit IgG Alexa Fluor 488 (Invitrogen) for 60 min. At last, embryos were
washed with PBS-Tween >5 h and sequentially taken up in 75% Glycerol for
confocal microscopy.
The antisense probes for ve-cadherin80 and esama24,81 were generated from
plasmid templates using T3 or Sp6 polymerase and DIG-labelled UTP (2 h, 37 °C)
and purified by precipitation81.
Photoswitching and FACS isolation of brain capillary ECs. Photoswitching of Tg
(fli1:gal4)ubs3;(UAS:kaede)rk8 embryos was performed using a Zeiss LSM 710
confocal microscope (Carl Zeiss, objective lenses: Plan-Apochromat ×20/0.8 M27)
after embryo anesthesia with a low dose of tricaine. Embryos were mounted lat-
erally in 1% low-melting agarose in glass-bottom Petri dishes (MatTek Corpora-
tion, Ashland, MA). Photoconversion of Kaede fluorescent protein was performed
by scanning the selected region of interest with a 405 nm diode laser (100% laser, 5
iterations, 50 s). After photoconversion, embryos were manually removed from the
agarose and placed in fresh egg water (0.3 g/L Instant Ocean Salt, 75 mg/L CaSO4;
1 mg/L Methylene Blue) additionally supplemented with N-Phenylthiourea (30 mg/
L, Sigma-Aldrich) and covered with aluminum foil to protect from the light before
trypsin treatment. After several washes in HBSS (Hank’s Balanced Salt Solution,
Gibco) without Ca2+/Mg2+, zebrafish embryos dissociation was performed at 28.5
°C during 30 min using 2 mL of trypsin-LE select (Gibco). Dissociation was
stopped by added 200 µL of FBS solution. After centrifugation, pellet was resus-
pended with HBSS with Ca2+/Mg2+ +5% FBS and filtered. Photoswitched ECs
were isolated on FACS Aria II. Cells were immediately centrifuged, frozen by liquid
nitrogen and stored at −80 °C.
RNA sequencing of zebrafish brain capillary ECs. For RNA-seq, RNA was
isolated from FACS sorted zebrafish CtAs ECs cells using the miRNeasy micro Kit
(Qiagen) combined with on-column DNase digestion (DNase-Free DNase Set,
Qiagen) to avoid contamination by genomic DNA. RNA and library preparation
integrity were verified with a BioAnalyzer 2100 (Agilent) or LabChip Gx Touch 24
(Perkin Elmer). RNA amount was adjusted on number of isolated cells by FACS
and ~250–500 pg total RNA was used as input for SMART-Seq® v4 Ultra® Low
Input RNA Kit (Takara Clontech) for cDNA pre-amplification. Obtained full-
length cDNA was checked on LabChip and fragmented by Ultrasonication by E220
machine (Covaris). Final Library Preparation was performed by Low Input Library
Prep Kit v2 (Takara Clontech). Sequencing was performed on the NextSeq500
instrument (Illumina) using v2 chemistry, resulting in minimum of 30M reads per
library with 1 × 75 bp single end setup. The resulting raw reads were assessed for
quality, adapter content, and duplication rates with FastQC (available online at:
http://www.bioinformatics.babraham.ac.uk/projects/fastqc). Reaper version 13–100
was employed to trim reads after a quality drop below a mean of Q20 in a window
of 10 nucleotides82. Only reads between 30 and 150 nucleotides were cleared for
further analyses. Trimmed and filtered reads were aligned versus the Zebrafish
genome version DanRer10 (GRCz10.87) using STAR 2.4.0a with the parameter “—
outFilterMismatchNoverLmax 0.1” to increase the maximum ratio of mismatches
to mapped length to 10%83. The number of reads aligning to genes was counted
with featureCounts 1.4.5-p1 tool from the Subread package84. Only reads mapping
at least partially inside exons were admitted and aggregated per gene. Reads
overlapping multiple genes or aligning to multiple regions were excluded. The
Ensemble annotation was enriched with UniProt data (release 06.06.2014) based on
Ensembl gene identifiers (activities at the Universal Protein Resource (UniProt)).
RNA isolation from zebrafish embryos and RT-qPCR. RNA was isolated from
zebrafish embryos with Trizol reagent (Thermo Fisher Scientific), and cDNA was
generated using the SuperScript II reverse transcriptase kit (Invitrogen). Real-time
quantitative PCR (RT-qPCR) was conducted using Power SYBR Green (Applied
Biosystems) and the following primers (see also Supplementary Table 1): axin2 fwd
5′-CCTGGAGGAGAGACTTCAAC-3′, axin2 rev 5′-GAGCAAAGGCAGA-
GAATGGG-3′, β-actin fwd 5′-CTGGACTTCGAGCAGGAGAT-3′, β-actin rev 5′-
GCAAGATTCCATACCCAGGA-3′, β-catenin fwd 5′-GCCGCCACCAAA-
CAGGAG-3′, β-catenin rev 5′-CAGCAGCACACGTCACCACG-3′, ccnd1 fwd 5′-
CTGTGCGACAGACGTCAACT-3′, ccnd1 rev 5′-GGTGAGGTTCTGGGAT-
GAGA-3′, lef1 fwd 5′-GTTGGACAGATGACCCCTCC-3′, lef1 rev 5′-
CTGTTTCACCTGTGGGTTGAC-3′.
Mouse brain primary EC isolation and culture. For immunostaining or gene
expression analysis of wild-type primary endothelial cells, C57BL/6J pups were
used. To inactivate S1pr1 in the postnatal endothelium, S1pr1lox/lox85 and Cdh5
(PAC)CreERT286 mice were interbred. The resulting offspring were injected at P1
and P2 with 50 µg of 4-OHT and samples processed at P3.
Mouse brain primary microvascular fragment isolation and culture was
performed as described34. In brief, brains were collected from mice at postnatal day
3 (P3) or adults (>8 weeks old) in ice-cold Dulbecco’s Modified Eagle’s Medium
(DMEM, Life technologies 11965–092) supplemented with 1% penicillin/
streptomycin (Gibco, 15140122) and L-Glutamine (Gibco, 25030081), hereafter
termed dissection media. Brains were transferred to a Petri dish, where olfactory
bulbs and cerebellum were removed. The hemispheres were mechanically disrupted
to small pieces and further digested for 10 min at 37 °C in 0.5 mg/mL collagenase
(Sigma-Aldrich, C6885) dissolved in dissection media (2 rounds of digestion for
samples from adult animals). Next, the cell suspension was mixed with an equal
volume of DMEM supplemented with 20% fetal bovine serum (FBS, Life
Technologies), filtered through a 70 μm nylon cell strainer (Falcon, 352350) and
centrifuged 5 min at 300 g. After centrifugation, the cell pellet was resuspended in
dissection media supplemented with 0.5 mg/mL heparin (Sigma-Aldrich, H3149)
and incubated for 40 min with CD31 (BD Pharmingen, 553370) -bound sheep anti-
rat IgG magnetic Dynabeads (Life Technologies, 110.35) on a rotary wheel at room
temperature. After incubation, microvascular fragments bound to magnetic beads
were retrieved using a DynaMag-2 magnet (Life Technologies, 12321D), washed 5
times with heparin-supplemented dissection media and finally resuspended in
TrypLE Select (Gibco, A12177-01) in order to dissociate them from the magnetic
beads. After 12 min incubation at 37 °C, unbound beads were removed with the
magnet and the suspension containing the microvascular fragments was mixed
with EGM2-supplemented EBM2 media (Lonza, CC-3456 and CC-4176). After
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centrifugation (10 min, 300×g) the microvascular fragments were resuspended in
EGM2–EBM2 media supplemented with puromycin (Sigma-Aldrich, P9620, 10 μg/
mL) and plated on collagen-I-coated μ-Slide 8-well ibiTreat cell culture chambers
(Ibidi, 80826) or 24-well cell culture plates. Hereafter, cells were kept in culture at
37 °C and 5% CO2. Twenty hours later, wells were washed three times with PBS to
remove dead and unattached cells and fresh EGM2–EBM2 media supplemented
with puromycin (5 μg/mL) was added. The next day, pharmacologic treatment
started with drugs diluted in EGM2–EBM2 media.
IWR-1 (Sigma-Aldrich) and VPC23019 (VPC, Cayman Chemical) were
dissolved in DMSO to a 10 mM concentration. Inhibition of Wnt signaling was
achieved after 48 h treatment with 10 or 20 μM IWR-1 for endothelial cells from
young pups or adult animals, respectively. Alternatively, 10 μM IWR-1-treated cells
from young pups were exposed in parallel to 2 μM VPC to assess the effect of
S1pr1 signaling blocking upon Wnt inhibition. Vehicle (DMSO) treated was used
in all experiments as control.
Immunohistochemistry of mouse brain primary EC. After inhibitor treatment,
cells growing in 8-well ibiTreat cell culture chambers were fixed in 4% paraf-
ormaldehyde (PFA, Sigma-Aldrich, P6148) for 15 min at room temperature,
washed three times with PBS and permeabilized with 0.2% Triton X-100 (Sigma-
Aldrich, T8787) in PBS for 15 min. After washing three times with PBS, cells were
blocked by incubation with 2% normal donkey serum (Abcam, ab7475) in PBS in a
humidified chamber for 30 min. Primary antibodies (goat polyclonal anti-CD31,
R&D Systems, AF3628, 1:100; rat monoclonal anti-VE-cadherin clone 11D4, BD
Biosciences, 555289, 1:100; and rabbit polyclonal anti-ZO-1, Invitrogen, 402200,
1:100) were diluted in blocking buffer and incubated with the cells in a humidified
chamber overnight at 4 °C. Wells were then washed three times with PBS and
secondary antibodies (donkey anti goat Alexa Fluor 488, Invitrogen, A11055, 1:400;
donkey anti rat Alexa Fluor Cy3, Jackson Immuno Research, 712-165-153, 1:400;
and donkey anti rabbit Alexa Fluor 647, Invitrogen, A31573, 1:400) together with
DAPI (Sigma-Aldrich, D9542, 1 μg/mL) were diluted in blocking buffer and
incubated at room temperature for 2 h. After secondary antibody incubation, cells
were washed as described above and covered with PBS until imaging.
RT-qPCR of mouse brain primary ECs. After inhibitor treatment, cells growing in
24-well cell culture plates were collected in 350 μL RLT Plus Buffer (Qiagen,
1053393) supplemented with 1% β-mercaptoethanol (Sigma, M6250) and total
RNA was isolated using the RNeasy Plus Micro Kit (Qiagen, 74034) following the
manufacturer’s instructions. Whole RNA was assessed in terms of quantity and
quality using Bioanalyzer 2000 (Agilent), reverse transcribed and converted to
complementary DNA (cDNA) using the iScript cDNA synthesis kit (BioRad, 170-
8890). The following FAM-conjugated TaqMan gene expression probes (all from
Thermo Fisher Scientific) were used: VE-cadherin (Cdh5, Mm00486938_m1),
Axin2 (Mm01265780_m1), Lef1 (Mm01310389_m1), and Ccnd1
(Mm00432360_m1). VIC-conjugated Actb (4352341E) TaqMan probe was used to
normalize gene expression. Quantitative PCR (qPCR) reactions were performed on
a CFX96 Touch Real-Time PCR Detection System (BioRad) using the Sso
Advanced Universal Probes Supermix (BioRad, 1725281). All relative gene
expression analyses were performed using the 2−ΔΔCt method in a minimum of
four animals per group with triplicate reactions for each gene evaluated.
Confocal microscopy. Confocal microscopy was performed using LSM780 and
LSM880 microscopes (Carl Zeiss Microscopy GmbH; objective lenses: Plan-
Apochromat ×20/0.8; LD C-Apochromat ×40/1.1W Korr M27). For filopodia
analysis in zebrafish at high resolution, images were acquired with the LSM880
Airyscan module. For life imaging of VE-cadherinTS embryos, the Online Fin-
gerprinting mode of the LSM880 microscope was utilized. In general, PFA-fixed or
living zebrafish embryos were embedded in 0.3% agarose, which was dissolved in
E3 medium and additionally supplemented with N-Phenylthiourea (30 mg/L,
Sigma-Aldrich) and Tricaine (19.2 mg/L, Sigma-Aldrich) for living embryos as
previously described59. For time-lapse analysis, the agarose was additionally sup-
plemented with IWR-1 or DMSO and a stable temperature of 28.5 °C was main-
tained using a heating chamber. Assembly of confocal stacks and time-lapse movies
was conducted using Imaris 8/9 software (Bitplane). Quantification of signal
intensity and volume was done using the Imaris surface-rendering algorithm.
Statistical analysis. For all quantifications, statistical analysis was performed
using Prism6 software (GraphPad). Graphs show mean ± standard deviation (SD)
or standard error of the mean (SEM) and p-values were calculated using unpaired
two-tailed Student’s t-test or one-way ANOVA for single and multiple compar-
isons as indicated for each experiment.
Animal models. All animal experiments were performed in compliance with the
relevant laws and institutional guidelines, were approved by local animal ethics
committees and were conducted at the University of Münster and the MPI for
Molecular Biomedicine with permissions granted by the Landesamt für Natur,
Umwelt und Verbraucherschutz (LANUV) of North Rhine-Westphalia.
Data availability
The authors declare that the data supporting the findings of this study are available
within the paper and its supplementary information files. The RNA sequencing
data of this study have been deposited in NCBI’s Gene Expression Omnibus and
are accessible through GEO Series accession number GSE121041. The rest of the
data are available from the authors upon reasonable request.
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Supplementary	  Information	  
	  	  
Wnt/β-­‐catenin	  signaling	  regulates	  VE-­‐cadherin-­‐mediated	  anastomosis	  of	  brain	  
capillaries	  by	  counteracting	  S1pr1	  signaling	  	   (Hübner	  et	  al.)	  	  	  	  	  	  	  	  	  	   	  
DMSO IWR-1
Figure S1
kdrl:GFP
gata1:dsRed
kdrl:GFP
gata1:dsRed
kdrl:GFP
he
ad
, d
or
sa
l v
ie
w
tru
nk
, l
at
er
al
 v
ie
w
32 29 72 hpf
IWR-1
+ cre mRNA
dGFPSTOP
14xTCF binding sites
kd
rl:
ra
s-
m
C
he
rr
y 
kd
rl:
ra
s-
m
C
he
rr
y 
Ve
nu
s-
P
es
t
*
*
axin2BAC Venus-Pest
dG
FP
b
a
c
14TCF:dGFP EC by kdrl:cre 
0:00 h 1:20 h 2:00 h 3:00 h 3:40 h 5:00 h
*
*
>kd
rl:
ra
s-
m
C
he
rr
y
14
TC
F:
dG
FP
14
TC
F:
dG
FP
dGFPSTOP
14xTCF binding sites
dGFP
+ kdrl:cre 14xTCF binding sites WntON 
dGFP
d
Supplementary	  Figure	  1	  	  
Wnt	  signaling	  is	  active	  in	  brain	  ECs	  during	  angiogenesis	  
a)	  Wnt	  signaling	  inhibition	  by	  IWR-­‐1	  treatment	  caused	  severe	  vascular	  defects	  and	  hemorrhages	  in	  the	  brain,	  but	  not	  in	  the	  trunk	  of	  zebrafish	  embryos.	  Confocal	  images	  showing	  dorsal	  views	  of	  the	  head	  (anterior	  to	  the	  left)	  or	  lateral	  views	  of	  the	  trunk	  (anterior	  to	  the	  left)	  of	  72	  hpf-­‐old	  embryos	  with	  ECs	  labeled	  with	  GFP	  (white,	  by	  
Tg(kdrl:GFP)s843)	  and	  erythrocytes	  labeled	  with	  dsRed	  (red,	  by	  Tg(gata1:dsRed)sd2),	  which	  were	  treated	  with	  IWR-­‐1	  or	  DMSO	  from	  29	  to	  72	  hpf.	  
b,c)	  At	  34	  hpf,	  Wnt	  signaling	  reporters	  are	  expressed	  in	  all	  CtA	  sprouts	  in	  the	  hindbrain,	  indicating	  active	  Wnt	  signaling	  during	  sprout	  migration	  (arrowheads	  in	  b,c).	  Confocal	  images	  of	  embryos	  (dorsal	  views)	  co-­‐expressing	  Tg(kdrl:ras-­‐mCherry)s896	  for	  labeling	  ECs	  (red)	  and	  β-­‐catenin	  dependent	  Wnt	  signaling	  reporters	  expressing	  short-­‐lived	  fluorophores:	  Tg(axin2BAC:Venus-­‐Pest)mu288	  (b)	  and	  Tg(14TCF:loxP-­‐STOP-­‐loxP-­‐dGFP)mu202	  injected	  with	  cre	  mRNA	  (c).	  Asterisk	  in	  c	  marks	  Venus-­‐Pest	  expression	  in	  the	  ear	  in	  
Tg(axin2BAC:Venus-­‐Pest)mu28	  embryos.	  
d)	  Vascular	  specific	  excision	  of	  the	  STOP	  cassette	  in	  Tg(14TCF:loxP-­‐STOP-­‐loxP-­‐
dGFP)mu202	  embryos	  by	  kdrl:cre.	  Expression	  of	  dGFP	  indicates	  active	  Wnt	  signaling	  in	  ECs.	  Expression	  of	  dGFP	  was	  detected	  in	  CtA	  ECs	  starting	  during	  tip	  cell	  formation	  within	  the	  PHBC	  until	  lumen	  formation	  finished.	  Still	  images	  from	  a	  confocal	  time	  lapse	  movie	  of	  Tg(14TCF:loxP-­‐STOP-­‐loxP-­‐dGFP)mu202;	  (kdrl:cre)s898	  double	  transgenic	  embryos	  with	  ECs	  labeled	  by	  Tg(kdrl:ras-­‐mCherry)s896.	  The	  dGFP	  channel	  is	  represented	  in	  inverted	  colors	  for	  better	  visualization.	  Arrows	  mark	  dGFP	  signal	  in	  CtA	  sprouts	  and	  open	  arrow	  indicates	  cell-­‐cell-­‐contact	  formation.	  Note,	  that	  the	  Wnt	  signaling	  responsive	  transgene	  (14TCF:loxP-­‐STOP-­‐loxP-­‐dGFP)	  is	  heterozygous,	  which	  lead	  to	  weaker	  fluorescence	  signal	  compared	  to	  the	  homozygous	  transgene	  expression	  in	  Fig.	  1b;	  CtA,	  central	  artery;	  ECs,	  endothelial	  cells;	  hpf,	  hours	  post	  fertilization;	  PHBC,	  primordial	  hindbrain	  channel.	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Supplementary	  Figure	  2	  	  
Validation	  of	  transgenic	  Wnt-­‐manipulating	  lines	  
a)	  For	  dnTcf	  expression	  in	  all	  cells,	  Tg(hsp70l:loxP-­‐STOP-­‐loxP-­‐mCherry-­‐dntcf)mu201	  embryos	  were	  injected	  with	  cre	  mRNA	  and	  subjected	  to	  heat	  shock	  to	  induce	  mCherry-­‐dnTcf	  expression	  (referred	  as	  mCherry-­‐dnTcfiHS).	  
b)	  Overexpression	  of	  dnTcf	  robustly	  blocks	  expression	  of	  Wnt	  target	  genes.	  Induction	  of	  mCherry-­‐dnTcf	  in	  all	  cells	  by	  heat	  shock	  can	  be	  detected	  by	  immunostaining	  in	  24	  hpf-­‐old	  Tg(hsp70l:loxP-­‐STOP-­‐loxP-­‐mCherry-­‐dntcf)mu201	  but	  not	  in	  Tg(hsp70l:loxP-­‐STOP-­‐loxP-­‐
mCherry)mu279	  embryos.	  Wnt	  signaling	  target	  genes	  axin2,	  lef1	  and	  ccnd1	  were	  down	  regulated	  after	  mCherry-­‐dnTcf	  expression,	  but	  the	  expression	  of	  β-­‐catenin	  was	  not	  significantly	  affected.	  Values	  represent	  mean	  ±	  SD.	  *p<0.05,	  **p<0.01,	  ***p<0.001,	  Student’s	  t-­‐test	  of	  three	  independent	  experiments.	  	  
c)	  For	  EC-­‐specific	  expression	  of	  dnTcf,	  Tg(hsp70l:loxP-­‐STOP-­‐loxP-­‐mCherry-­‐dntcf)mu201	  embryos	  were	  mated	  to	  Tg(kdrl:cre)s898	  and	  mCherry-­‐dnTcf	  expression	  was	  induced	  by	  heat	  shock	  at	  26	  hpf	  (referred	  as	  mCherry-­‐dnTcfiEC).	  	  
d)	  Expression	  of	  mCherryiEC	  or	  mCherry-­‐dnTcfiEC	  co-­‐localized	  with	  GFP	  expression	  from	  
Tg(kdrl:GFP)s843	  in	  CtAs	  and	  PHBC	  of	  32	  hpf-­‐old	  embryos.	  Therefore,	  the	  heat	  shock	  protocol	  is	  suitable	  to	  induce	  mCherry-­‐dnTcf	  during	  CtA	  angiogenesis.	  
e)	  Analysis	  of	  expression	  levels	  of	  Wnt	  target	  genes	  in	  DMSO	  or	  IWR-­‐1	  treated	  mouse	  primary	  BECs	  isolated	  from	  P3	  or	  adult	  animals	  by	  RT-­‐qPCR	  (P3:	  n=4,	  adult:	  n=7).	  Values	  in	  represent	  mean	  ±SD,	  *p<0.05,	  **p<0.01,	  ***p<0.001,	  n,	  number	  of	  biological	  replicates.	  	  Confocal	  images	  of	  zebrafish	  embryos	  show	  lateral	  views	  (anterior	  to	  the	  left).	  BECs,	  brain	  ECs,	  CtA,	  central	  artery;	  ECs,	  endothelial	  cells;	  PHBC,	  primordial	  hindbrain	  channel;	  Scale	  bars:	  50	  µm.	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Supplementary	  Figure	  3	  	  
Wnt	  signaling	  impacts	  EC	  number	  independent	  of	  proliferation	  
a,b)	  Inhibition	  of	  Wnt	  signaling	  by	  IWR-­‐1	  treatment	  (a)	  or	  by	  EC-­‐specific	  dnTcf	  expression	  induced	  by	  heat	  shock	  at	  26	  hpf	  (b)	  affected	  EC	  numbers	  in	  CtAs.	  
a)	  IWR-­‐1	  treatment	  from	  29	  to	  48	  hpf	  resulted	  in	  decreased	  total	  number	  of	  CtAs	  and	  also	  reduced	  EC	  number	  within	  CtAs	  compared	  to	  control	  (DMSO:	  CtA	  number	  n=35,	  EC	  number	  n=39;	  IWR-­‐1:	  CtA	  number	  n=20	  EC	  number	  n=22).	  
b)	  Expression	  of	  mCherry-­‐dnTcfiEC	  resulted	  in	  decreased	  total	  number	  of	  CtAs	  and	  reduced	  EC	  number	  within	  CtAs	  compared	  to	  mCherryiEC	  (mCherryiEC:	  CtA	  number	  n=39,	  EC	  number	  n=40;	  mCherry-­‐dnTcfiEC:	  CtA	  number	  n=12,	  EC	  number	  n=14).	  
c)	  Decreased	  EC	  numbers	  after	  Wnt	  signaling	  inhibition	  did	  not	  result	  from	  decreased	  EC	  proliferation.	  Embryos	  were	  treated	  with	  DMSO	  (control),	  IWR-­‐1,	  AHU	  or	  IWR-­‐1+AHU	  from	  26	  to	  32	  hpf	  or	  from	  29	  to	  48	  hpf.	  Inhibition	  of	  proliferation	  by	  AHU	  decreased	  the	  number	  of	  ECs	  in	  the	  PHBC	  at	  32	  hpf	  (n=5),	  but	  had	  no	  effect	  on	  the	  EC	  number	  within	  CtAs	  at	  48	  hpf,	  which	  was	  only	  affected	  by	  IWR-­‐1	  treatment	  (n=5).	  Confocal	  images	  show	  dorsal	  views	  of	  48	  hpf-­‐old	  embryos	  and	  lateral	  views	  of	  32	  hpf-­‐old	  embryos	  (anterior	  to	  the	  left)	  with	  GFP	  expression	  from	  Tg(fli1a:nGFP)y7	  	  and	  dsRed	  expression	  from	  Tg(fli1a:dsRed)um13.	  Values	  represent	  mean	  ±SD.	  *p<0.05,	  **p<0.01,	  ***p<0.001,	  Student’s	  t-­‐test	  (a,b)	  or	  One-­‐way	  ANOVA	  (c);	  n,	  number	  of	  analyzed	  embryos;	  CtAs,	  central	  arteries;	  ECs,	  endothelial	  cells;	  PHBC,	  primordial	  hindbrain	  channel;	  Scale	  bars:	  50	  µm.	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Supplementary	  Figure	  4	  	  
VE-­‐cadherin	  and	  Esama	  are	  required	  for	  CtA	  anastomosis	  
a)	  Lumen	  formation	  was	  completely	  impaired	  in	  homozygous	  ve-­‐cadherinubs8	  mutant	  embryos	  at	  48	  hpf,	  while	  the	  number	  of	  CtAs	  remained	  unaffected.	  Expression	  of	  an	  intracellular	  modified	  VE-­‐cadherinTS	  in	  ve-­‐cadherinubs8/ubs8	  mutants	  partially	  restored	  the	  lumen	  formation	  defects	  (wt:	  n=	  2;	  ve-­‐cadherinubs8/+:	  n=8;	  ve-­‐cadherinubs8/ubs8:	  n=7;	  
ve-­‐cadherinubs8/ubs8	  +	  TS:	  n=22).	  	  
b)	  Still	  images	  from	  time-­‐lapse	  movies	  of	  ve-­‐cadherinubs8	  mutant	  embryos	  expressing	  
Tg(fli1a:lifeact-­‐GFP)mu240.	  In	  homozygous	  ve-­‐cadherinubs8	  mutants	  anastomosis	  of	  CtAs	  was	  completely	  abolished.	  Heterozygous	  siblings	  did	  not	  exhibit	  anastomosis	  defects	  (ve-­‐cadherinubs8/ubs8:	  n	  =	  4;	  siblings:	  n	  =	  4).	  	  
c)	  Homozygous	  esamaubs19	  mutants	  showed	  decreased	  proportion	  of	  lumenized	  CtAs,	  but	  no	  changes	  in	  CtA	  numbers	  (esama+/ubs19:	  n=9;	  esamaubs19/ubs19:	  n=10).	  	  Confocal	  images	  show	  dorsal	  views	  (anterior	  to	  the	  left)	  and	  GFP	  expression	  of	  
Tg(fli1a:lifeact-­‐GFP)mu240	  (a,b)	  or	  mKate	  expression	  of	  Tg(kdrl:mKate-­‐CAAX)ubs16	  (c).	  	  
d)	  Overexpression	  of	  a	  truncated	  VE-­‐cadherin	  version	  (VE-­‐cadΔC-­‐EGFP)	  did	  not	  restore	  lumen	  formation	  defects	  in	  Wnt-­‐depleted	  embryos.	  Tg(kdrl:GFP)s843	  (control)	  or	  
Tg(fli1a:Gal4)ubs3;(UAS:	  VE-­‐cadΔC-­‐EGFP)ubs12	  embryos	  were	  treated	  from	  29	  to	  48	  hpf	  with	  IWR-­‐1	  or	  DMSO	  (control:	  DMSO:	  n=7,	  IWR-­‐1:	  n=8;	  VE-­‐cadΔC:	  DMSO:	  n=14,	  IWR-­‐1:	  
n=13).	  Values	  in	  a-­‐d	  represent	  mean	  ±	  SD.	  *p<0.05,	  **p<0.01,	  ***p<0.001,	  Student’s	  t-­‐test;	  n,	  number	  of	  analyzed	  embryos.	  
e)	  Inhibition	  of	  Wnt	  signaling	  by	  incubation	  with	  IWR-­‐1	  or	  heat	  shock	  induced	  EC-­‐specific	  dnTcf	  expression	  did	  not	  severely	  affect	  esama	  mRNA	  expression	  at	  32	  or	  42	  hpf.	  Expression	  of	  esama	  in	  CtA	  sprouts	  was	  slightly	  decreased	  after	  IWR-­‐1	  treatment	  or	  mCherry-­‐dnTcfiEC	  expression	  (32hpf:	  DMSO:	  n=15,	  N=5	  and	  IWR-­‐1:	  n=9,	  N=5,	  mCherryiEC:	  n=16,	  N=6	  and	  mCherry-­‐dnTcfiEC:	  n=10,	  N=5;	  42hpf:	  DMSO:	  n=24,	  N=5	  and	  IWR-­‐1:	  n=16,	  N=5,	  mCherry:	  n=16,	  N=5	  and	  mCherry-­‐dnTcf:	  n=9,	  N=4).	  Confocal	  images	  show	  lateral	  views	  (anterior	  to	  the	  left)	  of	  Tg(kdrl:GFP)s843	  embryos	  following	  display	  whole	  mount	  fluorescent	  in	  situ	  hybridization	  in	  combination	  with	  anti-­‐GFP	  immunostaining.	  Quantifications	  were	  represented	  by	  Box-­‐and-­‐Whisker	  plots	  with	  median	  (center	  line),	  25th	  and	  75th	  percentiles	  (bounds	  of	  box)	  and	  Min-­‐to-­‐Max	  (whiskers),	  *p<0.05,	  **p<0.01,	  ***p<0.001,	  Student’s	  t-­‐test;	  n,	  number	  of	  CtA	  volumes	  analyzed;	  N,	  number	  of	  embryos	  analyzed;	  CtAs,	  central	  arteries;	  ECs,	  endothelial	  cells;	  PHBC,	  primordial	  hindbrain	  channel,	  TS,	  tension	  sensor;	  Scale	  bars:	  50	  µm.	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Pharmacological	  targeting	  of	  S1pr	  receptors	  in	  zebrafish	  
a)	  Pharmacological	  inhibition	  of	  S1pr	  signaling	  causes	  extravasation	  of	  erythrocytes	  (red	  blood	  cells,	  RBCs).	  Embryos	  expressing	  GFP	  in	  ECs	  (by	  Tg(kdrl:GFP)s843)	  and	  dsRed	  in	  RBCs	  (by	  Tg(gata1:dsRed)sd2)	  were	  treated	  with	  VPC23019	  (VPC)	  or	  DMSO	  from	  48	  to	  72	  hpf	  (DMSO:	  n=9;	  VPC:	  n=9).	  	  
b)	  Expression	  levels	  of	  s1pr’s	  expressed	  in	  CtA	  ECs	  were	  not	  significantly	  changed	  by	  inhibition	  of	  Wnt	  signaling	  (RNA	  sequencing,	  see	  methods).	  	  
c-­‐g)	  S1pr’s	  (S1pr1,	  S1pr2,	  S1pr3a	  and	  S1pr5a)	  were	  overexpressed	  by	  mRNA	  injection	  into	  single-­‐cell	  stage	  embryos.	  Rescue	  experiments	  were	  performed	  by	  treatment	  with	  VPC23019	  (VPC,	  described	  S1pr1	  and	  S1pr3	  antagonist),	  TY52156	  (TY,	  described	  S1pr3	  antagonist)	  and	  JTE013	  (JTE,	  described	  S1pr2	  antagonist)	  from	  5.5	  hpf	  to	  24	  hpf	  (c,f,g).	  Embryos	  were	  sorted	  in	  categories	  according	  to	  phenotype	  (d):	  “normal”	  (white):	  wild	  type	  appearance,	  “mild”:	  little	  developmental	  delay,	  minor	  anterior-­‐posterior	  body	  axis	  formation	  defects	  (>60%	  of	  head	  and	  tail	  formed,	  intact	  eye	  and	  capacity	  of	  embryonic	  reflex),“strong”:	  severe	  developmental	  delays,	  profound	  anterior-­‐posterior	  axis	  defects	  (<60%	  of	  head	  and	  tail	  formed,	  obvious	  deformation	  or	  complete	  lack	  of	  tissues	  and	  organs,	  such	  as	  brain,	  eye	  and	  tail).	  VPC	  (described	  as	  S1pr1/S1pr3	  antagonist)	  rescued	  phenotypic	  defects	  of	  all	  s1pr	  overexpression	  scenarios	  (f,g),	  TY	  (described	  as	  S1pr3	  antagonist)	  specifically	  rescued	  s1pr1	  overexpression	  in	  zebrafish.	  The	  described	  S1pr2	  antagonist	  JTE,	  did	  not	  restore	  phenotypic	  defects	  in	  the	  tested	  overexpression	  scenarios	  (e:	  control:	  DMSO:	  n=8,	  VPC:	  n=8,	  TY:	  n=8,	  JTE:	  n=8;	  f,g:	  s1pr1	  mRNA:	  DMSO:	  
n=25,	  VPC:	  n=16,	  TY:	  n=20,	  JTE:	  n=24;	  s1pr2	  mRNA:	  DMSO:	  n=28,	  VPC:	  n=25,	  TY:	  n=27,	  JTE:	  n=30;	  s1pr3a	  mRNA:	  DMSO:	  n=33,	  VPC:	  n=33,	  TY:	  n=22,	  JTE:	  n=27;	  s1pr5a	  mRNA:	  DMSO:	  n=16,	  VPC:	  n=8,	  TY:	  n=14,	  JTE:	  n=14).	  
h)	  After	  mRNA	  injection	  overexpressed	  S1pr1	  can	  be	  stimulated	  by	  S1p	  co-­‐injection	  or	  treatment	  with	  pharmacological	  agonists.	  S1pr3	  agonist	  CYM5541	  or	  S1pr1	  agonist	  CYM5542	  aggravate	  phenotypic	  defects	  in	  comparison	  to	  control	  (s1pr1	  mRNA:	  DMSO:	  
n=17,	  CYM5541:	  n=20,	  CYM5542:	  n=15,	  S1p:	  n=30).	  Brightfield	  images	  (d,f)	  show	  lateral	  views	  (anterior	  to	  the	  left)	  of	  representative	  zebrafish	  embryos	  at	  24	  hpf.	  	  Values	  represent	  mean	  ±SD.	  *p<0.05,	  **p<0.01,	  ***p<0.001,	  student’s	  t-­‐test;	  n,	  number	  of	  analyzed	  embryos.	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Wnt	  and	  S1pr	  signaling	  regulate	  VE-­‐cadherin	  localization	  
a,b)	  Inhibition	  of	  S1pr1	  signaling	  together	  with	  blocking	  Wnt	  signaling	  rescued	  VE-­‐cadherin	  (a)	  and	  Esama	  (b)	  protein	  levels	  at	  the	  cell-­‐cell	  junctions.	  Immunostaining	  was	  performed	  for	  VE-­‐cadherin	  (a,	  red)	  and	  Esama	  (b,	  red)	  of	  42	  hpf-­‐old	  embryos	  after	  single	  or	  co-­‐treatment	  with	  IWR-­‐1	  and	  TY.	  Junction	  localization	  of	  VE-­‐cadherin	  and	  Esama	  (arrows	  show	  anastomosis	  rings)	  was	  reduced	  after	  IWR-­‐1	  treatment,	  not	  affected	  by	  TY	  treatment	  and	  restored	  in	  co-­‐treated	  embryos.	  
c)	  Expression	  of	  the	  VE-­‐cad-­‐TS	  in	  wild	  type	  embryos	  does	  not	  restore	  or	  worsen	  the	  lumen	  formation	  defects	  caused	  by	  Wnt	  signaling	  inhibition.	  Tg(ve-­‐cadBAC:ve-­‐cadTS)uq11bh	  embryos	  (and	  control	  siblings)	  were	  treated	  with	  DMSO	  or	  IWR-­‐1	  from	  29	  to	  48	  hpf	  (sibling:	  DMSO:	  n=6,	  IWR-­‐1:	  n=3;	  VE-­‐cad-­‐TS:	  DMSO:	  n=5,	  IWR-­‐1:	  n=8).	  Values	  represent	  mean	  ±SD.	  *p<0.05,	  **p<0.01,	  ***p<0.001,	  One-­‐way	  ANOVA;	  n,	  number	  of	  analyzed	  embryos.	  
d)	  Blocking	  of	  S1pr	  signaling	  rescued	  localization	  of	  VE-­‐cad-­‐TS	  in	  cell-­‐cell	  junctions	  as	  well	  as	  lumen	  formation	  in	  Wnt-­‐depleted	  embryos.	  Life	  imaging	  of	  VE-­‐cad-­‐TS	  embryos	  (Tg(ve-­‐cadBAC:ve-­‐cadTS)uq11bh)	  at	  48	  hpf	  following	  single	  or	  co-­‐treatment	  with	  IWR-­‐1	  and	  S1pr	  antagonist	  VPC	  or	  S1pr1	  antagonist	  TY	  starting	  from	  29	  hpf.	  	  Confocal	  images	  show	  dorsal	  views	  (anterior	  to	  the	  left)	  and	  ECs	  labeled	  by	  
Tg(fli1a:lifeact-­‐GFP)mu240	  (a-­‐c)	  or	  Tg(kdrl:tagBFP)mu293	  (d).	  CtAs,	  central	  arteries;	  S1pr,	  Sphingosine-­‐1-­‐phosphate	  receptor,	  TS,	  tension	  sensor,	  VE-­‐cad,	  VE-­‐cadherin;	  Scale	  bars:	  (a,b,d)	  30	  µm,	  (c)	  50	  µm.	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Wnt	  and	  S1pr1	  signaling	  act	  upstream	  of	  VE-­‐cadherin	  function	  
a)	  Pharmacologic	  inhibition	  of	  S1pr	  signaling	  or	  Rac1	  activity	  does	  not	  rescue	  CtA	  formation	  defects	  in	  ve-­‐cadherin	  or	  esama	  mutant	  embryos.	  Treatment	  of	  ve-­‐cadherin	  or	  
esama	  mutant	  embryos	  with	  DMSO,	  VPC	  (S1pr	  antagonist)	  or	  NSC	  (Rac1	  inhibitor)	  from	  29	  to	  48	  hpf	  (siblings:	  n=5;	  ve-­‐cadherin-­‐/-­‐:	  DMSO:	  n=5,	  VPC:	  n=5,	  NSC:	  n=5;	  esama-­‐/-­‐:	  DMSO:	  n=13,	  VPC:	  n=15,	  NSC:	  n=12).	  
b,c)	  Embryos	  were	  single	  or	  co-­‐treated	  with	  IWR-­‐1,	  MG132	  (proteasome	  inhibitor,b),	  Dynasore	  (dynamin	  inhibitor,	  b)	  or	  Chloroquine	  (lysosome	  inhibitor,	  c)	  from	  29	  to	  48	  hpf.	  Treatment	  with	  IWR-­‐1	  reduced	  CtA	  number	  and	  proportion	  of	  lumenized	  CtAs	  compared	  to	  control.	  Co-­‐treatment	  with	  MG132,	  Dynasore	  or	  Chloroquine	  could	  not	  restore	  lumen	  formation	  defects	  caused	  by	  IWR-­‐1	  (b:	  DMSO:	  n=10;	  MG132:	  n=10;	  Dynasore:	  n=5;	  IWR-­‐1:	  n=10;	  IWR-­‐1	  +	  MG132:	  n=10;	  IWR-­‐1	  +	  Dynasore:	  n=5;	  c:	  DMSO:	  
n=6;	  Chloroquine:	  n=6;	  IWR-­‐1:	  n=6;	  IWR-­‐1	  +	  Chloroquine:	  n=6).	  Confocal	  images	  show	  dorsal	  views	  (anterior	  to	  the	  left)	  and	  ECs	  labeled	  by	  Tg(kdrl:ras-­‐
Cherry)s896	  (a).	  or	  Tg(fli1a:lifeact-­‐GFP)mu240	  (b,c).	  Values	  represent	  mean	  ±	  SD.	  *p<0.05,	  **p<0.01,	  ***p<0.001,	  One-­‐way	  ANOVA;	  n,	  number	  of	  analyzed	  embryos;	  CtAs,	  central	  arteries;	  S1pr,	  Sphingosine-­‐1-­‐phosphate	  receptor;	  Scale	  bars:	  50	  µm.	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Manipulation	  of	  Rho	  does	  not	  rescue	  Wnt-­‐depleted	  embryos	  
a)	  Embryos	  were	  single	  or	  co-­‐treated	  with	  IWR-­‐1,	  Rho	  inhibitor	  or	  Rho	  activator	  from	  29	  to	  48	  hpf.	  CtA	  number	  and	  proportion	  of	  lumenized	  CtAs	  were	  reduced	  after	  treatment	  with	  IWR-­‐1	  and	  could	  not	  be	  rescued	  by	  co-­‐treatment	  with	  Rho	  activator	  or	  Rho	  inhibitor	  (DMSO:	  n=10;	  Rho	  inhibitor:	  n=5;	  Rho	  activator:	  n=5;	  IWR-­‐1:	  n=9;	  IWR-­‐1	  +	  Rho	  inhibitor:	  n=4;	  IWR-­‐1	  +	  Rho	  activator:	  n=5).	  
b)	  Pharmacologic	  inhibition	  of	  S1pr	  signaling	  does	  not	  rescue	  CtA	  sprouting	  defects	  in	  Wnt-­‐depleted	  embryos.	  Tg(fli1a:lifeact-­‐GFP)mu240	  embryos	  were	  single	  or	  co-­‐treated	  with	  IWR-­‐1	  and	  VPC	  starting	  from	  16	  ss	  (17	  hpf)	  to	  32	  hpf.	  CtA	  tip	  cell	  formation	  was	  abolished	  in	  IWR-­‐1	  and	  IWR-­‐1+VPC	  co-­‐treated	  embryos,	  but	  not	  affected	  in	  VPC	  single-­‐treated	  embryos	  in	  comparison	  to	  control	  (DMSO:	  n=5;	  VPC:	  n=5;	  IWR-­‐1:	  n=5;	  IWR-­‐1	  +	  VPC:	  n=5).	  
c)	  Pharmacologic	  inhibition	  of	  S1pr	  signaling	  does	  not	  rescue	  CtA	  formation	  defects	  in	  
gpr124	  mutant	  embryos.	  Treatment	  of	  gpr124	  mutant	  embryos	  with	  DMSO,	  VPC	  or	  TY	  from	  22	  to	  48	  hpf	  (wt:	  n=10;	  gpr124-­‐/-­‐:	  DMSO:	  n=10,	  VPC:	  n=8,	  TY:	  n=8).	  	  Confocal	  images	  show	  dorsal	  views	  (a,c)	  or	  lateral	  views	  (b)	  (anterior	  to	  the	  left)	  and	  GFP	  expression	  from	  Tg(fli1a:lifeact-­‐GFP)mu240(a,c)	  or	  Tg(kdrl:GFP)s843(b).	  Values	  represent	  mean	  ±	  SD.	  *p<0.05,	  **p<0.01,	  ***p<0.001,	  one-­‐way	  ANOVA;	  n,	  number	  of	  analyzed	  embryos;	  CtAs,	  central	  arteries;	  S1pr,	  Sphingosine-­‐1-­‐phosphate	  receptor;	  Scale	  bars:	  50	  µm.	  	  	  	   	  
Primer	  table	  
	  
Primer	   Sequence	  (5’	  –>	  3’)	  
s1pr1	  fwd	   ATGGATGACCTAATCGCC	  
s1pr1	  rev	   CGAGACGAAAAAGTTCACG	  
s1pr2	  fwd	   ATGACTACTTGCCGTCTG	  
s1pr2	  rev	   GGGATCTGCAAACACTTGG	  
s1pr3a	  fwd	   ATGGATGACGAGCTTGAACC	  
s1pr3a	  rev	   TCAGAACTTCCCCAAAGCG	  
s1pr5a	  fwd	   GGTCAGCAGAAGTGAAATGG	  
s1pr5a	  rev	   CAGACTTGTTTACTTGGCAG	  
s1pr1	  CRISPR	  	  genotyping	  fwd	   TCTATACTGCCAACATCCTG	  
s1pr1	  CRISPR	  	  genotyping	  rev	   CTGATGAGCATGAAGACCC	  qPCR	  axin2	  fwd	   CCTGGAGGAGAGACTTCAAC	  qPCR	  axin2	  rev	   GAGCAAAGGCAGAGAATGGG	  qPCR	  β-­‐actin	  fwd	   CTGGACTTCGAGCAGGAGAT	  qPCR	  β-­‐actin	  rev	   GCAAGATTCCATACCCAGGA	  qPCR	  β-­‐catenin	  fwd	   GCCGCCACCAAACAGGAG	  qPCR	  β-­‐catenin	  rev	   CAGCAGCACACGTCACCACG	  qPCR	  ccnd1	  fwd	   CTGTGCGACAGACGTCAACT	  qPCR	  ccnd1	  rev	   GGTGAGGTTCTGGGATGAGA	  qPCR	  lef1	  fwd	   GTTGGACAGATGACCCCTCC	  qPCR	  lef1	  rev	   CTGTTTCACCTGTGGGTTGAC	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Endothelial cell rearrangements during vascular patterning require PI3-
kinase-mediated inhibition of actomyosin contractility. 
 
Summary: 
Angulo-Urarte et al. investigated the contribution of the PI3K pathway to endothelial cell 
rearrangements in vivo and in vitro during vascular development. They show, that blocking 
PI3Kα signaling leads to impaired junctional remodeling and defective cell rearrangements. 
Additionally, cells grow in aberrant layers. Failure in rearrangements is reflected in the 
disability to stabilize new cell-cell contacts at sites of anastomosis. Furthermore, they 
uncovered a downstream pathway, namely NUAK1/MYPT1/MLCP, that drives cell 
rearrangements by inhibition of actomyosin contractility. 
 
Aim of the collaboration and my contribution: 
Aim of collaboration was to investigate junctional dynamics upon PI3K- inhibition using live 
in vivo time-lapse imaging. I treated embryos transgenically expressing EGFP-ZO1 with 
GDC0326 subjected to time-lapse imaging. Since embryos presented a dramatic increase in 
cell apoptosis that led to zebrafish embryonic death, I injected a morpholino against p53 
prior to inhibitor treatment. This was to overcome unspecified off-target effects. Finally, I 
performed over-night time lapse imaging and post-acquisition image preparation.  
 
 
ARTICLE
Endothelial cell rearrangements during vascular
patterning require PI3-kinase-mediated inhibition
of actomyosin contractility
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Ana M. Figueiredo1, Pau Castel4, Vinothini Rajeeve2, Maria Milà-Guasch1, Jaime Millan5, Cora Wiesner3,
Helena Serra1, Laia Muixi1, Oriol Casanovas 6, Francesc Viñals6,7, Markus Affolter3, Holger Gerhardt 8,9,10,
Stephan Huveneers11, Heinz-Georg Belting 3, Pedro R. Cutillas2 & Mariona Graupera1,12
Angiogenesis is a dynamic process relying on endothelial cell rearrangements within vascular
tubes, yet the underlying mechanisms and functional relevance are poorly understood. Here
we show that PI3Kα regulates endothelial cell rearrangements using a combination of a
PI3Kα-selective inhibitor and endothelial-specific genetic deletion to abrogate PI3Kα activity
during vessel development. Quantitative phosphoproteomics together with detailed cell
biology analyses in vivo and in vitro reveal that PI3K signalling prevents NUAK1-dependent
phosphorylation of the myosin phosphatase targeting-1 (MYPT1) protein, thereby allowing
myosin light chain phosphatase (MLCP) activity and ultimately downregulating actomyosin
contractility. Decreased PI3K activity enhances actomyosin contractility and impairs junc-
tional remodelling and stabilization. This leads to overstretched endothelial cells that fail to
anastomose properly and form aberrant superimposed layers within the vasculature. Our
findings define the PI3K/NUAK1/MYPT1/MLCP axis as a critical pathway to regulate acto-
myosin contractility in endothelial cells, supporting vascular patterning and expansion
through the control of cell rearrangement.
DOI: 10.1038/s41467-018-07172-3 OPEN
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T issue growth and homoeostasis require the establishmentof a functional hierarchical tubular network of blood ves-sels1. Blood vessels are mainly formed by a process known
as sprouting angiogenesis in which new vascular sprouts arise
from parental vessels, grow, and fuse to an adjacent sprout or a
pre-existing vessel1,2. Newly formed sprouts are highly dynamic
with endothelial cells interchanging their relative position within
the vascular tube3–7. This collective cell migration across the
vascular tubes relies on cell rearrangement; yet the regulation of
this cell behaviour during the formation and patterning of blood
vessels is poorly understood.
Endothelial cell rearrangement occurs through the reorgani-
zation of cell–cell junctional contacts thereby allowing the mod-
ification of cell−cell adhesion strengths7–10. In endothelial cells,
there are two types of vascular endothelial-cadherin (Cdh5/VE-
cadherin)-based junctional patterns, namely continuous or
straight, and discontinuous or serrated7,9,10. Straight junctional
VE-cadherin organization is mainly found in stable and mature
junctions, whereas the serrated VE-cadherin junctional pattern is
considered as immature or remodelling junctions9,10. Although
these VE-cadherin junctional patterns are not visible in the
endothelium during zebrafish developmental angiogenesis11,
computational models have proposed that spatial heterogeneity of
these junctional patterns is necessary for cells to rearrange
in vivo7. Yet, how these junctional profiles impact on the capacity
of endothelial cells to rearrange remains poorly understood.
Formation, remodelling, and stabilization of cell−cell adhesions
in cultured endothelial cells are mediated by actin structures12.
At mature junctions, linear VE-cadherin is aligned to parallel
cortical actin bundles. Instead, serrated immature junctions
are connected to perpendicular or radial tensile actin cables9,10.
The switch between stable and immature junctions is mediated
by actomyosin contraction-based pulling forces at the cell–cell
junctions9,10,13.
Among the different players of the angiogenic process, class I
PI3-kinases (PI3K) have emerged as a critical node14, for
both the physiology of endothelial cells15,16 and the pathogenesis
of venous malformations17,18, the most common type of vascular
malformations. PI3Ks are lipid kinases that signal downstream
of a variety of cell surface receptors and regulate cellular functions
including growth, proliferation, migration, and metabolism19.
Upon activation, these enzymes generate the lipid phosphatidly-
linositiol-3,4,5-triphosphate, a second messenger that triggers
signalling pathways, such as those mediated by the serine/
threonine kinase AKT and its substrates20. Of the class I PI3K
isoforms, PI3Kα has been shown to be the only isoform required
for endothelial-mediated vascular development15. Several studies
have demonstrated that PI3Kα signalling primary regulates
cell motility during angiogenesis in mouse and zebrafish15,21,22.
Our study uncovers a PI3K downstream pathway, namely
NUAK1/MYPT1/MLCP, as a critical node in the regulation of
cell rearrangement during vessel growth. We have found that
blockade of PI3Kα signalling impairs junctional remodelling, inhi-
bits cell rearrangement and drives endothelial cells to grow in
superimposed aberrant layers. We identify that a failure of cells to
rearrange results in cell stretching and inability to remodel and
stabilize new cell–cell contacts upon anastomosis. Through a
combination of in vivo and in vitro approaches together with an
unbiased and deep quantitative phosphoproteomic screening, we
have discovered that PI3Kα mediates cell rearrangement by inhi-
biting actomyosin contractility through NUAK1/MYPT1/MLCP.
Results
PI3Kα mediates rearrangement of endothelial cells. Here, we
investigated how endothelial cell rearrangements within the
vascular sprouts contribute to vessel expansion and patterning.
We and others have shown that the PI3Kα isoform regulates
endothelial cell motility (Supplementary Fig. 1, Supplementary
Movies 1 and 2, and refs. 15,21,22). Therefore, we predicted that
cell rearrangement would be altered upon blockage of this
signalling node. To validate our hypothesis, we first studied
vessel growth in zebrafish embryos treated with a PI3Kα
isoform-specific inhibitor (GDC-0326; ref. 23). We focused
our studies between 27 and 38 h post fertilization (hpf), when
intersegmental vessels (ISVs) that arise from the dorsal aorta
reach the dorsal roof and form the dorsal longitudinal anasto-
motic vessels (DLAVs)24. Treatment with GDC-0326 efficiently
inhibited PI3K signalling (Supplementary Fig. 2a) and this
led to aberrant endothelial cell junctional patterns. Junctions
were frequently disconnected in the dorsal region of the ISV
axis and the junctional elongation was reduced in both ISVs
and DLAV (Fig. 1a, b). We also observed the presence of ring-
shaped junctions in these embryos that suggests lack of
tight contact between adjacent endothelial cells (Fig. 1a). More-
over, GDC-0326-treated embryos showed a delay in the growth
of ISVs (Supplementary Fig. 2b-d), without an overall delay in
embryo development (Supplementary Fig. 2e). These aberrant
junctional patterns are indicative of defects in cell rearrange-
ments11. Conversely, in vehicle-treated embryos, ISV outgrowth
was accompanied by a normal extensive junctional remodelling
leading to a pattern of highly elongated endothelial cell junctions
(Fig. 1a, b).
In order to translate our observations into a mammalian
model, we inactivated PI3Kα in endothelial cells using genetic
approaches and we studied retinal angiogenesis. To maximize
Pik3ca deletion and avoid compensations by other PI3K isoforms
we studied Pik3caKD/flox mice, in which one Pik3ca allele is a
constitutive kinase-dead (KD)25, and the other is a lox-P-flanked
Pik3ca allele15. Pik3caKD/flox mice were crossed into the Pdgfb-
iCreER transgenic mouse, which expresses a tamoxifen-inducible
CRE recombinase specifically in endothelial cells26 (further
referred to as Pik3caKD/iΔEC) (Supplementary Table 1 provides
details of the mouse models used). To ensure that Pik3ca flox
allele is completely knocked out in our experimental settings,
we assessed PI3Kα half-life in Pik3caflox/flox mice crossed
into the Pdgfb-iCreER (referred to as Pik3caiΔEC/iΔEC). Complete
depletion of the PI3Kα protein was achieved at 96 h after 4-
hydroxytamoxifen (4-OHT) treatment (Supplementary Fig. 3a).
Thus, to reach complete PI3Kα depletion in vivo, we adminis-
tered 4-OHT at postnatal day (P) 1 and P2 and investigated
Pik3caKD/iΔEC retinas at P7. As compared to control retinas,
Pik3caKD/iΔEC P7 retinas showed a decrease in phospho-S6 (pS6)
(S240/4) and an enhanced nuclear FOXO1 staining confirming
the inactivation of the PI3K pathway (Supplementary Fig. 3b, c).
In line with our previous findings in zebrafish embryos, we
observed that endothelial cells in Pik3caKD/iΔEC retinas showed an
increased number of junctional gaps (Fig. 1c–e; yellow arrow-
heads). Furthermore, in a proportion of vascular tubes, the
junction gaps resulted either in isolated rings or single-dots of
VE-cadherin, indicating lack of tight contacts between endothelial
cells (Fig. 1c; red asterisks). To investigate this phenotype in
further detail, we analysed VE-cadherin-based cell−cell junctions
in cultured endothelial cells from Pik3caKD/iΔEC mice by
immunostaining for β-catenin and F-actin (Fig. 1f). These
experiments showed that Pik3caKD/iΔEC endothelial cells failed
to establish mature cell−cell junctions; instead, most of the
junctions remained immature and connected to radial actin
fibres (Fig. 1f–h). Together these data indicate that PI3Kα
signalling is involved in cell−cell junctional remodelling in
endothelial cells, a process required for cellular rearrangements
within the vasculature.
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Defects in cell rearrangements lead to anastomosis failure. P7
Pik3caKD/iΔEC retinas exhibited a significant reduction in vascular
radial outgrowth (Fig. 2a and Supplementary Fig. 4a) with no
detectable differences in sprouting activity (Supplementary
Fig. 4c, d). This phenotype was further increased at P10, with the
sprouting front of Pik3caKD/iΔEC retinas neither reaching the
periphery of the retina nor invading deeper retinal layers (Fig. 2a
and Supplementary Fig. 4b). However, P7 Pik3caKD/iΔEC retinas
showed an increase in vessel density with vascular tubes growing
in multiple layers (Fig. 2a–c; Supplementary Fig. 4e and
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Supplementary Movies 3 and 4); this superposition was more
pronounced at P10 (Supplementary Fig. 4b, f). Also, the vascular
tubes in Pik3caKD/iΔEC retinas showed smaller calibre (Fig. 2b, c).
Analysis of Pik3caKD/WT and Pik3caiΔEC/iΔEC retinas (Supple-
mentary Table 1) showed that the former appeared normal,
whereas Pik3caiΔEC/iΔEC retinas looked similar to Pik3caKD/iΔEC
retinas but with milder vascular defects (Supplementary Fig. 4a,
b).
Current models of enhanced vessel density involve an increase
in the number of endothelial cells16,17,27,28. However, immunos-
taining of endothelial cell nuclei revealed a significant reduction
in the total number of endothelial cells (Fig. 3a, b) and in
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Fig. 2 Endothelial PI3Kα regulates vascular growth. a Representative images of whole mount retinas stained with IB4 from control and Pik3caKD/iΔEC mouse
littermates at P7 and at P10. Veins (V) and arteries (A) are indicated. White arrowheads show areas where the vascular plexus is superimposed.
b Representative high-magnification images of whole mount retinas stained with IB4 from control and Pik3caKD/iΔEC mouse littermates at P7. Two
independent areas for Pik3caKD/iΔEC retinas are shown. White islets show higher magnification of selected regions shown below. c Quantification of number
of branch points per unit area and vessel width per unit area of control (Ctrl) and Pik3caKD/iΔEC (Pik3ca) retinas (n≥ 6 retinas per genotype). Scale bars,
100 µm (a), 20 µm (b, upper panels), 10 µm (b, lower panels). Data represent mean ± SEM (error bars). ***P < 0.001. Statistical analysis was performed by
the two-sided Mann–Whitney test
Fig. 1 Defects in junctional remodelling upon inactivation of PI3Kα in endothelial cells. a Lateral views of intersomitic vessels (ISV) in vehicle and GDC-
0326 (50 μM)-treated transgenic Tg(kdrl:EGFP)s843 (shown in red) embryos stained for ZO-1 (green) at 33 h post fertilization (hpf). Single ZO-1 staining is
shown in upper row. DA refers to dorsal aorta and DLAV refers to dorsal longitudinal anastomotic vessels. White lines indicate ZO-1 negative staining;
punctuate white lines indicate elongation of junction; yellow arrowheads show ring-shape junctions. b Quantification of the length of the dorsal part of the
ISVs without ZO-1 (left graph) and length of the ISVs with continuous ZO-1 staining (right graph) in vehicle and GDC-0326 treated embryos (n≥ 54 ISVs
per treatment). c Representative maximum intensity projections of anti-VE-cadherin (green) and isolectin B4 (IB4, red) immunostained control and
Pik3caKD/iΔEC mouse retinas at P7. Single channel is shown in upper row. Yellow islets show higher magnification of selected regions shown to the right.
Yellow arrowheads indicate vascular segments without VE-cadherin staining; red asterisks indicate VE-cadherin-positive isolated rings or single-dots within
the vascular tubes, indicating cell−cell junctional contacts that have not elongated. d, e Quantitative number of VE-cadherin-negative vessels (junctional
gaps) per unit area (n≥ 5 retinas per genotype) (d) and length of vessel structures without VE-cadherin (length of junctional gaps) (n≥ 6 retinas per
genotype) (e). f Confocal immunofluorescence images of primary mouse endothelial cells isolated from control and Pik3caKD/iΔEC mice stained for β-
catenin (green) and F-actin (red) after being treated with 4-OHT for 72 h and re-plated on gelatin-coated slides for 24 h. Yellow arrowheads indicate
straight junctional pattern; orange arrowheads indicate serrated junctional pattern. g Graph shows the average of β-catenin-positive area along junctional
linescans (n≥ 109 cells from six independent experiments). h Quantification of percentages of cells with serrated, straight or mixed junctions (n= 5
independent experiments). Scale bars, 30 µm (a), 20 µm (c), 10 µm (c small panel, f). Data in b, d, e, g, h represent mean ± SEM (error bars). *P < 0.05, **P
< 0.01, ****P < 0.0001 were considered statistically significant. Statistical analysis was performed by the two-sided Mann–Whitney test
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endothelial cells in S-phase in Pik3caKD/iΔEC retinas (Supple-
mentary Fig. 5a, b). Endothelial cells were highly stretched in
Pik3caKD/iΔEC retinal vessels, with the distance between adjacent
endothelial cell nuclei increased by twofold (Fig. 3a, b).
This suggests that these cells failed to elongate alongside
each other, a process known as cell pairing29, and as a
consequence the cells overstretched. Given the lower number
of endothelial cells in GDC-0326-treated embryos and in
Pik3caKD/iΔEC retinas, a reduction in cell number might
interfere with cell rearrangement during sprouting angiogenesis
0
1
2
3
4
0
5
10
15
20
25
0
10
20
30
a
N
o.
 o
f E
C 
nu
cle
i /
 1
04
 
μm
2
bControl
D
is
ta
nc
e 
be
tw
ee
n 
nu
cle
i (μ
m
)
**
Pik3caKD/iΔEC
Pik3caKD/iΔEC
Pik3caKD/iΔEC
Ctrlc
d
Pik3ca
Ctrl Pik3ca
Ce
ll a
re
a 
(μm
2  
*
 1
02
)
Control
mGFP ERG : mGFP ERG : mGFP : IB4
***
ERG:: IB4
***
Col-IV Col-IV Col-IV IB4Col-IV
IB4
e f
N
o.
 o
f s
pr
ou
t r
et
ra
ct
io
n
/ 1
04
 μ
m
2
Control
Col-IV
IB4
g
EGFP-UCHD
GDC-0326
0 min
60 min
120 min
180 min
240 min
300 min
360 min
mCherry-CAAX :
EGFP-UCHD 
0 min
60 min
120 min
180 min
240 min
300 min
360 min
Vehicle
EGFP-UCHD
mCherry-CAAX :
EGFP-UCHD 
0
10
20
30
40
Ctrl Pik3ca
Ctrl Pik3ca
*
Stabilization and elongation
of junctional contacts
h
x
Lack of stabilization
of junctional contacts 
Impaired elongation
of junctional contacts
Inhibition of PI3Kα
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-07172-3 ARTICLE
NATURE COMMUNICATIONS |          (2018) 9:4826 | DOI: 10.1038/s41467-018-07172-3 | www.nature.com/naturecommunications 5
(as shown in Fig. 1). To test this possibility, we inhibited cell
proliferation with systemic administration of mitomycin C at P5,
48 h before harvesting the retinas at P7, followed by assessing cell
proliferation and vascular patterning. As previously described30,
5-ethynyl-2′-deoxyuridine (EdU) incorporation showed a promi-
nent block in endothelial cell proliferation in mitomycin C-
treated retinas, leading to an overall reduction in endothelial cells
(Supplementary Fig. 5c-f). However, no major differences in VE-
cadherin junctional pattern were observed (Supplementary Fig. 5e,
f). Similar results were observed in zebrafish embryos upon
administration of the cell cycle blockers aphidicolin (APH) or
hydroxyurea (HU) (Supplementary Fig. 6a-g). These data indicate
that inhibition of cell proliferation per se does not impair cell
rearrangement.
We hypothesized that the increase in vascular branches
observed in Pik3caKD/iΔEC retinas (Fig. 2b, c) was the result of
stretched endothelial cells extending multiple protrusions. To
visualize single-cell morphology, we used R26-mTmG reporter
mice, which express a membrane-bound green fluorescent
protein (GFP) upon Cre recombination31. We crossed R26-
mTmG reporter mice with Pik3caKD/iΔEC mice and reduced the
tamoxifen dose in order to induce mosaic inactivation of PI3Kα
(Supplementary Fig. 7a). Analysis of single cells confirmed
stretched cell-shapes upon inactivation of PI3Kα (Fig. 3c, d). Cell
pairing is an important process for the formation of multicellular
vascular tubes; thus the absence of cell pairing might result in
defects in lumen formation. Staining for intracellular adhesion
molecule 2 (ICAM2), a marker of the apical side of vessels,
confirmed frequent lumenal gaps in Pik3caKD/iΔEC retinal vessels.
The lack of ICAM2 staining in Pik3caKD/iΔEC retinas was
principally observed in thin tubular structures (Supplementary
Fig. 7b, c; yellow asterisks), supporting the notion that the
nonluminized tubes are only cell protrusions. Inactivation of
PI3Kα also led to an increase in collagen IV empty sleeves in
newly formed sprout connections (Fig. 3e, f), showing a lack of
stabilization of new contacts and a failure to anastomose. In
zebrafish embryos treated with GDC-0326, time-lapse analysis of
DLAV formation confirmed that initial contacts between adjacent
sprouts occurred but they failed to stabilize, resulting in frequent
cell retraction and sprout disconnections (Fig. 3g; Supplementary
Movies 5 and 6).
Together, our data show that PI3Kα is necessary for cells to
rearrange by regulating remodelling, elongation and stabilization
of junctional contacts. Lack of cell rearrangements results in
stretched endothelial cells which extend multiple protrusions that
fail to anastomose and grow in superimposed aberrant layers
(Fig. 3h). While proliferation defects likely contribute to impaired
cell rearrangement upon inhibition of PI3K, our data indicate that
PI3K signalling primarily regulates junctional remodelling and
cell rearrangement.
PI3Kα inhibition upregulates phospho-MYPT1. To define the
molecular and signalling changes occurring upon inactivation
of PI3Kα in endothelial cells, we performed untargeted mass
spectrometry (MS)-based phosphoproteomics analyses in pri-
mary mouse endothelial cells from Pik3caflox/flox (control) and
Pik3caKD/iΔEC mice. We analysed four biological replicates
per genotype, each of which was treated with vehicle (ethanol)
for 24 h or 4-OHT for 24 and 96 h (Fig. 4a). We identified
a total of 6836 phosphopeptides in the 24 samples analysed,
which were quantified using a previously described label-free
methodology32, generating 328,128 data points. This analysis
identified: (i) 224 differently regulated phosphopeptides in
the Pik3caKD/flox endothelial cells relative to control; (ii) 122
deregulated phosphopeptides in Pik3caKD/iΔEC endothelial cells
upon 24 h treatment with 4-OHT; and (iii) 202 deregulated
phosphopeptides in Pik3caKD/iΔEC endothelial cells upon 96 h
treatment with 4-OHT (Fig. 4b, c).
We clustered the phosphorylation sites that were significantly
deregulated at 96 h post 4-OHT treatment by gene ontology
(Supplementary Fig. 3a). Of particular relevance for the cell
rearrangement phenotype observed, we found a total of 23
phosphosites from 14 cytoskeleton-related proteins that were
differently modulated between Pik3caKD/iΔEC and control
endothelial cells. These included the myosin light chain
phosphatase (MLCP), CDC42, RAC1, junctional proteins, focal
adhesions, intermediate filaments, and microtubules (Fig. 4d).
Among the different candidates, Pik3caKD/iΔEC endothelial
cells showed an upregulation on the S445 phosphosite (pS445) of
the phosphatase 1 regulatory subunit 12 A (Ppp1r12A) also
known as MYPT1 (Fig. 4d). This protein was of particular
interest because, together with PP1β and M20, it composes the
MLCP complex and regulates the dephosphorylation of the
myosin light-chain (MLC) 2 (refs. 33–36), which is required for
the contraction of actomyosin (illustration is shown in Supple-
mentary Fig. 8a). We validated the increase of pS445 MYPT1
in Pik3caKD/iΔEC endothelial cells by western blot (Fig. 4e;
Supplementary Fig. 8b, c). Also, we confirmed the PI3Kα-
mediated regulation of pS445 MYPT1 in wild-type endothelial
and HEK-293 cells treated with GDC-0326 (Fig. 4e; Supplemen-
tary Fig. 8b, c).
Fig. 3 Cell stretching defects and anastomosis failure in Pik3caKD/iΔEC vessels. a Representative images of retinas stained for ERG (green) and IB4 (red)
from control and Pik3caKD/iΔEC P7 pups. Higher magnification are shown to the right. b Quantification of endothelial cells per unit area assessed by ERG
positivity and of the distance between two adjacent endothelial cell nuclei (n≥ 6 retinas per genotype). c Immunostaining of single-cell labelling with
membrane-bound GFP (mGFP, blue), endothelial nuclei (ERG, green) and blood vessel (IB4, red). Retinas from Pdgfb-iCre;Pik3caWT/flox were used as
control. d Quantification of cell size of individual mGFP-positive cells in control and Pik3caKD/iΔEC retinas. At least 89 individual mGFP-positive cells from
four independent retinas per genotype were quantified. e Images of control and Pik3caKD/iΔEC P7 retinas stained for collagen IV (green) and IB4 (red).
Single channels are also shown. White punctuated islet in the image of a Pik3caKD/iΔEC retina shows higher magnification of selected region to the right. Red
arrowheads indicate a retracting sprout. f Quantification of retracting sprouts per area (n= 4 retinas per genotype). g Images from a time-lapse movie
(starting at 30 hpf) showing lateral views of ISV morphogenesis in transgenic Tg(UAS:EGFP-UCHD)ubs18;(kdrl:mCherry-CAAX)S916 embryos treated with
vehicle (left panel) or GDC-0326 (50 μM) (right panel). Endothelial cell membrane is visualized in red and the actin cytoskeleton is visualized by F-actin
binding domain of utrophin in green. Single channels are also shown. Red arrow shows a retracting event between two endothelial cells. h Schematic
illustration showing the vascular defects driven by inactivation of PI3Kα (designed by Ana Angulo-Urarte). During vessel growth remodelling, stabilization,
and elongation (punctuated arrow) of adherent junctional contacts is required between neighbouring endothelial cells to rearrange. Upon inactivation of
PI3Kα, endothelial cells fail to stabilize (black arrow) and elongate (crossed punctuated arrow) junctional contacts. Scale bars, 40 µm (a), 20 µm (a
amplified panels, e), 10 µm (c, e amplified panels) 15 µm (g). Data in b, d, and f represent mean ± SEM (error bars). *P < 0.05, **P < 0.01, ***P < 0.001.
Statistical analysis was performed by the two-sided Mann−Whitney test
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PI3Kα is required to suppress actomyosin contractility.
Zagoroska et al. found that S445 MYPT1 phosphorylation trig-
gers the binding of MYPT1 to 14-3-3, thereby blocking the ability
of the MLCP complex to dephosphorylate MLC2 in S19 and T18/
S19 (ref. 35). Thus, we predicted that inhibition of PI3Kα, and the
resultant increase of MYPT1 S445 phosphorylation, might pro-
mote the detachment of MLCP from the actomyosin machinery,
thereby increasing actomyosin contractility. Indeed, we detected
that the ability of MYPT1 to bind β-actin in an overlay assay was
reduced upon inhibition of PI3Kα (Fig. 5a). By knocking down
MYPT1 protein expression with small interference RNA (siRNA),
we found that phosphorylation of MLC2 at S20 (S19 in humans)
was increased upon MYPT1 downregulation in endothelial cells
(Fig. 5b–d).
Enhanced phosphorylation of MLC2 on S20 was also found
upon both genetic and pharmacologic inhibition of PI3Kα in
mouse endothelial cells (Supplementary Fig. 9a, b). Moreover,
pS20 MLC2 staining was enriched at the subcortical region of
Pik3caKD/iΔEC endothelial cells (Fig. 6a–c; Supplementary Fig. 9c).
This was correlated with subcortical accumulation of F-actin
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Fig. 4 Phosphoproteomics elucidate downstream effectors of PI3Kα in endothelial cells. a Schematic illustration of the untargeted label-free mass
spectrometry analysis. The study was conducted in Pik3caflox/flox (control) and Pdgfb-iCre;Pik3caKD/flox (Pik3caKD/iΔEC) mouse lung endothelial cells under
exponential growing conditions upon preincubation with vehicle (EtOH) or 4-OHT for the indicated time points. The vehicle condition for analysis of the
heterozygous inactivation of PI3Kα (Pik3caKD/flox without induction of CRE activity) was included as a further control and four different mice were analysed
in each condition (a total of 24 samples). b Volcano plots exhibiting changes in phosphopeptides across genotypes. The Y axis represent the negative log10
of P value and the X axis shows the log2 of the fold change between control and Pik3caKD/iΔEC endothelial cells treated with vehicle (EtOH) for 24 h, 4-OHT
for 24 h or 4-OHT for 96 h. Red and yellow dots represent significantly regulated phosphopeptides (P < 0.01 and P < 0.05 respectively) with a fold-change
higher than 0.8 or lower than −0.8. c Venn diagram showing the number and percentage of phosphopeptides which are significantly upregulated or
downregulated between experimental groups. Number and percentage of overlapping phosphopeptides between groups are also shown. d Heatmap
indicating fold-changes in the phosphorylation of proteins related to the cytoskeleton. Phosphopeptides identified to be down- or upregulated in Pik3caKD/
iΔEC vs. Ctrl are shown in blue and red, respectively across EtOH and 4-OHT treatments. Values shown represent mean fold-change over Ctrl. e Western
blot validation of pS445 MYPT1 in mouse lung endothelial cells and HEK-293 cells upon genetic and pharmacological inhibition of PI3Kα. Control and
Pik3caKD/iΔEC endothelial cells were treated with 4-OHT for 72 h, re-platted for 24 h and subjected to immunoblotting. Wild-type endothelial cells and HEK-
293 cells were treated with vehicle or GDC-0326 for 48 h and subjected to immunoblotting. Quantification of at least three independent experiments is
shown in Supplementary Figure 8
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Fig. 5MYPT1 promotes dephosphorylation of MLC2 in endothelial cells. a Immunoblot analysis of HEK-293 cells treated with vehicle or GDC-0326 for 48
h using the indicated antibodies. Endogenous MYPT1 was immunoprecipitated and its ability to interact with actin was assessed in an overlay assay. Bars to
the right show quantification of actin bound to total MYPT1 from three independent experiments. b Western blot analysis of MYPT1, pS20 MLC2 and β-
actin in lysates of wild-type mouse lung endothelial cells transfected with siControl (siCtrl) or siMYPT1. Bars to the right show quantification of pS20 MLC2
normalized to β-actin from three independent experiments. c Images of endothelial cells transfected with siCtrl or siMYPT1, seeded on gelatin-coated
plates 72 h post-transfection, and immunostained for β-catenin (green), pS20 MLC2 (red) and F-actin (blue). d Quantification of total cell pS20 MLC2
immunostaining intensity (shown as integrated density) of images shown in c (n≥ 6 independent experiments). Scale bars, 15 µm (c). Data in a, b, and
d represent mean ± SEM (error bars). *P < 0.05, **P < 0.01. Statistical analysis was performed in a, and b by the two-sided Student’s t test and in d by the
two-sided Mann–Whitney test
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(Fig. 6a–c; Supplementary Fig. 9d). Instead, control cells showed
stress fibres evenly distributed between the cytoplasm and the
subcortical area of the cell (Fig. 6a–c). Analysis of Pik3caKD/iΔEC
retinal vessels confirmed an increase in the intensity of pS20
MLC2 (Fig. 6d, e) and F-actin staining (Fig. 6f, g). Together, these
experiments show that PI3Kα activity is required to downregulate
actomyosin contractility and may also explain why Pik3caKD/iΔEC
endothelial cells fail to stabilize junctions in vivo (Fig. 1).
NUAK1 inhibition restores PI3Kα-driven vascular phenotypes.
Two non-related protein kinases are able to phosphorylate
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Fig. 6 Inactivation of PI3Kα results in increased actomyosin contractility. a pS20 MLC2 (green), F-actin (red) and β-catenin (blue) immunostaining of
endothelial cells isolated from control and Pik3caKD/iΔEC mice treated with 4-OHT for 72 h and re-plated on gelatin-coated slides for 24 h. b Yellow islets
show higher magnification of selected regions in a. c Representative fluorescence intensities of pS20 MLC2, β-catenin and F-actin immunostaining
corresponding to the area depicted by the white line in b. Vertical blue arrows indicate endothelial junction between two endothelial cells. Punctuated lines
highlight subcortical area. d pS20 MLC2 (green) and IB4 (red) staining of control and Pik3caKD/iΔEC P7 retinas. e Quantification of the intensity of pS20
MLC2 staining per vascular area (shown as integrated density) (n≥ 5 retinas per genotype). f F-actin (green) and IB4 (red) staining of control and
Pik3caKD/iΔEC P7 retinas. g High magnification of selected regions shown in (f) illustrates the increase in F-actin intensity induced in Pik3caKD/iΔEC
endothelium. h Quantification of F-actin staining per vascular area (shown as integrated density) (n≥ 6 retinas per genotype). Scale bars, 15 µm (a), 20 µm
(d, f), 10 µm (g). Data in e and g represent mean ± SEM (error bars). *P < 0.05, **P < 0.01. Statistical analysis was performed by the two-sided
Mann–Whitney test
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MYPT1 on S445, namely NUAK family kinase 1 (NUAK1)35 and
large tumour suppressor kinase 1 (LATS1)37. Up to date, only
NUAK1 has been reported to regulate phosphorylation of
MLC235. Based on these findings, we tested whether restoring
MLCP activity by blocking NUAK1 reduces pS20 MLC2 and
suppresses actomyosin contractility. Treatment of endothelial
cells with a selective NUAK1 inhibitor (NUAKi)38 reduced
phosphorylation of MLC2 and F-actin staining (Fig. 7a). Inhibi-
tion of ROCK, the main kinase that phosphorylates MLC2, was
not sufficient to completely abrogate actomyosin contractility in
Pik3caKD/iΔEC endothelial cells (Supplementary Fig. 10a, b). In
contrast, ROCK inhibitor completely abrogated pS20 MLC2 and
disrupted stress fibres in control cells (Supplementary Fig. 10a, b).
This further supports the role of PI3Kα in the regulation of the
phosphorylation of MLC2 in an MYPT1/MLCP-dependent
manner.
Next, we attempted to rescue the vascular phenotypes triggered
by the inactivation of PI3Kα in vivo by treating newborn mice
with NUAKi. While inhibition of NUAK1 did not impact on the
outgrowth of the vasculature, it normalized the hyperbranched
vascular plexus and the vessel width and prevented the three-
dimensional growth in Pik3caKD/iΔEC retinas (Fig. 7c, d and
Supplementary Fig. 10c). In line with the observations in cultured
endothelial cells, administration of ROCK inhibitor in vivo did
not rescue the Pik3caKD/iΔEC retinal phenotype (Supplementary
Fig 10d-f). This further supports that PI3K signalling does not
regulate pMLC2 in a ROCK-dependent manner. Altogether, these
data demonstrate that regulation of the NUAK1/MYPT1/MLC2
axis by PI3Kα is required to inhibit actomyosin contractility in
cultured endothelial cells and in growing vessels in vivo (Fig. 7e).
Discussion
In this study, we present evidence demonstrating that the PI3K
downstream pathway, the NUAK1/MYPT1/MLCP axis, controls
actin dynamics in endothelial cells. We uncover that failure of
endothelial cells to rearrange results in vascular tubes composed
of stretched cells, which grow in a superimposed fashion and fail
to stabilize upon anastomosis. Our data support that a tight
regulation of endothelial cell movement, beyond tip cells, is
necessary for the adequate patterning of the vascular plexus. Cell
rearrangement is critical for any process that implies collective
cell migration such as in epithelial sheets and neural crest cells
during development, and in cancer cells during collective
invasion39,40. Thus, our discoveries may be translated to the
cellular and molecular dynamics orchestrating these critical
pathophysiological processes.
The combination of a PI3Kα-selective inhibitor together with
an endothelial-specific inducible genetic system has allowed us to
fully abrogate PI3Kα activity during vessel development and
unravel functions of this signalling hub. We show here that
inhibition of PI3Kα hinders endothelial cell pairing and triggers
defects in cell elongation. These aberrant cellular behaviours
ultimately result in stretches of unicellular vascular tubes devoid
of lumen. Thus, our data demonstrate that rearrangement of
endothelial cells is required to form well-organized, multicellular
vascular tubes. Our experimental strategies also reveal cell pro-
liferation defects in PI3Kα-inhibited endothelial cells. Although
it is possible that such defects contribute to the overall phenotype,
the observation that blockade of proliferation per se does
not interfere with junctional patterns argues for impaired junc-
tional remodelling and cell motility as an independent defect
in Pik3caKD/iΔEC retinas. Previous data showing that partial
decrease in PI3K output selectively decreases endothelial cell
migration with no defects in cell proliferation further support
this interpretation15,22. Pik3caKD/iΔEC retinas show an atypical
phenotype consisting of hyperbranching but reduced numbers of
endothelial cells. In contrast, canonical reduction of endothelial
cell proliferation in vivo, by over-activation of Notch or depletion
of VEGFR2, results in a hypobranched plexus41–43. Our data thus
highlight that increased numbers of branches is not always
associated with an increase in endothelial cell proliferation as
previously described. Taken together, the present data establish
that PI3Kα is an important regulator of sprouting angiogenesis
and confirm that angiogenic endothelial cells are exquisitely
regulated by this signalling hub.
Previous studies have described that PI3K signalling regulates
planar cell rearrangement in epithelial cells by stimulating junc-
tional lengthening and stability44,45. Our data show that inacti-
vation of PI3K signalling also impairs junctional remodelling in
cultured endothelial cells and identify that this also occurs during
vessel growth in vivo. Aberrant junctional patterns are indicative
of defects in cell rearrangements11. Therefore, this suggests that
cell rearrangement defects in our PI3Kα-inhibited in vivo models
are caused by impaired junctional remodelling. We also identify
that the spatial heterogeneity of junctional patterns required for
cells to rearrange is lost in Pik3caKD/iΔEC endothelial cells, with a
concomitant shift towards serrated immature junctions. While
current understanding of junctional patterns associates serrated
junctions with highly motile cells and straight junctions with
non-moving cells46, our data suggest that the loss of junctional
pattern heterogeneity, regardless of the type, blocks cell rearran-
gement. This agrees with previous results based on computational
models which indicate that cells rearrange when differential
adhesion strengths are found between neighbouring cells7.
Mechanistically, we show that PI3Kα mediates endothelial cell
rearrangement by inhibiting actomyosin contractility at the sub-
cortical edge of the cells. This is in line with previous reports
documenting that inactivation of PI3K in vitro leads to both
enhanced actin contractility47 and aberrant actin pattern48.
Together, this supports the notion that actomyosin activity has to
be low for cell rearrangements to occur. This is not unique of
endothelial cells as it has also been observed in Drosophila epi-
thelial tracheal tubes and in tumour cells49,50. Upon contraction,
the actomyosin machinery transmits force to cell−cell contacts
and regulates junctional remodelling12,50. This process is required
for cells to change their adhesion strengths and propel cell
movement. We observe that inhibition of PI3K impairs junction
stabilization and actomyosin contractility, and in turn reduces cell
migration. PI3K is at the crossroad of many extracellular inputs14;
thus it is not surprising that other mechanisms activate PI3K
signalling to stimulate endothelial cell migration during vessel
growth51. Indeed, during angiogenesis, fibronectin, a critical
component of the extracellular matrix of endothelial cells, med-
iates cell migration through the activation of PI3K51. Given that
aberrant adhesion of endothelial cells to the extracellular matrix
compromises the formation of stable adherent junctions in vivo52,
we speculate that the regulation of cell−cell adhesion and cell
−matrix adhesion by PI3K synergize to mediate cell rearrange-
ment during vessel growth.
The growth of the junctional ring upon establishing new
contacts is also impaired upon inactivation of PI3K in both
mouse retinas and in zebrafish embryos. This fits with the
observation that junctional elongation requires cortical tension
from the actomyosin cytoskeleton11,53. We postulate that during
angiogenesis, a tight equilibrium between stimulation and sup-
pression of actomyosin contractility is required to allow proper
growth of the newly formed junctional contact points. This also
explains why reduced phosphorylation of MLC2 is associated
with junctional defects in angiogenesis54,55. Together, our data
indicate that the regulation of junctional remodelling and stability
by PI3Kα signalling underscores changes in both cell−cell
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Fig. 7 Blockade of NUAK1 restores the endothelial phenotypes imposed by PI3Kα inactivation. a Confocal images of control and Pik3caKD/iΔEC endothelial
cells treated with 4-OHT for 72 h, re-plated on gelatin-coated slides for 24 h and treated with 10 μM WZ4003 (NUAK1 inhibitor; NUAKi) or DMSO as
control for 10min, and stained for pS20 MLC2, β-catenin and F-actin. b Quantification of subcortical pS20 MLC2 (upper graph) and F-actin (lower graph)
immunostaining intensities (shown as integrated density) (n≥ 14 images of three independent experiments). c IB4-stained control and Pik3caKD/iΔEC
retinas treated with DMSO as control or WZ4003 (NUAKi) at P6 (16:00), and isolated at P7 (1000 hours). d Quantification of branch points per unit area,
vessel width per unit area, and superimposed vascular tubes per unit area (n≥ 4 retinas per genotype and treatment). e Molecular mechanism by which
PI3Kα suppresses actomyosin contractility. Scale bars, 15 µm (a), 100 µm (c). Data in b and d represent mean ± SEM (error bars). *P < 0.05, **P < 0.01.
Statistical analysis was performed by the two-sided Mann–Whitney test
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adhesion properties and junctional growth upon new cell−cell
contacts. Given the similarity between the vascular defects in
Pik3caKD/iΔEC retinas and GDC-0326-treated zebrafish and those
observed in cdh5-mutant zebrafish embryos and mouse retinas,
we propose that PI3Kα and VE-cadherin cooperate to regulate
cell rearrangement and contact expansion.
We have identified a molecular pathway regulated by PI3K
signalling that points towards a role of PI3K in regulating actin
dynamics. Specifically, we have discovered that inactivation of
PI3Kα leads to enhanced phosphorylation of MYPT1 at S445, a
site which can be phosphorylated by NUAK1 (ref. 35). We
demonstrate that blocking NUAK1 restores both actomyosin
contractility and the vascular patterning defects triggered by
inactivation of PI3Kα In contrast, NUAKi does not restore the
outgrowth of the vasculature in Pik3caKD/iΔEC retinas. This might
be explained by the inability of NUAKi to restore endothelial cell
proliferation; thereby further supporting that cell rearrangement
defects and altered cell proliferation in Pik3caKD/iΔEC retinas are
two non-related events. At the moment, it is still not fully clear
how PI3K signalling inhibits NUAK1. Given that AKT inhibits
liver kinase B1 (LKB1) through phosphorylation-dependent
nuclear retention56 and LKB1 activates NUAK1, it is tempting
to speculate that PI3Kα blocks the ability of LKB1 to phosphor-
ylate NUAK1. By preventing the phosphorylation of MYPT1 on
S445 by NUAK1, PI3Kα then promotes MLCP phosphatase
activity (Fig. 7e). Supporting this idea, genetic endothelial
depletion of LKB1 opposes Pik3caKD/iΔEC vascular phenotypes,
with enhanced retinal angiogenesis and increased endothelial cell
proliferation and migration57. However, taking into account the
complexity of the PI3K signalling cascade, other pathways may
also contribute to the vascular defects seen in the Pik3caKD/iΔEC
vasculature.
Taken together, our study discovers the PI3Kα/MYPT1/MLCP
signalling axis as a critical hub in endothelial cell rearrangement
and highlights the key role of cell rearrangement in the orches-
tration of collective cell migration during angiogenesis. The reg-
ulation of actomyosin remodelling by PI3K signalling has been
observed in a variety of primary and tumour cells; yet the
molecular mechanism behind this regulation has not been fully
understood. Therefore, our findings may be translated into other
developmental and pathological situations.
Methods
Reagents. All chemicals, unless otherwise stated, were from Sigma-Aldrich.
Growing mediums for cultured cells were from Gibco.
Zebrafish. Maintenance of zebrafish (Danio rerio) and experimental procedures
involving zebrafish embryos were carried out at the Biozentrum/Universität Basel
according to Swiss national guidelines of animal experimentation (TSchV). Zeb-
rafish lines were maintained under licences 1014 H and 1014G1 issued by the
Veterinäramt-Basel-Stadt. The fish were maintained using standard procedures
and embryos obtained via natural spawning58, and embryos were staged by hours
post-fertilization (hpf) at 28.5 (ref. 59). All experiments were performed in accor-
dance with federal guidelines and were approved by the Kantonales Veterinäramt
of Kanton Basel-Stadt (Switzerland). The following zebrafish lines were used: Tg
(kdrl:EGFP-nls)ubs1 (ref. 29), Tg(fli1ep:mCherry-nls)ubs10 (ref. 60), Tg(kdrl:EGFP)
s843 (ref. 61), Tg(kdrl:mCherry-CAAX)s916 (ref. 62), and Tg(UAS:EGFP-UCHD)ubs18
(ref. 11). For pharmacological inhibition of PI3Kα, dechorionated zebrafish
embryos were treated with dimethylsulphoxide (DMSO) or 50 μM GDC-0326
inhibitor (Genentech23) in E3 medium supplemented with 0.003% 1-phenyl-2-
thiourea from 22 hpf or 27 hpf, as indicated in the Results section. E3 medium
containing DMSO or 50 μM GDC-0326 was changed every 4 h. To overcome
unspecified off-target effects induced by the combination of PI3Kα inhibitor and
laser exposure, all experiments were done in a p53 morpholino background. P53
morpholino (Gene Tools) was dissolved in DEPC water containing 0.2% phenol
red and 5 ng were injected to 1−2 cell-stage embryos. In order to block cell cycle
during angiogenesis63, 26−28 hpf zebrafish embryos were treated with 20 mM
hydroxyurea (HU) and 150 μM aphidicolin (APH). Embryo treatment lasted
throughout live imaging or until the embryos were fixed in 2 % PFA and prepared
for immunofluorescence.
Mice. Mice were maintained under specific pathogen-free conditions and kept in
individually ventilated cages. Experiments were conducted in accordance with the
guidelines and laws of the Catalan Departament d’Agricultura, Ramaderia i Pesca
(Catalunya, Spain) under the Project License number: DMAH 6809, following
protocols approved by the local Ethics Committees of IDIBELL-CEEA. All PI3Kα
mutant mice and littermate controls were bred in the C57/BL/6 genetic background
(Supplementary Table 1). For the analysis of angiogenesis in the postnatal mouse
retina, CRE-mediated recombination was induced in newborn mice by intraper-
itoneal (i.p.) injections of 25 µg of 4-OHT (2.5 µl of a 10 mgml−1 solution in
absolute ethanol) at P1 and P2. Eyes were harvested at P7 and P10 for analysis.
Control animals were littermate Pik3caflox/flox pups without CRE expression and
injected with 4-OHT. For mosaic inactivation of PI3Kα, R26-mTmG reporter
mouse31 was crossed with Pik3caKD/iΔEC mice and 0.8 µg of 4-OHT (2.5 µl of a
0.33 mgml−1 solution in absolute ethanol) was injected i.p. at P1, and eyes were
harvested at P7. CRE-mediated recombination was assessed by the expression of
membrane-bound GFP. Injected retinas from R26-mTmG;Pdgfb-iCreER;Pik3caflox/
WT mice were used as control for the analysis. The R26-mTmG allele was kept
heterozygous. To block proliferation, wild-type pups were i.p. injected with 10 μg g
−1 of animal of mitomycin C solution (Sigma, #M4287) as described in ref. 30 at P5.
At P7, all pups were i.p. injected with EdU (Invitrogen) to assess proliferation (EdU
staining protocol below). For pharmacological rescue experiment studies the fol-
lowing protocols were used: ROCK was inhibited in half of the pups from the same
litter by i.p. injection of 30 mg kg−1 of animal of Y-27632 (Calbiochem, #688000)
dissolved in DMSO at P6 (18:00) and P7 (10:00), and eyes were harvested at P7
(14:00). NUAK1 was inhibited in half of the pups by a single subcutaneous
injection of 30 mg kg−1 of animal of WZ4003 (Selleckchem, #S7317) at P6
(16:00 hours), and eyes were harvested at P7 (10:00). Control mice were injected
with DMSO only.
Cells. Mouse lungs were digested with Dispase (Life Technologies, #17105-041; 4
units ml−1) for 1 h at 37 °C, followed by positive selection with anti-mouse vascular
endothelial-cadherin (Pharmingen, #555289) antibody coated with magnetic beads
(Dynal Biotech, #110-35). Cells were seeded on a 12-well plate and were coated
with gelatin (0.5%) in DMEM/F12 supplemented with 20% foetal calf serum and
EC growth factor (PromoCell, #C30140) and 1% penicillin/streptomycin. After the
first passage, the cells were re-purified with vascular endothelial-cadherin antibody-
coated magnetic beads. Cells were cultured until passage 5. Human umbilical vein
endothelial cells (HUVECs, Lonza, #C2519A) were cultured in EBM-2 culture
medium supplemented with EGM-2 BulletKit (Lonza, #CC-3162) on 0.5% gelatin-
coated plates and culture up to passage 5. Human embryonic kidney cells (HEK-
293, ATCC, CRL-1573) were cultured in DMEM (Lonza, #12-733F) supplemented
with 10% of inactivated FBS and 1% penicillin/streptomycin. To induce gene
deletion in mouse lung endothelial cells 4-OHT (1 µM) or vehicle (ethanol) was
added to the cultured medium for 24 h, followed by replacing the medium without
4-OHT or vehicle. All the experiments were performed 96 h after the addition of 4-
OHT or vehicle. For pharmacological inhibition of ROCK and NUAK1 kinases,
cells were cultured for 24 h followed by treatment with vehicle (DMSO), 10 μM
ROCK inhibitor for 10 or 30 min, or 10 μM NUAK1 inhibitor for 10 min. For
pharmacological inhibition of PI3Kα, cells were treated with vehicle (DMSO) and
1 μM GDC-0326 inhibitor (Genentech) for 48 h.
siRNA transfection. Solution A (493 μl of Opti-MEM (Gibco, #51985026) with
7.5 μl of 20 μM control (Dharmacon, #D-001206-13) or 20 μM MYPT1 (Dhar-
macon, #M-063177-02 SMART pool siRNA oligomer)) and solution B (493 μl of
Opti-MEM with 7.5 μl of lipofectamine RNAi Max (Thermo Fisher Scientific,
#13778075)) were prepared and incubated for 5 min at room temperature (RT) in
separated tubes following the manufacturer’s instructions. Subsequently, solution B
was added to solution A and incubated for 20 min at RT, followed by adding A+ B
solution to endothelial cells (750,000 cells) in suspension resuspended in 500 μl of
Opti-MEM without antibiotics on cover-slips in six-well plates (three cover-slips
per well previously coated with 0.5% gelatin). The medium was changed the day
after, and cells were either fixed for immunofluorescence assays or lysed for wes-
tern blotting 72 h after transfection.
Protein extraction, immunoprecipitation and immunoblotting. Zebrafish
embryos were subjected to a deyolking protocol to avoid the interference of yolk
proteins in our analyses. Dechorionated embryos were collected in a 1.5 ml tube
filled with 1 ml deyolking buffer (55 mM NaCl, 1.8 mM KCl and 1.25 mM
NaHCO3). By pipetting with a narrow tip the yolk sac was disrupted. The embryos
were shaken for 5 min at 200 × g to dissolve the yolk. Cells were pelleted at 300 × g
for 30 s and the supernatant discarded. Two additional washes were performed by
adding 1 ml of wash buffer (110 mM NaCl, 3.5 mM KCl, 2.7 mM CaCl2, 10 mM
Tris/Cl pH 8.5), shaking 2 min at 200 × g and pelletting the cells as before. For
protein extraction, deyolked zebrafish embryos, mouse lung endothelial cells and
HEK-293 cells were lysed in 50 mM Tris HCl pH 7.4, 5 mM EDTA, 150 mM NaCl
and 1 % Triton X-100 supplemented with 2 mgml−1 aprotinin, 1 mM sodium
fluoride, 1 mM pepstatin, 1 ng ml−1 leupeptin, 1 mM phenylmethysulfonyl-
fluoridem, 10 g ml−1 Na-p-tosyl-L-lysine chloro-methyl ketone hydrochloride, 1
mM sodium orthovanadate, 1 μM okadaic acid and 1 mM DTT followed by
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clearance of lysates by centrifugation. Supernatants were resolved on 8, 10 or 12%
SDS–PAGE gels, transferred onto nitrocellulose or PVDF membranes. Membranes
were blocked in 5% (w/v) skimmed milk, incubated with specific primary anti-
bodies overnight at 4 °C in 2% BSA in 0.1% Tween-20 TBS buffer (further referred
to as TBST), then washed three times with TBST and incubated with peroxidase-
conjugated secondary antibodies in 5% (w/v) skimmed milk in TBST at RT for 1 h.
The following primary antibodies were used: p-AKT (Ser 473) (Cell Signaling
Technology, #4060, diluted 1:1000), AKT (Cell Signaling Technology, #9272,
diluted 1:2000), VE-cadherin (Santa Cruz Biotechnology, #sc-6458, diluted 1:500),
p85 (Millipore, #ABS234, diluted 1:2000), PI3Kα (monoclonal clone U3A64),
Ser445 MYPT1 (MRC Reagents, #S508C35, 1 μg ml−1), MYPT1 (MRC Reagents,
#S110D, ref. 35, 1 μg ml−1 with a 10 μg ml−1 of a dephosphopeptide variant of the
antigen used to raise the antibody), pS19/S20 MLC2 (Rockland Antibodies,
#039600-401-416, diluted 1:500), β-actin (Abcam, #ab49900, diluted 1:10,000) and
α-tubulin (Sigma-Aldrich, #T6074, diluted 1:10,000). The following secondary
antibodies from DAKO were used in a 1:5000 dilution: swine anti-rabbit (#P0399),
rabbit anti-goat (#P0449), rabbit anti-mouse (#P0260), and rabbit anti-sheep
(#P0163).
MYPT1 immunoprecipitation (IP) was performed using a sheep polyclonal
MYPT1 antibody (MRC Reagents, #S110D) covalently coupled to protein G-
Sepharose (GE Healthcare, #17-0618-01) (1 μg of antibody per 1 μl of beads) with a
dimethyl pimelimidate cross-linking procedure35. Cells treated with DMSO or
GDC-0326 for 48 h were lysed with IP buffer (50 mM Tris pH 8.0, 150 mM NaCl,
0.1% SDS, 1% NP40, 0.5% sodium deoxycolate, 2 mg ml−1 aprotinin, 1 mM
pepstatin A, 1 ng ml−1 leupeptin, 10 g ml−1 TLCK, 1 mM PMSF, 1 mM NaF, 1 mM
NaVO3 and 1 μM okadaic acid) and clarified by centrifugation at maximum speed
for 15 min at 4 °C. Cell lysate (1 mg) was incubated with 5 μg of coupled antibody
for 1 h at 4 °C. Immunoprecipitates were washed four times with IP buffer and
resuspended in 1× SDS Sample Buffer. Immunoprecipitates and cell lysates (50 μg)
were subjected to electrophoresis on 8−12% SDS–PAGE and transferred to
nitrocellulose membranes. For sheep antibodies, the membranes were incubated for
30 min with TBST containing 10% (w/v) skimmed milk. The membranes were then
immunoblotted in 10% (w/v) skimmed milk in TBST with the MYPT1 primary
antibody (1 μg ml−1) overnight at 4 °C. The incubation with phosphospecific
MYPT1 sheep antibody was performed with the addition of 10 μg ml−1 of a
dephosphopeptide variant of the antigen used to raise the antibody. Uncropped
scans are shown in Supplementary Figures 11-13.
Live 2D wound healing assay. Mouse lung endothelial cells and HUVECs were
plated on six-well plate dishes coated with 0.5% gelatin to grow to confluence for
24 h. Cell monolayers were scratched with a p200 pipette tip to induce cell
migration. Phase-contrast images were performed every 10 min using a widefield
microscope (NIKON Eclipse TI) equipped with a ×10air objective and an Andor
Zyla 4.2 plus sCMOS camera. An Okolab cage incubator and humidified CO2 gas
chamber set to 37 °C and 5% CO2 were used during the imaging process.
Immunofluorescence analysis in zebrafish, retinas and cells. For immuno-
fluorescence and imaging of zebrafish embryos, dechorionated zebrafish embryos
were fixed in 2% paraformaldehyde and 0.1% Tween 20 in PBS overnight at 4 °C.
After fixation, embryos were washed four times with 0.1% Tween 20 in PBS
(hereafter refer to as PBST) for 5 min, permeabilized with 0.5% Triton-X-100 in
PBS at room temperature (RT) for 15−30 min, and blocked with 1% BSA, 5% goat
serum (Gibco, #16210-064) and 0.2% Triton X-100 in PBS at 4 °C overnight by
continuous shaking. Thereafter, embryos were incubated with mouse anti-human
ZO-1 (Zymed, #33-9111, diluted 1:200) in 500 μl of blocking buffer at 4 °C over-
night, washed in PBST at least six times for over 3 h, and incubated with Alexa-633
goat anti-mouse IgG (Invitrogen, #A-21053, diluted 1:1000) in 500 μl of blocking
buffer overnight at 4 °C. Embryos were finally washed in PBST at 4 °C overnight
with continuous shaking. Fixed or live fluorescence positive zebrafish embryos were
selected using a Leica MZ FLIII fluorescent, anaesthetized in E3 supplemented with
1× tricaine pH 7 (0.08%) and mounted in a 35 mm glass-bottomed dish (0.17 mm;
MatTek), using 0.7% low melting agarose containing 1× tricaine. For live imaging,
the mounting agarose was additionally supplemented with 0.003 % phenylthiourea
(PTU) and inhibitor if the case.
Mouse eyes were fixed in 4% PFA in PBS for 1 h on ice and washed in PBS for at
least 10 min. Retinas were isolated and fixed with 4% PFA in PBS for 1 h on ice.
After washing the retinas with PBS three times, they were incubated with blocking
buffer (1% BSA, 0.3% Triton X-100 in PBS) overnight at 4 °C. Then, retinas were
incubated with the specific primary antibodies diluted in blocking buffer overnight
at 4 °C. Primary antibodies against the following proteins were used: pSer240/244-
S6 (Cell Signaling Technology, #2215, diluted 1:100), FOXO1 (Cell Signaling
Technology, #2880S, diluted 1:100), VE-cadherin (BD Bioscience, #555289, diluted
1:50), ERG (Abcam, #AB92513, diluted 1:400), Collagen IV (Chemicon
international, #AB756P, diluted 1:50), ICAM-2 (BD Bioscience, #553326, diluted
1:100), pS19/S20 MLC2 (Rockland Antibodies, #039600-401-416, diluted 1:100).
Retinas were washed three times in PBST and then in Pblec buffer (1% Triton X-
100, 1 mM CaCl2, 1 mM MgCl2 and 1 mM MnCl2 in PBS, pH 6.8) for 30 min at
RT. Thereafter the retinas were incubated for 2 h at RT or overnight at 4 °C in
Pblec buffer containing Alexa-conjugated secondary antibodies (diluted 1:200) and
Alexa-conjugated Isolectin GS-B4 (IB4, Invitrogen, #I21411, #I21412, I32450,
diluted 1:300), washed three times with PBST and flat-mounted on microscope
glass slides with Mowiol (Calbiochem, #475904). For F-actin staining, Alexa-Fluor
568-conjugated phalloidin (Invitrogen, #A12380, diluted 1:400) was used. The
following secondary antibodies Alexa-Fluor conjugated were used (1:300 dilution):
Alexa-Fluor 488 goat anti-rat (Invitrogen, #A11006), Alexa-Fluor 488 goat anti-
rabbit (Invitrogen, #A11008), Alexa-Fluor 568 goat anti-rabbit (Invitrogen,
#A11011), Alexa-Fluor 647 donkey anti-rabbit (Invitrogen, #A31573). The
labelling of proliferative endothelial cells with EdU was performed at P7. Pups were
injected i.p. with 60 μl of EdU (0.5 mgml−1 in PBS, Invitrogen, #C10340) 2 h
before they were sacrificed. EdU-positive cells were detected in the retinal
vasculature with the Click-iT EdU Alexa Fluor-647 Imaging Kit (Invitrogen,
#C10340).
Endothelial cells were seeded on cover-slips in six-well plates coated with 0.5%
gelatin. 24 h later, corresponding treatment was done and cells were washed once
with cold PBS (supplemented with 1 mM CaCl2 and 0.5 mM MgCl2) and fixed in
4% PFA for 15 min at RT. Cells were then washed with PBS and permeabilized in
0.1% Triton X-100 in PBS for 30 min at RT and incubated in blocking solution (3%
BSA, 5% goat serum, 0.1% Triton X-100 in PBS) for 1 h at RT. Cover-slips were
removed from the culture plate and were incubated in the appropriate dilution of
primary antibodies in blocking solution ON at 4 °C in a wet chamber. Primary
antibodies against the following proteins were used: pS19/S20 MLC2 (Rockland
Antibodies, #039600-401-416, diluted 1:100) and β-catenin (BD Bioscience
#610153, diluted 1:200). The following day, cover-slips were washed three times
with PBS at RT and incubated in the appropriate dilution of Alexa-Fluor 488 goat
anti-rabbit (Invitrogen, #A11008, diluted 1:200), Alexa-Fluor 568 goat anti-mouse
(Invitrogen, #A21236, diluted 1:200) and Alexa-Fluor 633-conjugated phalloidin
(Invitrogen, #A22287, diluted 1:400) in PBS for 2 h at RT in a wet chamber. Three
washes with PBS were performed, adding 1 μg ml–1 of 4′,6-diamidino-2-
phenylindole (DAPI; Molecular Probes, #D1306) in the last one.
Imaging analysis and quantification. All quantifications obtained from confocal
(Leica SP5) or widefield microscopes (Nikon Eclipse 80i or Nikon Eclipse TI) were
performed using Image J software (http://fiji.sc/). Zebrafish movies were analysed
with ImageJ software. Photoshop and Illustrator (Adobe) software were used for
image processing.
In the zebrafish, images were taken at ×40(NA= 1.1) water immersion
objective, maximum intensity projections were used for quantification and five
ISVs were quantified per embryo. Measurements of ISVs length were made straight
from the edge of the aorta to the leading edge of the sprout and the number of
endothelial nuclei in that length was quantified. The number of endothelial nuclei
in the DLAV and DA was quantified per segment within five ISVs. Junctional
length and junctional gaps length were measured in embryos stained for ZO-1.
Only flat-mounted embryos were selected for quantification avoiding crooked ones.
In the retina, vascular parameter were quantified in at least four images of
comparable vascular areas per retina and of at least three mice of each genotype or
experimental conditions. All images shown in the figures are maximum intensity
projections unless otherwise specified. For the quantification of retinal vessel
progression overview, widefield images of IB4-stained retinal vasculature were
obtained with the ×10 objective (Nikon Eclipse 80i microscope). The distance of
vessel growth from the centre of the optic nerve to the edge of the angiogenic front
was measured per each retina leaflet. The mean of all leaflet measurements was
obtained per retina and compared between control and mutant groups. For all
other quantifications high-resolution confocal images at ×40 oil immersion
objective was used. The number of filopodia and sprouts were quantified at the
angiogenic front. The total number of filopodia and sprouts were normalized to a
vessel length of 100 μm at the angiogenic front. Endothelial branch points, vessel
width, superimposed vascular tubes, number of junctional gaps, length of
junctional gaps, distance between nuclei, endothelial cell numbers, collagen IV
empty sleeves and lumen disconnections were quantified behind the angiogenic
front in fields sized 100 μm× 100 μm. For quantification of cell shape, single GFP-
positive cells located behind the sprouting front were only considered. Vessel
width, distance between neighbouring cells, length of junctional gaps and area of
GFP-positive cells was determined using ImageJ software with the proper scale set
up. To assess the proliferation rate, double-positive EdU/ERG endothelial nuclei
were counted in field of 200 μm× 200 μm behind the vascular sprouting front and
the total number was divided by the total number of endothelial cells (ERG-
positive nuclei). For quantification of pS20 MLC2 and F-actin immunostaining,
signal intensity within IB4 positive area in images taken with the ×40 oil immersion
objective was measured. In brief, manual threshold was set to obtain binary images
of IB4 staining. IB4-positive area was measured and defined as a region of interest
(ROI). Integrated density of pS20 MLC2 or F-actin was measured in the IB4-
positive area for each image. Then, to calculate the corrected total fluorescence
(CTF), the following formula was used: CTF= Integrated Density – (Area selected
for IB4 positivity ×Mean fluorescence of background readings). The background
readings were taken from three areas close to the vasculature but negative for IB4.
3D reconstructions were generated by using the Leica LAS-X.
In phase-contrast wound healing assays, quantification of cell migration was
made by measuring the percentage of cell-free area. Cells from the first, second and
third row were manually tracked using the Manual Tracking plugin and cell
velocity, directionality and travelled distance were calculated with the chemotaxis
tool plugin.
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In cultured endothelial cells, maximum intensity projections of confocal images
with the ×63 oil immersion objective were acquired. Signal intensity of pS20 MLC2
and F-actin immunostaining/cell was quantified using the junctional staining of β-
catenin to select individual endothelial cells (ROI A1). Using the enlarge command
two concentric areas were drawn in each cell (distance of −2.5 μm (ROI A2) and
−7.5 μm (ROI A3) from the junctional β-catenin positive staining). Integrated
density was measured. For measuring total intensity levels: area from ROIs A1 was
used as templates to measure total integrate intensity of pS20 MLC2 and F-actin
staining in individual endothelial cells. For measuring subcortical levels: Integrate
density from ROIs A2 to ROI A3 was calculated in individual endothelial cells. The
mean of the integrate density of four cells per image, and at least four images per
genotype and treatment were used for the quantification. β-catenin junctional
positive area/cell perimeter was calculated per individual cell. For that, a manual
threshold was set to obtain binary images. Then, total β-catenin area—β-catenin
nuclear area in individual cells was calculated to obtain β-catenin junctional
positive area. Junctional staining of β-catenin was used to measure the perimeter of
individual cells. At least four cells per image and four images per genotype were
used for the quantification. To measure the type of junctional coverage, percentage
of junctional pattern was considered. ≥60% serrated pattern/cell= serrated, ≥ 60%
of straight junctional pattern/cell= straight, ≈50% of each pattern/cell=mixed.
Five cells per image and at least five images per genotype were used for the
quantification.
Mass spectrometry. Primary endothelial cells were washed twice with cold PBS
supplemented with 1 mM Na3VO4 and 1 mM NaF and lysed with 300 µl of urea
buffer (8 M Urea in 20 mM in HEPES pH 8.0 supplemented with 1 mM Na3VO4, 1
mM NaF, 1 mM Na4P2O7 and 1 mM sodium β-glycerophosphate) for 30 min. All
mass spectrometry solvents were prepared in LC-MS grade water (LGC Pro-
mochem, #SO-9368-B025). We used published methods for phosphoproteome
analyses32,65,66. In brief, 250 µg of protein were reduced and alkylated by sequential
incubation with 10 mM DTT and 16.6 mM iodoacetamide for 1 h. Urea con-
centration was diluted to 2M with 20 mM HEPES (pH 8.0), and 80 µl of trypsin
beads (50% slurry of TLCK-trypsin (Thermo-Fisher Scientific, #20230)) pre-
conditioned with three washes of 20 mM HEPES (pH 8.0) were added to the
samples, followed by incubating the tubes for 16 h at 37 °C with agitation. Trypsin
beads were removed by centrifugation at 2000 × g for 5 min at 5 °C. Following
trypsin digestion, peptide solutions were desalted using 10 mg OASIS-HLB car-
tridges (Waters, #186000383). Briefly, OASIS cartridges were accommodated in a
vacuum manifold (−5 mmHg), activated with 1 ml ACN (LGC Promochem, #SO-
9340-B025) and equilibrated with 1.5 ml of washing solution (1% ACN, 0.1% TFA
(LGC Promochem, #SO-9668-B001)). After loading the samples, cartridges were
washed with 1 ml of washing solution. Phosphopeptides were eluted with 500 µl of
glycolic acid buffer 1 (1 M glycolic acid (Acros Organics, #154515000), 50% ACN,
5% TFA) and subjected to phosphoenrichment. Phosphopeptides were enriched
using TiO2 (GL Sciences, #5020-75010). Sample volumes were normalized to 1 ml
using glycolic acid buffer 2 (1M glycolic acid, 80% ACN, 5% TFA), 50 µl of TiO2
beads (50% slurry in 1% TFA) were added to the peptide mixture, incubated for 5
min at RT with agitation and centrifuged for 30 s at 1500 × g. For each sample, 80%
of the supernatant was transferred to fresh tubes and stored in ice and the
remaining 20% used to resuspend the bead pellets that were loaded into an empty
prewashed PE-filtered spin-tips (Glygen, #TF2EMT.96) and packed by cen-
trifugation at 1500 × g for 3 min. After loading the remaining volume of the
supernatant by centrifugation at 1500 × g for 3 min, spin tips were sequentially
washed with 100 µl of glycolic acid buffer 2, ammonium acetate buffer (100 mM
ammonium acetate in 25% ACN) and 10% ACN by RT centrifugation for 3 min at
1500 × g. For phosphopeptide recovery, additional 50 µl of 5% ammonia solution
(LGC Promochem, HPA-0070-B010) followed by centrifugation for 5 min at
1500 × g was repeated four times. Eluents were snap frozen in dry ice, dried in a
speed vac (RVC 2-25, Martin Christ Gefriertrocknungsanlagen GmbH, Osterode
am Harz, Germany) and peptide pellets stored at −80 °C. Peptide pellets were
resuspended in 12 µl of reconstitution buffer (20 fmol/µl enolase (Waters,
#186002325) in 3% ACN, 0.1% TFA) and 5 µl were loaded onto an LC-MS/MS
system consisting of a Dionex UltiMate 3000 RSLC directly coupled to an Orbitrap
Q-Exactive Plus mass spectrometer (Thermo Fisher Scientific). Peptides were
trapped in a μ-pre-column (Acclaim PepMap 100, Themo Fisher Scientific,
#160454) and separated in an analytical column (Acclaim PepMap 100, Thermo
Fisher Scientific, #164569) using A (3% ACN, 0.1% FA (Thermo Fisher Scientific, #
F-1850-PB08)) and B (100% ACN, 0.1% FA) solutions as mobile phases. The
following parameters were used: 3−23% B gradient for 120 min and a flow rate of
0.3 µl min−1. As they eluted from the nano-LC system, peptides were infused into
the online connected Q-Exactive Plus system operating with a 2.1 s duty cycle.
Acquisition of full scan survey spectra (m/z 375−1500) with a 70,000 FWHM
resolution was followed by data-dependent acquisition in which the 20 most
intense ions were selected for HCD (higher energy collisional dissociation) and
MS/MS scanning (200−2000 m/z) with a resolution of 17,500 FWHM. A 30 s
dynamic exclusion period was enabled with an exclusion list with 10 ppm mass
window. Overall duty cycle generated chromatographic peaks of approximately 30
s at the base, which allowed the construction of extracted ion chromatograms
(XICs) with at least ten data points.
Peptide identification and quantification. Mascot Daemon 2.5.0 was used to
automate peptide identification from MS data. Peak list files (MGFs) from RAW
data were generated with Mascot Distiller v2.5.1.0 and searched into the Mascot
search engine (v2.5) in order to match MS/MS data to theoretical peptide frag-
mentation data67. The searches were performed against the SwissProt Database
(uniprot_sprot_2014_08.fasta) with an FDR of 1% (specific FDR for each phos-
phopeptide identification is included in Supplementary Data 1). A maximum of 2
trypsin missed cleavages and a mass tolerance of ±10 ppm for the MS scans and ±
25 mmu for the MS/MS scans were allowed. Carbamidomethyl Cys as fixed
modification, and phosphorylation at Ser, Thr, and Tyr, PyroGlu on N-terminal Gln
and oxidation of Met as variable modifications were considered. The accuracy of
phosphosite location within the identified peptides was assessed using delta score
values as described by Savitski et al.68. Delta scores for each phosphopeptide are
reported in Supplementary Data 1. In-house developed software (Pescal) was used
for label-free peptide quantification69. Pescal constructs extracted ion chromato-
grams (XIC) for each identified peptide and measures the area of the XICs for all the
peptides identified across all samples. Thresholds for XIC generation were ±7 ppm
and ±2min m/z and retention time windows, respectively and undetectable peptides
were given an intensity value of 0. Values of two technical replicates per sample
were averaged and intensity values for each peptide were normalized to total sample
intensity. Normalized quantitative data were used to calculate fold changes between
groups and statistical significance (assessed by Student’s t test) when necessary. The
construction of volcano plots and heatmaps was automated with a script generated
in R software using the ggplot package. Venn diagrams were constructed using the
software Venny (v2.1, http://bioinfogp.cnb.csic.es/tools/venny).
Statistics. Data were analysed using GraphPad Prism software and were presented
as mean ± SEM (error bars). Sample size and experimental replicates were indi-
cated in figure legends. Statistical analysis was performed by the nonparametric
Mann−Whitney’s test or the parametric Student’s t test. ns not significant; *P <
0.05; **P < 0.01; ***P < 0.001; and ****P < 0.001 were considered statistically
significant.
Code availability. The mass spectrometry data is deposited in the PRIDE repo-
sitory (www.ebi.ac.uk/pride/archive/) with the dataset identifier PXD007060. The
codes used for analysing the mass spectrometry data are annotated in Supple-
mentary Table 2.
Reporting Summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The mass spectrometry data that support the findings of this study have been
deposited and are publicly available at the ProteomeXchange Consortium via the
PRIDE70 partner repository (www.ebi.ac.uk/pride/archive/) with the dataset iden-
tifier PXD007060. The rest of the data and materials generated within this study are
available from the corresponding author upon request. A reporting summary for
this article is available as a Supplementary Information file.
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Endothelial cell rearrangements during vascular patterning require 
PI3-kinase-mediated inhibition of actomyosin contractility
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Supplementary Figure 1. Inactivation of PI3Kα impairs collective cell migration. (a) Representative phase contrast 
images of primary mouse endothelial cells isolated from control (top) and Pik3caKD/i∆EC (bottom) mice immediately after 
performing the scratch, and 12 h and 24 h later. Cells were treated with 4-OHT for 96 h before performing the scratch. 
(b) Representative phase contrast images of vehicle (DMSO, top) and GDC-0326 (1 µM, bottom) -treated HUVECs 
immediately after performing the scratch, and 4 h and 12 h later. Cells were treated with DMSO or GDC-0326 for 24 h 
before performing the scratch. Green dashed lines highlight open scratch-area in a and b. (c, d) Quantification of wound 
closure area at the indicated time-points after the scratch. n≥ 20 scratch areas per condition from three independent 
experiments in c, and n≥ 15 scratch areas per treatment from two independent experiments in d. (e, f) Plots depicting 
cell migration of control and Pik3caKD/i∆EC primary mouse endothelial cells during 20 h in a wound healing assay (e), and 
during 8 h in vehicle and GDC-0326 treated HUVECs (f). X and Y axis in the plots represent distance in µm. (g, h) Mean 
velocity directionality and travelled distance of individual cells measured during 20 h in g and 8 h in h after performing 
the scratch. n≥ 55 cells per condition from three independent experiments in g, and n≥ 104 cells per treatment from three 
independent experiments in h. Scale bars, 100 µm (a, b). Data in c, d, g, and h represent mean ± S.E.M. (error bars). 
*P<0.05, **P<0.01, ***P<0.001, and ****P<0.0001. Statistical analysis was performed with the two-sided Mann–Whitney 
test.
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Supplementary Figure 2. Inactivation of PI3Kα in zebrafish embryos. (a) Wild type sibling zebrafish embryos were 
treated with vehicle (DMSO) or GDC-0326 (50 µM) at 22 hpf for 2 h, 4 h and 8 h followed by immunoblotting with the 
indicated antibodies. (b) Representative images of vehicle and GDC-0326 (50 µM) treated Tg(kdrl:EGFP)s843 zebrafish 
embryos from 22 to 32 hpf. DA refers to dorsal aorta, PCV refers to posterior cardinal vein, ISV refers to intersomitic ves-
sels, and DLAV refers to dorsal longitudinal anastomotic vessels. (c) Representative images of vehicle and GDC-0326 
(50 µM) treated Tg(kdrl:EGFP-nls)ubs1/(kdrl:mCherry-CAAX)s916 transgenic embryos from 22 to 27 hpf (upper panel) or to 
38 hpf (lower panel). ISV length (white punctuated lines) and nucleus number per ISV measurements are exemplified. 
Numbers indicate endothelial cell nuclei. (d) Quantitative analysis of vessel length and number of endothelial cells per 
ISV in zebrafish embryos shown in c (n≥ 52 ISVs per treatment). (e) Quantitative analysis of ISV length from the ISVs 
that have reached the top roof and started to form the DLAV at 38 hpf. Scale bars, 30 µm (b, c). Data in d and e rep-
resent mean ± S.E.M. (error bars). **P<0.01 and ****P<0.0001. Statistical analysis was performed with the two-sided 
Mann–Whitney test.
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Supplementary Figure 3. Inactivation of PI3Kα in the mouse retinas. (a) Control and Pik3cai∆EC/i∆EC mouse lung en-
dothelial cells were incubated with 4-OHT for 24 h, 48 h, 72 h or 96 h, followed by immunoblotting using the indicated 
antibodies. (b) Representative images of pS6 240/242 (red) and IB4 (green)-stained P7 retinas of control and Pik3caKD/
i∆EC genotypes. (c) Confocal images of FOXO1 (cyan) and IB4 (red)-stained P7 retinas of control and Pik3caKD/i∆EC gen-
otypes. Scale bars, 30 µm (b, c).
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Supplementary Figure 4. Endothelial inactivation of PI3Kα leads to abnormal vessel growth. (a) Whole mount vi-
sualization of blood vessels by IB4 staining of P7 retinas from control, Pik3caKD/flox , Pik3ca∆EC/i∆EC and Pik3caKD/i∆EC mouse 
littermates injected with 4-OHT at P1 and P2. Bars to the right show quantification of radial expansion of the vascular 
plexus in P7 retinas of respective genotypes. n≥ 4 retinas per genotype. (b) Whole mount visualization of blood vessels 
by IB4 staining of P10 retinas from control, Pik3caKD/flox, Pik3ca∆EC/i∆EC, and Pik3caKD/i∆EC mouse littermates injected with 
4-OHT at P1 and P2. Bars to the right show quantification of the radial expansion of the vascular plexus in P10 retinas 
of respective genotypes. n≥ 3 retinas per genotype. (c) Whole mount visualization of blood vessels by IB4 staining of 
control and Pik3caKD/i∆EC retinas at P7. (d) Quantitative analysis of number of sprouts (n≥ 13 retinas per genotype) and 
filopodial extensions (n≥ 9 retinas per genotype) of images shown in c. (e, f) Representative images corresponding to 
the top, middle and bottom layer of control and Pik3caKD/i∆EC P7 (e) and P10 (f) retinas visualized by IB4 staining. The 
same number and width of Z-stacks was taken per retina of each genotype. Scale bars, 150 µm (a), 200 µm (b), 50 
µm (c), 20 µm (e, f). Data in a, b, and d represent mean ± S.E.M. (error bars). *P<0.05, **P<0.01, ***P<0.001, and 
****P<0.0001. Statistical analysis was performed with the two-sided Mann–Whitney test.
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Supplementary Figure 5. Reduced proliferation does not interfere with junctional pattern in postnatal retinas. 
(a) EdU (green), ERG (red) and IB4 (blue) staining of control and Pik3caKD/i∆EC P7 retinas. (b) Quantification of EdU-pos-
itive endothelial cells per total number of endothelial cells in control and Pik3caKD/i∆EC P7 retinas (n≥4 retinas per gen-
otype). (c) EdU (green), ERG (red) and IB4 (blue) staining of whole mount retinas from wild type mouse littermates 
treated with vehicle (DMSO) or mitomycin C at P5, and isolated at P7. (d) Quantification of endothelial cells per unit 
area assessed by ERG positivity (left panel) and of EdU positive endothelial cells per total number of endothelial cells 
(n≥ 4 retinas per treatment). (e) Representative images of whole mount retinas stained for VE-cadherin (green), ERG 
(red) and IB4 (blue) from wild type mouse littermates treated with vehicle or mitomycin C at P5 and isolated at P7. (f) 
Quantification of branch points, vessel width, and number of junctional gaps per unit area of images shown in e (n≥ 6 
retinas per treatment). Scale bars, 20 µm (a, e), 140 µm (c). Data in d, f represent mean ± S.E.M. (error bars). ns: not 
significant,*P<0.05, **P<0.01. Statistical analysis was performed with the two-sided Mann–Whitney test.
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Supplementary Figure 6. Reduced proliferation does not interfere with junctional pattern in zebrafish embryos. 
(a) Images of vehicle and HU/APH-treated Tg(kdrl:EGFP-nls)ubs1/(kdrl:mCherry-CAAX)s916 transgenic embryos from 26 
hpf + 4 h (treatment) (upper panel) or to 26 hpf  + 12 h treatment (lower panel). ISV length (white punctuated lines) 
and nucleus number per ISV measurements are exemplified. Number indicates endothelial cell nuclei. (b) Analysis of 
number of endothelial cells per ISV, DLAV and dorsal aorta (within 5 ISVs) in vehicle and HU/APH-treated zebrafish 
embryos (n=11 embryos per treatment, 5 ISVs per embryo, three independent experiments). (c) Analysis of ISV length 
(n≥42 ISVs per treatment, from 11-12 embryos analyzed from three independent experiments) in vehicle and HU/
APH-treated zebrafish embryos. (d) Lateral views of intersomitic vessels (ISV) in vehicle or HU/APH treated transgenic 
Tg(fli1ep:mCherry-nls)ubs10 (shown in red) embryos stained for ZO-1 (green) at 33-34 hpf. Single ZO-1 staining is shown 
in row 1. White lines indicate ZO-1 negative staining (junctional gaps); white punctuate lines indicate elongation of junc-
tion. (e) Quantification of the length of the ISVs with continuous ZO-1 staining (n≥42  ISVs per treatment, from 11-12 
embryos analyzed from three independent experiments). (f) Quantification of the length of the dorsal part of the ISVs 
without ZO-1 (length of junctional gaps) (ISVs without junctional gaps were excluded, n≥15  ISVs per treatment, from 
11-12 embryos analyzed from three independent experiments). (g) Average number of gaps per ISV in vehicle and HU/
APH-treated embryos (n=11 embryos per treatment, 5 ISVs per embryo, three independent experiments). Scale bars, 
30 µm (a, d). Data in b, c, e, f and g represent mean ± S.E.M. (error bars). ns: not significant, **P<0.01, ***P<0.001, 
****P<0.0001. Statistical analysis was performed with the two-sided Mann–Whitney test.
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Supplementary Figure 7. Aberrant shape and lumen formation in Pik3caKD/I∆EC endothelium. (a) Overview of im-
munostaining of single-cell labelling using Cre-induced expression of membrane-bound GFP (mGFP, shown in green in 
the image), endothelial nuclei (ERG, shown in red) and blood vessel (IB4, shown in blue).  (b) Control and Pik3caKD/i∆EC 
P7 retinas showing ICAM2 (green), ERG (red), and IB4 (blue). Yellow asterisks indicate IB4 positive/ICAM2 negative 
protrusions. (c) Quantification of ICAM2 negative vessels per unit area of images shown in b (n=4 retinas per genotype). 
Scale bars, 100 µm (a), 40 µm (b, upper panel), 10 µm (b, lower panel). Data represent mean ± S.E.M. (error bars). 
*P<0.05. Statistical analysis was performed with the two-sided Mann–Whitney test.
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Supplementary Figure 8. Analysis of phosphoproteomic screening. (a) Schematic representation of the expected 
impact of inhibition of PI3Kα signalling on pS20 MLC2 and actomyosin contractility. MLCP is a trimeric heteroenzyme 
(PP1 catalytic subunit, MYPT1 regulatory subunit, and M20 subunit) that inactivates non-muscle myosin II by the de-
phosphorylation of MLC2. We observed that inhibition of PI3Kα results in phosphorylation of MYPT1 on the S445 resi-
due favouring the delocalization of the MLCP complex from its substrate leading to an increase in the phosphorylation of 
MLC2 on S20, and as result, an increase in actomyosin contractility. Designed by Piotr Kobialka and Mariona Graupera. 
(b, c) Quantification of the relative immunoreactivity of pS445 MYPT1 normalized to total MYPT1 (b) and of pS473 AKT 
normalized to total AKT (c) from western blots shown in Fig. 4e and represented as the mean of at least three indepen-
dent experiments. Data represent mean ± S.E.M. (error bars). *P<0.05, **P<0.01, and  ****P<0.0001. Statistical analysis 
was performed by the two-sided Student´s t test.
Supplementary Figure 8
Supplementary Figure 9. Impact of inactivation of PI3Kα on pS20 MLC2 and its localization in endothelial cells. 
(a) Control and Pik3caKD/i∆EC endothelial cells treated  with 4-OHT for 96 h, followed by immunoblotting using the indicat-
ed antibodies. Quantification of pS20 MLC2 is shown to the right (n=5 independent experiments). (b) Wild type mouse 
lung endothelial cells were incubated with vehicle (DMSO) or GDC-0326 (1 µm) for 48 h followed by immunoblotting 
using the indicated antibodies. Quantification of pS20 MLC2 is shown to the right (n=4 independent experiments). (c, 
d) Quantification of pS20 MLC2 (c) and F-actin (d) immunostaining intensity at the subcortical location (shown as inte-
grated density) of control and Pik3caKD/i∆EC endothelial cells treated with 4-OHT for 96 h (n≥5 independent experiments). 
Data in a, b, c and d represent mean ± S.E.M. (error bars). *P<0.05 and **P<0.01. Statistical analysis was performed 
with the two-sided Mann–Whitney test.
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This figure continues in the next page.
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Supplementary Figure 10. Inactivation of ROCK does not restore the endothelial phenotypes imposed by PI3Kα 
inactivation. (a) Assessment of pS20 MLC2 (green), F-actin (red), and β-catenin (blue) of control and Pik3caKD/i∆EC 
endothelial cells treated with 4-OHT for 96 h and incubated with DMSO as control or 10 µM Y-27632 (ROCK inhibitor; 
ROCKi) for 10 or 30 min. (b) Subcortical quantification of pS20 MLC2 (left panel) and F-actin (right panel) immunostain-
ing intensities (shown as integrated density) of images shown in a. (n≥ 28 images of at least three independent exper-
iments). (c) High magnification confocal images of Pik3caKD/i∆EC P7 retinas treated with DMSO or WZ4003 (NUAKi) at 
P6. (d) IB4-stained control and Pik3caKD/i∆EC P7 retinas treated with DMSO or Y-27632 (ROCKi) at P6 and P7 (10 am). 
(e) Quantification of branch points per unit area and vessel width per unit area (n≥5 retinas per genotype and treatment). 
(f) High magnification confocal images of Pik3caKD/i∆EC P7 retinas treated with DMSO or Y-27632. Scale bars, 15 µm (a), 
20 µm (c), 100 µm (d), 20 µm (f). Data in b and e represent mean ± S.E.M. (error bars). ns: not significant, *P<0.05, 
**P<0.01, ***P<0.001, and ****P<0.0001. Statistical analysis was performed with the two-sided Mann–Whitney test.
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Supplementary Figure 11. Uncropped western blots. (a) Blots related to Supplementary Figure 2a. Left panels show 
the merge with the molecular markers and the right panels show the boxes indicating the cropped sections used in the 
corresponding figures. (b) Blots related to Supplementary Figure 3a. Boxes indicate the cropped sections used in the 
corresponding figures. 
Of note, for some immunoblotting assays membranes were cut into several pieces to incubate with different antibodies.
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Supplementary Figure 12. Uncropped western blots. Blots related to Figure 4e. Left panels show the merge with 
the molecular markers and the right panels show the boxes indicating the cropped sections used in the corresponding 
figures. Of note, for some immunoblotting assays membranes were cut into several pieces to incubate with different 
antibodies.
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Supplementary Figure 13. Uncropped western blots. (a) Blots related to Figure 5a. (b) Blots related to Figure 5b. (c) 
Blots related to Supplementary Figure 9a. (d) Blots related to Supplementary Figure 9b. Left panels show the merge 
with the molecular markers and the right panels show the boxes indicating the cropped sections used in the correspond-
ing figures. Of note, for some immunoblotting assays membranes were cut into several pieces to incubate with different 
antibodies.
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Supplementary Table 1. Summary of genetic models use to study Pik3ca inactivation
Mouse model
Name after 
4-OHT treatment
Description
 Pik3caflox/flox Control Control. No Cre recombinase expression
 Pik3caKD/flox Pik3caKD/flox
Heterozygous kinase dead (KD). One Pik3ca alelle expresses 
constitutively a kinase dead form of the PI3Kα protein. Half of the 
PI3Kα protein is inactive. 
 Pdgfb-iCreER Pik3caflox/flox Pik3cai∆EC/i∆EC
Endothelial specific knockout mouse (KO). Endothelial specific 
deletion of both Pi3kca alleles after 4-HOT administration 
 Pdgfb-iCreER Pik3caKD/flox Pik3caKD/i∆EC
Kinase dead allele and endothelial specific knockout allele. One 
Pik3ca allele expresses constitutively a kinase dead form of the 
PI3Kα protein and the other is deleted after 4-OHT administra-
tion. Main model of study in this manuscript.
Supplementary Table 2. Codes used for the analysis of the mass spectrometry data.
Sample Name Animal ID Genotype Treatment Replicate
R_b1822p5_S10_SF622_24h_ETH_Phos_R1.raw SF622 Control 24h ethanol 1
R_b1822p5_S10_SF622_24h_ETH_Phos_R2.raw SF622 Control 24h ethanol 2
R_b1822p5_S11_SF622_24h_4HTA_Phos_R1.raw SF622 Control 24h 4OHT 1
R_b1822p5_S11_SF622_24h_4HTA_Phos_R2.raw SF622 Control 24h 4OHT 2
R_b1822p5_S12_SF622_96h_4HTA_Phos_R1.raw SF622 Control 96h 4OHT 1
R_b1822p5_S12_SF622_96h_4HTA_Phos_R2.raw SF622 Control 96h 4OHT 2
R_b1822p5_S13_SF602_24h_ETH_Phos_R1.raw SF602 Control 24h ethanol 1
R_b1822p5_S13_SF602_24h_ETH_Phos_R2.raw SF602 Control 24h ethanol 2
R_b1822p5_S14_SF602_24h_4HTA_Phos_R1.raw SF602 Control 24h 4OHT 1
R_b1822p5_S14_SF602_24h_4HTA_Phos_R2.raw SF602 Control 24h 4OHT 2
R_b1822p5_S15_SF602_96h_4HTA_Phos_R1.raw SF602 Control 96h 4OHT 1
R_b1822p5_S15_SF602_96h_4HTA_Phos_R2.raw SF602 Control 96h 4OHT 2
R_b1822p5_S16_SF603_24h_ETH_Phos_R1.raw SF603 Control 24h ethanol 1
R_b1822p5_S16_SF603_24h_ETH_Phos_R2.raw SF603 Control 24h ethanol 2
R_b1822p5_S17_SF603_24h_4HTA_Phos_R1.raw SF603 Control 24h 4OHT 1
R_b1822p5_S17_SF603_24h_4HTA_Phos_R2.raw SF603 Control 24h 4OHT 2
R_b1822p5_S18_SF603_96h_4HTA_Phos_R1.raw SF603 Control 96h 4OHT 1
R_b1822p5_S18_SF603_96h_4HTA_Phos_R2.raw SF603 Control 96h 4OHT 2
R_b1822p5_S19_SF604_24h_ETH_Phos_R1.raw SF604 Pik3CAKD/Flox 24h ethanol 1
R_b1822p5_S19_SF604_24h_ETH_Phos_R2.raw SF604 Pik3CAKD/Flox 24h ethanol 2
R_b1822p5_S1_SF619_24h_ETH_Phos_R1.raw SF604 Pik3CAKD/Flox 24h ethanol 1
R_b1822p5_S1_SF619_24h_ETH_Phos_R2.raw SF604 Pik3CAKD/Flox 24h ethanol 2
R_b1822p5_S20_SF604_24h_4HTA_Phos_R1.raw SF604 Pik3CAKD/Flox 24h 4OHT 1
R_b1822p5_S20_SF604_24h_4HTA_Phos_R2.raw SF604 Pik3CAKD/Flox 24h 4OHT 2
R_b1822p5_S21_SF604_96h_4HTA_Phos_R1.raw SF604 Pik3CAKD/Flox 96h 4OHT 1
R_b1822p5_S21_SF604_96h_4HTA_Phos_R2.raw SF604 Pik3CAKD/Flox 96h 4OHT 2
R_b1822p5_S22_SF607_24h_ETH_Phos_R1.raw SF607 Pik3CAKD/Flox 24h ethanol 1
R_b1822p5_S22_SF607_24h_ETH_Phos_R2.raw SF607 Pik3CAKD/Flox 24h ethanol 2
R_b1822p5_S23_SF607_24h_4HTA_Phos_R1.raw SF607 Pik3CAKD/Flox 24h 4OHT 1
R_b1822p5_S23_SF607_24h_4HTA_Phos_R2.raw SF607 Pik3CAKD/Flox 24h 4OHT 2
R_b1822p5_S24_SF607_96h_4HTA_Phos_R1.raw SF607 Pik3CAKD/Flox 96h 4OHT 1
R_b1822p5_S24_SF607_96h_4HTA_Phos_R2.raw SF607 Pik3CAKD/Flox 96h 4OHT 2
R_b1822p5_S2_SF619_24h_4HTA_Phos_R1.raw SF619 Pik3CAKD/Flox 24h 4OHT 1
R_b1822p5_S2_SF619_24h_4HTA_Phos_R2.raw SF619 Pik3CAKD/Flox 24h 4OHT 2
R_b1822p5_S3_SF619_96h_4HTA_Phos_R1.raw SF619 Pik3CAKD/Flox 96h 4OHT 1
R_b1822p5_S3_SF619_96h_4HTA_Phos_R2.raw SF619 Pik3CAKD/Flox 96h 4OHT 2
R_b1822p5_S4_SF624_24h_ETH_Phos_R1.raw SF624 Control 24h ethanol 1
R_b1822p5_S4_SF624_24h_ETH_Phos_R2.raw SF624 Control 24h ethanol 2
R_b1822p5_S5_SF624_24h_4HTA_Phos_R1.raw SF624 Control 24h 4OHT 1
R_b1822p5_S5_SF624_24h_4HTA_Phos_R2.raw SF624 Control 24h 4OHT 2
R_b1822p5_S6_SF624_96h_4HTA_Phos_R1.raw SF624 Control 96h 4OHT 1
R_b1822p5_S6_SF624_96h_4HTA_Phos_R2.raw SF624 Control 96h 4OHT 2
R_b1822p5_S7_SF621_24h_ETH_Phos_R1.raw SF621 Pik3CAKD/Flox 24h ethanol 1
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Junction-based lamellipodia drive endothelial cell rearrangements in vivo 
via a VE-cadherin-F-actin based oscillatory cell-cell interaction. 
 
Summary: 
Paatero et al. describe a novel mechanism, in which endothelial cells use junction-based 
lamellipodia (JBL) for cellular rearrangement and concomitant cell elongation. JBL are 
characterized as F-actin dependent structures emanating from cell junctions in the 
direction of movements. They show an oscillatory behavior and are highly dependent on 
VE-cadherin and its interaction with the actin cytoskeleton. They hypothesize, that JBL 
provide the physical means for cell rearrangements and that it might be a general 
mechanism of endothelial cells employed during vascular remodeling.   
 
My contribution: 
For this publication, I was experimentally analyzing the role of Rac1 during junctional 
rearrangements. Prior to imaging, I treated embryos transgenically expressing EGFP-ZO1 
with a Rac1 inhibitor (NSC23766) or DMSO and performed high resolution time-lapse 
imaging during the process of junctional ring elongation. Analysis proved the formation of 
double junctions to be a hallmark during the JBL cycle and provided the basis for 
experiments performed in this thesis. The results obtained are integrated in the manuscript 
in Figure 6 e and are also part of my thesis (depicted in Figure 26). Additionally, I was 
extensively involved in proof-reading and giving suggestions for improvements until final 
submission of the manuscript. 
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Junction-based lamellipodia drive endothelial cell
rearrangements in vivo via a VE-cadherin-F-actin
based oscillatory cell-cell interaction
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Angiogenesis and vascular remodeling are driven by extensive endothelial cell movements.
Here, we present in vivo evidence that endothelial cell movements are associated with
oscillating lamellipodia-like structures, which emerge from cell junctions in the direction of
cell movements. High-resolution time-lapse imaging of these junction-based lamellipodia
(JBL) shows dynamic and distinct deployment of junctional proteins, such as F-actin, VE-
cadherin and ZO1, during JBL oscillations. Upon initiation, F-actin and VE-cadherin are broadly
distributed within JBL, whereas ZO1 remains at cell junctions. Subsequently, a new junction is
formed at the front of the JBL, which then merges with the proximal junction. Rac1 inhibition
interferes with JBL oscillations and disrupts cell elongation—similar to a truncation in ve-
cadherin preventing VE-cad/F-actin interaction. Taken together, our observations suggest an
oscillating ratchet-like mechanism, which is used by endothelial cells to move over each other
and thus provides the physical means for cell rearrangements.
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Organ morphogenesis is driven by a wealth of tightlyorchestrated cellular behaviors, which ensure properorgan assembly and function. The cardiovascular system
is one of the most ramified vertebrate organs and is characterized
by an extraordinary plasticity. It forms during early embryonic
development, and it expands and remodels to adapt to the needs
of the growing embryo. In adult life, this plasticity allows flexible
responses, for example, during inflammation and wound
healing1,2.
At the cellular level, blood vessel morphogenesis and remo-
deling are accomplished by endothelial cell behaviors including
cell migration, cell rearrangement and cell shape changes3–5. This
repertoire of dynamic behaviors allows endothelial cells to rapidly
respond to different contextual cues, for example during angio-
genic sprouting, anastomosis, diapedesis or regeneration. In
particular, it has been shown that endothelial cells are very motile,
not only during sprouting, but also within established vessels,
where they migrate against the blood flow6,7.
Endothelial cell migration has been extensively studied in dif-
ferent in vivo and in vitro systems mainly focusing on angiogenic
tip cell behavior and the interaction of endothelial cells with the
extracellular matrix (ECM)8,9. However, endothelial cells can also
shuffle positions within an angiogenic sprout10, and these cellular
rearrangements require the junctional adhesion protein VE-cad-
herin/CDH511–13. Moreover, in vivo analyses in avian and fish
embryos have shown that endothelial cells can migrate within
patent blood vessels emphasizing that regulation of endothelial
cell adhesion and motility is critical during vascular remodeling
processes6,7,14,15.
Although many aspects of sprouting angiogenesis and vascular
remodeling rely on endothelial cell interactions3, the exact role of
endothelial cell junctions (and in particular that of VE-cad) in these
processes is not well understood. Indeed, rather than supporting an
active function for VE-cad in dynamic cell behaviors, most studies
point to a restrictive or permissive role, consistent with the main-
tenance of endothelial integrity16–18. On the other hand, the
observation that loss of VE-cad function can inhibit cell rearran-
gements suggests an active contribution to this process12,13.
To decipher the cellular and molecular mechanisms, which
enable cells to move within the endothelium, we have focused on
the process of anastomosis during the formation of the dorsal
longitudinal anastomotic vessel (DLAV) in the zebrafish embryo
by high-resolution time-lapse microscopy. This process occurs in a
relatively stereotypical manner and involves a convergence
movement of endothelial cells, which is illustrated by extensive cell
junction elongation19. Ultimately, this process alters tube archi-
tecture and converts unicellular vessels to multicellular vessels20.
By in vivo time-lapse imaging of several junctional components
and pharmacological interference with F-actin dynamics, we are
able to describe a actin-based mechanism, which allows endo-
thelial cells to move along each other while maintaining junctional
integrity. In particular, we describe a rearrangement mechanism,
which is initiated by junction-based lamellipodia (JBL) leading to
the formation of distal, VE-cad based attachment sites, which in
turn serve as an anchor point for junction elongation. We propose
that the oscillating behavior of JBL, which depends on F-actin
polymerization as well as contractility, provides a general
mechanism of endothelial cell movement during blood vessel
formation and vascular remodeling.
Results
Changes of vessel architecture during blood vessel formation.
Blood vessel formation is associated with prominent cell shape
changes and cell rearrangements. The DLAV presents a well-
defined in vivo model to analyze how a wide repertoire of
endothelial cell activities leads to the formation of a new blood
vessel, starting with establishment of an interendothelial contact
point, followed by the formation of a continuous luminal surface
and the transformation from a unicellular to a multicellular
tubular architecture. Unicellular and multicellular tubes are easily
discerned by junctional patterns, whereas unicellular tubes dis-
play isolated rings separated by segments without any junction,
multicellular tubes have a continuous network of multiple junc-
tions along their longitudinal axis (Fig. 1a). To gain more insight
into this transformation process, we used a reporter line
expressing a full-length VE-cadherin fluorescent protein fusion
(VE-cad-Venus)21 (Fig. 1b–e, Supplementary Movie 1) and per-
formed in vivo time-lapse experiments between 27 and 40 h post
fertilization (hpf). These experiments showed that most DLAVs
were initially unicellular tubes, and that the majority (69%, n= 26
(8 embryos)) of DLAV segments were transformed to a multi-
cellular configuration before 40 hpf (Fig. 1b–e, Supplementary
Fig. 1a). The transformation from the initial tip cell contact to a
multicellular vessel, with a continuous cell–cell junction network,
took several hours (median 190 min, segments n= 14
(8 embryos), Supplementary Fig.1b), with high variability
between individual segments. During this time window, the
endothelial cell–cell junctions expanded extensively from initial
spot-like structures to elongated junctions covering the entire
DLAV segment. However, movement of the junctions was also
seen in perfused vessels (Supplementary Fig. 1c). The cellular
rearrangements are thus occurring both in nascent non-
lumenized vessels and also in inflated, perfused vessels.
The thickness of remodeling junctions is polarized. When we
analyzed ring-shaped junctions in the DLAV of VE-cad-Venus
embryos in more detail, we observed that the junctions were not
uniform in thickness along their circumference in unicellular
vessels. In medial regions, the junctions formed significantly
thicker, and more diffuse, pattern than on the lateral sides
(Fig. 1f, j), coinciding with the general direction of endothelial cell
movements during anastomosis. In contrast, we did not observe
such junctional polarity in multicellular vessels (Fig. 1j). We
confirmed these observations by immunostainings for the junc-
tional proteins VE-cadherin and ZO1, which showed that in the
newly formed junctions in unicellular configuration, the medial
junctional domains were consistently thicker than the lateral
domains (Fig. 1g–i, k). Again, this polarity of junctional thickness
was not seen in vessel areas of more mature multicellular archi-
tecture (Fig. 1k).
Remodeling junctions form junction-based lamellipodia. To
gain insight into the nature of this junctional polarity, we per-
formed live-imaging experiments on Cdh5-Venus expressing
transgenic embryos at high temporal resolution. Here, we
observed that the polarized junctional thickenings are formed by
dynamic lamellipodia-like protrusions (Fig. 2a, b, Supplementary
Movie 2). In addition, we used a F-actin visualizing EGFP-UCHD
transgenic fish line in a similar setup (Fig. 2c, d, Supplementary
Movie 3). Remarkably, F-actin and VE-cadherin, both showed
similar oscillatory dynamics with a median duration of 6 min
(Fig. 2e). Moreover, the protrusions were oriented along the
vessel axis (Fig. 2f), which is consistent with the increased junc-
tional thickness of medial junctional domains.
To test whether this dynamic junctional behavior is restricted
to the process of anastomosis or is a more general behavior, we
further analyzed the F-actin fluctuations during junctional
remodeling in the dorsal aorta. Here, we found that the relative
intensity of EGFP-UCHD was increased at the site of forming
protrusions (Fig. 3a, b, Supplementary Movie 4), indicating
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recruitment of additional F-actin. We further analyzed the
dynamic behavior of junctional F-actin using kymographs
(Fig. 3c, d) and found that the fluctuations in intensity occurred
in rather rhythmic patterns, and at the same junctional site,
protrusions were generated repeatedly within regular intervals,
indicative for oscillations in F-actin intensity in the remodeling
junction.
The polarized occurrence and directionality of protrusions
along the direction of vessel growth suggests that they are
involved in endothelial cell movements. To address this, we
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Fig. 1 Polarized thickness in remodeling junctions. a Schematic model of cellular rearrangements during formation and maturation of dorsal longitudinal
anastomosing vessel (DLAV) in zebrafish. At first, the tip cells (Cell A and B) of two anastomosing endothelial sprouts contact and form a de novo junction.
Next, a vessel with unicellular architecture is formed, where junctions are not interconnected but are visible as separate rings. Then, through cellular
rearrangement and elongation, the junctions elongate along vessel axis until junctions are interconnected and vessel reaches the final multicellular
architecture. The edges of the junctional gaps in the unicellular vessels are marked with green and yellow triangles. b–e Still pictures of a time-lapse movie
(Supplementary Movie 1) showing EC junctions of Tg(BAC(cdh5:cdh5-ts)) embryo, which expresses VE-cad-Venus fusion protein, during transition from
unicellular to multicellular vessel during DLAV formation, in inversed contrast starting around 28 hpf. The edges of the junctional gaps in the unicellular
vessels are marked with green and yellow triangles. f Close-up image of VE-cad-Venus embryos. The diffuse thickening of medial domain of the junction is
marked with a yellow arrow. g–i Whole-mount immunofluorescence staining of the DLAV using anti-ZO1, anti-VE-cad (rat) of 28–30 hpf (Tg(kdrl:
EGFPs843)) embryos. h The yellow arrow points to the medial junctional domain and the green arrow to the lateral junctional domain. j Quantification of
junctional thickness measurements. n= 44 unicellular junctions and 48 multicellular junctions from 5 VE-cad-Venus Tg(BAC(cdh5:cdh5-ts)) embryos.
Non-parametric Kruskal–Wallis test was used. k Quantification of the junctional thickness measurements from immunostainings of Tg(kdrl:EGFPs843)
embryos. n= 58 unicellular junctions and 17 multicellular junctions from 8 embryos. Non-parametric Kruskal–Wallis test was used. Scale bars 10 µm
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analyzed the potential association between local junctional
movements and the occurrence of F-actin protrusions in the
dorsal aorta (Fig. 3c, d). Analysis of F-actin intensities showed
that higher intensities were associated with local forward
movement of junctions than with reverse movement (Fig. 3e).
Taken together, we observe an F-actin-based protrusive
endothelial behavior, which occurs during junctional remodeling
in vivo. Because of their similarity to ‘classical’ lamellipodia, their
oscillating behavior and structural connection with endothelial
cell junctions, we call these protrusions junction-based lamelli-
podia or JBL.
JBL form at the front end of elongating junctions. Blood vessel
anastomosis is driven by the convergence movement of two tip
cells and is associated with an elongation of their mutual cell
junction. The formation of JBL at the junctional poles suggested
that these dynamic structures may generate tractive forces, which
contribute to junction elongation. However, cell junctions
demarcate the interface between two cells and our above analyses
did not differentiate, whether cells form JBL at their respective
junctional front or rear ends or both. To analyze the contribu-
tions of individual cells to F-actin protrusions, we generated a
transgenic zebrafish line expressing a photoconvertible mCLAV-
UCHD fusion protein in endothelial cells. For mosaic analysis, we
photoconverted mCLAV-UCHD in single SeA sprouts 2–3 h
prior to contact initiation between tip cells from neighboring
segments and recorded the behavior of the junctional F-actin later
during anastomosis and formation of the DLAV (Fig. 4a). In vivo
photoconversion resulted in efficient green-to-red conversion
(Fig. 4b), allowing the analysis of differentially labeled F-actin
pools during DLAV formation (Fig. 4c). Photoconverted and
non-converted mCLAV-UCHD-labeled endothelial cell junctions
and showed matching patterns within the anastomotic junctional
ring—except for the poles of the anastomotic ring where F-actin
based protrusions were forming. Here, the colocalization of the
two markers was suspended and we found elevated levels of either
of the two F-actin pools at the front end of the junction with
respect to cell movement (green JBL over red cell, or vice versa,
24 out of 28 events, p < 0.001). This oriented localization is
consistent with an involvement of JBL in the forward movement
of tip cells during anastomotic convergence movements.
F-actin protrusions precede junctional movements. Since the
above observations suggest a step-wise mechanism of cell–cell
interaction during JBL function, we set out to explore the spatio-
temporal relationship between F-actin dynamics and the
dynamics of other junctional components. To this end we gen-
erated transgenic fish lines expressing red F-actin (mRuby2-
UCHD), which allows a direct comparison with other fluores-
cently labeled junctional components (e.g., EGFP-ZO1 and VE-
cad-Venus) (Fig. 5a, b and c, d, respectively; Supplementary
movies 5 and 6). Both VE-cad-Venus and EGFP-ZO1 followed
the junctional F-actin front (11 and 9 movies analyzed, respec-
tively); however, a different distribution pattern was observed
during JBL formation. VE-cadherin localized diffusely at the
front, largely overlapping with the F-actin protrusions (Fig. 5b,
60–120 s.). In contrast, EGFP-ZO1 showed a more defined loca-
lization and initially remained associated with the junction at the
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proximal end of the protrusion (Fig. 5d, 0–36 s.). However, at
later time points (Fig. 5d, 72 s.), we observed EGFP-ZO1 accu-
mulation also at the front edge of the JBL, indicating the for-
mation of a new junction at this site (Fig. 5d). To directly
differentiate the distribution of VE-cadherin and ZO1, we injec-
ted a mCherry-ZO1 encoding plasmid into VE-cad-Venus reci-
pients. The differential localization of both proteins confirmed
our previous observations and showed that ZO1 distribution is
largely restricted to cell junctions. In contrast, VE-cad was also
found within areas outside of these junctions (Fig. 5e, f, Supple-
mentary Movie 7).
Therefore, the respective distribution of ZO1 and VE-cad
represent different aspects of JBL formation and illustrates a
stepwise mechanism of JBL function. First, F-actin based JBL
emanate from EC junctions, which are maintained. The JBL
contains diffusely distributed VE-cad. This population of VE-cad
precedes formation of the new junction in front of the JBL and
may therefore provide adhesive properties for the JBL prior to
formation of the new junction. Interestingly, a gradual movement
of the old junction towards the new junction was observed in the
EGFP-ZO1 movies (Fig. 5d). This indicates that the proximal
junction is not resolved in situ, but is actually pulled forward and
eventually merges with the distal junction.
F-actin is required for JBL formation and junction elongation.
To elucidate the molecular mechanism underlying JBL function
during endothelial cell movements, we examined the requirement
of F-actin dynamics by pharmacological interference. Latrunculin
B and NSC23766 (a Rac1 inhibitor) are potent inhibitors of
F-actin polymerization and lamellipodial F-actin remodeling,
respectively22,23. We used acute treatments to avoid secondary
effects and performed live-imaging on rearranging endothelial
cell junctions. Inhibition of F-actin polymerization led to pro-
nounced defects in JBL formation. In 5 movies, we observed only
13 JBL, compared to 50 JBL in control embryos (Fig. 6a, b,
Supplementary Movies 8 and 9). Moreover, those JBL, which did
form in the presence of Latrunculin B, lasted longer, indicating
additional defects in lamellipodial dynamics. Inhibition of Rac1
did not interfere as strongly with JBL formation as inhibition of
F-actin polymerization. Here, we observed 49 JBL in 10 movies.
However, these JBL displayed prolonged duration indicating
defects in JBL dynamics (Fig. 6a, b, Supplementary Movie 10).
To test whether interfering with F-actin and JBL dynamics
has consequences for endothelial cell rearrangements, we
analyzed the effect of Latrunculin B and NSC23766 on junction
elongation. Both compounds inhibited the elongation of the
junction during DLAV formation (Fig. 6c, d) indicating that
proper function of JBL is necessary for junctional elongation
during anastomosis.
Although the gross morphology of JBL—based on VE-cad-
Venus—looked relatively normal upon Rac1 inhibition, we
wondered whether localization of other junctional proteins was
affected. During the late phase of JBL oscillation, ZO1 is often
localized in two lines outlining the distal (new) and proximal
(old) junctions (Fig. 5d). When we compared EGFP-ZO1
distribution in control and NSC23766 treated embryos, we found
that distal junctions were forming, showing that Rac1 inhibition
did not abrogate de novo junction formation (Fig. 6e). Further-
more, despite the appearance of double junctions, we still did not
observe any junction elongation in these instances.
As the above results suggested that Rac1 is primarily involved
in the regulation of JBL dynamics rather than their structural
properties, we analyzed the dynamics of junctional F-actin
intensity oscillations (Supplementary Fig. 3b-d). In control
embryos we observed a periodic pattern of JBL dynamics, but
in NSC23766-treated embryos the periodicity was reduced
(Supplementary Fig. 3e), indicating that junctional F-actin
oscillations become less coordinated upon Rac1 inhibition.
VE-cadherin/F-actin interaction is required for JBL function.
Next, we wanted to explore the role of VE-cad in JBL function,
because several lines of evidence suggested that VE-cad may play
mClav-UCHD (converted) mClav-UCHD (unconverted)
Unconverted
Converted
Unconverted sprouts Tip cell of the sprout
 photoconverted
Imaging of newly
generated junction
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b c
*
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Fig. 4 JBL formation at the distal tip of the junction during DLAV anastomosis. a Schematic representation of the mClav2-UCHD photoconversion
experiment. b Image of photoconverted and unconverted mClav2-UCHD cells in the DLAV of an Tg(fli:Gal4ffubs3;UAS:mClav2-UCHDubs27) embryo, at
32 hpf. c A close up of the inset in b. Arrows point to differentially labeled JBL and asterisk (*) marks the junction outside JBL. Scale bar 5 µm
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an important role in this process. In ve-cadherin zebrafish null
mutants (ve-cad/cdh5ubs8), blood vessel architecture is generally
disrupted and discontinuous lumens prohibit blood flow13,24.
These defects are caused by an inability of mutant ECs to perform
coordinated cell junction elongation, which is required for mul-
ticellular tube formation during angiogenesis. Furthermore, the
ve-cad mutant defects in junction elongation can be copied by the
inhibition of F-actin polymerization13.
Our finding that VE-cad accumulates in JBL prior to junction
formation is consistent with the above observations, and
collectively, they indicate a functional interaction between
VE-cad and F-acting during junction elongation. To address this
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possibility, we generated a targeted mutation in ve-cad
(cdh5ubs25), which results in a “tailless” protein, lacking a portion
of the cytoplasmic domain of VE-cad including the ß-catenin
binding site, essential for VE-cad/F-actin interaction (Supple-
mentary Fig. 4).
Despite the deletion, the VE-cadherin protein correctly
localizes in the endothelial cell–cell junctions (Fig. 7h, k and
Supplementary Fig. 4e). Homozygous ve-cadubs25 mutants are
embryonic lethal and display phenotypes similar to those of null
mutants, including tip cell/stalk cell dissociation and defective
blood circulation (Supplementary Fig. 5a-e)13. However, some of
the defects are less pronounced and we observed blood flow in the
DA and—in rare cases—in the DLAV (Supplementary Fig. 5a,
Supplementary Movie 11). This shows that the extracellular
domain of VE-cad mediates some inter-endothelial adhesion,
which leads to a hypomorphic phenotype.
To assess the requirement for VE-cadherin/F-actin interaction
for JBL formation, we first examined whether the junctional rings
of VE-cad truncation (cdh5ubs25) mutants displayed polarized
thickness during anastomosis. Immunofluorescent staining for
ZO1 revealed that medial junctions of mutants were narrower
compared to heterozygotes, while the thickness of the lateral sides
was not affected (Fig. 7a, b). We then tested whether the
dynamics of F-actin protrusions were affected in VE-cad
truncation (cdh5ubs25) mutants. Time-lapse analyses in embryos
expressing EGFP-UCHD indicated that F-actin protrusions
oscillated more slowly in cdh5ubs25 mutants compared to wild-
types in a manner similar to how protrusions behaved in the
presence of the Rac1 inhibitor (Fig. 7c). Furthermore, by
measuring the time-intervals between the end and the beginning
of a JBL cycle, we found that this “lag phase” is more than
doubled (Supplementary Fig. 4f) suggesting that full-length VE-
cad is required for the initiation of JBL formation.
To test whether these defects in JBL have consequences for
vascular morphogenesis, we examined the junctional architecture
of forming SeA. In cdh5ubs25 mutants, we observed increased
interjunctional gaps, which indicate a defect in multicellular tube
formation due to a failure in junction elongation (Fig. 7d–l). We
also compared relative nuclear movements, which are associated
with stalk cell elongation. Consistent with the observed defects in
junctional rearrangement, cdh5ubs25 mutants displayed signifi-
cantly slower rearrangement of EC cell nuclei compared to wild-
types (Fig. 7m, n). Taken together, these findings show that VE-
cadherin plays an important role in F-actin dynamics and that the
VE-cadherin/F-actin interaction is essential for JBL function,
junction elongation and endothelial cell rearrangements in vivo.
Discussion
In this study, we have investigated the mechanisms by which
junctional dynamics contribute to endothelial cell movements
during blood vessel formation in vivo.
By time-lapse imaging of different structural components of
endothelial cell junctions, we observe a dynamic and differential
deployment of these proteins during junctional remodeling,
which leads to the formation of transient lamellipodia-like
protrusions, that we call JBL. Together with our analyses of
F-actin dynamics and VE-cad function, our findings suggest a
mechanism of cellular and molecular interactions, which allows
endothelial cells to use each other as adhesive substrates and for
force transmission during cell migration and elongation (Fig. 8).
In essence, JBL act by a ratchet-like mechanism, which consists of
F-actin-based protrusions and VE-cad based interendothelial cell
adhesion. While F-actin protrusions provide the motive force,
VE-cad based adhesion serves as an intercellular clutch.
Our time-lapse experiments show that junction elongation is
associated with oscillating JBL, which occur at a frequency of
about one every 6 min. This oscillatory behavior, their polarized
localization at the leading edge of the junction, their role in cell
movements together with their dependency on F-actin poly-
merization as well as Rac1 GTPase activity indicates that these
protrusions share a functional basis with “classical” lamellipo-
dia25. However, and in contrast with “classical” lamellipodia, the
protrusions, which we are describing, emanate from inter-
endothelial cell junctions and require VE-cad for adhesion and
force transmission.
Here, we describe the role of JBL during angiogenesis in the
zebrafish, where they promote endothelial cell elongation and
rearrangements. It remains to be seen, whether JBL are unique to
endothelial cells or employed more widely during morphogenetic
processes of different cell types. Cadherin-based cell interactions
have been shown to be essential for dynamic cell movements in
several morphogenetic processes (reviewed by refs. 26,27). In some
aspects, the mechanism of JBL function appears to be similar to
the one described for border cell migration during Drosophila
oogenesis28. Here, actin-based cell protrusions and E-cadherin
interactions between border and nurse cells are thought to be
important to form an anchor point at the leading edge of border
cells.
Oscillatory junctional protrusions of endothelial cells have also
been described in cultured HUVECs29,30. Here, so-called junc-
tion-associated intermittent lamellipodia (JAIL) form in similar
intervals as JBL. However, several characteristic differences sug-
gest that JAIL and JBL represent different cellular activities. As
the name indicates, JAIL formation is preceded by the local dis-
solution of the existing junction, which is thought to trigger the
formation of an actin-based protrusion followed by the formation
and stabilization of a new junction. In contrast, JBL formation is
not associated with the dissolution of an existing junction. This
leads to the formation of a characteristic double junction (prox-
imal and distal) at the pole of the junctional ring (Fig. 8). Con-
ceptually, maintenance of cell junctions should be a prerequisite
for endothelial cell rearrangements in a perfused vessel in order to
maintain the vascular seal and to prevent hemorrhage. We
therefore predict that in the in vivo situation (i.e. developmental
angiogenesis), JBL may be more prevalent than JAIL.
The distinct temporal and spatial distribution of VE-cad,
F-actin and ZO1 during JBL oscillation suggested that these
proteins also partake in JBL function. In agreement with this
view, interference with VE-cadherin function, as well as F-actin
dynamics inhibited JBL dynamics and junction elongation.
Fig. 5 Distinct dynamics of VE-cadherin, F-actin and ZO1 during JBL formation. a, b Still images (Supplementary Movie 5) of an embryo showing the
DLAV around 32 hpf in an embryo expressing both mRuby2-UCHD and VE-cad-Venus Tg(fli:Gal4ffubs3;UAS:mRuby2-UCHDubs20;BAC(cdh5:cdh5-Venus)).
b A time series magnification of the inset in a. Individual channels are shown in inversed contrast. Similar observations were made in 11 movies. Open arrow
head points to established junctions and black arrowhead to pioneering junction. c and d) Still images of an embryo showing DLAV around 32 hpf
(Supplementary Movie 5) in an embryo expressing EGFP-ZO1 and mRuby2-UCHD (Tg(fli:Gal4ffubs3;UAS:mRuby2-UCHDubs20;UAS:EGFP-hZO1ubs5)). Imaged
at rate of 12 s/stack. Similar observations were made in 9 movies. Open arrow head points to established junctions and black arrowhead to pioneering
junction. e Images of endothelial cells in a VE-cad-Venus expressing embryo injected with mCherry-ZO1 encoding plasmid Tg(BAC(cdh5:cdh5-ts)); fli1ep:
mCherry-ZO1)) (n= 7 embryos). f Close-up from panel e. Both channels are shown in inverted contrast. Scale bars 1 µm (b–d) and 10 µm (a, e)
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Previous studies have emphasized the importance for VE-
cadherin in dynamic endothelial cell interactions including cell
rearrangements11,12 and cell elongation13. We generated a ve-cad
mutation, which disrupts VE-cad/F-actin interaction. The phe-
notype observed in these mutants is slightly milder than in the
null mutant suggesting that the mutant protein still allows
interendothelial adhesion. Nevertheless, the increase of dis-
continuous junctions in SeAs illustrates an inability of mutant
endothelial cells to generate multicellular tubes, which in turn
suggests defects in cell rearrangements. Consistent with this view,
ve-cadubs25 show reduced spatial distribution of cell nuclei in the
SeA. Furthermore, analysis of JBL showed that polarity and
oscillatory behavior are disturbed in ve-cadubs25 mutants. Taken
together, these results show that VE-cadherin actively contributes
to morphogenetic cell movements via its interaction with the
F-actin cytoskeleton.
The connection between VE-cad and F-actin in JBL function is
also supported by F-actin interference experiments. Blocking
F-actin polymerization by latrunculin-B effectively inhibits JBL
formation and those JBL, which do form, show decreased oscil-
lation. Furthermore, junctional rings do not elongate during this
treatment. Inhibition of Rac1 by NSC23766 treatment did not
lead to obvious defects in JBL formation, but in a reduction in
their oscillation frequency as well as a defect in junction elon-
gation. During NSC23766 treatment JBL looked relatively nor-
mal. When using a EGFP-ZO1 reporter, we also observed “double
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junctions”, indicating that JBL are able to form a distal junction
and that Rac1 may be required during later stages of JBL function.
A recent study has shown that JAIL formation requires
polarized Rac1 at endothelial cell junctions in HUVECs30. It is
therefore surprising that Rac1 inhibition does not block forma-
tion of JBL in zebrafish embryos. It is possible that even at high
doses, we do not achieve full Rac1 inhibition in vivo.
Alternatively, Rac1 may have a different function in JBL than in
JAIL and formation of either protrusion may require different
regulators.
Taken together, we have uncovered a hitherto non-described
junction-based mechanism of active cell movements, which can
be used by endothelial cell (and possibly other cell types) to
rearrange and adapt their shape as needed. Inhibition of JBL
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function blocks these processes and results in a failure to form
multi-cellular tubes and prevents formation of a patent vascu-
lature. The salient feature of our proposed JBL model is that
endothelial cells use each other as migratory substrates via VE-
cadherin. Our model suggests that VE-cadherin provides an
extracellular clutch, by generating an intercellular adhesion patch,
which serves as an anchor for intracellular actomyosin contrac-
tions. This cell–cell interaction may be analogous to integrin-
ECM-based adhesion patches of classical lamellipodia. Further-
more, these VE-cadherin adhesion complexes give rise to a distal
junction with an underlying F-actin arc. Similar F-actin arcs have
been described to be essential for the function of lamellipodia
during migration of human endothelial cells (HUVECs)
in vitro31. Future studies will aim to uncover the exact mechan-
isms of traction force generation and transmission during JBL-
driven junction elongation. While F-actin dynamics are essential
for junction elongation, we have never observed prominent stress
fibers in this process, suggesting that F-actin-based traction forces
are acting locally rather than over the longitudinal extent of the
endothelial cells.
Although we have focused our studies on JBL formation and
function in the process of blood vessel anastomosis, we observed
JBL also within larger caliber vessels such as the dorsal aorta at
stages, when endothelial cells are extensively rearranging and
undergoing cell shape changes21. Our studies therefore indicate
that endothelial cells employ JBL as a general means for rear-
rangements and shape changes during blood vessel assembly and
vascular remodeling. Using interendothelial adhesion for force
transmission allows dynamic endothelial activities while main-
taining the vascular seal. We therefore envision that JBL may
underlie many morphogenetic endothelial cell behaviors during
blood vessel expansion, normalization, regression and endothelial
shear stress response. Remodeling and reorganization of adherens
junctions is essential for developmental morphogenesis32,33.
Whether similar JBL occur also in different tissues, besides vas-
culature and endothelial cells, remains to be elucidated.
Methods
Fish strains and maintenance. Maintenance of fish and experimental procedures
involving zebrafish embryos were carried out at the Biozentrum/Universität Basel
according to Swiss national guidelines of animal experimentation (TSchV). Zeb-
rafish lines were generated and maintained under licenses 1014H and 1014G1
issued by the Veterinäramt-Basel-Stadt. Fish strains carrying following transgenes
and mutations were used in this study: kdrl:EGFPs843 34, VE-cad-Venus (BAC(cdh5:
cdh5-TS), fli:GFFubs3 19, UAS:EGFP-hZO1ubs5 19, UAS:EGFP-UCHDPubs18 13, UAS:
mRuby2-UCHDubs20 (this study), UAS:mCLAV2-UCHDubs27 (this study), UAS:
mRFP35, cdh5ubs25 (this study), and Tg(kdrl:EGFPnls)ubs1 36. The fish were main-
tained using standard procedures and embryos obtained via natural spawning37.
Generation of transgenic fish lines. The EGFP sequence of pT24xnrUAS:EGFP-
UCHD was replaced by the sequence of mRuby2 (amplified from pcDNA3-
mRuby2 was a gift from Michael Lin; Addgene plasmid #40260)38 or by the
sequence of mClav2 (amplified from pmClavGR2-NT; Allele Biotechnology) to
generate the final plasmids pT24xnrUAS:mRuby2-UCHD and pT24xnrUAS:
mClav2-UCHD respectively. These final plasmids were injected individually,
together with tol2 RNA into Tg(fli1:Gal4ff)ubs3 embryos and that were raised to
adulthood and eventually stable transgenic fish lines Tg(UAS:mRuby2-UCHD)ubs20
and Tg(UAS:mClav2-UCHD)ubs27 were isolated and maintained.
Fig. 7 Truncation of Ve-cadherin inhibits both JBL and endothelial cell remodeling. a Images of anti-ZO1 immunostained junctions in cdh5ubs25/+ and
cdh5ubs25/ubs25 embryos. Arrows point to medial site of the junction. b Quantitation of the medial and lateral junctional thickness, based on immunostaining
for ZO1; cdh5ubs25/+, n= 44 junctions (17 embryos); cdh5ubs25/ubs25, n= 40 (11 embryos); wild-type n= 28 (9 embryos). Black lines are medians. Non-
parametric Kruskal–Wallis statistical test was used. c Quantitation of the duration of JBL based on EGFP-UCHD signal; cdh5ubs25/+, n= 122 (8 embryos),
cdh5ubs25/ubs25 n= 103 (8 embryos) and wild-type n= 43 (3 embryos). All embryos carry the UAS:EGFP-UCHD transgene Tg(fli:GFFubs3;UAS:EGFP-
UCHDubs18). d–l Tg(kdrl:EGFPs843);cdh5ubs25/+ (d–g) and Tg(kdrl:EGFPs843);cdh5ubs25/ubs25 (h–k) embryos stained for VE-cadherin (rabbit antibody, green)
and ZO1 (red). Individual channels are shown in inversed contrast. Both wild-type and mutant VE-cad show junctional localization (solid arrow in panels
d, f, h, and j). The junctional gap in the VE-cadherin staining of a SeA in a mutant embryo (cdh5ubs25/ubs25) is marked with dashed double arrow in panel h. l
Quantification of the length of junctional gaps in control (cdh5 ubs25/+, n= 72 gaps, 23 embryos) and mutant (cdh5ubs25/ubs25, n= 139 gaps, 33 embryos)
embryos. Black lines are medians. Non-parametric Mann–Whitney statistical test was used. m Still images from a confocal time-lapse of endothelial nuclei
(Tg; kdrl:nlsEGFPubs1) in wild-type or cdh5ubs25/ubs25 embryos during SeA formation. T tip cell, S1 stalk cell 1, S2 stalk cell 2; double-headed arrow indicates
the distance of S1 and S2 nuclei. n Quantification of movement of stalk cell 1 (S1) nuclei in relation to stalk cell 2 (S2) nuclei during cell rearrangements in
SeA; cdh5ubs25/+, n= 22 SeA (4 embryos); cdh5ubs25/ubs25, n= 17 SeA (4 embryos); wild-type n= 20 SeA (4 embryos). Black lines are medians. Non-
parametric Kruskal–Wallis statistical test was used. Scale bars 5 µm (a), 10 µm (d, h, m)
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Fig. 8 A Ratchet-like molecular mechanism of junction remodeling.
a Stepwise elongation of an endothelial cell junction during anastomosis. As
two endothelial cells move over each other (bottom), the junction becomes
elongated. The three proteins investigated in this study are indicated in
different colors. b Proposed oscillatory mechanism of JBL function. A single
cycle is depicted. F-actin protrusions emanate distally from a stable
junction. These protrusions also contain diffuse VE-cadherin, but not ZO1.
At the distal end of the protrusion, F-actin, ZO1 and VE-cadherin are
components of a newly formed junction with VE-cadherin-mediated
contact to the underlying cell. Eventually, dynamic F-actin remodeling pulls
the proximal junction towards the new junction
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Transient expression of mCherry-ZO1 in zebrafish embryos. To transiently
express mCherry-ZO1 in endothelial cells of zebrafish embryo, ~50 pg of plasmid
fli1ep:mCherry-ZO139 was injected together with Tol2-transposase mRNA into
1–4 cell stage embryos (Tg(BAC(cdh5:cdh5-ts))). Twenty-four hours after injection
healthy embryos expressing mCherry were selected, mounted in low-melting point
agarose and imaged using Leica SP5 confocal microscope.
Generation of ve-cadherin mutants. The ve-cadherin truncation allele (cdh5ubs25)
was generated using CRISPR/CAS technology40. We sequenced exon 12 of cdh5
(encoding the cytoplasmic domain) of ABC, Tubingen (TU) and tupfel;long-fin
(TL) strains and found a potential target sequence in ABC (5′-GGGACCTGCA
CTCTATGCCATGG-3′). Target guide RNA and Cas9 protein were synthetized by
standard procedures40 and co-injected into ABC/TU embryos. Offspring of G0 fish
containing germline mutations were screened by PCR analysis for the loss of a NcoI
restriction site, which is present on the wild-type allele. For subsequent genotyping,
multiplex PCR was performed using allele-specific primers:
VE-cad-fwd: 5′-GAAACCCATATCAAACAGACCTGC-3′,
VE-cad-rev: 5′-CAGAGCCGTCTACTCCATAAAGC-3′,
VE-cad-ubs25-fwd: 5′-GACCTGCACTCTATGGAA-3′,
VE-cad-wild-type-rev: 5′-GCAGGAGGTTTCTTTACC-3′.
The genotyping protocol of cdh5ubs8 has been described earlier13. Following
primers were used:
cdh5-FWD: 5′-TTGGTGTAACTGACAATGGGG-3′
cdh5-REV: 5′-ACAGTCTTGGTGTTACCATTGGG-3′
cdh5-WT-FWD: 5′-ATCCCCGTTTTCGATTCTGAC-3′
cdh5-ubs8-REV: 5′-CTGATGGATCCAGATTGGAATC-3′
Live imaging of zebrafish embryos. Embryos were anesthesized using Tricaine
(MS-222, 160 mg l−1, #E10521 Sigma-Aldrich) and embedded in 0.7% low-melting
point agarose (Sigma-Aldrich) supplemented with Tricaine in glass-bottom dish.
After the agarose solidified, it was overlaid with E3-medium supplemented with
Tricaine. All the imaging was performed at 28.5 °C. The imaging was performed
using Leica SP5 Matrix confocal microscope equipped with resonance scanner
using ×63 NA 1.2 or ×40 NA 1.1 water immersion objectives. For imaging of
JBL, the time points were 60–120 s intervals and in case of double-color imaging,
12–60 s.
For the pharmacological experiments, the treatment of embryos with inhibitors
(DMSO 1%, Latrunculin B (150 ng ml−1), NSC23766 (300–900 μM)) begun 1 h
prior to embedding into low-melting point-agarose and confocal imaging. The
inhibitors were present throughout the whole experiment.
Generation of polyclonal rat anti-zf-VE-CAD antibodies. A cDNA fragment
encoding a polypeptide comprising the extracellular domain of zebrafish VE-cad
(Ala22 to Lys464) was expressed in E. coli using the T7 expression system. The
protein was purified on Ni-charged IMAC resin (BioRad) under denaturing con-
ditions. Antiserum was raised in rats by ThermoFisher Scientific using standard
immunization procedures.
Immunofluorescence analysis. Embryos were fixed with 2% paraformaldehyde
(Electron Microscopy Sciences) in PBST (PBS+ 0.1% Tween-20) at room tem-
perature for 90 min, and immunostained using following protocol: Fixation with
2% PFA/PBST (PBS+ 0.1% Tween-20) for 90 min at room temperature followed
by washes with PBST. After permeabilization (PBST+ 0.5% Triton X-100, 30 min),
the samples were blocked (PBST+ 0.1% Triton X100+ 10% normal goat serum+
1%BSA+ 0.01% Sodium Azide, overnight, 4 °C). Subsequently, primary antibodies
were added (diluted in Pierce Immunostain enhancer, #46644, Thermofisher Sci-
entific) and incubated overnight at 4 °C. After several washes with PBST at room
temperature, the secondary antibodies were added (1:2000 dilution in Pierce
staining Enhancer) and incubated overnight at 4 °C. After several washes with
PBST at room temperature, the embryos were mounted onto glass-bottom dishes
using low-melting point agarose.
Mouse anti-hZO1 (dilution 1:400, Invitrogen #33–9100; use in zebrafish in
ref. 36, rat anti-VE-cad (dilution 1:500) and rabbit anti-VE-cad (dilution 1:500)
primary antibodies were used. Rat anti-VE-cad was validated by
immunofluorescence by using ve-cad null mutant (cdh5ubs8, Tg(kdlr:EGFPs843))
embryos13 as control for specificity (Supplementary Fig. 2). Rabbit anti-VE-cad has
been described and validated previously36 and also validated with ve-cad null
mutants13. Fluorescent secondary antibodies Alexa-568 goat anti-mouse IgG,
Alexa-633 goat anti-rat IgG, and Alexa-633 goat anti-rabbit IgG (all from
Invitrogen) were used.
Photoconversion experiment. Twenty-four hours post fertilization zebrafish
embryos (Tg(Fli:GFFubs3;UAS:mClav2-UCHDubs27) were embedded in 0.7% low-
melting point agarose onto 35 mm glass bottom dishes. Tip cells of vascular sprouts
of segmental arteries were photoconverted on a Leica SP5 confocal microscope
using a ×40 NA 1.1 water immersion objective. Photoconversion was performed
with a 405 nm laser (20% power) until no further increase in converted UCHD-
mClav2 signal was observed (conversion time 10–30 s). After this the embryos were
allowed to develop for ~4 h before imaging of anastomosis events in DLAV.
Junction elongation experiment. Junctional elongation was analyzed by observing
anastomosis and elongation of isolated junctional rings during DLAV formation.
Inhibitor treatments Latrunculin B (150 ng ml−1), NSC23766 (300–900 μM) or
DMSO (1%) were applied 1 h before mounting of embryos into 0.7% low-melting
point agarose and imaging the junctions for 1–2 h on a Leica SP5 (×40 NA 1.1
water immersion objective).
Cell rearrangement experiment. Embryos carrying nuclear GFP (Tg(kdrl:
EGFPnlsubs1)) were used. Confocal Z-stacks were obtained as described above in
12–14 min intervals. To control small variations in the developmental phases of the
individual SeA, t= 0 min was the time point when tip cell had reached the dorsal
side and started to sprout in anteroposterior directions. The endpoint for analysis
was 10 time points later (t= 10; 120–140 min). At t= 0 and t= 10 the distance (d)
of stalk cell S1 and S2 was measured using FIJI. Speed of movement of S1 and S2 in
relative to each other was calculated using equation:
speed ¼ dt0  dt10j j
Δt
ð1Þ
Image analysis and preparation. Image analysis and measurements were per-
formed using FIJI. Deconvolution was performed using Huygens Remote Manager
software41. Maximum Z-projections were used. Noise was reduced using Gaussian
filtering (radius 1.0) and background subtracted (rolling ball radius 50) using FIJI.
Contrast and brightness of images were linearly adjusted. Kymographs were gen-
erated from the sum Z-projections of time-lapse series using FIJI. Perpendicular
straight line across the junction was drawn and kymograph generated using reslice
tool. Colocalization analysis was performed using FIJI. First, background was
subtracted (rolling ball radius 25), regions of interests (ROIs) of separate cell–cell
junctions were selected and then colocalization analysis was done on these ROIs
using Colocalization Test plugin with Fay image randomization ((written by Tony
Collins, McMaster University, Hamilton, Canada). Publication figures were pre-
pared using FIJI, OMERO Fig. and Adobe Illustrator.
Statistical analyses. Statistical analyses were performed using Microsoft Excel,
IBM SPSS statistics 22 and GraphPad Prism version 6.05 for Windows software.
Non-parametric two-sided Kruskal–Wallis H-test, Mann–Whitney U-test and
binomial probability (photoconversion experiments, test probability 0.5) were used.
The data reasonably met the assumptions of the tests. In Fig. 1e, f, where the data
was non-normal and heteroscedastic similar p-values were obtained with
Kruskal–Wallis H-test, Welch’s t-test and median test.
No statistical power analysis was used to determine samples size. Systematic
randomization was not used. Experiments with cdh5ubs25 (Fig. 7) were performed
essentially blinded as the genotype was determined after data capture and analysis.
In all other experiments blinding was not used. Samples of low technical quality
were excluded from the subsequent analyses. In all figures (exception Fig. 2f
and Supplementary Fig. 3d) the individual data points are plotted and median
indicated with horizontal line as has been recommended42. In Fig. 2f,
Supplementary Fig. 1a and c, the data are binned and the number of events in
the given bin is plotted.
To formally analyze periodicity of F-actin intensity fluctuations, we calculated
the autocorrelation function (ACF) using IBM SPSS statistics 22 software. Next, we
analyzed the level of noise in the fluctuations (phase diffusion) that gradually
reduces the oscillation of the ACF. To quantify this effect, we fitted each of the
ACFs using a sinusoidal function enveloped by an exponential decay using Igor Pro
6.37 (WaveMetrics Inc, Lake Oswego, OR, USA). The function used was:
ACF tð Þ ¼ A ´ sin f ´ t þ θð Þ ´ e tτð Þ ð2Þ
where t is the lagtime of the ACF, A is amplitude, f the frequency, θ is the phase,
and τ is the characteristic lifetime of the decay.
Data availability
The data that support the findings of this study are available from the corresponding
authors upon reasonable request.
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Supplementary Figure 1. Description of the transition of dorsal longitudinal anastomosing 
vessel (DLAV) from unicellular to multicellular architecture. 
a) Quantification of the fraction of multicellular DLAV segments using Tg(BAC(cdh5:cdh5-
ts)) embryos during development. n=26 DLAV segments (8 embryos). b) Quantification of 
the duration from anastomosis until final conversion into a multicellular tube. Black line is 
median. n=14 segments (8 embryos). c) Quantification of DLAV segments carrying blood 
flow during development. n=26 segments (8 embryos). hpf, hours post-fertilization. 
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Supplementary Figure 2. Validation of the rat Ve-cadherin antibody in zebrafish embryo 
whole-mount immunofluorescence analysis.  
a-h) Confocal images of a Tg(kdrl:EGFP
s843
) wild-type sibling (a-d) or a VE-cad null mutant 
embryo (Tg(kdrl:EGFP
s843
);cdh5
ubs8/ubs8
) (e-h), stained for VE-cadherin (rat anti-Cdh5) and 
ZO1. a and e shows the merged channels, b-d and e-h the individual channels. Arrow points 
to an endothelial cell-cell junction. Scale bar 20 µm. 
  
4 
 
 
 
Supplementary Figure 3. Analysis of F-actin oscillations of the remodeling junctions. 
a) Kymograph across the junction in dorsal aorta in EGFP-UCHD fish (data generated as in 
Fig. 3). Solid arrow denotes forward movement. b) Intensity plotting of EGFP-UCHD 
kymographs. c) Averaged autocorrelation functions of EGFP-UCHD intensity. DMSO, n=14 
kymographs; Latrunculin B, n=16 kymographs; NSC23766, n=16 kymographs. d) 
Comparison of autocorrelation lifetime (tau parameter). Means and standard deviations are 
plotted. ANOVA and Dunnet´s post-hoc test was used. 
  
5 
 
Supplementary Figure 4. Generation and validation of VE-cad truncation mutant allele.  
a) Sequencing chromatogram of wild-type ve-cadherin (encoded by cdh5 gene) sequence 
(exon 12) and respective truncation mutant cdh5
ubs25 
sequence. b) The wild-type and mutant 
DNA sequences and their respective translations. The cdh5
ubs25
 mutation leads to a premature 
stop. c) Schematic illustration of the domains in both full-length wild-type VE-cad and in 
truncated VE-cad (Cdh5
ubs25
). d) Example of genotyping PCR and different cdh5
ubs25
 allelic 
combinations. e) Plot showing colocalization of ZO1 and truncated Cdh5 at endothelial cell 
junctions. Pearson correlation coefficients of colocalization analysis of anti-VEC and anti-
ZO1 in heterozygote (cdh5
ubs25+/- 
) and homozygote (cdh5
ubs25/ubs25
) VE-cad mutants. 
cdh5
ubs25/+ 
, n=30 cell-cell junctions (2 embryos) ; cdh5
ubs25/ubs25 
, n=20 cell-cell junctions (1 
embryo).n.s., non-significant (p=0.75, non-parametric Mann-Whitney test).  f) Quantitation of 
the interval of subsequently occuring JBLs based on EGFP-UCHD signal. Time from end of 
the first JBL to emergence of new JBL in the same spot was measured ; wild-type n=15 (2 
embryos) and cdh5
ubs25/ubs25 
n=36 (4 embryos). All embryos carried EGFP-UCHD transgene 
Tg(fli:GFF ; UAS:EGFP-UCHD). Non-parametric Mann-Whitney statistical test was used. 
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Supplementary Figure 5. Phenotypic analysis of the ve-cad truncation mutant zebrafish. 
a) Table of blood flow phenotype of 56hpf VE-cadherin null mutant (cdh5
ubs8/ubs8
) and the 
truncation mutant (cdh5
ubs8/ubs8
) embryos. b) Stereomicroscope images of the embryos. 
Arrows point to pericardiac area, pronounced oedema is observed in mutant embryos. Scale 
bar, 400µm. c) Fluorescence images of Tg(kdrl:EGFP
s843
) embryos at 48hpf. Arrow points of 
enlarged cardinal vein in cdh5
ubs25
 homozygote embryo. Scale bar, 200 µm. d) Confocal 
images illustrating the tip cell /stalk cell disconnection (arrow) in the cdh5
ubs25
 homozygote 
embryo. In normal SeA the connection between tip cell and stalk cell is intact. Scale bar, 20 
µm. e) Quantification of tip cell stalk cell disconnection; cdh5
ubs25/+
, n=7 SeA; cdh5
ubs25/ubs25
, 
n=36 SeA; wild-type n=22 SeA.  
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